data_1c01_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c01 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.865 0.364 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.09 52.19 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.324 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -110.8 151.99 27.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.0 m -140.13 148.65 41.98 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 m -154.69 155.04 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.347 1.029 . . . . 0.0 112.854 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.5 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 9.1 m-90 -125.83 154.35 42.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.6 m -78.48 -13.35 59.87 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.49 145.62 4.3 Favored Glycine 0 N--CA 1.504 3.231 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.687 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -76.04 -53.78 0.15 OUTLIER 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 118.171 0.985 . . . . 0.0 110.091 8.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.22 -127.6 4.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 105.25 -3.14 . . . . 0.0 105.25 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.438 ' H ' ' HB3' ' A' ' 64' ' ' CYS . 21.8 p -96.87 57.53 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -138.81 53.33 1.77 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.674 -0.811 . . . . 0.0 112.425 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -173.53 -122.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.66 145.87 3.42 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 123.428 0.691 . . . . 0.0 112.576 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.88 114.89 22.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -149.64 132.57 16.13 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -119.2 163.63 16.79 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.7 95.74 2.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.305 -1.77 . . . . 0.0 106.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.0 t -112.86 -22.33 10.71 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -51.33 147.13 6.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 123.859 0.724 . . . . 0.0 112.728 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.3 t -60.51 160.3 9.14 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.19 -148.01 32.37 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 27.8 p -128.9 172.26 11.5 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.1 p -151.55 136.93 17.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.438 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.93 112.56 17.34 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.979 0.799 . . . . 0.0 111.788 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.02 146.48 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.989 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -125.18 -14.51 6.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.382 1.051 . . . . 0.0 108.456 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -70.69 100.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -86.99 56.64 4.1 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.551 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.1 -97.16 0.63 Allowed Glycine 0 N--CA 1.501 3.017 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.231 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.1 162.35 14.01 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -144.56 108.72 4.78 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.367 1.079 . . . . 0.0 111.788 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -108.7 162.31 14.29 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.18 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -148.67 157.77 43.68 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.53 -1.213 . . . . 0.0 108.469 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 t -146.68 103.1 3.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 124.668 1.23 . . . . 0.0 108.947 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -79.05 151.81 31.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.282 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -174.82 73.39 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.86 -37.19 2.32 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.021 -1.899 . . . . 0.0 111.402 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -89.9 125.49 35.37 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.507 0.67 . . . . 0.0 112.188 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 m -85.58 164.15 17.93 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.284 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.4 148.42 27.45 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.374 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.5 148.53 34.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 124.479 1.112 . . . . 0.0 109.684 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.482 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -87.13 159.69 18.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.206 1.003 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -137.91 113.84 9.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 111.58 -2.555 . . . . 0.0 108.331 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.485 ' H ' ' CD2' ' A' ' 54' ' ' HIS . 16.7 t30 -55.47 -14.62 2.09 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.349 1.031 . . . . 0.0 113.11 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.4 ' CD ' ' N ' ' A' ' 46' ' ' GLN . 2.9 pm0 -119.51 132.13 55.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.134 0.896 . . . . 0.0 109.983 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.94 150.58 0.26 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 114.038 -1.437 . . . . 0.0 113.592 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.9 34.03 37.05 Favored Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.421 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.557 ' H ' ' HG ' ' A' ' 71' ' ' SER . 22.4 p 39.03 44.66 0.92 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.783 0.931 . . . . 0.0 112.454 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -86.07 37.7 0.73 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.337 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.86 -145.64 4.36 Favored Glycine 0 N--CA 1.495 2.576 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.321 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -103.88 157.18 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.65 175.73 6.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.808 0.693 . . . . 0.0 111.434 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.485 ' CD2' ' H ' ' A' ' 45' ' ' ASN . 69.4 m-70 -142.83 -59.0 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 123.974 0.796 . . . . 0.0 111.717 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.9 m -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.885 0.74 . . . . 0.0 111.312 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.8 ttt85 -95.35 163.63 13.17 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.684 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -140.72 149.72 42.54 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.38 -5.19 3.01 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 124.638 1.211 . . . . 0.0 110.159 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.4 m -149.86 150.81 32.49 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.7 p -45.66 119.27 2.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.889 0.743 . . . . 0.0 111.172 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.49 92.01 3.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.12 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -82.96 68.31 9.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.158 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.02 159.13 21.26 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.869 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.438 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 58.5 m -138.96 27.12 2.42 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.064 0.935 . . . . 0.0 109.449 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -82.7 164.96 44.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.644 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.05 167.44 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.356 2.037 . . . . 0.0 110.649 170.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.27 177.1 2.93 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.823 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.0 -6.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.482 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 4.0 m-90 -142.5 -160.54 1.11 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -128.74 -45.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 123.28 0.362 . . . . 0.0 111.341 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.557 ' HG ' ' H ' ' A' ' 49' ' ' CYS . 26.2 p -124.77 166.01 16.98 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 124.337 1.023 . . . . 0.0 112.745 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.52 126.22 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -106.01 143.04 34.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.1 mt -143.49 117.19 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.81 162.27 28.82 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.022 0.826 . . . . 0.0 110.829 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.156 -1.878 . . . . 0.0 110.702 179.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.21 147.21 14.38 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 36.2 t80 -97.91 108.44 21.15 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.084 -1.417 . . . . 0.0 109.537 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 m -93.49 131.47 38.68 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 m -136.49 148.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 123.668 0.605 . . . . 0.0 111.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.402 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 21.2 m-90 -115.76 160.75 19.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.7 p -69.55 -9.97 56.2 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.61 153.41 18.2 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 123.752 0.657 . . . . 0.0 111.584 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.41 -64.25 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.685 0 O-C-N 123.118 1.062 . . . . 0.0 111.656 17.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.86 -150.87 15.62 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -93.07 41.97 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.824 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -124.41 -128.32 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 38.3 -142.05 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -70.75 140.78 51.44 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -106.86 148.22 28.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.083 0.865 . . . . 0.0 111.194 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.29 167.21 30.7 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -140.17 158.84 43.41 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.463 0.649 . . . . 0.0 112.317 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -142.36 84.84 1.88 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.869 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -112.98 17.22 19.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.739 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -63.07 127.32 30.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.758 0.789 . . . . 0.0 111.364 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -73.34 119.69 17.93 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.545 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.58 -98.58 0.88 Allowed Glycine 0 N--CA 1.493 2.439 0 O-C-N 124.535 1.147 . . . . 0.0 111.182 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.473 ' SG ' ' CD2' ' A' ' 73' ' ' PHE . 60.1 m -142.24 147.03 35.82 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.157 0.563 . . . . 0.0 112.132 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.6 p -160.42 126.83 4.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.72 126.88 31.51 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 136.65 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 123.757 0.66 . . . . 0.0 109.687 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -100.97 -46.57 5.06 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.477 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.53 ' N ' HE21 ' A' ' 28' ' ' GLN . 0.0 OUTLIER -51.43 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.704 1.252 . . . . 0.0 111.944 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -90.47 68.96 6.83 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.243 1.021 . . . . 0.0 108.596 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.84 -106.73 0.26 Allowed Glycine 0 N--CA 1.493 2.499 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.463 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.46 160.03 27.64 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CE1' ' CE2' ' A' ' 67' ' ' PHE . 49.2 m-85 -147.61 159.05 44.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.585 0.815 . . . . 0.0 108.879 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -169.8 159.42 7.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 59.7 t80 -135.54 159.87 40.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 t -147.14 91.36 1.98 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.469 1.106 . . . . 0.0 108.269 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -70.33 150.3 46.47 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.075 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.5 p -140.08 -35.26 0.52 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.99 -12.09 0.02 OUTLIER Glycine 0 N--CA 1.479 1.558 0 CA-C-N 112.322 -2.217 . . . . 0.0 108.24 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -112.77 126.81 55.83 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.2 m -81.21 168.43 18.51 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.035 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.91 113.54 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.477 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.55 165.33 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 57' ' ' PHE . 40.0 mt -129.56 102.36 6.34 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.391 0.615 . . . . 0.0 109.639 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.463 ' CG ' ' HA ' ' A' ' 49' ' ' CYS . 59.7 m-85 -84.01 133.42 34.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.718 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -74.23 -8.64 56.9 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -120.64 138.35 53.97 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.27 145.61 1.63 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.94 54.4 11.94 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.974 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 44' ' ' TYR . 25.7 p 44.31 22.29 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 t -90.55 45.51 1.27 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.542 0.687 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.81 -130.81 2.04 Favored Glycine 0 N--CA 1.495 2.605 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.387 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.31 144.21 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 124.595 0.821 . . . . 0.0 109.44 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.69 103.69 5.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.517 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.32 -40.2 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.779 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.5 m -144.03 164.75 29.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.152 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -147.1 -172.38 3.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.718 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 43' ' ' LEU . 53.7 m-85 -143.81 104.24 4.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.023 0.827 . . . . 0.0 112.858 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.65 -12.23 55.96 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 t -153.8 141.93 20.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 91.2 p -41.16 132.85 2.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.66 121.83 7.76 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 123.994 0.809 . . . . 0.0 111.968 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -83.37 91.85 7.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 60.99 4.6 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 m -57.03 -18.27 13.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -77.2 160.18 76.35 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.82 139.91 68.26 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.091 1.861 . . . . 0.0 109.163 169.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.04 -146.17 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.39 21.2 0.28 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.038 -1.077 . . . . 0.0 114.996 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 5.3 m-90 -108.15 146.36 32.83 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -84.41 -46.69 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.0 p -131.65 174.7 9.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 124.496 1.123 . . . . 0.0 113.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.1 tt -136.52 137.37 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 112.699 -2.046 . . . . 0.0 109.967 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.473 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 4.7 t80 -107.98 129.91 55.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.2 mt -119.3 129.63 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -61.61 80.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.789 1.93 . . . . 0.0 114.109 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.319 179.858 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.59 104.69 2.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.945 0.778 . . . . 0.0 110.348 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 45.9 t80 -96.87 89.29 4.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -75.42 152.52 37.98 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 m -148.84 158.13 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.693 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.44 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.6 m-90 -134.59 145.44 48.66 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.417 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 84.1 p -61.54 -38.98 89.42 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.35 149.71 6.15 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.723 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -78.51 -56.13 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.808 0 N-CA-C 109.34 -1.061 . . . . 0.0 109.34 9.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.77 -132.54 6.18 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 64' ' ' CYS . 25.0 p -89.65 48.23 1.57 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -140.01 80.18 1.75 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.324 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.44 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 5.8 p30 171.71 -146.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.528 HH12 HE21 ' A' ' 28' ' ' GLN . 5.6 ptm180 -64.91 171.28 3.6 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.0 23.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -161.18 134.14 6.31 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -108.23 131.62 54.49 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -110.15 78.7 1.14 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.08 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -116.16 -8.2 11.78 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.98 139.7 58.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.052 0.845 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.16 104.71 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.002 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.09 -177.12 19.58 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.126 0.892 . . . . 0.0 113.117 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 m -77.2 143.31 39.12 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.749 -1.225 . . . . 0.0 109.923 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.4 p -148.11 126.69 12.47 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.012 0.82 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.32 119.47 22.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.354 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.63 115.41 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.134 -1.393 . . . . 0.0 109.451 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -95.2 -29.29 14.61 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.528 HE21 HH12 ' A' ' 14' ' ' ARG . 22.7 mp0 -77.91 95.61 4.81 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.862 0.726 . . . . 0.0 109.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -80.56 40.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.53 -103.3 2.75 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.06 18.55 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.6 m-85 -150.84 120.54 7.01 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -114.98 106.76 14.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.196 0.31 . . . . 0.0 110.817 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -80.95 157.68 25.47 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -148.15 109.12 4.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.353 1.033 . . . . 0.0 108.55 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -84.03 152.21 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.483 -2.144 . . . . 0.0 110.536 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.42 52.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.7 -32.0 5.55 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.583 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -94.15 125.3 38.7 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.477 0.656 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 41' ' ' ALA . 23.3 m -86.54 -170.49 3.1 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.584 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.51 ' H ' HG22 ' A' ' 40' ' ' THR . . . -160.23 151.1 18.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.76 152.74 41.84 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.513 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.3 mm? -117.22 123.59 47.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.315 0.384 . . . . 0.0 111.359 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.431 ' C ' ' H ' ' A' ' 46' ' ' GLN . 96.3 m-85 -115.51 128.86 56.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 125.067 1.479 . . . . 0.0 108.496 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -73.66 13.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.877 0.736 . . . . 0.0 112.02 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 44' ' ' TYR . 62.1 mm-40 -133.67 127.26 32.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.46 139.03 2.2 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.58 50.69 56.29 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.783 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 79.4 m 50.27 23.49 1.22 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.4 m -83.93 40.79 0.77 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.402 0.62 . . . . 0.0 112.424 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.17 -149.96 5.5 Favored Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.237 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.85 145.74 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.76 164.95 4.28 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.929 0.768 . . . . 0.0 111.921 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.488 ' HD1' ' HG1' ' A' ' 55' ' ' THR . 23.6 t-80 -146.59 -48.85 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.441 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.488 ' HG1' ' HD1' ' A' ' 54' ' ' HIS . 27.1 m -133.07 152.27 51.97 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.134 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -141.03 119.17 12.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.06 122.0 39.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.091 0.87 . . . . 0.0 111.35 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.65 24.38 4.91 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.0 p -165.46 128.9 2.23 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.595 -0.802 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.0 m -41.27 110.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.12 0.887 . . . . 0.0 111.967 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.16 91.58 3.56 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.271 0.982 . . . . 0.0 111.19 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -74.29 79.96 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.39 144.96 25.32 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.136 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 66.8 m -134.73 47.02 2.4 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.446 1.117 . . . . 0.0 109.242 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -140.75 154.95 69.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.683 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -55.83 156.11 20.33 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.988 2.459 . . . . 0.0 111.611 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.49 -135.63 0.29 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.866 0.729 . . . . 0.0 112.182 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.28 -3.33 0.06 OUTLIER Glycine 0 N--CA 1.497 2.75 0 CA-C-O 118.601 -1.11 . . . . 0.0 115.251 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.513 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 3.0 m-90 -90.62 166.57 13.11 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.77 1.285 . . . . 0.0 110.395 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -100.19 -41.58 7.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.828 0.705 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.8 p -138.1 177.09 8.14 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.314 1.009 . . . . 0.0 112.391 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.419 HD13 ' CB ' ' A' ' 3' ' ' PHE . 15.3 tt -144.39 127.33 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.695 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.603 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 7.3 t80 -84.85 94.4 8.73 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.406 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -76.9 116.26 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.366 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -68.66 137.12 53.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 123.906 0.754 . . . . 0.0 110.407 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.672 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.93 121.13 26.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 33.3 t80 -92.78 173.86 7.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.1 m -158.84 152.85 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -150.91 158.18 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.671 1.232 . . . . 0.0 108.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.437 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.1 m-90 -132.5 145.85 51.48 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -52.43 -42.71 64.33 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 145.08 152.55 5.65 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -82.07 -60.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 123.15 1.079 . . . . 0.0 111.53 17.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.56 -141.55 11.09 Favored Glycine 0 N--CA 1.485 1.917 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 p -94.31 44.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.656 -1.272 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -123.21 -129.3 0.26 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.433 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 38.2 -144.31 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -76.81 128.27 34.3 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -94.43 154.02 17.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.186 0.929 . . . . 0.0 112.266 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -161.64 118.51 2.17 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.447 ' HE ' ' HG ' ' A' ' 19' ' ' SER . 30.4 ttp-105 -86.38 157.1 19.93 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.463 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -136.53 61.49 1.63 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.054 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.447 ' HG ' ' HE ' ' A' ' 17' ' ' ARG . 93.4 p -94.43 6.51 48.52 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.008 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.56 118.25 7.92 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 103.83 0.25 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.458 1.099 . . . . 0.0 108.196 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.71 -164.33 18.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.88 150.21 30.67 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 p -160.24 132.12 6.09 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.961 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.21 115.91 19.15 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.04 105.75 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.545 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -96.2 -16.68 21.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.987 -1.461 . . . . 0.0 113.67 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -76.09 94.81 3.52 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.39 0.614 . . . . 0.0 110.312 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -83.91 60.27 5.72 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.145 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.59 -90.04 0.68 Allowed Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.19 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.86 169.12 21.64 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 47.4 p90 -161.73 135.36 6.5 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.57 158.74 24.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 58.9 t80 -130.03 157.36 42.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -146.94 100.31 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 124.069 0.856 . . . . 0.0 110.128 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.475 ' H ' ' HG ' ' A' ' 60' ' ' SER . 46.1 t80 -81.12 149.1 29.31 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.644 -1.617 . . . . 0.0 107.835 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -168.48 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.092 0.87 . . . . 0.0 109.342 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.99 -43.17 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.25 166.87 22.75 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 40' ' ' THR . 68.3 p -87.63 -174.58 4.84 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 113.305 -1.77 . . . . 0.0 111.105 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -158.11 113.68 2.71 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.605 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.66 157.05 27.33 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -126.38 94.64 4.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.851 0.834 . . . . 0.0 109.907 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -79.86 141.42 36.17 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.603 -1.635 . . . . 0.0 114.094 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.26 23.09 12.99 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.256 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.75 141.65 49.57 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.056 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.9 132.89 37.81 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.102 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.16 68.49 Favored Glycine 0 N--CA 1.495 2.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.173 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.2 m 54.33 29.15 10.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.356 0.68 . . . . 0.0 112.438 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.6 p -85.98 52.07 2.38 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.979 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.61 -121.91 0.61 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.12 150.17 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.59 178.93 1.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.142 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.504 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 18.6 t-80 -139.3 -69.55 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.888 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -118.16 83.07 1.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.127 0.892 . . . . 0.0 108.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 57' ' ' PHE . 5.1 tmm_? -70.57 162.19 29.32 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.6 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 51.4 m-85 -131.11 135.76 47.78 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.43 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.73 -2.57 4.34 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.1 m -152.58 136.82 16.58 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.475 ' HG ' ' H ' ' A' ' 36' ' ' TYR . 19.3 m -38.05 112.33 0.21 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.153 0.908 . . . . 0.0 111.15 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.71 106.9 11.35 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 124.279 0.987 . . . . 0.0 113.196 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -80.73 75.2 7.64 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.69 165.28 13.79 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.493 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.3 m -149.92 4.91 0.57 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -69.07 152.44 96.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.537 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.6 150.13 88.77 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.777 2.318 . . . . 0.0 110.198 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -154.43 -172.65 4.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 123.985 0.803 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.15 54.77 0.36 Allowed Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.557 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.504 ' HE1' ' CB ' ' A' ' 54' ' ' HIS . 1.9 m-90 -88.4 150.33 23.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 11.6 mptt -86.0 -22.83 27.1 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.504 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.1 p -175.66 167.81 3.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.628 1.205 . . . . 0.0 113.131 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.453 ' CD1' ' CG ' ' A' ' 3' ' ' PHE . 7.3 tt -130.7 130.3 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.838 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.95 93.28 4.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.484 1.115 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.5 mm -72.53 113.4 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.887 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -64.35 108.83 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.743 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 130.02 11.55 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.415 ' CB ' HD12 ' A' ' 72' ' ' ILE . 79.7 t80 -93.74 91.21 6.89 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.94 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.0 m -73.39 148.87 42.95 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.42 137.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 123.801 0.688 . . . . 0.0 109.684 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 19.9 m-90 -112.93 155.22 25.11 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -66.66 -42.55 86.46 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.97 156.04 9.14 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -76.97 -51.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.753 0 O-C-N 122.651 0.816 . . . . 0.0 110.786 8.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.97 -111.16 3.04 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.7 p -111.99 53.4 0.73 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -138.19 69.41 1.39 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 2.3 p30 178.31 -144.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.401 HH22 ' CG ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -79.72 177.57 8.79 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.375 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -162.17 178.8 8.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CG ' HH22 ' A' ' 14' ' ' ARG . 59.9 mt-10 -143.38 121.76 12.35 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 112.899 -1.955 . . . . 0.0 107.725 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -100.51 100.03 10.72 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.147 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.9 92.58 6.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -103.23 -31.18 10.22 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.22 127.89 34.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.827 0.704 . . . . 0.0 109.251 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.4 p -69.92 123.45 21.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.489 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.8 176.55 28.08 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.1 m -82.44 74.14 9.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.258 0.622 . . . . 0.0 109.609 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -85.28 132.12 34.31 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.282 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 142.48 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.76 149.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -142.39 14.87 2.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.903 0.752 . . . . 0.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -103.37 104.57 14.69 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.189 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.1 59.03 4.34 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.844 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.2 -78.15 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.553 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.75 175.39 32.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -161.01 131.79 5.31 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.39 103.72 11.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.562 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.61 154.81 29.97 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -142.42 103.46 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 124.35 1.031 . . . . 0.0 108.224 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.53 113.57 15.47 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.184 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.411 ' HG1' ' H ' ' A' ' 38' ' ' GLY . 74.8 p -146.28 -39.67 0.22 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' H ' ' HG1' ' A' ' 37' ' ' THR . . . -91.99 -62.04 1.19 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -160.35 177.78 10.26 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.984 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.8 p -66.27 174.64 2.53 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.629 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.39 124.43 3.62 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.78 167.75 11.24 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD13 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -130.32 105.16 7.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.304 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -86.04 147.92 25.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.401 HD22 ' HB2' ' A' ' 54' ' ' HIS . 27.2 m-80 -96.42 14.23 25.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.061 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.415 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 56.8 mm-40 -138.21 141.33 40.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.62 128.34 20.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.553 1.158 . . . . 0.0 112.14 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.52 53.24 33.13 Favored Glycine 0 N--CA 1.496 2.642 0 CA-C-N 114.306 -1.315 . . . . 0.0 112.652 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 76.8 m 51.67 29.21 5.43 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.1 m -81.59 34.73 0.39 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.797 0.808 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.94 -145.38 4.28 Favored Glycine 0 N--CA 1.494 2.511 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.965 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.27 153.15 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 113.823 -1.189 . . . . 0.0 108.527 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.21 -169.08 0.46 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.58 0.55 . . . . 0.0 111.314 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.445 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 5.7 t60 -153.93 -59.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.708 0.63 . . . . 0.0 110.249 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.1 m -112.9 119.84 39.36 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.243 0.964 . . . . 0.0 111.661 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -94.07 149.08 21.56 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.633 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.47 148.27 52.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.864 0.727 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.52 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.494 2.561 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.086 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -156.11 135.3 12.14 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -37.72 117.08 0.54 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.68 85.08 2.06 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.95 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -73.41 71.51 1.29 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.97 152.44 20.7 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.884 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 63.6 m -134.33 40.07 3.03 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -113.03 143.38 29.03 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.392 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -63.07 170.9 6.9 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.367 2.044 . . . . 0.0 111.325 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.36 -169.87 2.45 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.066 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.96 58.1 0.46 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CG ' HD13 ' A' ' 43' ' ' LEU . 5.0 m-90 -105.54 146.28 29.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.62 -46.24 10.96 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.099 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.1 p -153.99 156.35 37.26 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.962 1.414 . . . . 0.0 113.088 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 3' ' ' PHE . 6.2 tt -112.67 131.28 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.69 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.561 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 13.6 t80 -100.51 88.43 3.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.481 1.113 . . . . 0.0 111.124 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -85.58 137.82 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -89.71 170.53 10.37 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.178 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 116.166 -1.873 . . . . 0.0 111.358 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.91 141.72 5.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.927 0.767 . . . . 0.0 112.088 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.55 ' CG ' HD11 ' A' ' 72' ' ' ILE . 50.8 t80 -92.57 140.9 29.08 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.4 m -128.6 151.03 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.4 ' CG1' ' CE2' ' A' ' 3' ' ' PHE . 16.2 m -147.34 166.77 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.153 0.908 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -141.47 133.35 27.42 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 88.8 p -43.5 -33.51 1.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.408 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 134.99 154.11 6.99 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -82.58 -57.93 0.1 OUTLIER 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.315 1.166 . . . . 0.0 111.151 13.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.64 -145.34 14.98 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.03 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 63' ' ' ALA . 76.2 m -93.3 50.42 1.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.59 -1.305 . . . . 0.0 111.886 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.64 -126.97 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.408 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 37.76 -141.88 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 119.57 1.077 . . . . 0.0 113.734 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -69.89 154.41 41.99 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.52 111.65 14.03 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.432 0.457 . . . . 0.0 112.135 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -117.54 166.77 11.98 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -151.71 157.0 41.46 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.613 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -142.38 93.61 2.55 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.4 p -100.05 -11.37 20.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -55.74 128.19 33.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 123.856 0.723 . . . . 0.0 111.516 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.66 167.3 17.27 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.0 -84.26 1.29 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.3 p -174.31 157.31 2.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.497 0.763 . . . . 0.0 111.062 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -160.19 146.76 15.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.246 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.72 163.65 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.827 0.705 . . . . 0.0 109.623 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mt -134.57 151.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.674 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -23.07 4.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.205 0.941 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -82.76 97.34 8.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.939 0.774 . . . . 0.0 110.808 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -82.95 12.97 4.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.37 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.76 -112.97 0.39 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.266 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.6 159.44 19.75 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 124.982 1.048 . . . . 0.0 110.837 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -161.28 131.64 5.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.456 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 8.2 t70 -104.47 174.87 5.69 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.151 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 65.3 t80 -148.8 157.89 43.76 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.406 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 55.4 m -139.23 139.06 37.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -122.18 138.85 54.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.903 1.377 . . . . 0.0 113.202 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.4 p -152.35 66.68 0.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.89 36.5 93.37 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -153.63 99.49 2.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -71.97 157.48 37.75 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.08 166.42 15.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.712 1.258 . . . . 0.0 110.314 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.78 152.21 40.0 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.125 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.446 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 80.9 mt -113.17 98.63 7.26 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.385 1.088 . . . . 0.0 110.071 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.39 115.2 14.8 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.638 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -48.46 -65.22 0.6 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.012 1.445 . . . . 0.0 109.97 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.57 155.89 36.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.402 1.064 . . . . 0.0 112.142 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.54 179.44 7.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.503 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.37 54.3 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.977 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 24.0 m 59.35 30.7 20.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.7 p -115.84 35.7 4.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.719 0.771 . . . . 0.0 111.269 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.97 157.6 15.08 Favored Glycine 0 N--CA 1.493 2.496 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.13 149.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.91 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.713 0.768 . . . . 0.0 109.296 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.442 ' HD1' ' HG1' ' A' ' 55' ' ' THR . 21.5 t-80 -79.69 -23.34 42.49 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.266 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.442 ' HG1' ' HD1' ' A' ' 54' ' ' HIS . 50.0 m -146.92 136.34 22.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.958 0.787 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -114.52 147.33 39.55 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.33 1.019 . . . . 0.0 111.79 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -132.31 98.61 4.44 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.44 1.088 . . . . 0.0 108.248 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.54 12.14 66.41 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.3 t -164.47 142.14 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.6 p -40.51 127.9 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.141 0.9 . . . . 0.0 111.916 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.56 113.34 12.94 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 124.051 0.844 . . . . 0.0 112.767 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -81.26 71.36 8.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.396 1.06 . . . . 0.0 112.803 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.406 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . -91.28 157.98 16.83 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.379 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.2 m -147.39 10.06 0.96 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.55 0.69 . . . . 0.0 109.567 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -74.68 167.78 33.16 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.729 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -56.29 144.51 81.86 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.205 1.936 . . . . 0.0 111.936 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -73.99 167.42 21.54 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.14 17.13 1.18 Allowed Glycine 0 N--CA 1.501 3.014 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.47 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.446 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.0 m-90 -138.43 -166.65 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -129.98 -36.71 1.54 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.7 p -134.09 168.87 18.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 124.306 1.004 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.55 HD11 ' CG ' ' A' ' 3' ' ' PHE . 3.3 tt -130.78 121.47 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.533 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -98.02 119.05 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.889 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.9 mt -117.94 150.3 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -74.28 -179.75 4.09 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 116.896 -1.526 . . . . 0.0 109.799 179.804 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.78 121.37 2.85 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.188 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.461 ' CG ' HD12 ' A' ' 72' ' ' ILE . 76.8 t80 -93.63 102.56 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.173 0.92 . . . . 0.0 110.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.6 m -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -151.82 138.64 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 123.774 0.672 . . . . 0.0 110.086 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.487 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 24.9 m-90 -109.3 150.48 27.91 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.1 p -61.35 -38.76 88.1 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.98 153.64 6.66 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.88 -56.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.769 0 O-C-N 122.858 0.925 . . . . 0.0 109.982 7.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.19 -132.35 6.27 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.06 54.98 1.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -139.42 64.2 1.47 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.004 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 4.7 p30 -178.46 -150.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.76 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -72.05 169.62 15.6 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.94 173.66 12.22 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -151.11 140.41 21.34 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.056 -1.884 . . . . 0.0 107.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -110.93 153.06 26.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 123.735 0.647 . . . . 0.0 111.243 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -139.5 75.17 1.5 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -105.71 -20.97 13.29 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.179 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.59 135.13 57.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 123.632 0.583 . . . . 0.0 110.338 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -60.64 109.35 1.01 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.465 1.103 . . . . 0.0 110.35 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.66 166.95 13.7 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.8 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 m -78.73 74.8 5.26 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.618 -1.291 . . . . 0.0 109.88 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -80.6 136.0 36.16 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.44 126.86 31.36 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 mp -89.22 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -135.76 -29.92 1.01 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.707 0.63 . . . . 0.0 112.045 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -78.85 104.53 9.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.787 0.679 . . . . 0.0 109.279 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -90.26 18.27 6.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.347 1.03 . . . . 0.0 113.675 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.01 -87.59 0.25 Allowed Glycine 0 N--CA 1.497 2.745 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.297 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.23 169.83 20.44 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -161.62 132.17 5.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 2.9 t70 -107.05 166.06 10.89 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.321 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.465 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 68.6 t80 -145.7 151.89 38.75 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -132.62 151.48 51.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -135.71 133.91 38.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 124.213 0.946 . . . . 0.0 110.473 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.0 p -149.67 70.03 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.61 98.11 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.844 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -158.37 115.37 2.84 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.153 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 m -83.25 165.84 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.122 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.63 162.08 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.643 -1.617 . . . . 0.0 108.301 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.53 137.28 21.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.86 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HG ' ' CD2' ' A' ' 69' ' ' TRP . 3.9 mm? -91.71 158.71 16.22 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -147.74 121.29 9.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 125.28 1.612 . . . . 0.0 109.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -66.3 -8.03 22.46 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.456 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -122.95 134.08 54.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 124.074 0.859 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 133.57 8.1 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.844 -1.526 . . . . 0.0 115.006 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.01 44.49 83.11 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.7 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 71.9 m 52.17 31.9 9.79 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -82.73 29.43 0.45 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.207 1.003 . . . . 0.0 112.796 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 49' ' ' CYS . . . -161.2 -175.17 31.94 Favored Glycine 0 N--CA 1.49 2.258 0 CA-C-N 113.219 -1.809 . . . . 0.0 108.863 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -81.9 156.5 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.78 161.92 28.85 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.589 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.53 ' HD1' ' HE1' ' A' ' 69' ' ' TRP . 57.2 t-80 -123.37 -32.42 3.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 124.346 1.029 . . . . 0.0 110.459 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.466 ' HG1' ' HD1' ' A' ' 54' ' ' HIS . 91.5 m -141.06 167.42 22.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.998 0.812 . . . . 0.0 109.085 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -143.29 143.4 31.69 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.465 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 23.0 m-85 -139.36 105.2 5.16 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.058 0.849 . . . . 0.0 110.184 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.19 31.44 5.46 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.0 t -175.51 127.25 0.25 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -30.64 111.19 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 124.507 1.13 . . . . 0.0 113.074 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.29 93.68 4.13 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 124.306 1.004 . . . . 0.0 109.831 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -81.97 68.03 8.2 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.23 -1.35 . . . . 0.0 113.168 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.78 169.18 12.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.794 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.31 39.84 0.84 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.409 1.1 . . . . 0.0 108.439 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -100.44 165.55 14.2 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 112.741 -2.027 . . . . 0.0 109.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.06 164.79 33.56 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.539 2.159 . . . . 0.0 110.339 164.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.54 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 30.9 p90 -162.26 -163.72 0.96 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.511 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.47 43.32 0.43 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.55 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CE3' ' CD2' ' A' ' 67' ' ' PHE . 4.8 m-90 -91.73 133.38 35.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.77 -48.93 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.3 p -135.57 169.8 16.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.988 1.43 . . . . 0.0 112.743 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.461 HD12 ' CG ' ' A' ' 3' ' ' PHE . 10.9 tt -140.31 119.26 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.95 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.645 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 37.1 t80 -84.2 121.06 26.95 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.144 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.4 mm -108.7 132.41 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -85.7 -179.9 6.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.895 0.747 . . . . 0.0 110.024 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 115.532 -2.175 . . . . 0.0 110.23 179.77 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.96 132.22 11.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.464 ' CG ' HD12 ' A' ' 72' ' ' ILE . 85.2 t80 -95.75 93.59 7.18 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.895 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.6 m -72.51 152.3 41.97 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.01 155.13 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 124.267 0.979 . . . . 0.0 110.88 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.536 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.0 m-90 -133.93 157.23 46.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.5 p -60.45 -40.55 91.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.496 1.123 . . . . 0.0 113.127 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.1 157.05 8.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.2 -45.22 0.37 Allowed 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.152 1.08 . . . . 0.0 111.386 19.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.29 -137.75 8.84 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -105.44 40.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.189 -1.506 . . . . 0.0 107.349 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -140.65 68.16 1.35 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -169.83 -88.17 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.556 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -90.46 91.73 8.58 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.248 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 115.06 5.22 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.821 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -145.98 154.58 42.05 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -151.05 151.61 32.26 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.0 93.79 4.14 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.477 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.4 p -105.65 -26.81 11.68 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -52.11 145.08 11.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 123.958 0.786 . . . . 0.0 112.912 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 t -65.67 168.36 7.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.183 0.927 . . . . 0.0 109.349 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.49 -177.63 43.28 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 107.194 -2.362 . . . . 0.0 107.194 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 29.7 p -96.34 142.65 28.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.213 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.7 p -127.24 140.22 52.38 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.708 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.36 122.08 25.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 123.865 0.728 . . . . 0.0 109.776 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.54 150.06 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.823 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -134.41 -13.55 2.32 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.24 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -86.2 84.72 7.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 123.07 1.414 . . . . 0.0 109.807 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -89.99 64.67 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.886 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.29 -58.26 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.533 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.1 168.74 35.84 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -161.1 132.03 5.35 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.152 -1.019 . . . . 0.0 113.723 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -114.15 104.47 12.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.781 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 79.0 t80 -82.68 153.42 25.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -146.04 100.79 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.277 0.986 . . . . 0.0 109.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' H ' ' HG ' ' A' ' 60' ' ' SER . 79.5 t80 -72.04 134.45 45.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.199 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.1 p -146.58 55.11 1.13 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.93 -23.56 13.6 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 113.863 -1.517 . . . . 0.0 110.555 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -99.13 125.83 44.76 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.175 0.512 . . . . 0.0 111.501 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 m -85.98 164.84 17.16 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.89 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.61 171.04 13.03 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.33 131.42 6.5 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.346 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.524 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -96.49 116.73 29.55 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.632 0.729 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -99.43 122.62 42.79 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 0.0 110.567 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -74.55 -1.39 21.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.64 139.4 47.12 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 138.75 56.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 124.018 0.824 . . . . 0.0 110.775 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.519 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 52.91 43.95 61.35 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.8 p 39.33 40.04 0.51 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.3 m -89.25 42.02 1.07 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.973 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.68 -122.18 0.62 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.388 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.59 153.07 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.64 -174.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.34 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -148.55 -45.58 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.819 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -138.91 116.02 10.99 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.058 0.849 . . . . 0.0 109.428 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.28 152.27 18.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.863 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.438 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 17.9 m-85 -131.2 114.8 15.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.064 0.853 . . . . 0.0 110.153 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.48 11.42 28.26 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 p -161.05 135.62 7.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 123.979 0.458 . . . . 0.0 110.437 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.44 ' HG ' ' H ' ' A' ' 36' ' ' TYR . 16.2 m -39.67 115.82 0.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.319 1.012 . . . . 0.0 112.408 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.04 93.73 4.19 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.205 0.941 . . . . 0.0 109.242 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -74.48 75.37 1.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.333 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.35 161.87 15.41 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.201 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 m -148.1 58.44 1.1 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.079 0.943 . . . . 0.0 110.307 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.49 153.42 43.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 113.751 -1.568 . . . . 0.0 108.864 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.98 178.37 2.43 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.354 2.036 . . . . 0.0 110.28 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.25 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.072 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.89 19.15 3.74 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-O 118.504 -1.165 . . . . 0.0 114.033 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.524 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 5.1 m-90 -91.87 161.0 15.02 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 118.852 1.326 . . . . 0.0 111.014 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.63 -41.39 7.74 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.162 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 p -146.28 -179.94 7.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.432 1.082 . . . . 0.0 110.985 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.464 HD12 ' CG ' ' A' ' 3' ' ' PHE . 11.0 tt -146.5 117.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.369 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.59 114.16 19.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.062 -1.881 . . . . 0.0 108.772 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.65 140.02 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.54 150.74 29.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.142 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 116.576 -1.678 . . . . 0.0 110.373 179.888 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.29 103.99 2.9 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.185 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.425 ' CB ' HD12 ' A' ' 72' ' ' ILE . 85.4 t80 -96.69 90.69 5.39 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.07 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -77.49 154.57 32.39 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 m -148.28 166.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 123.703 0.627 . . . . 0.0 109.397 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.43 ' CD1' ' HB1' ' A' ' 15' ' ' ALA . 29.4 m-90 -141.88 139.64 32.66 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -51.95 -41.15 61.84 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.12 151.03 5.47 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -79.07 -62.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.592 0 O-C-N 122.975 0.987 . . . . 0.0 111.396 19.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.18 -129.41 6.55 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 p -95.5 49.96 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.292 -0.954 . . . . 0.0 111.373 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' ND2' ' N ' ' A' ' 12' ' ' ASN . 2.3 m-80 -124.33 -132.01 0.26 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.9 p30 36.66 -150.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -78.63 -176.75 5.02 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' A' ' 6' ' ' TRP . . . -153.17 159.79 42.75 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -139.78 163.76 31.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 111.724 -2.489 . . . . 0.0 104.677 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -146.87 136.39 22.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -117.27 73.83 0.89 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.683 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.2 p -95.9 -5.63 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.032 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -66.71 111.74 3.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.084 0.865 . . . . 0.0 108.872 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 7.0 p -64.85 114.95 4.85 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.028 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.37 -95.83 0.16 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.58 -1.295 . . . . 0.0 114.405 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -156.19 133.06 10.43 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.612 0.831 . . . . 0.0 110.118 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -160.24 134.22 7.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.473 0.483 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.76 126.09 30.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.39 150.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -137.03 0.64 2.39 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.758 0.661 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -101.26 101.16 11.79 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.836 0.827 . . . . 0.0 109.596 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -79.53 -2.97 44.66 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.662 -1.608 . . . . 0.0 113.749 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.58 -101.89 0.03 OUTLIER Glycine 0 N--CA 1.497 2.722 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.38 166.22 14.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 63' ' ' ALA . 30.8 p90 -161.45 145.27 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.84 152.51 43.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -121.5 157.02 31.54 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 t -145.59 101.24 3.54 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -70.67 137.46 49.86 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 111.952 -2.385 . . . . 0.0 108.778 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.6 m -143.52 61.89 1.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.66 -14.05 10.81 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.711 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -113.49 125.04 53.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 120.933 0.396 . . . . 0.0 111.693 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.1 m -80.15 162.18 24.86 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.45 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.17 174.3 6.41 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.419 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.1 140.97 19.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.607 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -112.56 133.04 54.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 123.639 0.587 . . . . 0.0 111.554 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -117.77 134.28 55.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 125.033 1.458 . . . . 0.0 111.601 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -66.93 -36.57 82.53 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.065 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -92.4 119.72 32.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.971 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -39.13 146.99 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 125.433 1.708 . . . . 0.0 113.814 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.5 39.42 93.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.1 p 43.79 35.85 1.17 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 125.007 1.063 . . . . 0.0 111.543 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -90.23 46.05 1.32 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.205 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.44 -135.57 1.86 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.307 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.47 154.61 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.196 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.13 178.32 1.91 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.437 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -156.56 -40.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -142.95 129.33 20.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.979 0.799 . . . . 0.0 110.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.91 135.32 54.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -115.36 114.0 24.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.776 0.673 . . . . 0.0 110.663 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.84 13.05 38.35 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 p -164.34 136.14 4.6 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m -41.1 121.6 1.6 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.11 0.881 . . . . 0.0 111.724 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.25 111.76 9.9 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -78.2 76.21 4.72 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.775 0.672 . . . . 0.0 111.294 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . . . -90.91 71.92 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.389 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.5 m -62.23 -6.91 3.48 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -70.87 164.13 58.75 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.52 178.57 2.57 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.62 2.213 . . . . 0.0 111.614 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 -149.26 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.07 15.74 0.43 Allowed Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.161 0.913 . . . . 0.0 110.855 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.607 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 1.9 m-90 -100.93 126.22 47.55 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -90.45 2.79 55.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.143 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.1 p -163.58 173.66 12.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.05 0.844 . . . . 0.0 112.468 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.425 HD12 ' CB ' ' A' ' 3' ' ' PHE . 6.7 tt -149.27 123.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.128 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -99.51 127.41 45.57 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -131.9 143.98 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -72.54 164.88 25.73 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.043 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 116.883 -1.532 . . . . 0.0 110.566 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 96.92 2.92 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 121.004 0.431 . . . . 0.0 111.291 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 64.7 t80 -97.31 101.99 13.66 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.5 m -84.38 155.54 22.25 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -150.71 161.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 123.31 0.381 . . . . 0.0 111.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.536 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 21.2 m-90 -145.98 140.14 26.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 m -55.19 -21.77 14.96 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' CA ' ' HA3' ' A' ' 30' ' ' GLY . . . 124.46 163.94 11.81 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 123.782 0.676 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.3 -54.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.678 0 O-C-N 123.058 1.031 . . . . 0.0 111.462 13.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.07 -123.55 4.57 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 75.3 m -122.16 80.2 1.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -147.79 -54.73 0.21 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.305 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.6 p30 -49.31 -120.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.99 80.9 0.08 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.66 110.26 3.65 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -131.45 172.66 11.93 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -153.38 158.67 41.83 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.735 -0.786 . . . . 0.0 113.119 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -136.77 80.16 1.8 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.843 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.1 t -108.68 1.33 21.12 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.687 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -61.4 118.64 7.22 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.781 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -62.29 102.13 0.28 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.322 1.014 . . . . 0.0 108.946 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.33 -118.48 1.02 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.3 t -140.71 154.59 46.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 124.315 0.656 . . . . 0.0 111.762 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 p -160.15 139.54 10.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.88 140.97 38.02 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.673 0.608 . . . . 0.0 111.772 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 mt -117.56 127.29 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.815 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -125.7 32.85 5.21 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.046 0.841 . . . . 0.0 108.779 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -113.47 99.27 7.64 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.284 -1.325 . . . . 0.0 108.285 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.14 18.26 6.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 111.85 -2.432 . . . . 0.0 112.491 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' CA ' ' A' ' 8' ' ' GLY . . . -92.24 -74.64 1.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.908 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' CA ' ' HA ' ' A' ' 64' ' ' CYS . . . -152.84 164.46 30.79 Favored Glycine 0 N--CA 1.486 2.006 0 CA-C-N 113.836 -1.182 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 23.4 p90 -161.23 132.25 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.79 161.8 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.362 -1.744 . . . . 0.0 107.253 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -142.25 153.16 43.73 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -146.86 114.03 6.23 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.654 1.222 . . . . 0.0 108.203 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.2 112.49 17.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.357 -2.201 . . . . 0.0 105.295 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.4 m -132.66 -66.6 0.67 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.74 -70.05 1.31 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -141.31 -168.52 2.65 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.226 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -77.17 -167.95 1.0 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.122 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.12 142.04 12.89 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.687 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.41 149.32 38.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.266 0.979 . . . . 0.0 108.818 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 ' CE2' ' A' ' 57' ' ' PHE . 38.1 mt -114.16 101.35 9.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.747 0.654 . . . . 0.0 111.3 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.53 144.92 26.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.368 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -91.99 -0.19 57.48 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -113.89 148.26 37.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 123.553 0.533 . . . . 0.0 110.137 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.72 134.03 55.86 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.827 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.33 30.85 77.33 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.433 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.545 ' H ' ' HG ' ' A' ' 71' ' ' SER . 58.7 m 54.7 29.42 11.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 124.61 0.829 . . . . 0.0 112.623 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 t -88.45 59.81 5.36 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.868 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.48 -125.45 0.85 Allowed Glycine 0 N--CA 1.495 2.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.834 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.79 144.08 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.2 121.88 21.01 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.484 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.78 -60.29 2.41 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -124.49 148.87 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.697 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.97 -177.89 4.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 123.545 0.528 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' CE2' HD12 ' A' ' 43' ' ' LEU . 44.3 m-85 -141.32 158.08 44.36 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.685 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.08 -11.87 0.15 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -151.35 147.18 26.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -41.47 117.84 0.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.929 0.768 . . . . 0.0 112.78 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.8 99.82 7.37 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.331 1.02 . . . . 0.0 109.428 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -84.79 70.18 10.8 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.39 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.24 165.47 13.44 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.436 ' HA ' ' CA ' ' A' ' 31' ' ' GLY . 67.4 m -150.85 26.64 0.73 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.842 0.83 . . . . 0.0 111.958 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -97.25 168.51 10.09 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.111 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.34 178.49 0.86 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.364 2.043 . . . . 0.0 110.946 163.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.85 -151.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.21 49.17 0.4 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -127.37 142.17 51.5 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -93.85 -20.74 19.78 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 49' ' ' CYS . 61.5 p -161.93 178.43 8.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 124.29 0.993 . . . . 0.0 112.052 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.0 tt -140.4 123.85 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.52 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -91.47 84.64 5.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.931 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.4 mm -69.19 125.05 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -72.06 136.21 46.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.805 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.55 0 CA-C-N 113.316 -1.766 . . . . 0.0 111.549 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.66 134.56 5.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.503 ' CG ' HD11 ' A' ' 72' ' ' ILE . 88.5 t80 -101.76 107.06 18.16 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.886 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.8 m -91.75 152.3 20.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 m -154.46 152.92 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.719 0.637 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 -122.63 153.28 39.55 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 23.3 t -55.93 -50.56 70.39 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.61 154.17 7.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -80.05 -56.0 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 118.273 1.037 . . . . 0.0 110.075 12.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.5 -136.32 8.28 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -87.85 42.33 1.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.3 -0.95 . . . . 0.0 112.554 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 12' ' ' ASN . 1.9 m-80 -111.93 -135.0 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 7' ' ' SER . 6.8 p30 34.8 -141.21 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -89.44 156.74 18.47 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.02 171.61 7.28 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.905 0.753 . . . . 0.0 111.991 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -171.82 125.44 0.57 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -98.42 155.49 17.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -138.16 94.84 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.4 p -130.42 13.69 5.53 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.604 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -54.75 128.5 33.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.632 0.582 . . . . 0.0 110.959 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.4 t -69.55 94.22 0.75 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.457 1.123 . . . . 0.0 108.913 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.29 -106.06 0.36 Allowed Glycine 0 N--CA 1.488 2.129 1 N-CA-C 101.287 -4.725 . . . . 0.0 101.287 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.26 164.29 25.05 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.992 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 p -158.1 148.3 20.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 126.62 31.03 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.388 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mt -78.78 148.9 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.576 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -124.92 -32.36 3.05 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.288 0.993 . . . . 0.0 111.615 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -71.63 97.44 1.72 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.146 0.974 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -90.42 61.29 4.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.369 -2.196 . . . . 0.0 109.545 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.98 -89.82 0.25 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.37 157.54 17.64 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -143.99 117.44 9.11 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.775 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -126.83 153.12 46.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.056 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 92.5 t80 -133.35 155.07 50.13 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -137.11 131.26 32.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -109.69 148.34 31.54 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.411 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -166.56 55.12 0.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.52 -33.84 4.02 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.42 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -82.06 120.78 25.72 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.451 0.643 . . . . 0.0 110.726 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 m -91.9 168.78 11.18 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.201 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.04 147.28 23.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 123.63 0.581 . . . . 0.0 112.275 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.26 150.23 29.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.432 HD23 ' CE3' ' A' ' 69' ' ' TRP . 25.8 tp -120.11 108.68 14.55 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -89.09 124.16 34.05 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.123 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 57.5 t-20 -63.56 -41.81 98.39 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.152 -1.84 . . . . 0.0 106.66 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.462 ' CD ' ' H ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -78.93 157.43 28.22 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.274 -1.785 . . . . 0.0 108.06 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.1 172.94 6.04 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 33.96 44.79 0.37 Allowed Glycine 0 N--CA 1.505 3.251 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.601 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.503 ' H ' ' HG ' ' A' ' 71' ' ' SER . 31.9 p 34.35 61.64 0.53 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 125.218 1.187 . . . . 0.0 113.214 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.9 m -78.31 -154.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.641 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.02 162.26 49.88 Favored Glycine 0 N--CA 1.498 2.815 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.258 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t 61.87 107.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 113.416 -1.392 . . . . 0.0 112.381 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.95 -174.95 2.84 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.756 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.428 ' CD2' ' HE1' ' A' ' 69' ' ' TRP . 8.8 t60 -136.91 -49.86 0.64 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 m -138.16 160.86 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.87 127.68 14.39 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.736 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 25.3 m-85 -101.78 146.04 28.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.24 0.962 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.27 17.13 0.79 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 p -165.82 129.87 2.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.9 m -37.03 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.079 0.862 . . . . 0.0 113.112 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.98 101.55 8.86 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 115.041 -0.982 . . . . 0.0 112.041 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -83.13 76.73 9.84 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.68 165.5 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.445 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 m -153.8 36.55 0.45 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 121.763 0.792 . . . . 0.0 109.374 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.402 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 72.7 m-80 -70.07 -167.04 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.094 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.576 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 65' ' ' ASN . 1.4 Cg_endo -73.3 165.94 31.26 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.733 2.288 . . . . 0.0 111.24 144.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.75 171.11 15.44 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.41 18.1 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.672 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 13.7 m-90 -141.93 -162.59 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.97 0.453 . . . . 0.0 112.0 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.2 -30.22 0.47 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.927 0.767 . . . . 0.0 111.04 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.503 ' HG ' ' H ' ' A' ' 49' ' ' CYS . 17.5 p -150.32 162.45 40.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.918 0.761 . . . . 0.0 111.809 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.503 HD11 ' CG ' ' A' ' 3' ' ' PHE . 10.2 tt -137.88 134.78 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.243 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -96.02 106.78 18.99 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.403 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -101.03 139.31 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -105.39 162.61 13.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.034 0.834 . . . . 0.0 110.741 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 116.94 -1.505 . . . . 0.0 110.475 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.64 95.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 123.97 0.793 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -82.18 98.92 8.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.313 1.008 . . . . 0.0 110.813 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -84.11 151.76 24.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 p -163.25 146.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.525 1.155 . . . . 0.0 112.506 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.455 ' CZ3' ' SG ' ' A' ' 11' ' ' CYS . 8.2 m-90 -124.23 151.41 44.16 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 111.851 -2.431 . . . . 0.0 107.304 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.7 p -68.82 9.84 0.34 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.34 163.21 37.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -76.66 -53.79 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.649 0 O-C-N 123.055 1.029 . . . . 0.0 111.107 16.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.52 -143.5 13.83 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 71.5 m -107.85 70.81 0.78 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -142.14 -49.06 0.37 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.942 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.551 ' H ' HD21 ' A' ' 13' ' ' ASN . 1.4 p30 -53.94 -135.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.717 -2.038 . . . . 0.0 115.974 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -54.25 129.27 34.52 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.76 116.15 31.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.928 0.767 . . . . 0.0 110.565 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -147.81 138.84 23.4 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -123.78 158.69 31.17 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.426 ' HH ' HE22 ' A' ' 28' ' ' GLN . 59.9 m-85 -136.32 82.17 1.93 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.5 p -105.71 -14.76 15.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.555 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.69 141.68 58.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.185 0.928 . . . . 0.0 109.544 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 44.0 t -71.76 174.7 6.49 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.02 -112.02 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 p -172.42 147.31 1.9 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.094 0.526 . . . . 0.0 111.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -158.77 154.45 26.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.171 0.919 . . . . 0.0 110.987 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.93 140.36 36.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.373 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.2 mt -97.0 115.78 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.158 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -79.27 -45.39 19.84 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.468 ' H ' ' CD ' ' A' ' 28' ' ' GLN . 1.7 pm0 -81.83 82.11 7.61 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.798 -1.546 . . . . 0.0 108.699 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.7 55.85 2.83 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.035 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.09 -114.35 2.85 Favored Glycine 0 N--CA 1.498 2.801 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.357 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.54 158.35 28.55 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-O 118.412 -1.215 . . . . 0.0 110.329 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -161.76 134.92 6.23 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -110.42 167.73 9.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -145.3 155.62 43.32 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.3 t -144.99 109.64 4.98 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -81.78 147.64 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 113.056 -1.884 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -173.36 76.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.62 -26.3 3.64 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-N 112.788 -2.006 . . . . 0.0 113.06 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -109.14 137.19 47.42 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.4 m -97.79 166.48 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.761 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.81 174.77 9.41 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.309 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.55 122.37 3.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.153 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD13 ' CZ3' ' A' ' 69' ' ' TRP . 98.4 mt -99.22 135.88 39.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 123.847 0.717 . . . . 0.0 111.615 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.43 ' CE2' ' OG ' ' A' ' 71' ' ' SER . 8.8 p90 -148.24 138.43 22.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.212 0.945 . . . . 0.0 109.255 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -72.59 -10.27 59.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.621 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 46' ' ' GLN . 3.1 mp0 -86.4 89.66 7.95 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.321 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.22 164.9 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.87 28.09 72.97 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.011 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 m 60.64 18.51 8.52 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.052 0.501 . . . . 0.0 110.614 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -90.49 41.04 1.04 Allowed 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -161.69 -170.29 26.19 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.081 -1.533 . . . . 0.0 115.921 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.21 145.96 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 112.351 -1.924 . . . . 0.0 107.772 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 179.98 0.12 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -153.27 -48.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.574 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 m -132.83 106.14 7.55 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.824 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -96.54 158.08 15.6 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -126.0 106.04 9.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 124.189 0.931 . . . . 0.0 110.664 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.43 -4.31 57.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 t -155.47 140.15 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.42 ' H ' ' HG ' ' A' ' 60' ' ' SER . 18.7 m -35.91 110.86 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.98 -178.48 4.82 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -166.2 51.88 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.25 0.547 . . . . 0.0 111.576 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.78 165.47 16.0 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.1 m -147.56 11.09 0.98 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.945 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -79.84 157.59 73.92 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.73 143.92 27.82 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.452 2.101 . . . . 0.0 112.043 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.16 156.68 37.01 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.787 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.26 22.5 3.22 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 123.996 0.81 . . . . 0.0 111.417 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.445 ' CZ3' HD13 ' A' ' 43' ' ' LEU . 13.2 m-90 -138.26 -161.58 1.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -138.63 -20.14 1.04 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.544 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.43 ' OG ' ' CE2' ' A' ' 44' ' ' TYR . 14.7 p -153.72 170.28 21.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.267 0.979 . . . . 0.0 110.795 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.4 tt -137.04 149.48 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.465 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -119.93 136.19 54.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.7 mt -138.44 155.95 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 124.069 0.856 . . . . 0.0 110.738 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -88.12 173.18 8.99 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.99 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 88.8 m . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.771 -1.585 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.414 ' HG ' ' H ' ' A' ' 39' ' ' GLN . 74.6 m . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.741 0.305 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.09 174.23 15.21 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.403 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -137.67 97.43 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.53 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.1 m -77.3 150.52 35.25 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -148.61 153.96 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 123.622 0.576 . . . . 0.0 110.39 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.519 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 25.0 m-90 -135.61 142.97 45.34 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.5 p -66.18 0.85 1.77 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.406 ' HA2' ' C ' ' A' ' 9' ' ' PRO . . . 104.29 155.33 23.48 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 123.504 0.502 . . . . 0.0 113.349 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.406 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 12.1 Cg_endo -72.93 -54.88 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.851 0 O-C-N 123.023 1.012 . . . . 0.0 112.863 18.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.33 -128.67 5.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -108.89 69.44 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 113.96 -1.12 . . . . 0.0 109.419 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -143.4 -55.71 0.39 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.125 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.8 p30 -47.05 -118.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 5.9 tpm_? -62.78 100.77 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.352 0.596 . . . . 0.0 111.76 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.59 83.46 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.062 0.934 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -101.57 161.79 13.38 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.43 -1.713 . . . . 0.0 107.652 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -142.06 153.65 44.36 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -135.63 83.09 1.99 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.7 p -108.76 -12.01 14.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.056 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -53.09 143.53 17.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.336 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 126.92 29.61 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.819 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.58 28.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.572 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 20.2 p -114.15 162.23 16.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.5 p -160.57 158.59 29.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.351 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.43 151.25 30.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 123.699 0.625 . . . . 0.0 110.554 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 28' ' ' GLN . 3.3 mp -121.26 131.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 124.275 0.984 . . . . 0.0 109.333 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -101.28 -6.65 23.88 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.196 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.419 ' H ' HG22 ' A' ' 26' ' ' ILE . 26.2 mp0 -93.62 64.79 3.6 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.471 1.605 . . . . 0.0 108.729 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.14 8.8 3.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 111.187 -2.733 . . . . 0.0 115.063 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -74.2 -61.97 3.07 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.627 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.95 161.3 28.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.67 135.1 6.41 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -109.89 161.2 15.7 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 90.1 t80 -132.22 158.05 42.77 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.9 t -140.4 121.98 15.2 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -104.56 111.58 24.32 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.8 p -148.53 -49.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' N ' ' HG ' ' A' ' 1' ' ' SER . . . -83.6 -80.08 1.03 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.414 ' H ' ' HG ' ' A' ' 1' ' ' SER . 99.4 mm-40 -137.53 -176.93 4.57 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.5 m -75.95 170.81 15.53 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.45 169.63 21.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.257 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -152.94 163.93 38.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.04 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.558 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.0 mm? -111.27 143.36 42.17 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.82 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.76 120.26 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.737 1.273 . . . . 0.0 108.681 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -62.34 -5.68 2.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.164 0.915 . . . . 0.0 112.193 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -125.9 123.17 38.02 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.971 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.472 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -37.98 148.13 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.436 -1.711 . . . . 0.0 114.305 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.572 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.96 37.47 44.83 Favored Glycine 0 N--CA 1.494 2.521 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.0 p 36.27 45.11 0.32 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.978 1.046 . . . . 0.0 113.192 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -85.31 41.66 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.676 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.52 -120.05 0.54 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.0 156.05 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.434 0.726 . . . . 0.0 109.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.62 165.09 17.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.624 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -132.4 -62.82 0.82 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.7 m -110.53 142.68 42.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -133.25 126.67 32.04 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.34 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.457 ' CE2' HD23 ' A' ' 43' ' ' LEU . 37.4 m-85 -94.33 132.99 38.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.17 0.918 . . . . 0.0 110.892 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.28 8.04 5.97 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.6 p -162.19 136.22 6.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.3 p -42.05 116.6 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 123.619 0.574 . . . . 0.0 110.976 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.5 107.43 12.86 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.54 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -78.13 73.82 4.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.516 1.135 . . . . 0.0 112.773 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 156.3 18.28 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.69 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.7 m -144.96 18.37 1.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -82.37 162.78 55.16 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.331 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -53.96 152.48 23.48 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.342 2.028 . . . . 0.0 110.589 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -69.8 166.14 19.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.759 0.662 . . . . 0.0 110.344 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.55 -0.72 1.53 Allowed Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.86 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.558 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.3 m-90 -127.1 -141.82 0.27 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 20.3 ttmm -146.58 -25.16 0.42 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.021 0.373 . . . . 0.0 110.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 p -146.91 158.73 44.0 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.795 0.807 . . . . 0.0 111.98 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 26' ' ' ILE . 6.5 tp -119.35 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 112.884 -1.962 . . . . 0.0 108.319 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -104.01 125.78 50.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.594 1.184 . . . . 0.0 108.392 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 mm -113.82 134.2 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -67.1 88.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 124.362 1.039 . . . . 0.0 110.476 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.79 -1.576 . . . . 0.0 114.491 179.896 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' H ' ' HG ' ' A' ' 35' ' ' SER . . . -160.36 119.88 2.77 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.355 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.412 ' CB ' HD12 ' A' ' 72' ' ' ILE . 72.4 t80 -87.63 92.11 8.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.1 m -73.1 152.63 41.13 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 m -154.31 153.59 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.571 1.169 . . . . 0.0 110.26 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.409 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 29.8 m-90 -135.63 150.09 49.53 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 96.4 p -63.41 -10.44 17.09 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 106.71 158.83 21.65 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -73.43 -53.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.63 0 O-C-N 122.897 0.946 . . . . 0.0 110.885 25.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.51 -123.69 4.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 74.0 m -101.39 39.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.799 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.26 -130.65 0.3 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.1 p30 36.24 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -82.01 149.31 28.19 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.227 0.329 . . . . 0.0 110.261 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.63 152.72 23.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 123.765 0.666 . . . . 0.0 112.758 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -163.2 143.18 8.92 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.458 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -124.55 159.84 29.72 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.47 86.31 2.26 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.558 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -114.46 -8.17 12.81 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.25 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -54.6 121.01 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.19 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.45 97.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.421 1.076 . . . . 0.0 109.872 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.95 -177.48 21.88 Favored Glycine 0 N--CA 1.493 2.461 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.3 m -79.97 141.3 36.12 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.961 -1.119 . . . . 0.0 109.959 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.2 p -156.45 136.93 13.1 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.202 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.02 130.52 35.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 123.726 0.641 . . . . 0.0 112.614 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.2 mt -88.61 138.72 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -105.79 -56.27 2.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.041 0.838 . . . . 0.0 112.658 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.477 ' H ' ' CD ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -77.25 76.36 3.8 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 123.38 1.562 . . . . 0.0 111.146 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -71.93 18.87 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.245 -2.252 . . . . 0.0 115.46 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.35 -76.29 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.17 168.66 21.37 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -161.63 130.31 4.39 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -114.42 101.1 8.83 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.098 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -78.49 151.42 32.6 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.423 ' HG ' ' H ' ' A' ' 2' ' ' ALA . 77.9 p -135.82 147.55 48.33 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 124.782 1.301 . . . . 0.0 107.703 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CG ' ' N ' ' A' ' 37' ' ' THR . 77.8 t80 -132.14 156.74 45.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.359 1.037 . . . . 0.0 108.506 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' A' ' 36' ' ' TYR . 5.8 t -163.49 -24.21 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.022 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.05 -25.34 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -123.71 118.56 27.52 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.492 ' H ' ' NE2' ' A' ' 75' ' ' GLN . 60.8 m -83.62 170.65 14.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.009 -1.905 . . . . 0.0 109.406 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.77 159.57 41.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.013 0.821 . . . . 0.0 111.066 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.13 133.24 24.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.049 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.48 ' HG ' ' CE3' ' A' ' 69' ' ' TRP . 4.3 mm? -79.59 169.43 18.02 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.691 0.619 . . . . 0.0 109.433 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -153.52 124.06 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.512 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -70.67 -30.83 67.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.442 ' CD ' ' N ' ' A' ' 46' ' ' GLN . 3.5 mp0 -89.65 112.38 23.61 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -41.5 143.35 0.48 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.78 41.58 90.9 Favored Glycine 0 N--CA 1.497 2.724 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.963 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 60.7 m 52.76 30.8 9.44 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.162 0.566 . . . . 0.0 112.414 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.6 t -81.0 30.56 0.32 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.278 1.037 . . . . 0.0 113.006 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 49' ' ' CYS . . . -161.68 -161.66 12.12 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.6 t -95.64 145.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.97 148.56 50.89 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.571 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.619 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 12.6 t-80 -95.62 -69.41 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.417 ' HG1' ' HD1' ' A' ' 54' ' ' HIS . 60.5 m -112.36 118.84 36.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 123.94 0.775 . . . . 0.0 111.036 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -98.77 170.34 8.84 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.215 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.09 -172.39 2.82 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.424 0.63 . . . . 0.0 111.087 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.42 -36.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -145.53 159.32 43.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.877 -1.161 . . . . 0.0 108.99 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -42.29 117.39 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.53 90.26 3.3 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.761 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -75.29 69.78 2.15 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.09 168.3 11.73 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.798 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.38 8.97 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.779 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.92 157.16 83.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.12 156.28 65.5 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.074 1.849 . . . . 0.0 109.421 167.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CG ' ' CE3' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -138.14 -164.4 1.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.31 27.38 2.76 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.15 0.906 . . . . 0.0 112.663 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.619 ' HE1' ' CG ' ' A' ' 54' ' ' HIS . 4.9 m-90 -94.29 131.73 39.6 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -86.41 -18.11 32.61 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.379 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.2 p -156.42 179.55 9.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.292 0.995 . . . . 0.0 113.007 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.412 ' HB ' HD11 ' A' ' 43' ' ' LEU . 13.9 tt -153.35 141.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.344 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.588 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 69.2 t80 -104.97 135.15 46.85 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.497 -1.683 . . . . 0.0 107.907 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.6 mm -123.2 132.58 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.492 ' NE2' ' H ' ' A' ' 40' ' ' THR . 24.6 mt-30 -76.19 173.21 11.64 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 116.11 -1.9 . . . . 0.0 111.51 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.89 129.0 49.45 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -98.14 94.03 6.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 124.297 0.998 . . . . 0.0 109.838 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -77.09 155.17 32.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.577 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 25.2 m -154.56 160.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 124.211 0.944 . . . . 0.0 108.91 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -139.65 135.86 33.7 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -43.37 -44.28 5.55 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 147.1 151.65 5.47 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -79.44 -62.86 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.593 0 O-C-N 123.002 1.001 . . . . 0.0 111.794 18.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.43 -138.47 10.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.09 52.89 2.37 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.105 -1.047 . . . . 0.0 111.919 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -132.18 -130.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.1 p30 35.42 -144.01 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -66.31 149.36 50.48 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.11 148.73 45.35 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 123.44 0.462 . . . . 0.0 111.646 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -166.78 153.59 8.85 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.348 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -123.09 153.35 40.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.08 0.863 . . . . 0.0 111.313 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -134.59 79.87 1.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.523 -1.671 . . . . 0.0 107.423 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -103.45 8.97 37.9 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.731 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 138.05 57.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.164 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.95 155.91 36.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.009 0.818 . . . . 0.0 110.049 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.4 -92.47 1.66 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 103.828 -3.709 . . . . 0.0 103.828 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -171.56 164.79 6.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.93 1.018 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 p -160.0 141.73 12.84 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.448 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.49 135.77 36.73 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.451 HD11 ' HA ' ' A' ' 71' ' ' SER . 3.2 mp -102.98 156.38 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -121.22 -20.51 6.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 124.155 0.91 . . . . 0.0 110.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.36 97.34 2.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.15 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -90.1 62.91 5.68 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.04 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 -118.31 1.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.33 162.89 26.08 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 125.077 1.104 . . . . 0.0 111.325 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 14.9 p90 -161.73 136.01 6.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 3.4 t70 -120.76 165.88 14.5 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.362 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.41 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 70.3 t80 -133.86 155.61 49.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -147.21 85.56 1.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.36 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -49.09 133.82 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 112.948 -1.933 . . . . 0.0 113.293 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.4 m -152.48 82.85 1.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.73 19.06 57.92 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.83 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.429 ' HG2' ' N ' ' A' ' 76' ' ' CYS . 5.5 tp-100 -159.86 161.36 34.41 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.344 -0.943 . . . . 0.0 113.195 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -112.67 177.42 4.64 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.487 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.76 172.29 13.51 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.568 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.57 150.79 28.11 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.52 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -106.65 126.88 52.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.611 0.72 . . . . 0.0 111.365 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.64 101.47 10.78 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -61.36 -13.67 21.5 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.916 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -92.92 130.52 38.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.71 151.49 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.99 22.86 67.16 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.741 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 21.5 m 59.64 13.99 3.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.175 0.573 . . . . 0.0 112.471 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -87.61 63.04 7.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.939 0.775 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.0 -137.67 2.93 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.094 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.54 175.52 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.25 144.26 26.54 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.732 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -120.44 -51.46 2.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.8 m -123.18 121.51 36.1 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.505 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.68 118.89 37.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.253 0.971 . . . . 0.0 111.606 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -102.04 93.56 5.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.344 1.028 . . . . 0.0 108.351 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.29 -23.3 44.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.1 t -135.59 144.07 45.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.485 0.756 . . . . 0.0 109.258 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.442 ' H ' ' HG ' ' A' ' 60' ' ' SER . 14.3 m -35.06 124.01 0.58 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.435 1.084 . . . . 0.0 111.929 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.65 105.74 5.71 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.787 0.68 . . . . 0.0 111.13 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -76.44 75.18 3.19 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.325 1.016 . . . . 0.0 112.905 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.8 153.69 20.05 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.289 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.53 19.86 2.03 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -79.18 165.02 51.52 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -56.0 148.22 59.28 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.938 1.759 . . . . 0.0 110.372 172.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.27 173.01 4.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.788 0.68 . . . . 0.0 109.473 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.19 7.46 0.12 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.197 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.52 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.2 m-90 -128.29 -171.29 2.42 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.957 0.445 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.94 -24.67 3.44 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.451 ' HA ' HD11 ' A' ' 26' ' ' ILE . 10.1 p -146.53 163.69 34.96 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.681 0.613 . . . . 0.0 111.399 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.04 114.68 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.975 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -93.79 121.06 34.85 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.52 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.3 mt -130.08 128.54 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.425 ' CD ' ' H ' ' A' ' 75' ' ' GLN . 3.2 mp0 -78.35 9.86 3.54 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.429 ' N ' ' HG2' ' A' ' 39' ' ' GLN . 14.6 p . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.38 123.68 10.92 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CG ' HD13 ' A' ' 72' ' ' ILE . 67.3 t80 -89.65 104.6 17.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' ASP . 53.1 m -94.16 137.02 33.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -139.59 162.32 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.429 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 18.2 m-90 -128.18 140.33 51.97 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.449 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 78.2 p -55.58 -31.18 61.98 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.443 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 142.06 148.38 5.0 Favored Glycine 0 N--CA 1.5 2.929 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.41 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -73.61 -65.14 0.03 OUTLIER 'Cis proline' 0 N--CA 1.503 2.066 0 CA-C-N 118.428 1.114 . . . . 0.0 112.581 20.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.33 -125.42 4.12 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 105.393 -3.083 . . . . 0.0 105.393 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -99.27 73.01 1.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -139.18 -53.11 0.56 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.138 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 7' ' ' SER . 7.6 p30 -57.22 -136.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.926 -1.943 . . . . 0.0 116.145 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -58.13 141.07 51.42 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.17 82.24 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 124.73 1.269 . . . . 0.0 111.168 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.67 165.03 14.47 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.189 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -152.19 156.21 39.32 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.454 0.645 . . . . 0.0 112.374 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.93 69.19 1.36 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.2 t -90.7 -18.64 24.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.355 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -57.09 129.59 42.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.609 0.568 . . . . 0.0 111.602 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.48 122.18 15.64 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.552 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.43 -169.99 13.51 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-O 122.596 1.109 . . . . 0.0 114.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.5 t -56.74 130.38 45.29 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.612 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -160.81 120.42 2.68 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.615 0.572 . . . . 0.0 111.02 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.72 126.3 30.76 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 mt -87.75 154.52 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -138.6 -9.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.571 0.545 . . . . 0.0 110.939 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.86 105.32 7.85 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.165 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.76 62.01 5.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.177 0.923 . . . . 0.0 108.845 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.74 -108.27 0.69 Allowed Glycine 0 N--CA 1.497 2.744 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.06 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.03 166.49 21.25 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -146.1 165.5 28.91 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 3.2 t70 -169.22 163.11 10.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.424 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 58.0 t80 -138.61 155.81 48.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -142.3 94.8 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.19 0.932 . . . . 0.0 109.436 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.86 151.42 31.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.042 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -174.19 -22.8 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.366 1.041 . . . . 0.0 108.653 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.37 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -122.02 159.81 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.5 p -91.11 -163.8 1.09 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.844 -1.98 . . . . 0.0 110.444 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.405 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . . . -155.11 176.18 12.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.9 131.21 6.75 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 114.942 -1.027 . . . . 0.0 108.308 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.485 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -92.12 154.94 18.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.81 120.04 14.7 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.802 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -62.86 -7.48 5.18 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -118.05 122.08 42.24 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.856 0.722 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -40.08 145.84 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 124.685 1.241 . . . . 0.0 113.749 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.99 42.47 96.9 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.819 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.487 ' H ' ' HG ' ' A' ' 71' ' ' SER . 25.7 p 44.11 25.57 0.12 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.156 1.15 . . . . 0.0 112.977 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 t -87.24 44.02 1.15 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.633 0.73 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.54 -155.26 6.39 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.405 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.55 150.14 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.04 156.52 33.52 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.336 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.435 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -141.3 -45.88 0.38 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.026 0.829 . . . . 0.0 110.968 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -137.13 118.89 15.07 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.775 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -105.37 162.48 13.41 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.738 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -139.65 133.88 31.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.043 0.839 . . . . 0.0 110.351 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.87 14.9 5.18 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.5 t -162.68 124.17 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 m -35.88 113.88 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 124.291 0.994 . . . . 0.0 112.955 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.84 15.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.957 0.786 . . . . 0.0 110.529 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -86.95 94.46 9.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 158.94 16.53 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.49 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.2 m -151.37 15.08 0.7 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -88.56 166.24 23.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.01 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -50.03 165.23 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.692 2.261 . . . . 0.0 112.245 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.58 179.36 2.14 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.556 0.694 . . . . 0.0 111.804 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.22 -5.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.141 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.485 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.6 m-90 -138.79 -156.19 0.66 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -140.87 -40.74 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.487 ' HG ' ' H ' ' A' ' 49' ' ' CYS . 58.7 p -131.95 178.38 6.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 124.704 1.253 . . . . 0.0 111.377 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.486 HD13 ' CG ' ' A' ' 3' ' ' PHE . 11.2 tt -150.91 147.39 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.77 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -119.94 130.42 54.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.528 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.36 152.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 66.7 mt-30 -73.85 -159.59 0.08 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 75' ' ' GLN . 24.4 p . . . . . 0 N--CA 1.504 2.23 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.59 134.5 42.38 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.377 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -109.15 91.3 3.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.437 1.086 . . . . 0.0 108.85 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.0 m -81.25 133.81 35.5 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.978 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.14 145.65 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 123.645 0.591 . . . . 0.0 111.382 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.442 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 8.4 m-90 -114.3 143.27 45.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 79.1 p -64.34 -10.27 23.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' N ' ' HA3' ' A' ' 30' ' ' GLY . . . 120.35 154.6 9.42 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 123.596 0.56 . . . . 0.0 113.326 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -75.35 -64.18 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.835 0 O-C-N 123.221 1.116 . . . . 0.0 112.468 12.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.42 -136.13 6.39 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -106.12 66.07 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.411 -1.395 . . . . 0.0 109.792 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -141.86 -59.39 0.47 Allowed 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.774 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 7' ' ' SER . 2.0 p30 -32.56 -104.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -72.18 -164.16 0.13 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.412 1.005 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.69 59.68 0.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.834 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.13 151.14 28.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -145.75 116.81 7.82 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.385 0.612 . . . . 0.0 111.488 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HH ' ' H ' ' A' ' 27' ' ' HIS . 27.7 m-85 -97.9 73.08 2.26 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.884 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.7 p -81.32 -14.29 57.48 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -64.63 133.27 51.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 123.949 0.781 . . . . 0.0 110.835 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.6 m -63.29 175.51 0.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.359 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.74 -161.94 45.85 Favored Glycine 0 N--CA 1.492 2.381 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.18 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -97.95 125.27 42.79 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.5 p -131.14 135.84 47.82 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.003 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.99 117.8 20.4 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.52 138.01 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.377 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.41 ' H ' ' HH ' ' A' ' 18' ' ' TYR . 67.4 m80 -118.86 59.59 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.99 98.77 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.663 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -91.3 61.11 4.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA3' ' N ' ' A' ' 8' ' ' GLY . . . -144.06 -109.63 0.68 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.647 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.72 166.87 21.75 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -147.37 147.29 30.15 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -151.0 154.21 36.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -128.16 157.6 40.36 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.1 m -144.52 93.57 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.774 0.797 . . . . 0.0 110.016 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -71.4 151.75 43.76 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.775 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -172.76 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.222 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.53 -64.59 0.22 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -126.83 166.17 17.95 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.423 ' HG1' ' NH2' ' A' ' 56' ' ' ARG . 82.5 p -93.06 171.97 8.61 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.888 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.78 178.55 5.87 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.579 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.88 131.61 6.98 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.94 161.63 23.0 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -137.61 106.5 5.95 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.556 -2.111 . . . . 0.0 107.92 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -55.27 -23.67 24.17 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.316 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -95.98 135.57 37.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.161 0.913 . . . . 0.0 109.768 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.47 119.06 1.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.898 1.374 . . . . 0.0 113.074 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 43.71 74.21 0.21 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 124.618 1.199 . . . . 0.0 113.458 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.45 ' H ' ' HG ' ' A' ' 71' ' ' SER . 1.0 OUTLIER 44.22 25.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m -82.35 32.13 0.4 Allowed 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.988 0.899 . . . . 0.0 112.238 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 49' ' ' CYS . . . -161.74 -129.61 1.04 Allowed Glycine 0 N--CA 1.49 2.257 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.2 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -127.22 162.21 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.33 -177.39 1.12 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.046 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -148.62 -60.88 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.3 m -104.22 167.6 9.65 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.069 0.856 . . . . 0.0 109.796 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.423 ' NH2' ' HG1' ' A' ' 40' ' ' THR . 20.5 mmm180 -142.45 144.77 33.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.462 1.101 . . . . 0.0 109.923 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -128.12 100.62 5.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.102 0.876 . . . . 0.0 109.528 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.37 -25.17 52.15 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.954 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.9 p -148.99 148.29 29.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.07 0.512 . . . . 0.0 111.339 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -33.78 115.32 0.22 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 124.434 1.083 . . . . 0.0 112.353 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.73 108.58 10.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.097 0.873 . . . . 0.0 111.644 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -82.03 87.5 6.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.101 0.876 . . . . 0.0 112.999 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 163.26 14.69 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.87 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 m -148.0 11.6 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.14 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -69.76 164.13 53.77 Favored Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.234 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.54 165.02 1.81 Allowed 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.45 2.1 . . . . 0.0 110.464 167.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.57 174.01 3.77 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.694 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.48 -3.52 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -143.13 -176.02 4.75 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -114.26 -39.34 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 49' ' ' CYS . 19.7 p -132.58 165.7 23.79 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.35 112.75 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.204 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -90.81 143.37 26.79 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.445 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.6 mt -135.05 132.5 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -60.2 -37.58 80.7 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.162 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 115.71 -2.09 . . . . 0.0 115.114 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.12 121.03 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.439 ' CB ' HD11 ' A' ' 72' ' ' ILE . 70.7 t80 -97.83 84.47 3.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.293 0.996 . . . . 0.0 110.076 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -68.07 151.04 47.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.74 154.93 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.428 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.5 m-90 -134.08 140.8 46.87 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.3 p -48.88 -43.33 38.96 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.476 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.11 157.27 7.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -81.47 -62.13 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.537 0 O-C-N 123.023 1.012 . . . . 0.0 110.33 14.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -128.0 3.12 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -106.98 49.61 0.8 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.706 -1.247 . . . . 0.0 109.308 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -119.49 -128.49 0.28 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.476 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 11.0 p30 35.94 -142.11 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -77.06 140.12 40.22 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.41 131.33 49.14 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.837 0.711 . . . . 0.0 110.662 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -136.83 118.37 14.85 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -98.23 124.67 42.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.276 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.14 81.98 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.9 m -106.21 -20.1 13.5 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.773 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -50.16 139.38 14.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.368 1.043 . . . . 0.0 112.912 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 162.69 11.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -151.16 43.3 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 22.0 p -129.98 154.19 47.63 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.029 -1.068 . . . . 0.0 113.558 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -143.39 151.76 40.79 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.118 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.47 124.47 28.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.031 0.832 . . . . 0.0 112.09 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.71 118.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -93.14 -25.67 17.77 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.467 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -78.91 102.52 8.3 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 80.3 tttt -90.06 13.49 14.78 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.181 0.926 . . . . 0.0 111.43 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.32 -90.02 0.37 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.466 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.48 169.86 21.18 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -162.0 136.4 6.83 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -120.35 131.79 55.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.441 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.434 ' CG ' ' N ' ' A' ' 35' ' ' SER . 59.5 t80 -101.55 160.65 14.26 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.3 t -147.0 90.14 1.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -74.71 137.27 41.98 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.886 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -148.95 -44.99 0.14 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.751 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.8 -42.37 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.04 134.4 55.0 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.2 m -81.61 168.9 17.68 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.679 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.94 24.28 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.666 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.08 146.19 28.75 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD11 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -109.33 98.8 8.15 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.252 -179.546 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -75.63 130.48 38.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.764 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -94.59 27.71 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.498 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.36 145.21 29.21 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.93 142.32 12.02 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.425 -1.261 . . . . 0.0 114.281 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.93 33.46 13.4 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 113.538 -1.664 . . . . 0.0 113.512 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.3 p 41.44 42.76 1.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.7 p -98.78 47.4 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.633 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.71 -128.34 0.95 Allowed Glycine 0 N--CA 1.498 2.816 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.487 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -119.3 140.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.471 0.748 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.49 153.1 27.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -107.65 -36.81 6.33 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.12 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -138.82 123.74 18.84 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.07 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -101.7 163.29 12.33 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -138.86 92.8 2.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.668 0.605 . . . . 0.0 112.459 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.02 16.07 62.11 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.8 t -170.46 138.31 1.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.1 p -44.61 129.45 6.85 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.06 97.05 4.5 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.97 0.794 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.0 mtt-85 -72.04 71.65 0.83 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.06 14.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.326 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.5 m -142.95 -11.26 0.77 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -71.47 156.41 91.52 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.964 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.37 176.98 0.93 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.684 2.256 . . . . 0.0 112.056 173.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.413 ' CE1' ' HA ' ' A' ' 29' ' ' LYS . 39.8 p90 -158.12 -167.45 2.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.088 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.43 56.52 0.46 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.455 ' CG ' HD11 ' A' ' 43' ' ' LEU . 5.0 m-90 -109.36 163.38 13.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.68 -44.58 5.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.54 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 p -155.41 164.65 38.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.716 1.26 . . . . 0.0 112.432 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.439 HD11 ' CB ' ' A' ' 3' ' ' PHE . 7.1 tt -125.98 129.83 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.721 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -99.22 147.69 24.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 125.255 1.597 . . . . 0.0 107.418 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.3 mt -141.97 137.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.99 149.46 32.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.947 0.779 . . . . 0.0 111.267 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 116.919 -1.515 . . . . 0.0 110.515 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 19' ' ' SER . . . -157.39 107.84 2.25 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CB ' HD12 ' A' ' 72' ' ' ILE . 56.2 t80 -96.89 93.78 6.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.051 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -76.17 148.2 37.93 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 m -149.64 132.36 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.8 0.688 . . . . 0.0 110.384 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.483 ' CD1' ' HB3' ' A' ' 15' ' ' ALA . 23.6 m-90 -103.72 152.21 22.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -65.25 -10.41 31.8 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.837 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.97 160.75 19.71 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 123.976 0.798 . . . . 0.0 112.066 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.93 -58.61 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 O-C-N 123.134 1.07 . . . . 0.0 111.797 17.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.21 -132.06 7.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 69.1 m -109.77 73.11 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.45 -51.03 0.47 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.933 0.873 . . . . 0.0 110.401 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.508 ' H ' HD21 ' A' ' 13' ' ' ASN . 2.9 p30 -56.93 -159.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.417 -2.174 . . . . 0.0 114.302 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -70.55 172.92 7.71 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . . . -155.83 178.34 10.38 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -150.08 141.16 23.01 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 111.362 -2.654 . . . . 0.0 105.256 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.33 131.02 53.95 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.524 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.419 ' HH ' HE22 ' A' ' 28' ' ' GLN . 88.8 m-85 -103.96 68.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.652 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 58.6 p -86.8 -13.23 45.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -59.1 124.94 21.62 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.38 123.65 21.77 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.504 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -167.73 13.89 Favored Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -78.48 145.75 34.79 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.1 p -160.04 131.77 6.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.611 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.81 138.28 38.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 123.641 0.588 . . . . 0.0 111.784 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.27 146.32 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -125.7 -22.55 4.21 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.041 0.838 . . . . 0.0 109.876 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.435 ' H ' ' NE2' ' A' ' 28' ' ' GLN . 3.9 mp0 -74.45 100.25 3.78 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.197 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.14 62.93 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.221 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.41 -105.49 1.17 Allowed Glycine 0 N--CA 1.495 2.614 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.25 170.63 14.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -161.27 130.17 4.56 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -114.69 105.81 13.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.375 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 35' ' ' SER . 83.6 t80 -80.7 157.48 25.88 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.201 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.3 m -142.47 129.23 20.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 124.843 1.339 . . . . 0.0 108.992 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -112.05 146.84 37.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.6 t -164.06 -33.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.695 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.64 -9.31 0.05 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -131.21 131.96 44.34 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 m -81.96 174.14 11.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.29 159.2 43.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.614 0.721 . . . . 0.0 112.14 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.54 145.84 35.61 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.665 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.441 HD12 ' CE2' ' A' ' 57' ' ' PHE . 47.5 mt -116.55 96.24 5.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.458 0.647 . . . . 0.0 112.073 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -85.94 136.0 33.44 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.741 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -87.2 5.08 39.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.347 -1.751 . . . . 0.0 110.726 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -115.97 150.54 37.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.855 0.722 . . . . 0.0 110.827 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 132.97 54.69 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.522 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.88 31.03 74.59 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.365 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.0 m 55.41 30.74 15.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.6 t -90.76 59.51 4.19 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.151 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.02 -147.7 5.0 Favored Glycine 0 N--CA 1.497 2.713 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.174 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -111.24 142.5 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 114.239 -0.98 . . . . 0.0 108.366 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.82 119.7 23.07 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.45 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -79.58 -36.54 38.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.3 m -145.65 133.79 21.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.049 0.843 . . . . 0.0 110.035 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -118.92 149.62 41.27 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.096 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 43' ' ' LEU . 25.7 m-85 -123.2 132.07 53.91 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.055 0.847 . . . . 0.0 111.143 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -2.42 11.22 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -154.32 139.52 17.5 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.4 m -37.73 120.26 0.81 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.04 0.838 . . . . 0.0 112.75 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.71 88.1 2.83 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 124.111 0.882 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -73.72 69.8 1.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.43 14.65 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.734 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.9 m -147.77 36.37 0.87 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.775 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -110.04 162.42 20.49 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.132 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.44 175.64 3.29 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.452 2.101 . . . . 0.0 111.649 171.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 15.4 p90 -161.22 -165.51 1.35 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.31 56.11 0.41 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.426 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.4 m0 -114.8 127.45 55.73 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -82.54 -8.48 59.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 123.72 0.637 . . . . 0.0 109.968 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.8 p -174.29 165.25 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.466 1.104 . . . . 0.0 112.213 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.45 HD12 ' CB ' ' A' ' 3' ' ' PHE . 11.1 tt -134.18 122.35 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-N 112.627 -2.078 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -99.48 107.8 20.08 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.847 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.7 mt -104.62 147.56 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.364 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -72.21 -172.4 0.9 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.118 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 116.25 -1.833 . . . . 0.0 110.387 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.49 142.77 1.69 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.655 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.41 ' CE2' ' CG1' ' A' ' 5' ' ' VAL . 88.7 t80 -93.87 104.04 16.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.696 1.248 . . . . 0.0 112.3 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -81.2 158.72 24.79 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG1' ' CE2' ' A' ' 3' ' ' PHE . 10.3 m -153.62 122.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 124.008 0.818 . . . . 0.0 112.184 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.502 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.1 m-90 -95.58 146.5 24.42 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.6 p -60.44 -16.61 37.91 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.362 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.19 162.54 13.14 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 124.283 0.99 . . . . 0.0 112.181 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -75.21 -59.64 0.11 OUTLIER 'Cis proline' 0 N--CA 1.498 1.766 0 O-C-N 123.12 1.063 . . . . 0.0 111.053 11.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.47 -147.63 22.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 6' ' ' TRP . 7.6 p -102.25 66.84 1.02 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -136.89 -49.16 0.63 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.502 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 3.8 p30 -56.97 -152.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.256 -1.793 . . . . 0.0 114.519 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -74.35 162.49 28.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.7 12.97 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -147.39 154.88 41.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.997 -1.911 . . . . 0.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -115.95 144.34 44.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.737 0.648 . . . . 0.0 110.604 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -125.94 95.48 4.43 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.773 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -114.52 -7.43 12.81 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.894 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -49.7 123.29 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.881 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 23.8 t -72.71 90.23 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.745 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.24 113.59 21.7 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -124.87 132.93 53.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.882 0.739 . . . . 0.0 112.939 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.87 116.7 21.65 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.546 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.9 135.95 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.551 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -106.87 -32.12 8.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.571 1.169 . . . . 0.0 111.37 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -79.44 91.62 5.14 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.593 1.187 . . . . 0.0 108.173 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -90.49 62.72 5.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.566 -2.106 . . . . 0.0 111.753 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.08 -113.48 1.33 Allowed Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.022 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 165.44 34.03 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -161.89 129.47 4.01 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 1.1 t70 -112.07 167.98 9.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.6 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.409 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 59.5 t80 -148.41 155.33 41.09 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.184 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 58.5 m -137.25 147.11 45.51 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -134.3 145.53 49.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.717 1.261 . . . . 0.0 109.768 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -172.85 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.751 0.657 . . . . 0.0 111.561 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.8 -12.64 1.3 Allowed Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.044 0.84 . . . . 0.0 111.536 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.31 20.55 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.7 m -84.56 166.65 17.01 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.938 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.41 157.7 46.0 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 131.89 10.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.914 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.71 163.61 13.69 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 49' ' ' CYS . 5.6 p90 -167.75 135.08 2.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.652 -2.067 . . . . 0.0 108.905 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.473 ' H ' HD21 ' A' ' 45' ' ' ASN . 2.0 m-80 -66.91 11.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.261 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.41 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 mm-40 -131.69 113.54 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.394 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -40.61 147.41 0.11 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.618 1.199 . . . . 0.0 112.428 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.98 44.74 62.08 Favored Glycine 0 N--CA 1.499 2.846 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.725 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.461 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 5.1 p 42.06 36.84 0.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 m -95.54 42.69 1.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.748 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.19 -164.4 15.21 Favored Glycine 0 N--CA 1.5 2.961 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.229 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.43 153.69 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.46 143.94 26.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.409 ' CD2' ' ND2' ' A' ' 45' ' ' ASN . 20.9 m-70 -112.62 -52.69 2.77 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.662 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -122.75 106.37 10.87 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -96.4 117.39 30.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.215 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -91.75 108.33 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 123.717 0.636 . . . . 0.0 110.521 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.93 45.51 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 t -146.32 159.85 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.46 0.741 . . . . 0.0 109.374 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.0 p -36.05 124.72 0.75 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.218 0.949 . . . . 0.0 113.308 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.42 101.21 5.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.143 0.902 . . . . 0.0 110.65 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -84.46 68.52 10.31 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.37 168.87 15.18 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.397 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 16.7 m -147.88 10.83 0.93 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -67.54 164.29 39.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.42 147.14 79.64 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 110.559 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.62 162.21 6.8 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 124.012 0.82 . . . . 0.0 109.874 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.55 18.76 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -136.14 -155.67 0.65 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.562 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 19.4 ttmm -141.1 -32.31 0.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -154.26 162.46 41.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.091 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.405 HD12 ' CB ' ' A' ' 3' ' ' PHE . 16.7 tt -129.44 143.6 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.015 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -113.67 132.1 55.91 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.488 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.0 mt -138.09 146.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 124.263 0.977 . . . . 0.0 108.753 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -88.41 169.08 12.1 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 91.4 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 116.099 -1.905 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.865 0.364 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.09 52.19 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.324 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -110.8 151.99 27.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.0 m -140.13 148.65 41.98 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 m -154.69 155.04 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.347 1.029 . . . . 0.0 112.854 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.5 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 9.1 m-90 -125.83 154.35 42.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.6 m -78.48 -13.35 59.87 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.49 145.62 4.3 Favored Glycine 0 N--CA 1.504 3.231 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.687 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -76.04 -53.78 0.15 OUTLIER 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 118.171 0.985 . . . . 0.0 110.091 8.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.22 -127.6 4.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 105.25 -3.14 . . . . 0.0 105.25 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.438 ' H ' ' HB3' ' A' ' 64' ' ' CYS . 21.8 p -96.87 57.53 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -138.81 53.33 1.77 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.674 -0.811 . . . . 0.0 112.425 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -173.53 -122.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.66 145.87 3.42 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 123.428 0.691 . . . . 0.0 112.576 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.88 114.89 22.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -149.64 132.57 16.13 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -119.2 163.63 16.79 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.7 95.74 2.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.305 -1.77 . . . . 0.0 106.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.0 t -112.86 -22.33 10.71 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -51.33 147.13 6.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 123.859 0.724 . . . . 0.0 112.728 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.3 t -60.51 160.3 9.14 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.19 -148.01 32.37 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 27.8 p -128.9 172.26 11.5 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.1 p -151.55 136.93 17.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.438 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.93 112.56 17.34 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.979 0.799 . . . . 0.0 111.788 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.02 146.48 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.989 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -125.18 -14.51 6.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.382 1.051 . . . . 0.0 108.456 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -70.69 100.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -86.99 56.64 4.1 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.551 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.1 -97.16 0.63 Allowed Glycine 0 N--CA 1.501 3.017 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.231 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.1 162.35 14.01 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -144.56 108.72 4.78 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.367 1.079 . . . . 0.0 111.788 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -108.7 162.31 14.29 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.18 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -148.67 157.77 43.68 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.53 -1.213 . . . . 0.0 108.469 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 t -146.68 103.1 3.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 124.668 1.23 . . . . 0.0 108.947 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -79.05 151.81 31.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.282 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -174.82 73.39 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.86 -37.19 2.32 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.021 -1.899 . . . . 0.0 111.402 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -89.9 125.49 35.37 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.507 0.67 . . . . 0.0 112.188 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 m -85.58 164.15 17.93 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.284 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.4 148.42 27.45 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.374 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.5 148.53 34.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 124.479 1.112 . . . . 0.0 109.684 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.482 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -87.13 159.69 18.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.206 1.003 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -137.91 113.84 9.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 111.58 -2.555 . . . . 0.0 108.331 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.485 ' H ' ' CD2' ' A' ' 54' ' ' HIS . 16.7 t30 -55.47 -14.62 2.09 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.349 1.031 . . . . 0.0 113.11 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.4 ' CD ' ' N ' ' A' ' 46' ' ' GLN . 2.9 pm0 -119.51 132.13 55.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.134 0.896 . . . . 0.0 109.983 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.94 150.58 0.26 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 114.038 -1.437 . . . . 0.0 113.592 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.9 34.03 37.05 Favored Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.421 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.557 ' H ' ' HG ' ' A' ' 71' ' ' SER . 22.4 p 39.03 44.66 0.92 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.783 0.931 . . . . 0.0 112.454 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -86.07 37.7 0.73 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.337 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.86 -145.64 4.36 Favored Glycine 0 N--CA 1.495 2.576 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.321 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -103.88 157.18 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.65 175.73 6.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.808 0.693 . . . . 0.0 111.434 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.485 ' CD2' ' H ' ' A' ' 45' ' ' ASN . 69.4 m-70 -142.83 -59.0 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 123.974 0.796 . . . . 0.0 111.717 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.9 m -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.885 0.74 . . . . 0.0 111.312 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.8 ttt85 -95.35 163.63 13.17 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.684 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -140.72 149.72 42.54 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.38 -5.19 3.01 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 124.638 1.211 . . . . 0.0 110.159 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.4 m -149.86 150.81 32.49 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.7 p -45.66 119.27 2.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.889 0.743 . . . . 0.0 111.172 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.49 92.01 3.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.12 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -82.96 68.31 9.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.158 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.02 159.13 21.26 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.869 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.438 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 58.5 m -138.96 27.12 2.42 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.064 0.935 . . . . 0.0 109.449 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -82.7 164.96 44.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.644 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.05 167.44 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.356 2.037 . . . . 0.0 110.649 170.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.27 177.1 2.93 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.823 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.0 -6.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.482 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 4.0 m-90 -142.5 -160.54 1.11 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -128.74 -45.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 123.28 0.362 . . . . 0.0 111.341 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.557 ' HG ' ' H ' ' A' ' 49' ' ' CYS . 26.2 p -124.77 166.01 16.98 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 124.337 1.023 . . . . 0.0 112.745 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.52 126.22 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -106.01 143.04 34.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.1 mt -143.49 117.19 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.81 162.27 28.82 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.022 0.826 . . . . 0.0 110.829 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.156 -1.878 . . . . 0.0 110.702 179.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.21 147.21 14.38 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 36.2 t80 -97.91 108.44 21.15 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.084 -1.417 . . . . 0.0 109.537 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 m -93.49 131.47 38.68 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 m -136.49 148.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 123.668 0.605 . . . . 0.0 111.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.402 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 21.2 m-90 -115.76 160.75 19.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.7 p -69.55 -9.97 56.2 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.61 153.41 18.2 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 123.752 0.657 . . . . 0.0 111.584 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.41 -64.25 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.685 0 O-C-N 123.118 1.062 . . . . 0.0 111.656 17.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.86 -150.87 15.62 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -93.07 41.97 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.824 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -124.41 -128.32 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 38.3 -142.05 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -70.75 140.78 51.44 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -106.86 148.22 28.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.083 0.865 . . . . 0.0 111.194 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.29 167.21 30.7 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -140.17 158.84 43.41 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.463 0.649 . . . . 0.0 112.317 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -142.36 84.84 1.88 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.869 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -112.98 17.22 19.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.739 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -63.07 127.32 30.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.758 0.789 . . . . 0.0 111.364 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -73.34 119.69 17.93 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.545 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.58 -98.58 0.88 Allowed Glycine 0 N--CA 1.493 2.439 0 O-C-N 124.535 1.147 . . . . 0.0 111.182 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.473 ' SG ' ' CD2' ' A' ' 73' ' ' PHE . 60.1 m -142.24 147.03 35.82 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.157 0.563 . . . . 0.0 112.132 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.6 p -160.42 126.83 4.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.72 126.88 31.51 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 136.65 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 123.757 0.66 . . . . 0.0 109.687 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -100.97 -46.57 5.06 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.477 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.53 ' N ' HE21 ' A' ' 28' ' ' GLN . 0.0 OUTLIER -51.43 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.704 1.252 . . . . 0.0 111.944 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -90.47 68.96 6.83 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.243 1.021 . . . . 0.0 108.596 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.84 -106.73 0.26 Allowed Glycine 0 N--CA 1.493 2.499 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.463 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.46 160.03 27.64 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CE1' ' CE2' ' A' ' 67' ' ' PHE . 49.2 m-85 -147.61 159.05 44.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.585 0.815 . . . . 0.0 108.879 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -169.8 159.42 7.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 59.7 t80 -135.54 159.87 40.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 t -147.14 91.36 1.98 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.469 1.106 . . . . 0.0 108.269 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -70.33 150.3 46.47 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.075 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.5 p -140.08 -35.26 0.52 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.99 -12.09 0.02 OUTLIER Glycine 0 N--CA 1.479 1.558 0 CA-C-N 112.322 -2.217 . . . . 0.0 108.24 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -112.77 126.81 55.83 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.2 m -81.21 168.43 18.51 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.035 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.91 113.54 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.477 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.55 165.33 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 57' ' ' PHE . 40.0 mt -129.56 102.36 6.34 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.391 0.615 . . . . 0.0 109.639 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.463 ' CG ' ' HA ' ' A' ' 49' ' ' CYS . 59.7 m-85 -84.01 133.42 34.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.718 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -74.23 -8.64 56.9 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -120.64 138.35 53.97 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.27 145.61 1.63 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.94 54.4 11.94 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.974 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 44' ' ' TYR . 25.7 p 44.31 22.29 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 t -90.55 45.51 1.27 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.542 0.687 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.81 -130.81 2.04 Favored Glycine 0 N--CA 1.495 2.605 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.387 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.31 144.21 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 124.595 0.821 . . . . 0.0 109.44 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.69 103.69 5.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.517 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.32 -40.2 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.779 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.5 m -144.03 164.75 29.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.152 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -147.1 -172.38 3.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.718 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 43' ' ' LEU . 53.7 m-85 -143.81 104.24 4.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.023 0.827 . . . . 0.0 112.858 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.65 -12.23 55.96 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 t -153.8 141.93 20.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 91.2 p -41.16 132.85 2.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.66 121.83 7.76 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 123.994 0.809 . . . . 0.0 111.968 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -83.37 91.85 7.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 60.99 4.6 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 m -57.03 -18.27 13.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -77.2 160.18 76.35 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.82 139.91 68.26 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.091 1.861 . . . . 0.0 109.163 169.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.04 -146.17 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.39 21.2 0.28 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.038 -1.077 . . . . 0.0 114.996 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 5.3 m-90 -108.15 146.36 32.83 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -84.41 -46.69 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.0 p -131.65 174.7 9.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 124.496 1.123 . . . . 0.0 113.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.1 tt -136.52 137.37 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 112.699 -2.046 . . . . 0.0 109.967 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.473 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 4.7 t80 -107.98 129.91 55.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.2 mt -119.3 129.63 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -61.61 80.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.789 1.93 . . . . 0.0 114.109 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.319 179.858 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.59 104.69 2.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.945 0.778 . . . . 0.0 110.348 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 45.9 t80 -96.87 89.29 4.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -75.42 152.52 37.98 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 m -148.84 158.13 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.693 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.44 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.6 m-90 -134.59 145.44 48.66 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.417 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 84.1 p -61.54 -38.98 89.42 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.35 149.71 6.15 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.723 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -78.51 -56.13 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.808 0 N-CA-C 109.34 -1.061 . . . . 0.0 109.34 9.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.77 -132.54 6.18 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 64' ' ' CYS . 25.0 p -89.65 48.23 1.57 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -140.01 80.18 1.75 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.324 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.44 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 5.8 p30 171.71 -146.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.528 HH12 HE21 ' A' ' 28' ' ' GLN . 5.6 ptm180 -64.91 171.28 3.6 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.0 23.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -161.18 134.14 6.31 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -108.23 131.62 54.49 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -110.15 78.7 1.14 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.08 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -116.16 -8.2 11.78 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.98 139.7 58.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.052 0.845 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.16 104.71 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.002 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.09 -177.12 19.58 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.126 0.892 . . . . 0.0 113.117 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 m -77.2 143.31 39.12 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.749 -1.225 . . . . 0.0 109.923 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.4 p -148.11 126.69 12.47 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.012 0.82 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.32 119.47 22.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.354 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.63 115.41 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.134 -1.393 . . . . 0.0 109.451 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -95.2 -29.29 14.61 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.528 HE21 HH12 ' A' ' 14' ' ' ARG . 22.7 mp0 -77.91 95.61 4.81 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.862 0.726 . . . . 0.0 109.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -80.56 40.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.53 -103.3 2.75 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.06 18.55 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.6 m-85 -150.84 120.54 7.01 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -114.98 106.76 14.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.196 0.31 . . . . 0.0 110.817 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -80.95 157.68 25.47 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -148.15 109.12 4.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.353 1.033 . . . . 0.0 108.55 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -84.03 152.21 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.483 -2.144 . . . . 0.0 110.536 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.42 52.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.7 -32.0 5.55 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.583 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -94.15 125.3 38.7 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.477 0.656 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 41' ' ' ALA . 23.3 m -86.54 -170.49 3.1 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.584 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.51 ' H ' HG22 ' A' ' 40' ' ' THR . . . -160.23 151.1 18.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.76 152.74 41.84 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.513 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.3 mm? -117.22 123.59 47.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.315 0.384 . . . . 0.0 111.359 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.431 ' C ' ' H ' ' A' ' 46' ' ' GLN . 96.3 m-85 -115.51 128.86 56.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 125.067 1.479 . . . . 0.0 108.496 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -73.66 13.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.877 0.736 . . . . 0.0 112.02 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 44' ' ' TYR . 62.1 mm-40 -133.67 127.26 32.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.46 139.03 2.2 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.58 50.69 56.29 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.783 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 79.4 m 50.27 23.49 1.22 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.4 m -83.93 40.79 0.77 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.402 0.62 . . . . 0.0 112.424 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.17 -149.96 5.5 Favored Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.237 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.85 145.74 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.76 164.95 4.28 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.929 0.768 . . . . 0.0 111.921 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.488 ' HD1' ' HG1' ' A' ' 55' ' ' THR . 23.6 t-80 -146.59 -48.85 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.441 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.488 ' HG1' ' HD1' ' A' ' 54' ' ' HIS . 27.1 m -133.07 152.27 51.97 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.134 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -141.03 119.17 12.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.06 122.0 39.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.091 0.87 . . . . 0.0 111.35 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.65 24.38 4.91 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.0 p -165.46 128.9 2.23 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.595 -0.802 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.0 m -41.27 110.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.12 0.887 . . . . 0.0 111.967 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.16 91.58 3.56 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.271 0.982 . . . . 0.0 111.19 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -74.29 79.96 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.39 144.96 25.32 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.136 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 66.8 m -134.73 47.02 2.4 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.446 1.117 . . . . 0.0 109.242 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -140.75 154.95 69.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.683 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -55.83 156.11 20.33 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.988 2.459 . . . . 0.0 111.611 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.49 -135.63 0.29 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.866 0.729 . . . . 0.0 112.182 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.28 -3.33 0.06 OUTLIER Glycine 0 N--CA 1.497 2.75 0 CA-C-O 118.601 -1.11 . . . . 0.0 115.251 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.513 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 3.0 m-90 -90.62 166.57 13.11 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.77 1.285 . . . . 0.0 110.395 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -100.19 -41.58 7.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.828 0.705 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.8 p -138.1 177.09 8.14 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.314 1.009 . . . . 0.0 112.391 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.419 HD13 ' CB ' ' A' ' 3' ' ' PHE . 15.3 tt -144.39 127.33 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.695 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.603 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 7.3 t80 -84.85 94.4 8.73 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.406 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -76.9 116.26 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.366 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -68.66 137.12 53.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 123.906 0.754 . . . . 0.0 110.407 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.672 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.93 121.13 26.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 33.3 t80 -92.78 173.86 7.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.1 m -158.84 152.85 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -150.91 158.18 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.671 1.232 . . . . 0.0 108.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.437 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.1 m-90 -132.5 145.85 51.48 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -52.43 -42.71 64.33 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 145.08 152.55 5.65 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -82.07 -60.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 123.15 1.079 . . . . 0.0 111.53 17.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.56 -141.55 11.09 Favored Glycine 0 N--CA 1.485 1.917 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 p -94.31 44.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.656 -1.272 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -123.21 -129.3 0.26 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.433 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 38.2 -144.31 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -76.81 128.27 34.3 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -94.43 154.02 17.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.186 0.929 . . . . 0.0 112.266 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -161.64 118.51 2.17 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.447 ' HE ' ' HG ' ' A' ' 19' ' ' SER . 30.4 ttp-105 -86.38 157.1 19.93 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.463 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -136.53 61.49 1.63 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.054 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.447 ' HG ' ' HE ' ' A' ' 17' ' ' ARG . 93.4 p -94.43 6.51 48.52 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.008 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.56 118.25 7.92 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 103.83 0.25 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.458 1.099 . . . . 0.0 108.196 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.71 -164.33 18.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.88 150.21 30.67 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 p -160.24 132.12 6.09 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.961 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.21 115.91 19.15 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.04 105.75 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.545 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -96.2 -16.68 21.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.987 -1.461 . . . . 0.0 113.67 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -76.09 94.81 3.52 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.39 0.614 . . . . 0.0 110.312 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -83.91 60.27 5.72 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.145 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.59 -90.04 0.68 Allowed Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.19 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.86 169.12 21.64 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 47.4 p90 -161.73 135.36 6.5 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.57 158.74 24.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 58.9 t80 -130.03 157.36 42.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -146.94 100.31 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 124.069 0.856 . . . . 0.0 110.128 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.475 ' H ' ' HG ' ' A' ' 60' ' ' SER . 46.1 t80 -81.12 149.1 29.31 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.644 -1.617 . . . . 0.0 107.835 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -168.48 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.092 0.87 . . . . 0.0 109.342 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.99 -43.17 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.25 166.87 22.75 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 40' ' ' THR . 68.3 p -87.63 -174.58 4.84 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 113.305 -1.77 . . . . 0.0 111.105 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -158.11 113.68 2.71 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.605 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.66 157.05 27.33 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -126.38 94.64 4.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.851 0.834 . . . . 0.0 109.907 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -79.86 141.42 36.17 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.603 -1.635 . . . . 0.0 114.094 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.26 23.09 12.99 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.256 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.75 141.65 49.57 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.056 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.9 132.89 37.81 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.102 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.16 68.49 Favored Glycine 0 N--CA 1.495 2.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.173 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.2 m 54.33 29.15 10.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.356 0.68 . . . . 0.0 112.438 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.6 p -85.98 52.07 2.38 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.979 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.61 -121.91 0.61 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.12 150.17 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.59 178.93 1.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.142 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.504 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 18.6 t-80 -139.3 -69.55 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.888 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -118.16 83.07 1.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.127 0.892 . . . . 0.0 108.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 57' ' ' PHE . 5.1 tmm_? -70.57 162.19 29.32 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.6 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 51.4 m-85 -131.11 135.76 47.78 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.43 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.73 -2.57 4.34 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.1 m -152.58 136.82 16.58 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.475 ' HG ' ' H ' ' A' ' 36' ' ' TYR . 19.3 m -38.05 112.33 0.21 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.153 0.908 . . . . 0.0 111.15 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.71 106.9 11.35 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 124.279 0.987 . . . . 0.0 113.196 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -80.73 75.2 7.64 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.69 165.28 13.79 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.493 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.3 m -149.92 4.91 0.57 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -69.07 152.44 96.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.537 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.6 150.13 88.77 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.777 2.318 . . . . 0.0 110.198 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -154.43 -172.65 4.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 123.985 0.803 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.15 54.77 0.36 Allowed Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.557 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.504 ' HE1' ' CB ' ' A' ' 54' ' ' HIS . 1.9 m-90 -88.4 150.33 23.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 11.6 mptt -86.0 -22.83 27.1 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.504 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.1 p -175.66 167.81 3.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.628 1.205 . . . . 0.0 113.131 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.453 ' CD1' ' CG ' ' A' ' 3' ' ' PHE . 7.3 tt -130.7 130.3 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.838 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.95 93.28 4.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.484 1.115 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.5 mm -72.53 113.4 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.887 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -64.35 108.83 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.743 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 130.02 11.55 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.415 ' CB ' HD12 ' A' ' 72' ' ' ILE . 79.7 t80 -93.74 91.21 6.89 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.94 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.0 m -73.39 148.87 42.95 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.42 137.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 123.801 0.688 . . . . 0.0 109.684 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 19.9 m-90 -112.93 155.22 25.11 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -66.66 -42.55 86.46 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.97 156.04 9.14 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -76.97 -51.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.753 0 O-C-N 122.651 0.816 . . . . 0.0 110.786 8.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.97 -111.16 3.04 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.7 p -111.99 53.4 0.73 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -138.19 69.41 1.39 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 2.3 p30 178.31 -144.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.401 HH22 ' CG ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -79.72 177.57 8.79 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.375 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -162.17 178.8 8.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CG ' HH22 ' A' ' 14' ' ' ARG . 59.9 mt-10 -143.38 121.76 12.35 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 112.899 -1.955 . . . . 0.0 107.725 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -100.51 100.03 10.72 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.147 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.9 92.58 6.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -103.23 -31.18 10.22 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.22 127.89 34.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.827 0.704 . . . . 0.0 109.251 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.4 p -69.92 123.45 21.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.489 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.8 176.55 28.08 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.1 m -82.44 74.14 9.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.258 0.622 . . . . 0.0 109.609 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -85.28 132.12 34.31 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.282 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 142.48 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.76 149.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -142.39 14.87 2.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.903 0.752 . . . . 0.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -103.37 104.57 14.69 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.189 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.1 59.03 4.34 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.844 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.2 -78.15 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.553 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.75 175.39 32.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -161.01 131.79 5.31 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.39 103.72 11.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.562 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.61 154.81 29.97 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -142.42 103.46 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 124.35 1.031 . . . . 0.0 108.224 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.53 113.57 15.47 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.184 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.411 ' HG1' ' H ' ' A' ' 38' ' ' GLY . 74.8 p -146.28 -39.67 0.22 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' H ' ' HG1' ' A' ' 37' ' ' THR . . . -91.99 -62.04 1.19 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -160.35 177.78 10.26 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.984 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.8 p -66.27 174.64 2.53 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.629 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.39 124.43 3.62 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.78 167.75 11.24 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD13 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -130.32 105.16 7.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.304 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -86.04 147.92 25.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.401 HD22 ' HB2' ' A' ' 54' ' ' HIS . 27.2 m-80 -96.42 14.23 25.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.061 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.415 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 56.8 mm-40 -138.21 141.33 40.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.62 128.34 20.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.553 1.158 . . . . 0.0 112.14 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.52 53.24 33.13 Favored Glycine 0 N--CA 1.496 2.642 0 CA-C-N 114.306 -1.315 . . . . 0.0 112.652 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 76.8 m 51.67 29.21 5.43 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.1 m -81.59 34.73 0.39 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.797 0.808 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.94 -145.38 4.28 Favored Glycine 0 N--CA 1.494 2.511 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.965 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.27 153.15 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 113.823 -1.189 . . . . 0.0 108.527 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.21 -169.08 0.46 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.58 0.55 . . . . 0.0 111.314 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.445 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 5.7 t60 -153.93 -59.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.708 0.63 . . . . 0.0 110.249 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.1 m -112.9 119.84 39.36 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.243 0.964 . . . . 0.0 111.661 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -94.07 149.08 21.56 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.633 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.47 148.27 52.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.864 0.727 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.52 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.494 2.561 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.086 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -156.11 135.3 12.14 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -37.72 117.08 0.54 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.68 85.08 2.06 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.95 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -73.41 71.51 1.29 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.97 152.44 20.7 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.884 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 63.6 m -134.33 40.07 3.03 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -113.03 143.38 29.03 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.392 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -63.07 170.9 6.9 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.367 2.044 . . . . 0.0 111.325 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.36 -169.87 2.45 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.066 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.96 58.1 0.46 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CG ' HD13 ' A' ' 43' ' ' LEU . 5.0 m-90 -105.54 146.28 29.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.62 -46.24 10.96 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.099 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.1 p -153.99 156.35 37.26 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.962 1.414 . . . . 0.0 113.088 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 3' ' ' PHE . 6.2 tt -112.67 131.28 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.69 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.561 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 13.6 t80 -100.51 88.43 3.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.481 1.113 . . . . 0.0 111.124 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -85.58 137.82 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -89.71 170.53 10.37 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.178 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 116.166 -1.873 . . . . 0.0 111.358 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.91 141.72 5.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.927 0.767 . . . . 0.0 112.088 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.55 ' CG ' HD11 ' A' ' 72' ' ' ILE . 50.8 t80 -92.57 140.9 29.08 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.4 m -128.6 151.03 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.4 ' CG1' ' CE2' ' A' ' 3' ' ' PHE . 16.2 m -147.34 166.77 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.153 0.908 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -141.47 133.35 27.42 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 88.8 p -43.5 -33.51 1.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 134.99 154.11 6.99 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -82.58 -57.93 0.1 OUTLIER 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.315 1.166 . . . . 0.0 111.151 13.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.64 -145.34 14.98 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.03 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 63' ' ' ALA . 76.2 m -93.3 50.42 1.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.59 -1.305 . . . . 0.0 111.886 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.64 -126.97 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.408 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 37.76 -141.88 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 119.57 1.077 . . . . 0.0 113.734 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -69.89 154.41 41.99 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.52 111.65 14.03 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.432 0.457 . . . . 0.0 112.135 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -117.54 166.77 11.98 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -151.71 157.0 41.46 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.613 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -142.38 93.61 2.55 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.4 p -100.05 -11.37 20.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -55.74 128.19 33.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 123.856 0.723 . . . . 0.0 111.516 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.66 167.3 17.27 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.0 -84.26 1.29 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.3 p -174.31 157.31 2.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.497 0.763 . . . . 0.0 111.062 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -160.19 146.76 15.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.246 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.72 163.65 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.827 0.705 . . . . 0.0 109.623 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mt -134.57 151.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.674 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -23.07 4.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.205 0.941 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -82.76 97.34 8.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.939 0.774 . . . . 0.0 110.808 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -82.95 12.97 4.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.37 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.76 -112.97 0.39 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.266 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.6 159.44 19.75 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 124.982 1.048 . . . . 0.0 110.837 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -161.28 131.64 5.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.456 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 8.2 t70 -104.47 174.87 5.69 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.151 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 65.3 t80 -148.8 157.89 43.76 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.406 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 55.4 m -139.23 139.06 37.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -122.18 138.85 54.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.903 1.377 . . . . 0.0 113.202 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.4 p -152.35 66.68 0.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.89 36.5 93.37 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -153.63 99.49 2.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -71.97 157.48 37.75 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.08 166.42 15.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.712 1.258 . . . . 0.0 110.314 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.78 152.21 40.0 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.125 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.446 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 80.9 mt -113.17 98.63 7.26 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.385 1.088 . . . . 0.0 110.071 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.39 115.2 14.8 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.638 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -48.46 -65.22 0.6 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.012 1.445 . . . . 0.0 109.97 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.57 155.89 36.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.402 1.064 . . . . 0.0 112.142 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.54 179.44 7.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.503 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.37 54.3 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.977 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 24.0 m 59.35 30.7 20.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.7 p -115.84 35.7 4.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.719 0.771 . . . . 0.0 111.269 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.97 157.6 15.08 Favored Glycine 0 N--CA 1.493 2.496 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.13 149.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.91 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.713 0.768 . . . . 0.0 109.296 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.442 ' HD1' ' HG1' ' A' ' 55' ' ' THR . 21.5 t-80 -79.69 -23.34 42.49 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.266 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.442 ' HG1' ' HD1' ' A' ' 54' ' ' HIS . 50.0 m -146.92 136.34 22.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.958 0.787 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -114.52 147.33 39.55 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.33 1.019 . . . . 0.0 111.79 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -132.31 98.61 4.44 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.44 1.088 . . . . 0.0 108.248 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.54 12.14 66.41 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.3 t -164.47 142.14 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.6 p -40.51 127.9 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.141 0.9 . . . . 0.0 111.916 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.56 113.34 12.94 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 124.051 0.844 . . . . 0.0 112.767 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -81.26 71.36 8.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.396 1.06 . . . . 0.0 112.803 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.406 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . -91.28 157.98 16.83 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.379 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.2 m -147.39 10.06 0.96 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.55 0.69 . . . . 0.0 109.567 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -74.68 167.78 33.16 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.729 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -56.29 144.51 81.86 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.205 1.936 . . . . 0.0 111.936 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -73.99 167.42 21.54 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.14 17.13 1.18 Allowed Glycine 0 N--CA 1.501 3.014 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.47 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.446 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.0 m-90 -138.43 -166.65 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -129.98 -36.71 1.54 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.7 p -134.09 168.87 18.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 124.306 1.004 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.55 HD11 ' CG ' ' A' ' 3' ' ' PHE . 3.3 tt -130.78 121.47 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.533 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -98.02 119.05 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.889 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.9 mt -117.94 150.3 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -74.28 -179.75 4.09 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 116.896 -1.526 . . . . 0.0 109.799 179.804 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.78 121.37 2.85 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.188 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.461 ' CG ' HD12 ' A' ' 72' ' ' ILE . 76.8 t80 -93.63 102.56 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.173 0.92 . . . . 0.0 110.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.6 m -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -151.82 138.64 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 123.774 0.672 . . . . 0.0 110.086 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.487 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 24.9 m-90 -109.3 150.48 27.91 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.1 p -61.35 -38.76 88.1 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.98 153.64 6.66 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.88 -56.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.769 0 O-C-N 122.858 0.925 . . . . 0.0 109.982 7.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.19 -132.35 6.27 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.06 54.98 1.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -139.42 64.2 1.47 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.004 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 4.7 p30 -178.46 -150.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.76 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -72.05 169.62 15.6 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.94 173.66 12.22 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -151.11 140.41 21.34 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.056 -1.884 . . . . 0.0 107.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -110.93 153.06 26.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 123.735 0.647 . . . . 0.0 111.243 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -139.5 75.17 1.5 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -105.71 -20.97 13.29 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.179 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.59 135.13 57.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 123.632 0.583 . . . . 0.0 110.338 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -60.64 109.35 1.01 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.465 1.103 . . . . 0.0 110.35 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.66 166.95 13.7 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.8 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 m -78.73 74.8 5.26 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.618 -1.291 . . . . 0.0 109.88 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -80.6 136.0 36.16 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.44 126.86 31.36 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 mp -89.22 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -135.76 -29.92 1.01 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.707 0.63 . . . . 0.0 112.045 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -78.85 104.53 9.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.787 0.679 . . . . 0.0 109.279 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -90.26 18.27 6.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.347 1.03 . . . . 0.0 113.675 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.01 -87.59 0.25 Allowed Glycine 0 N--CA 1.497 2.745 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.297 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.23 169.83 20.44 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -161.62 132.17 5.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 2.9 t70 -107.05 166.06 10.89 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.321 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.465 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 68.6 t80 -145.7 151.89 38.75 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -132.62 151.48 51.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -135.71 133.91 38.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 124.213 0.946 . . . . 0.0 110.473 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.0 p -149.67 70.03 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.61 98.11 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.844 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -158.37 115.37 2.84 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.153 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 m -83.25 165.84 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.122 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.63 162.08 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.643 -1.617 . . . . 0.0 108.301 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.53 137.28 21.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.86 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HG ' ' CD2' ' A' ' 69' ' ' TRP . 3.9 mm? -91.71 158.71 16.22 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -147.74 121.29 9.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 125.28 1.612 . . . . 0.0 109.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -66.3 -8.03 22.46 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.456 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -122.95 134.08 54.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 124.074 0.859 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 133.57 8.1 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.844 -1.526 . . . . 0.0 115.006 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.01 44.49 83.11 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.7 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 71.9 m 52.17 31.9 9.79 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -82.73 29.43 0.45 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.207 1.003 . . . . 0.0 112.796 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 49' ' ' CYS . . . -161.2 -175.17 31.94 Favored Glycine 0 N--CA 1.49 2.258 0 CA-C-N 113.219 -1.809 . . . . 0.0 108.863 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -81.9 156.5 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.78 161.92 28.85 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.589 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.53 ' HD1' ' HE1' ' A' ' 69' ' ' TRP . 57.2 t-80 -123.37 -32.42 3.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 124.346 1.029 . . . . 0.0 110.459 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.466 ' HG1' ' HD1' ' A' ' 54' ' ' HIS . 91.5 m -141.06 167.42 22.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.998 0.812 . . . . 0.0 109.085 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -143.29 143.4 31.69 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.465 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 23.0 m-85 -139.36 105.2 5.16 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.058 0.849 . . . . 0.0 110.184 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.19 31.44 5.46 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.0 t -175.51 127.25 0.25 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -30.64 111.19 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 124.507 1.13 . . . . 0.0 113.074 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.29 93.68 4.13 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 124.306 1.004 . . . . 0.0 109.831 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -81.97 68.03 8.2 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.23 -1.35 . . . . 0.0 113.168 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.78 169.18 12.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.794 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.31 39.84 0.84 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.409 1.1 . . . . 0.0 108.439 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -100.44 165.55 14.2 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 112.741 -2.027 . . . . 0.0 109.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.06 164.79 33.56 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.539 2.159 . . . . 0.0 110.339 164.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.54 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 30.9 p90 -162.26 -163.72 0.96 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.511 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.47 43.32 0.43 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.55 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CE3' ' CD2' ' A' ' 67' ' ' PHE . 4.8 m-90 -91.73 133.38 35.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.77 -48.93 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.3 p -135.57 169.8 16.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.988 1.43 . . . . 0.0 112.743 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.461 HD12 ' CG ' ' A' ' 3' ' ' PHE . 10.9 tt -140.31 119.26 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.95 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.645 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 37.1 t80 -84.2 121.06 26.95 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.144 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.4 mm -108.7 132.41 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -85.7 -179.9 6.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.895 0.747 . . . . 0.0 110.024 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 115.532 -2.175 . . . . 0.0 110.23 179.77 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.96 132.22 11.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.464 ' CG ' HD12 ' A' ' 72' ' ' ILE . 85.2 t80 -95.75 93.59 7.18 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.895 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.6 m -72.51 152.3 41.97 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.01 155.13 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 124.267 0.979 . . . . 0.0 110.88 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.536 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.0 m-90 -133.93 157.23 46.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.5 p -60.45 -40.55 91.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.496 1.123 . . . . 0.0 113.127 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.1 157.05 8.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.2 -45.22 0.37 Allowed 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.152 1.08 . . . . 0.0 111.386 19.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.29 -137.75 8.84 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -105.44 40.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.189 -1.506 . . . . 0.0 107.349 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -140.65 68.16 1.35 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -169.83 -88.17 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.556 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -90.46 91.73 8.58 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.248 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 115.06 5.22 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.821 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -145.98 154.58 42.05 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -151.05 151.61 32.26 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.0 93.79 4.14 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.477 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.4 p -105.65 -26.81 11.68 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -52.11 145.08 11.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 123.958 0.786 . . . . 0.0 112.912 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 t -65.67 168.36 7.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.183 0.927 . . . . 0.0 109.349 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.49 -177.63 43.28 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 107.194 -2.362 . . . . 0.0 107.194 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 29.7 p -96.34 142.65 28.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.213 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.7 p -127.24 140.22 52.38 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.708 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.36 122.08 25.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 123.865 0.728 . . . . 0.0 109.776 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.54 150.06 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.823 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -134.41 -13.55 2.32 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.24 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -86.2 84.72 7.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 123.07 1.414 . . . . 0.0 109.807 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -89.99 64.67 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.886 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.29 -58.26 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.533 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.1 168.74 35.84 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -161.1 132.03 5.35 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.152 -1.019 . . . . 0.0 113.723 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -114.15 104.47 12.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.781 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 79.0 t80 -82.68 153.42 25.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -146.04 100.79 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.277 0.986 . . . . 0.0 109.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' H ' ' HG ' ' A' ' 60' ' ' SER . 79.5 t80 -72.04 134.45 45.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.199 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.1 p -146.58 55.11 1.13 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.93 -23.56 13.6 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 113.863 -1.517 . . . . 0.0 110.555 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -99.13 125.83 44.76 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.175 0.512 . . . . 0.0 111.501 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 m -85.98 164.84 17.16 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.89 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.61 171.04 13.03 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.33 131.42 6.5 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.346 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.524 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -96.49 116.73 29.55 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.632 0.729 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -99.43 122.62 42.79 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 0.0 110.567 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -74.55 -1.39 21.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.64 139.4 47.12 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 138.75 56.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 124.018 0.824 . . . . 0.0 110.775 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.519 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 52.91 43.95 61.35 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.8 p 39.33 40.04 0.51 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.3 m -89.25 42.02 1.07 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.973 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.68 -122.18 0.62 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.388 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.59 153.07 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.64 -174.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.34 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -148.55 -45.58 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.819 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -138.91 116.02 10.99 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.058 0.849 . . . . 0.0 109.428 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.28 152.27 18.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.863 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.438 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 17.9 m-85 -131.2 114.8 15.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.064 0.853 . . . . 0.0 110.153 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.48 11.42 28.26 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 p -161.05 135.62 7.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 123.979 0.458 . . . . 0.0 110.437 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.44 ' HG ' ' H ' ' A' ' 36' ' ' TYR . 16.2 m -39.67 115.82 0.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.319 1.012 . . . . 0.0 112.408 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.04 93.73 4.19 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.205 0.941 . . . . 0.0 109.242 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -74.48 75.37 1.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.333 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.35 161.87 15.41 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.201 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 m -148.1 58.44 1.1 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.079 0.943 . . . . 0.0 110.307 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.49 153.42 43.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 113.751 -1.568 . . . . 0.0 108.864 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.98 178.37 2.43 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.354 2.036 . . . . 0.0 110.28 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.25 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.072 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.89 19.15 3.74 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-O 118.504 -1.165 . . . . 0.0 114.033 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.524 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 5.1 m-90 -91.87 161.0 15.02 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 118.852 1.326 . . . . 0.0 111.014 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.63 -41.39 7.74 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.162 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 p -146.28 -179.94 7.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.432 1.082 . . . . 0.0 110.985 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.464 HD12 ' CG ' ' A' ' 3' ' ' PHE . 11.0 tt -146.5 117.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.369 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.59 114.16 19.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.062 -1.881 . . . . 0.0 108.772 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.65 140.02 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.54 150.74 29.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.142 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 116.576 -1.678 . . . . 0.0 110.373 179.888 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.29 103.99 2.9 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.185 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.425 ' CB ' HD12 ' A' ' 72' ' ' ILE . 85.4 t80 -96.69 90.69 5.39 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.07 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -77.49 154.57 32.39 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 m -148.28 166.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 123.703 0.627 . . . . 0.0 109.397 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.43 ' CD1' ' HB1' ' A' ' 15' ' ' ALA . 29.4 m-90 -141.88 139.64 32.66 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -51.95 -41.15 61.84 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.12 151.03 5.47 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -79.07 -62.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.592 0 O-C-N 122.975 0.987 . . . . 0.0 111.396 19.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.18 -129.41 6.55 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 p -95.5 49.96 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.292 -0.954 . . . . 0.0 111.373 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' ND2' ' N ' ' A' ' 12' ' ' ASN . 2.3 m-80 -124.33 -132.01 0.26 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.9 p30 36.66 -150.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -78.63 -176.75 5.02 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' A' ' 6' ' ' TRP . . . -153.17 159.79 42.75 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -139.78 163.76 31.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 111.724 -2.489 . . . . 0.0 104.677 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -146.87 136.39 22.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -117.27 73.83 0.89 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.683 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.2 p -95.9 -5.63 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.032 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -66.71 111.74 3.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.084 0.865 . . . . 0.0 108.872 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 7.0 p -64.85 114.95 4.85 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.028 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.37 -95.83 0.16 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.58 -1.295 . . . . 0.0 114.405 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -156.19 133.06 10.43 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.612 0.831 . . . . 0.0 110.118 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -160.24 134.22 7.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.473 0.483 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.76 126.09 30.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.39 150.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -137.03 0.64 2.39 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.758 0.661 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -101.26 101.16 11.79 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.836 0.827 . . . . 0.0 109.596 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -79.53 -2.97 44.66 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.662 -1.608 . . . . 0.0 113.749 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.58 -101.89 0.03 OUTLIER Glycine 0 N--CA 1.497 2.722 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.38 166.22 14.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 63' ' ' ALA . 30.8 p90 -161.45 145.27 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.84 152.51 43.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -121.5 157.02 31.54 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 t -145.59 101.24 3.54 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -70.67 137.46 49.86 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 111.952 -2.385 . . . . 0.0 108.778 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.6 m -143.52 61.89 1.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.66 -14.05 10.81 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.711 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -113.49 125.04 53.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 120.933 0.396 . . . . 0.0 111.693 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.1 m -80.15 162.18 24.86 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.45 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.17 174.3 6.41 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.419 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.1 140.97 19.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.607 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -112.56 133.04 54.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 123.639 0.587 . . . . 0.0 111.554 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -117.77 134.28 55.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 125.033 1.458 . . . . 0.0 111.601 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -66.93 -36.57 82.53 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.065 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -92.4 119.72 32.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.971 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -39.13 146.99 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 125.433 1.708 . . . . 0.0 113.814 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.5 39.42 93.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.1 p 43.79 35.85 1.17 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 125.007 1.063 . . . . 0.0 111.543 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -90.23 46.05 1.32 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.205 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.44 -135.57 1.86 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.307 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.47 154.61 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.196 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.13 178.32 1.91 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.437 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -156.56 -40.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -142.95 129.33 20.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.979 0.799 . . . . 0.0 110.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.91 135.32 54.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -115.36 114.0 24.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.776 0.673 . . . . 0.0 110.663 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.84 13.05 38.35 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 p -164.34 136.14 4.6 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m -41.1 121.6 1.6 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.11 0.881 . . . . 0.0 111.724 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.25 111.76 9.9 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -78.2 76.21 4.72 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.775 0.672 . . . . 0.0 111.294 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . . . -90.91 71.92 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.389 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.5 m -62.23 -6.91 3.48 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -70.87 164.13 58.75 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.52 178.57 2.57 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.62 2.213 . . . . 0.0 111.614 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 -149.26 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.07 15.74 0.43 Allowed Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.161 0.913 . . . . 0.0 110.855 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.607 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 1.9 m-90 -100.93 126.22 47.55 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -90.45 2.79 55.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.143 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.1 p -163.58 173.66 12.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.05 0.844 . . . . 0.0 112.468 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.425 HD12 ' CB ' ' A' ' 3' ' ' PHE . 6.7 tt -149.27 123.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.128 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -99.51 127.41 45.57 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -131.9 143.98 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -72.54 164.88 25.73 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.043 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 116.883 -1.532 . . . . 0.0 110.566 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 96.92 2.92 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 121.004 0.431 . . . . 0.0 111.291 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 64.7 t80 -97.31 101.99 13.66 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.5 m -84.38 155.54 22.25 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -150.71 161.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 123.31 0.381 . . . . 0.0 111.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.536 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 21.2 m-90 -145.98 140.14 26.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 m -55.19 -21.77 14.96 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' CA ' ' HA3' ' A' ' 30' ' ' GLY . . . 124.46 163.94 11.81 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 123.782 0.676 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.3 -54.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.678 0 O-C-N 123.058 1.031 . . . . 0.0 111.462 13.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.07 -123.55 4.57 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 75.3 m -122.16 80.2 1.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -147.79 -54.73 0.21 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.305 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.6 p30 -49.31 -120.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.99 80.9 0.08 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.66 110.26 3.65 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -131.45 172.66 11.93 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -153.38 158.67 41.83 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.735 -0.786 . . . . 0.0 113.119 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -136.77 80.16 1.8 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.843 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.1 t -108.68 1.33 21.12 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.687 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -61.4 118.64 7.22 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.781 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -62.29 102.13 0.28 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.322 1.014 . . . . 0.0 108.946 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.33 -118.48 1.02 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.3 t -140.71 154.59 46.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 124.315 0.656 . . . . 0.0 111.762 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 p -160.15 139.54 10.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.88 140.97 38.02 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.673 0.608 . . . . 0.0 111.772 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 mt -117.56 127.29 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.815 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -125.7 32.85 5.21 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.046 0.841 . . . . 0.0 108.779 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -113.47 99.27 7.64 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.284 -1.325 . . . . 0.0 108.285 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.14 18.26 6.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 111.85 -2.432 . . . . 0.0 112.491 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' CA ' ' A' ' 8' ' ' GLY . . . -92.24 -74.64 1.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.908 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' CA ' ' HA ' ' A' ' 64' ' ' CYS . . . -152.84 164.46 30.79 Favored Glycine 0 N--CA 1.486 2.006 0 CA-C-N 113.836 -1.182 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 23.4 p90 -161.23 132.25 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.79 161.8 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.362 -1.744 . . . . 0.0 107.253 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -142.25 153.16 43.73 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -146.86 114.03 6.23 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.654 1.222 . . . . 0.0 108.203 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.2 112.49 17.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.357 -2.201 . . . . 0.0 105.295 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.4 m -132.66 -66.6 0.67 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.74 -70.05 1.31 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -141.31 -168.52 2.65 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.226 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -77.17 -167.95 1.0 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.122 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.12 142.04 12.89 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.687 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.41 149.32 38.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.266 0.979 . . . . 0.0 108.818 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 ' CE2' ' A' ' 57' ' ' PHE . 38.1 mt -114.16 101.35 9.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.747 0.654 . . . . 0.0 111.3 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.53 144.92 26.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.368 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -91.99 -0.19 57.48 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -113.89 148.26 37.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 123.553 0.533 . . . . 0.0 110.137 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.72 134.03 55.86 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.827 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.33 30.85 77.33 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.433 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.545 ' H ' ' HG ' ' A' ' 71' ' ' SER . 58.7 m 54.7 29.42 11.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 124.61 0.829 . . . . 0.0 112.623 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 t -88.45 59.81 5.36 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.868 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.48 -125.45 0.85 Allowed Glycine 0 N--CA 1.495 2.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.834 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.79 144.08 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.2 121.88 21.01 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.484 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.78 -60.29 2.41 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -124.49 148.87 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.697 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.97 -177.89 4.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 123.545 0.528 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' CE2' HD12 ' A' ' 43' ' ' LEU . 44.3 m-85 -141.32 158.08 44.36 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.685 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.08 -11.87 0.15 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -151.35 147.18 26.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -41.47 117.84 0.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.929 0.768 . . . . 0.0 112.78 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.8 99.82 7.37 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.331 1.02 . . . . 0.0 109.428 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -84.79 70.18 10.8 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.39 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.24 165.47 13.44 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.436 ' HA ' ' CA ' ' A' ' 31' ' ' GLY . 67.4 m -150.85 26.64 0.73 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.842 0.83 . . . . 0.0 111.958 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -97.25 168.51 10.09 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.111 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.34 178.49 0.86 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.364 2.043 . . . . 0.0 110.946 163.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.85 -151.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.21 49.17 0.4 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -127.37 142.17 51.5 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -93.85 -20.74 19.78 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 49' ' ' CYS . 61.5 p -161.93 178.43 8.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 124.29 0.993 . . . . 0.0 112.052 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.0 tt -140.4 123.85 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.52 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -91.47 84.64 5.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.931 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.4 mm -69.19 125.05 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -72.06 136.21 46.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.805 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.55 0 CA-C-N 113.316 -1.766 . . . . 0.0 111.549 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.66 134.56 5.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.503 ' CG ' HD11 ' A' ' 72' ' ' ILE . 88.5 t80 -101.76 107.06 18.16 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.886 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.8 m -91.75 152.3 20.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 m -154.46 152.92 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.719 0.637 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 -122.63 153.28 39.55 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 23.3 t -55.93 -50.56 70.39 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.61 154.17 7.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -80.05 -56.0 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 118.273 1.037 . . . . 0.0 110.075 12.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.5 -136.32 8.28 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -87.85 42.33 1.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.3 -0.95 . . . . 0.0 112.554 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 12' ' ' ASN . 1.9 m-80 -111.93 -135.0 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 7' ' ' SER . 6.8 p30 34.8 -141.21 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -89.44 156.74 18.47 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.02 171.61 7.28 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.905 0.753 . . . . 0.0 111.991 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -171.82 125.44 0.57 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -98.42 155.49 17.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -138.16 94.84 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.4 p -130.42 13.69 5.53 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.604 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -54.75 128.5 33.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.632 0.582 . . . . 0.0 110.959 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.4 t -69.55 94.22 0.75 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.457 1.123 . . . . 0.0 108.913 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.29 -106.06 0.36 Allowed Glycine 0 N--CA 1.488 2.129 1 N-CA-C 101.287 -4.725 . . . . 0.0 101.287 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.26 164.29 25.05 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.992 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 p -158.1 148.3 20.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 126.62 31.03 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.388 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mt -78.78 148.9 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.576 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -124.92 -32.36 3.05 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.288 0.993 . . . . 0.0 111.615 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -71.63 97.44 1.72 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.146 0.974 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -90.42 61.29 4.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.369 -2.196 . . . . 0.0 109.545 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.98 -89.82 0.25 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.37 157.54 17.64 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -143.99 117.44 9.11 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.775 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -126.83 153.12 46.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.056 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 92.5 t80 -133.35 155.07 50.13 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -137.11 131.26 32.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -109.69 148.34 31.54 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.411 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -166.56 55.12 0.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.52 -33.84 4.02 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.42 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -82.06 120.78 25.72 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.451 0.643 . . . . 0.0 110.726 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 m -91.9 168.78 11.18 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.201 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.04 147.28 23.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 123.63 0.581 . . . . 0.0 112.275 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.26 150.23 29.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.432 HD23 ' CE3' ' A' ' 69' ' ' TRP . 25.8 tp -120.11 108.68 14.55 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -89.09 124.16 34.05 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.123 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 57.5 t-20 -63.56 -41.81 98.39 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.152 -1.84 . . . . 0.0 106.66 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.462 ' CD ' ' H ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -78.93 157.43 28.22 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.274 -1.785 . . . . 0.0 108.06 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.1 172.94 6.04 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 33.96 44.79 0.37 Allowed Glycine 0 N--CA 1.505 3.251 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.601 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.503 ' H ' ' HG ' ' A' ' 71' ' ' SER . 31.9 p 34.35 61.64 0.53 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 125.218 1.187 . . . . 0.0 113.214 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.9 m -78.31 -154.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.641 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.02 162.26 49.88 Favored Glycine 0 N--CA 1.498 2.815 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.258 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t 61.87 107.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 113.416 -1.392 . . . . 0.0 112.381 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.95 -174.95 2.84 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.756 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.428 ' CD2' ' HE1' ' A' ' 69' ' ' TRP . 8.8 t60 -136.91 -49.86 0.64 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 m -138.16 160.86 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.87 127.68 14.39 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.736 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 25.3 m-85 -101.78 146.04 28.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.24 0.962 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.27 17.13 0.79 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 p -165.82 129.87 2.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.9 m -37.03 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.079 0.862 . . . . 0.0 113.112 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.98 101.55 8.86 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 115.041 -0.982 . . . . 0.0 112.041 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -83.13 76.73 9.84 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.68 165.5 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.445 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 m -153.8 36.55 0.45 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 121.763 0.792 . . . . 0.0 109.374 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.402 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 72.7 m-80 -70.07 -167.04 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.094 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.576 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 65' ' ' ASN . 1.4 Cg_endo -73.3 165.94 31.26 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.733 2.288 . . . . 0.0 111.24 144.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.75 171.11 15.44 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.41 18.1 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.672 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 13.7 m-90 -141.93 -162.59 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.97 0.453 . . . . 0.0 112.0 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.2 -30.22 0.47 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.927 0.767 . . . . 0.0 111.04 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.503 ' HG ' ' H ' ' A' ' 49' ' ' CYS . 17.5 p -150.32 162.45 40.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.918 0.761 . . . . 0.0 111.809 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.503 HD11 ' CG ' ' A' ' 3' ' ' PHE . 10.2 tt -137.88 134.78 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.243 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -96.02 106.78 18.99 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.403 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -101.03 139.31 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -105.39 162.61 13.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.034 0.834 . . . . 0.0 110.741 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 116.94 -1.505 . . . . 0.0 110.475 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.64 95.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 123.97 0.793 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -82.18 98.92 8.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.313 1.008 . . . . 0.0 110.813 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -84.11 151.76 24.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 p -163.25 146.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.525 1.155 . . . . 0.0 112.506 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.455 ' CZ3' ' SG ' ' A' ' 11' ' ' CYS . 8.2 m-90 -124.23 151.41 44.16 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 111.851 -2.431 . . . . 0.0 107.304 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.7 p -68.82 9.84 0.34 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.34 163.21 37.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -76.66 -53.79 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.649 0 O-C-N 123.055 1.029 . . . . 0.0 111.107 16.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.52 -143.5 13.83 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 71.5 m -107.85 70.81 0.78 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -142.14 -49.06 0.37 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.942 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.551 ' H ' HD21 ' A' ' 13' ' ' ASN . 1.4 p30 -53.94 -135.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.717 -2.038 . . . . 0.0 115.974 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -54.25 129.27 34.52 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.76 116.15 31.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.928 0.767 . . . . 0.0 110.565 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -147.81 138.84 23.4 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -123.78 158.69 31.17 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.426 ' HH ' HE22 ' A' ' 28' ' ' GLN . 59.9 m-85 -136.32 82.17 1.93 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.5 p -105.71 -14.76 15.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.555 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.69 141.68 58.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.185 0.928 . . . . 0.0 109.544 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 44.0 t -71.76 174.7 6.49 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.02 -112.02 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 p -172.42 147.31 1.9 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.094 0.526 . . . . 0.0 111.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -158.77 154.45 26.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.171 0.919 . . . . 0.0 110.987 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.93 140.36 36.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.373 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.2 mt -97.0 115.78 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.158 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -79.27 -45.39 19.84 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' H ' ' CD ' ' A' ' 28' ' ' GLN . 1.7 pm0 -81.83 82.11 7.61 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.798 -1.546 . . . . 0.0 108.699 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.7 55.85 2.83 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.035 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.09 -114.35 2.85 Favored Glycine 0 N--CA 1.498 2.801 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.357 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.54 158.35 28.55 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-O 118.412 -1.215 . . . . 0.0 110.329 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -161.76 134.92 6.23 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -110.42 167.73 9.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -145.3 155.62 43.32 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.3 t -144.99 109.64 4.98 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -81.78 147.64 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 113.056 -1.884 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -173.36 76.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.62 -26.3 3.64 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-N 112.788 -2.006 . . . . 0.0 113.06 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -109.14 137.19 47.42 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.4 m -97.79 166.48 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.761 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.81 174.77 9.41 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.309 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.55 122.37 3.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.153 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD13 ' CZ3' ' A' ' 69' ' ' TRP . 98.4 mt -99.22 135.88 39.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 123.847 0.717 . . . . 0.0 111.615 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.43 ' CE2' ' OG ' ' A' ' 71' ' ' SER . 8.8 p90 -148.24 138.43 22.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.212 0.945 . . . . 0.0 109.255 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -72.59 -10.27 59.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.621 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 46' ' ' GLN . 3.1 mp0 -86.4 89.66 7.95 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.321 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.22 164.9 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.87 28.09 72.97 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.011 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 m 60.64 18.51 8.52 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.052 0.501 . . . . 0.0 110.614 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -90.49 41.04 1.04 Allowed 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -161.69 -170.29 26.19 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.081 -1.533 . . . . 0.0 115.921 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.21 145.96 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 112.351 -1.924 . . . . 0.0 107.772 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 179.98 0.12 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -153.27 -48.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.574 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 m -132.83 106.14 7.55 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.824 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -96.54 158.08 15.6 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -126.0 106.04 9.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 124.189 0.931 . . . . 0.0 110.664 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.43 -4.31 57.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 t -155.47 140.15 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.42 ' H ' ' HG ' ' A' ' 60' ' ' SER . 18.7 m -35.91 110.86 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.98 -178.48 4.82 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -166.2 51.88 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.25 0.547 . . . . 0.0 111.576 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.78 165.47 16.0 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.1 m -147.56 11.09 0.98 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.945 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -79.84 157.59 73.92 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.73 143.92 27.82 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.452 2.101 . . . . 0.0 112.043 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.16 156.68 37.01 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.787 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.26 22.5 3.22 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 123.996 0.81 . . . . 0.0 111.417 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.445 ' CZ3' HD13 ' A' ' 43' ' ' LEU . 13.2 m-90 -138.26 -161.58 1.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -138.63 -20.14 1.04 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.544 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.43 ' OG ' ' CE2' ' A' ' 44' ' ' TYR . 14.7 p -153.72 170.28 21.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.267 0.979 . . . . 0.0 110.795 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.4 tt -137.04 149.48 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.465 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -119.93 136.19 54.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.7 mt -138.44 155.95 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 124.069 0.856 . . . . 0.0 110.738 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -88.12 173.18 8.99 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.99 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 88.8 m . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.771 -1.585 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.414 ' HG ' ' H ' ' A' ' 39' ' ' GLN . 74.6 m . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.741 0.305 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.09 174.23 15.21 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.403 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -137.67 97.43 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.53 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.1 m -77.3 150.52 35.25 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -148.61 153.96 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 123.622 0.576 . . . . 0.0 110.39 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.519 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 25.0 m-90 -135.61 142.97 45.34 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.5 p -66.18 0.85 1.77 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.406 ' HA2' ' C ' ' A' ' 9' ' ' PRO . . . 104.29 155.33 23.48 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 123.504 0.502 . . . . 0.0 113.349 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.406 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 12.1 Cg_endo -72.93 -54.88 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.851 0 O-C-N 123.023 1.012 . . . . 0.0 112.863 18.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.33 -128.67 5.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -108.89 69.44 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 113.96 -1.12 . . . . 0.0 109.419 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -143.4 -55.71 0.39 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.125 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.8 p30 -47.05 -118.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 5.9 tpm_? -62.78 100.77 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.352 0.596 . . . . 0.0 111.76 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.59 83.46 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.062 0.934 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -101.57 161.79 13.38 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.43 -1.713 . . . . 0.0 107.652 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -142.06 153.65 44.36 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -135.63 83.09 1.99 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.7 p -108.76 -12.01 14.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.056 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -53.09 143.53 17.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.336 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 126.92 29.61 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.819 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.58 28.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.572 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 20.2 p -114.15 162.23 16.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.5 p -160.57 158.59 29.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.351 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.43 151.25 30.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 123.699 0.625 . . . . 0.0 110.554 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 28' ' ' GLN . 3.3 mp -121.26 131.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 124.275 0.984 . . . . 0.0 109.333 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -101.28 -6.65 23.88 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.196 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.419 ' H ' HG22 ' A' ' 26' ' ' ILE . 26.2 mp0 -93.62 64.79 3.6 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.471 1.605 . . . . 0.0 108.729 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.14 8.8 3.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 111.187 -2.733 . . . . 0.0 115.063 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -74.2 -61.97 3.07 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.627 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.95 161.3 28.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.67 135.1 6.41 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -109.89 161.2 15.7 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 90.1 t80 -132.22 158.05 42.77 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.9 t -140.4 121.98 15.2 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -104.56 111.58 24.32 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.8 p -148.53 -49.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' N ' ' HG ' ' A' ' 1' ' ' SER . . . -83.6 -80.08 1.03 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.414 ' H ' ' HG ' ' A' ' 1' ' ' SER . 99.4 mm-40 -137.53 -176.93 4.57 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.5 m -75.95 170.81 15.53 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.45 169.63 21.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.257 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -152.94 163.93 38.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.04 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.558 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.0 mm? -111.27 143.36 42.17 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.82 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.76 120.26 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.737 1.273 . . . . 0.0 108.681 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -62.34 -5.68 2.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.164 0.915 . . . . 0.0 112.193 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -125.9 123.17 38.02 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.971 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.472 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -37.98 148.13 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.436 -1.711 . . . . 0.0 114.305 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.572 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.96 37.47 44.83 Favored Glycine 0 N--CA 1.494 2.521 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.0 p 36.27 45.11 0.32 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.978 1.046 . . . . 0.0 113.192 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -85.31 41.66 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.676 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.52 -120.05 0.54 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.0 156.05 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.434 0.726 . . . . 0.0 109.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.62 165.09 17.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.624 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -132.4 -62.82 0.82 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.7 m -110.53 142.68 42.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -133.25 126.67 32.04 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.34 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.457 ' CE2' HD23 ' A' ' 43' ' ' LEU . 37.4 m-85 -94.33 132.99 38.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.17 0.918 . . . . 0.0 110.892 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.28 8.04 5.97 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.6 p -162.19 136.22 6.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.3 p -42.05 116.6 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 123.619 0.574 . . . . 0.0 110.976 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.5 107.43 12.86 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.54 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -78.13 73.82 4.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.516 1.135 . . . . 0.0 112.773 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 156.3 18.28 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.69 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.7 m -144.96 18.37 1.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -82.37 162.78 55.16 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.331 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -53.96 152.48 23.48 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.342 2.028 . . . . 0.0 110.589 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -69.8 166.14 19.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.759 0.662 . . . . 0.0 110.344 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.55 -0.72 1.53 Allowed Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.86 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.558 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.3 m-90 -127.1 -141.82 0.27 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 20.3 ttmm -146.58 -25.16 0.42 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.021 0.373 . . . . 0.0 110.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 p -146.91 158.73 44.0 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.795 0.807 . . . . 0.0 111.98 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 26' ' ' ILE . 6.5 tp -119.35 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 112.884 -1.962 . . . . 0.0 108.319 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -104.01 125.78 50.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.594 1.184 . . . . 0.0 108.392 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 mm -113.82 134.2 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -67.1 88.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 124.362 1.039 . . . . 0.0 110.476 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.79 -1.576 . . . . 0.0 114.491 179.896 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' H ' ' HG ' ' A' ' 35' ' ' SER . . . -160.36 119.88 2.77 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.355 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.412 ' CB ' HD12 ' A' ' 72' ' ' ILE . 72.4 t80 -87.63 92.11 8.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.1 m -73.1 152.63 41.13 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 m -154.31 153.59 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.571 1.169 . . . . 0.0 110.26 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.409 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 29.8 m-90 -135.63 150.09 49.53 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 96.4 p -63.41 -10.44 17.09 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 106.71 158.83 21.65 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -73.43 -53.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.63 0 O-C-N 122.897 0.946 . . . . 0.0 110.885 25.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.51 -123.69 4.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 74.0 m -101.39 39.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.799 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.26 -130.65 0.3 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.1 p30 36.24 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -82.01 149.31 28.19 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.227 0.329 . . . . 0.0 110.261 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.63 152.72 23.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 123.765 0.666 . . . . 0.0 112.758 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -163.2 143.18 8.92 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.458 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -124.55 159.84 29.72 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.47 86.31 2.26 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.558 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -114.46 -8.17 12.81 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.25 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -54.6 121.01 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.19 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.45 97.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.421 1.076 . . . . 0.0 109.872 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.95 -177.48 21.88 Favored Glycine 0 N--CA 1.493 2.461 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.3 m -79.97 141.3 36.12 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.961 -1.119 . . . . 0.0 109.959 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.2 p -156.45 136.93 13.1 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.202 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.02 130.52 35.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 123.726 0.641 . . . . 0.0 112.614 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.2 mt -88.61 138.72 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -105.79 -56.27 2.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.041 0.838 . . . . 0.0 112.658 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.477 ' H ' ' CD ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -77.25 76.36 3.8 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 123.38 1.562 . . . . 0.0 111.146 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -71.93 18.87 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.245 -2.252 . . . . 0.0 115.46 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.35 -76.29 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.17 168.66 21.37 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -161.63 130.31 4.39 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -114.42 101.1 8.83 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.098 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -78.49 151.42 32.6 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.423 ' HG ' ' H ' ' A' ' 2' ' ' ALA . 77.9 p -135.82 147.55 48.33 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 124.782 1.301 . . . . 0.0 107.703 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CG ' ' N ' ' A' ' 37' ' ' THR . 77.8 t80 -132.14 156.74 45.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.359 1.037 . . . . 0.0 108.506 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' A' ' 36' ' ' TYR . 5.8 t -163.49 -24.21 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.022 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.05 -25.34 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -123.71 118.56 27.52 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.492 ' H ' ' NE2' ' A' ' 75' ' ' GLN . 60.8 m -83.62 170.65 14.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.009 -1.905 . . . . 0.0 109.406 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.77 159.57 41.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.013 0.821 . . . . 0.0 111.066 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.13 133.24 24.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.049 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.48 ' HG ' ' CE3' ' A' ' 69' ' ' TRP . 4.3 mm? -79.59 169.43 18.02 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.691 0.619 . . . . 0.0 109.433 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -153.52 124.06 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.512 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -70.67 -30.83 67.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.442 ' CD ' ' N ' ' A' ' 46' ' ' GLN . 3.5 mp0 -89.65 112.38 23.61 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -41.5 143.35 0.48 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.78 41.58 90.9 Favored Glycine 0 N--CA 1.497 2.724 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.963 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 60.7 m 52.76 30.8 9.44 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.162 0.566 . . . . 0.0 112.414 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.6 t -81.0 30.56 0.32 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.278 1.037 . . . . 0.0 113.006 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 49' ' ' CYS . . . -161.68 -161.66 12.12 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.6 t -95.64 145.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.97 148.56 50.89 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.571 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.619 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 12.6 t-80 -95.62 -69.41 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.417 ' HG1' ' HD1' ' A' ' 54' ' ' HIS . 60.5 m -112.36 118.84 36.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 123.94 0.775 . . . . 0.0 111.036 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -98.77 170.34 8.84 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.215 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.09 -172.39 2.82 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.424 0.63 . . . . 0.0 111.087 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.42 -36.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -145.53 159.32 43.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.877 -1.161 . . . . 0.0 108.99 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -42.29 117.39 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.53 90.26 3.3 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.761 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -75.29 69.78 2.15 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.09 168.3 11.73 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.798 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.38 8.97 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.779 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.92 157.16 83.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.12 156.28 65.5 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.074 1.849 . . . . 0.0 109.421 167.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CG ' ' CE3' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -138.14 -164.4 1.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.31 27.38 2.76 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.15 0.906 . . . . 0.0 112.663 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.619 ' HE1' ' CG ' ' A' ' 54' ' ' HIS . 4.9 m-90 -94.29 131.73 39.6 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -86.41 -18.11 32.61 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.379 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.2 p -156.42 179.55 9.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.292 0.995 . . . . 0.0 113.007 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.412 ' HB ' HD11 ' A' ' 43' ' ' LEU . 13.9 tt -153.35 141.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.344 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.588 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 69.2 t80 -104.97 135.15 46.85 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.497 -1.683 . . . . 0.0 107.907 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.6 mm -123.2 132.58 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.492 ' NE2' ' H ' ' A' ' 40' ' ' THR . 24.6 mt-30 -76.19 173.21 11.64 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 116.11 -1.9 . . . . 0.0 111.51 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.89 129.0 49.45 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -98.14 94.03 6.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 124.297 0.998 . . . . 0.0 109.838 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -77.09 155.17 32.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.577 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 25.2 m -154.56 160.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 124.211 0.944 . . . . 0.0 108.91 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -139.65 135.86 33.7 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -43.37 -44.28 5.55 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 147.1 151.65 5.47 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -79.44 -62.86 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.593 0 O-C-N 123.002 1.001 . . . . 0.0 111.794 18.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.43 -138.47 10.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.09 52.89 2.37 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.105 -1.047 . . . . 0.0 111.919 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -132.18 -130.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.1 p30 35.42 -144.01 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -66.31 149.36 50.48 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.11 148.73 45.35 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 123.44 0.462 . . . . 0.0 111.646 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -166.78 153.59 8.85 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.348 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -123.09 153.35 40.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.08 0.863 . . . . 0.0 111.313 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -134.59 79.87 1.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.523 -1.671 . . . . 0.0 107.423 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -103.45 8.97 37.9 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.731 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 138.05 57.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.164 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.95 155.91 36.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.009 0.818 . . . . 0.0 110.049 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.4 -92.47 1.66 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 103.828 -3.709 . . . . 0.0 103.828 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -171.56 164.79 6.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.93 1.018 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 p -160.0 141.73 12.84 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.448 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.49 135.77 36.73 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.451 HD11 ' HA ' ' A' ' 71' ' ' SER . 3.2 mp -102.98 156.38 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -121.22 -20.51 6.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 124.155 0.91 . . . . 0.0 110.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.36 97.34 2.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.15 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -90.1 62.91 5.68 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.04 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 -118.31 1.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.33 162.89 26.08 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 125.077 1.104 . . . . 0.0 111.325 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 14.9 p90 -161.73 136.01 6.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 3.4 t70 -120.76 165.88 14.5 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.362 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.41 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 70.3 t80 -133.86 155.61 49.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -147.21 85.56 1.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.36 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -49.09 133.82 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 112.948 -1.933 . . . . 0.0 113.293 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.4 m -152.48 82.85 1.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.73 19.06 57.92 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.83 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.429 ' HG2' ' N ' ' A' ' 76' ' ' CYS . 5.5 tp-100 -159.86 161.36 34.41 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.344 -0.943 . . . . 0.0 113.195 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -112.67 177.42 4.64 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.487 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.76 172.29 13.51 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.568 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.57 150.79 28.11 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.52 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -106.65 126.88 52.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.611 0.72 . . . . 0.0 111.365 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.64 101.47 10.78 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -61.36 -13.67 21.5 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.916 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -92.92 130.52 38.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.71 151.49 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.99 22.86 67.16 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.741 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 21.5 m 59.64 13.99 3.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.175 0.573 . . . . 0.0 112.471 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -87.61 63.04 7.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.939 0.775 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.0 -137.67 2.93 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.094 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.54 175.52 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.25 144.26 26.54 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.732 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -120.44 -51.46 2.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.8 m -123.18 121.51 36.1 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.505 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.68 118.89 37.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.253 0.971 . . . . 0.0 111.606 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -102.04 93.56 5.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.344 1.028 . . . . 0.0 108.351 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.29 -23.3 44.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.1 t -135.59 144.07 45.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.485 0.756 . . . . 0.0 109.258 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.442 ' H ' ' HG ' ' A' ' 60' ' ' SER . 14.3 m -35.06 124.01 0.58 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.435 1.084 . . . . 0.0 111.929 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.65 105.74 5.71 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.787 0.68 . . . . 0.0 111.13 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -76.44 75.18 3.19 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.325 1.016 . . . . 0.0 112.905 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.8 153.69 20.05 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.289 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.53 19.86 2.03 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -79.18 165.02 51.52 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -56.0 148.22 59.28 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.938 1.759 . . . . 0.0 110.372 172.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.27 173.01 4.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.788 0.68 . . . . 0.0 109.473 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.19 7.46 0.12 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.197 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.52 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.2 m-90 -128.29 -171.29 2.42 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.957 0.445 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.94 -24.67 3.44 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.451 ' HA ' HD11 ' A' ' 26' ' ' ILE . 10.1 p -146.53 163.69 34.96 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.681 0.613 . . . . 0.0 111.399 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.04 114.68 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.975 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -93.79 121.06 34.85 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.52 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.3 mt -130.08 128.54 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.425 ' CD ' ' H ' ' A' ' 75' ' ' GLN . 3.2 mp0 -78.35 9.86 3.54 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.429 ' N ' ' HG2' ' A' ' 39' ' ' GLN . 14.6 p . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.38 123.68 10.92 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CG ' HD13 ' A' ' 72' ' ' ILE . 67.3 t80 -89.65 104.6 17.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' ASP . 53.1 m -94.16 137.02 33.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -139.59 162.32 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.429 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 18.2 m-90 -128.18 140.33 51.97 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.449 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 78.2 p -55.58 -31.18 61.98 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.443 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 142.06 148.38 5.0 Favored Glycine 0 N--CA 1.5 2.929 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.41 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -73.61 -65.14 0.03 OUTLIER 'Cis proline' 0 N--CA 1.503 2.066 0 CA-C-N 118.428 1.114 . . . . 0.0 112.581 20.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.33 -125.42 4.12 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 105.393 -3.083 . . . . 0.0 105.393 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -99.27 73.01 1.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -139.18 -53.11 0.56 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.138 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 7' ' ' SER . 7.6 p30 -57.22 -136.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.926 -1.943 . . . . 0.0 116.145 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -58.13 141.07 51.42 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.17 82.24 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 124.73 1.269 . . . . 0.0 111.168 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.67 165.03 14.47 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.189 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -152.19 156.21 39.32 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.454 0.645 . . . . 0.0 112.374 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.93 69.19 1.36 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.2 t -90.7 -18.64 24.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.355 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -57.09 129.59 42.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.609 0.568 . . . . 0.0 111.602 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.48 122.18 15.64 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.552 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.43 -169.99 13.51 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-O 122.596 1.109 . . . . 0.0 114.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.5 t -56.74 130.38 45.29 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.612 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -160.81 120.42 2.68 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.615 0.572 . . . . 0.0 111.02 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.72 126.3 30.76 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 mt -87.75 154.52 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -138.6 -9.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.571 0.545 . . . . 0.0 110.939 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.86 105.32 7.85 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.165 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.76 62.01 5.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.177 0.923 . . . . 0.0 108.845 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.74 -108.27 0.69 Allowed Glycine 0 N--CA 1.497 2.744 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.06 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.03 166.49 21.25 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -146.1 165.5 28.91 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 3.2 t70 -169.22 163.11 10.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.424 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 58.0 t80 -138.61 155.81 48.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -142.3 94.8 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.19 0.932 . . . . 0.0 109.436 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.86 151.42 31.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.042 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -174.19 -22.8 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.366 1.041 . . . . 0.0 108.653 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.37 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -122.02 159.81 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.5 p -91.11 -163.8 1.09 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.844 -1.98 . . . . 0.0 110.444 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . . . -155.11 176.18 12.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.9 131.21 6.75 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 114.942 -1.027 . . . . 0.0 108.308 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.485 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -92.12 154.94 18.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.81 120.04 14.7 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.802 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -62.86 -7.48 5.18 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -118.05 122.08 42.24 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.856 0.722 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -40.08 145.84 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 124.685 1.241 . . . . 0.0 113.749 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.99 42.47 96.9 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.819 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.487 ' H ' ' HG ' ' A' ' 71' ' ' SER . 25.7 p 44.11 25.57 0.12 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.156 1.15 . . . . 0.0 112.977 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 t -87.24 44.02 1.15 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.633 0.73 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.54 -155.26 6.39 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.405 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.55 150.14 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.04 156.52 33.52 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.336 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.435 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -141.3 -45.88 0.38 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.026 0.829 . . . . 0.0 110.968 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -137.13 118.89 15.07 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.775 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -105.37 162.48 13.41 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.738 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -139.65 133.88 31.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.043 0.839 . . . . 0.0 110.351 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.87 14.9 5.18 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.5 t -162.68 124.17 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 m -35.88 113.88 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 124.291 0.994 . . . . 0.0 112.955 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.84 15.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.957 0.786 . . . . 0.0 110.529 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -86.95 94.46 9.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 158.94 16.53 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.49 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.2 m -151.37 15.08 0.7 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -88.56 166.24 23.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.01 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -50.03 165.23 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.692 2.261 . . . . 0.0 112.245 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.58 179.36 2.14 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.556 0.694 . . . . 0.0 111.804 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.22 -5.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.141 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.485 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.6 m-90 -138.79 -156.19 0.66 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -140.87 -40.74 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.487 ' HG ' ' H ' ' A' ' 49' ' ' CYS . 58.7 p -131.95 178.38 6.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 124.704 1.253 . . . . 0.0 111.377 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.486 HD13 ' CG ' ' A' ' 3' ' ' PHE . 11.2 tt -150.91 147.39 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.77 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -119.94 130.42 54.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.528 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.36 152.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 66.7 mt-30 -73.85 -159.59 0.08 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 75' ' ' GLN . 24.4 p . . . . . 0 N--CA 1.504 2.23 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.59 134.5 42.38 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.377 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -109.15 91.3 3.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.437 1.086 . . . . 0.0 108.85 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.0 m -81.25 133.81 35.5 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.978 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.14 145.65 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 123.645 0.591 . . . . 0.0 111.382 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.442 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 8.4 m-90 -114.3 143.27 45.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 79.1 p -64.34 -10.27 23.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' N ' ' HA3' ' A' ' 30' ' ' GLY . . . 120.35 154.6 9.42 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 123.596 0.56 . . . . 0.0 113.326 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -75.35 -64.18 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.835 0 O-C-N 123.221 1.116 . . . . 0.0 112.468 12.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.42 -136.13 6.39 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -106.12 66.07 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.411 -1.395 . . . . 0.0 109.792 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -141.86 -59.39 0.47 Allowed 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.774 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 7' ' ' SER . 2.0 p30 -32.56 -104.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -72.18 -164.16 0.13 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.412 1.005 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.69 59.68 0.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.834 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.13 151.14 28.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -145.75 116.81 7.82 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.385 0.612 . . . . 0.0 111.488 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HH ' ' H ' ' A' ' 27' ' ' HIS . 27.7 m-85 -97.9 73.08 2.26 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.884 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.7 p -81.32 -14.29 57.48 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -64.63 133.27 51.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 123.949 0.781 . . . . 0.0 110.835 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.6 m -63.29 175.51 0.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.359 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.74 -161.94 45.85 Favored Glycine 0 N--CA 1.492 2.381 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.18 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -97.95 125.27 42.79 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.5 p -131.14 135.84 47.82 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.003 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.99 117.8 20.4 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.52 138.01 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.377 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.41 ' H ' ' HH ' ' A' ' 18' ' ' TYR . 67.4 m80 -118.86 59.59 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.99 98.77 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.663 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -91.3 61.11 4.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA3' ' N ' ' A' ' 8' ' ' GLY . . . -144.06 -109.63 0.68 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.647 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.72 166.87 21.75 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -147.37 147.29 30.15 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -151.0 154.21 36.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -128.16 157.6 40.36 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.1 m -144.52 93.57 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.774 0.797 . . . . 0.0 110.016 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -71.4 151.75 43.76 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.775 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -172.76 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.222 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.53 -64.59 0.22 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -126.83 166.17 17.95 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.423 ' HG1' ' NH2' ' A' ' 56' ' ' ARG . 82.5 p -93.06 171.97 8.61 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.888 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.78 178.55 5.87 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.579 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.88 131.61 6.98 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.94 161.63 23.0 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -137.61 106.5 5.95 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.556 -2.111 . . . . 0.0 107.92 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -55.27 -23.67 24.17 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.316 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -95.98 135.57 37.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.161 0.913 . . . . 0.0 109.768 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.47 119.06 1.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.898 1.374 . . . . 0.0 113.074 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 43.71 74.21 0.21 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 124.618 1.199 . . . . 0.0 113.458 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.45 ' H ' ' HG ' ' A' ' 71' ' ' SER . 1.0 OUTLIER 44.22 25.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m -82.35 32.13 0.4 Allowed 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.988 0.899 . . . . 0.0 112.238 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 49' ' ' CYS . . . -161.74 -129.61 1.04 Allowed Glycine 0 N--CA 1.49 2.257 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.2 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -127.22 162.21 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.33 -177.39 1.12 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.046 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -148.62 -60.88 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.3 m -104.22 167.6 9.65 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.069 0.856 . . . . 0.0 109.796 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.423 ' NH2' ' HG1' ' A' ' 40' ' ' THR . 20.5 mmm180 -142.45 144.77 33.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.462 1.101 . . . . 0.0 109.923 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -128.12 100.62 5.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.102 0.876 . . . . 0.0 109.528 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.37 -25.17 52.15 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.954 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.9 p -148.99 148.29 29.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.07 0.512 . . . . 0.0 111.339 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -33.78 115.32 0.22 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 124.434 1.083 . . . . 0.0 112.353 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.73 108.58 10.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.097 0.873 . . . . 0.0 111.644 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -82.03 87.5 6.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.101 0.876 . . . . 0.0 112.999 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 163.26 14.69 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.87 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 m -148.0 11.6 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.14 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -69.76 164.13 53.77 Favored Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.234 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.54 165.02 1.81 Allowed 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.45 2.1 . . . . 0.0 110.464 167.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.57 174.01 3.77 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.694 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.48 -3.52 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -143.13 -176.02 4.75 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -114.26 -39.34 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 49' ' ' CYS . 19.7 p -132.58 165.7 23.79 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.35 112.75 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.204 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -90.81 143.37 26.79 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.445 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.6 mt -135.05 132.5 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -60.2 -37.58 80.7 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.162 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 115.71 -2.09 . . . . 0.0 115.114 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.12 121.03 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.439 ' CB ' HD11 ' A' ' 72' ' ' ILE . 70.7 t80 -97.83 84.47 3.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.293 0.996 . . . . 0.0 110.076 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -68.07 151.04 47.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.74 154.93 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.428 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.5 m-90 -134.08 140.8 46.87 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.3 p -48.88 -43.33 38.96 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.476 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.11 157.27 7.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -81.47 -62.13 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.537 0 O-C-N 123.023 1.012 . . . . 0.0 110.33 14.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -128.0 3.12 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -106.98 49.61 0.8 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.706 -1.247 . . . . 0.0 109.308 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -119.49 -128.49 0.28 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.476 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 11.0 p30 35.94 -142.11 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -77.06 140.12 40.22 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.41 131.33 49.14 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.837 0.711 . . . . 0.0 110.662 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -136.83 118.37 14.85 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -98.23 124.67 42.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.276 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.14 81.98 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.9 m -106.21 -20.1 13.5 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.773 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -50.16 139.38 14.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.368 1.043 . . . . 0.0 112.912 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 162.69 11.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -151.16 43.3 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 22.0 p -129.98 154.19 47.63 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.029 -1.068 . . . . 0.0 113.558 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -143.39 151.76 40.79 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.118 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.47 124.47 28.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.031 0.832 . . . . 0.0 112.09 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.71 118.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -93.14 -25.67 17.77 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.467 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -78.91 102.52 8.3 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 80.3 tttt -90.06 13.49 14.78 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.181 0.926 . . . . 0.0 111.43 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.32 -90.02 0.37 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.466 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.48 169.86 21.18 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -162.0 136.4 6.83 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -120.35 131.79 55.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.441 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.434 ' CG ' ' N ' ' A' ' 35' ' ' SER . 59.5 t80 -101.55 160.65 14.26 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.3 t -147.0 90.14 1.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -74.71 137.27 41.98 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.886 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -148.95 -44.99 0.14 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.751 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.8 -42.37 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.04 134.4 55.0 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.2 m -81.61 168.9 17.68 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.679 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.94 24.28 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.666 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.08 146.19 28.75 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD11 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -109.33 98.8 8.15 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.252 -179.546 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -75.63 130.48 38.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.764 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -94.59 27.71 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.498 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.36 145.21 29.21 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.93 142.32 12.02 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.425 -1.261 . . . . 0.0 114.281 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.93 33.46 13.4 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 113.538 -1.664 . . . . 0.0 113.512 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.3 p 41.44 42.76 1.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.7 p -98.78 47.4 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.633 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.71 -128.34 0.95 Allowed Glycine 0 N--CA 1.498 2.816 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.487 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -119.3 140.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.471 0.748 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.49 153.1 27.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -107.65 -36.81 6.33 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.12 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -138.82 123.74 18.84 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.07 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -101.7 163.29 12.33 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -138.86 92.8 2.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.668 0.605 . . . . 0.0 112.459 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.02 16.07 62.11 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.8 t -170.46 138.31 1.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.1 p -44.61 129.45 6.85 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.06 97.05 4.5 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.97 0.794 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.0 mtt-85 -72.04 71.65 0.83 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.06 14.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.326 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.5 m -142.95 -11.26 0.77 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -71.47 156.41 91.52 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.964 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.37 176.98 0.93 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.684 2.256 . . . . 0.0 112.056 173.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.413 ' CE1' ' HA ' ' A' ' 29' ' ' LYS . 39.8 p90 -158.12 -167.45 2.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.088 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.43 56.52 0.46 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.455 ' CG ' HD11 ' A' ' 43' ' ' LEU . 5.0 m-90 -109.36 163.38 13.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.68 -44.58 5.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.54 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 p -155.41 164.65 38.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.716 1.26 . . . . 0.0 112.432 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.439 HD11 ' CB ' ' A' ' 3' ' ' PHE . 7.1 tt -125.98 129.83 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.721 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -99.22 147.69 24.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 125.255 1.597 . . . . 0.0 107.418 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.3 mt -141.97 137.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.99 149.46 32.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.947 0.779 . . . . 0.0 111.267 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 116.919 -1.515 . . . . 0.0 110.515 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 19' ' ' SER . . . -157.39 107.84 2.25 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CB ' HD12 ' A' ' 72' ' ' ILE . 56.2 t80 -96.89 93.78 6.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.051 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -76.17 148.2 37.93 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 m -149.64 132.36 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.8 0.688 . . . . 0.0 110.384 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.483 ' CD1' ' HB3' ' A' ' 15' ' ' ALA . 23.6 m-90 -103.72 152.21 22.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -65.25 -10.41 31.8 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.837 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.97 160.75 19.71 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 123.976 0.798 . . . . 0.0 112.066 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.93 -58.61 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 O-C-N 123.134 1.07 . . . . 0.0 111.797 17.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.21 -132.06 7.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 69.1 m -109.77 73.11 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.45 -51.03 0.47 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.933 0.873 . . . . 0.0 110.401 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.508 ' H ' HD21 ' A' ' 13' ' ' ASN . 2.9 p30 -56.93 -159.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.417 -2.174 . . . . 0.0 114.302 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -70.55 172.92 7.71 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 6' ' ' TRP . . . -155.83 178.34 10.38 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -150.08 141.16 23.01 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 111.362 -2.654 . . . . 0.0 105.256 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.33 131.02 53.95 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.524 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.419 ' HH ' HE22 ' A' ' 28' ' ' GLN . 88.8 m-85 -103.96 68.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.652 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 58.6 p -86.8 -13.23 45.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -59.1 124.94 21.62 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.38 123.65 21.77 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.504 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -167.73 13.89 Favored Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -78.48 145.75 34.79 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.1 p -160.04 131.77 6.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.611 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.81 138.28 38.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 123.641 0.588 . . . . 0.0 111.784 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.27 146.32 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -125.7 -22.55 4.21 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.041 0.838 . . . . 0.0 109.876 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.435 ' H ' ' NE2' ' A' ' 28' ' ' GLN . 3.9 mp0 -74.45 100.25 3.78 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.197 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.14 62.93 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.221 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.41 -105.49 1.17 Allowed Glycine 0 N--CA 1.495 2.614 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.25 170.63 14.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -161.27 130.17 4.56 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -114.69 105.81 13.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.375 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 35' ' ' SER . 83.6 t80 -80.7 157.48 25.88 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.201 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.3 m -142.47 129.23 20.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 124.843 1.339 . . . . 0.0 108.992 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -112.05 146.84 37.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.6 t -164.06 -33.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.695 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.64 -9.31 0.05 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -131.21 131.96 44.34 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 m -81.96 174.14 11.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.29 159.2 43.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.614 0.721 . . . . 0.0 112.14 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.54 145.84 35.61 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.665 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.441 HD12 ' CE2' ' A' ' 57' ' ' PHE . 47.5 mt -116.55 96.24 5.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.458 0.647 . . . . 0.0 112.073 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -85.94 136.0 33.44 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.741 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -87.2 5.08 39.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.347 -1.751 . . . . 0.0 110.726 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -115.97 150.54 37.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.855 0.722 . . . . 0.0 110.827 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 132.97 54.69 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.522 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.88 31.03 74.59 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.365 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.0 m 55.41 30.74 15.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.6 t -90.76 59.51 4.19 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.151 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.02 -147.7 5.0 Favored Glycine 0 N--CA 1.497 2.713 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.174 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -111.24 142.5 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 114.239 -0.98 . . . . 0.0 108.366 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.82 119.7 23.07 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.45 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -79.58 -36.54 38.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.3 m -145.65 133.79 21.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.049 0.843 . . . . 0.0 110.035 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -118.92 149.62 41.27 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.096 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 43' ' ' LEU . 25.7 m-85 -123.2 132.07 53.91 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.055 0.847 . . . . 0.0 111.143 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -2.42 11.22 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -154.32 139.52 17.5 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.4 m -37.73 120.26 0.81 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.04 0.838 . . . . 0.0 112.75 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.71 88.1 2.83 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 124.111 0.882 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -73.72 69.8 1.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.43 14.65 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.734 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.9 m -147.77 36.37 0.87 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.775 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -110.04 162.42 20.49 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.132 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.44 175.64 3.29 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.452 2.101 . . . . 0.0 111.649 171.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 15.4 p90 -161.22 -165.51 1.35 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.31 56.11 0.41 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.426 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.4 m0 -114.8 127.45 55.73 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -82.54 -8.48 59.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 123.72 0.637 . . . . 0.0 109.968 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.8 p -174.29 165.25 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.466 1.104 . . . . 0.0 112.213 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.45 HD12 ' CB ' ' A' ' 3' ' ' PHE . 11.1 tt -134.18 122.35 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-N 112.627 -2.078 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -99.48 107.8 20.08 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.847 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.7 mt -104.62 147.56 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.364 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -72.21 -172.4 0.9 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.118 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 116.25 -1.833 . . . . 0.0 110.387 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.49 142.77 1.69 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.655 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.41 ' CE2' ' CG1' ' A' ' 5' ' ' VAL . 88.7 t80 -93.87 104.04 16.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.696 1.248 . . . . 0.0 112.3 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -81.2 158.72 24.79 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG1' ' CE2' ' A' ' 3' ' ' PHE . 10.3 m -153.62 122.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 124.008 0.818 . . . . 0.0 112.184 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.502 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.1 m-90 -95.58 146.5 24.42 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.6 p -60.44 -16.61 37.91 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.362 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.19 162.54 13.14 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 124.283 0.99 . . . . 0.0 112.181 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -75.21 -59.64 0.11 OUTLIER 'Cis proline' 0 N--CA 1.498 1.766 0 O-C-N 123.12 1.063 . . . . 0.0 111.053 11.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.47 -147.63 22.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 6' ' ' TRP . 7.6 p -102.25 66.84 1.02 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -136.89 -49.16 0.63 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.502 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 3.8 p30 -56.97 -152.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.256 -1.793 . . . . 0.0 114.519 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -74.35 162.49 28.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.7 12.97 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -147.39 154.88 41.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.997 -1.911 . . . . 0.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -115.95 144.34 44.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.737 0.648 . . . . 0.0 110.604 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -125.94 95.48 4.43 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.773 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -114.52 -7.43 12.81 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.894 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -49.7 123.29 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.881 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 23.8 t -72.71 90.23 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.745 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.24 113.59 21.7 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -124.87 132.93 53.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.882 0.739 . . . . 0.0 112.939 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.87 116.7 21.65 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.546 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.9 135.95 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.551 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -106.87 -32.12 8.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.571 1.169 . . . . 0.0 111.37 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -79.44 91.62 5.14 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.593 1.187 . . . . 0.0 108.173 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -90.49 62.72 5.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.566 -2.106 . . . . 0.0 111.753 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.08 -113.48 1.33 Allowed Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.022 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 165.44 34.03 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -161.89 129.47 4.01 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 1.1 t70 -112.07 167.98 9.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.6 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.409 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 59.5 t80 -148.41 155.33 41.09 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.184 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 58.5 m -137.25 147.11 45.51 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -134.3 145.53 49.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.717 1.261 . . . . 0.0 109.768 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -172.85 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.751 0.657 . . . . 0.0 111.561 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.8 -12.64 1.3 Allowed Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.044 0.84 . . . . 0.0 111.536 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.31 20.55 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.7 m -84.56 166.65 17.01 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.938 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.41 157.7 46.0 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 131.89 10.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.914 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.71 163.61 13.69 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 49' ' ' CYS . 5.6 p90 -167.75 135.08 2.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.652 -2.067 . . . . 0.0 108.905 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.473 ' H ' HD21 ' A' ' 45' ' ' ASN . 2.0 m-80 -66.91 11.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.261 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.41 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 mm-40 -131.69 113.54 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.394 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -40.61 147.41 0.11 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.618 1.199 . . . . 0.0 112.428 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.98 44.74 62.08 Favored Glycine 0 N--CA 1.499 2.846 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.725 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.461 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 5.1 p 42.06 36.84 0.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 m -95.54 42.69 1.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.748 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.19 -164.4 15.21 Favored Glycine 0 N--CA 1.5 2.961 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.229 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.43 153.69 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.46 143.94 26.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.409 ' CD2' ' ND2' ' A' ' 45' ' ' ASN . 20.9 m-70 -112.62 -52.69 2.77 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.662 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -122.75 106.37 10.87 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -96.4 117.39 30.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.215 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -91.75 108.33 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 123.717 0.636 . . . . 0.0 110.521 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.93 45.51 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 t -146.32 159.85 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.46 0.741 . . . . 0.0 109.374 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.0 p -36.05 124.72 0.75 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.218 0.949 . . . . 0.0 113.308 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.42 101.21 5.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.143 0.902 . . . . 0.0 110.65 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -84.46 68.52 10.31 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.37 168.87 15.18 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.397 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 16.7 m -147.88 10.83 0.93 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -67.54 164.29 39.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.42 147.14 79.64 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 110.559 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.62 162.21 6.8 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 124.012 0.82 . . . . 0.0 109.874 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.55 18.76 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -136.14 -155.67 0.65 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.562 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 19.4 ttmm -141.1 -32.31 0.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -154.26 162.46 41.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.091 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.405 HD12 ' CB ' ' A' ' 3' ' ' PHE . 16.7 tt -129.44 143.6 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.015 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -113.67 132.1 55.91 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.488 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.0 mt -138.09 146.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 124.263 0.977 . . . . 0.0 108.753 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -88.41 169.08 12.1 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 91.4 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 116.099 -1.905 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.865 0.364 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.09 52.19 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.324 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -110.8 151.99 27.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 33' ' ' ASP . 92.0 m -140.13 148.65 41.98 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 32' ' ' TYR . 17.9 m -154.69 155.04 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.347 1.029 . . . . 0.0 112.854 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.553 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 9.1 m-90 -125.83 154.35 42.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.6 m -78.48 -13.35 59.87 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.438 ' H ' HD21 ' A' ' 13' ' ' ASN . . . 145.49 145.62 4.3 Favored Glycine 0 N--CA 1.504 3.231 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.687 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -76.04 -53.78 0.15 OUTLIER 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 118.171 0.985 . . . . 0.0 110.091 8.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.22 -127.6 4.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 105.25 -3.14 . . . . 0.0 105.25 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.473 ' HA ' ' CG ' ' A' ' 6' ' ' TRP . 21.8 p -96.87 57.53 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -138.81 53.33 1.77 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.674 -0.811 . . . . 0.0 112.425 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.553 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -173.53 -122.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -48.66 145.87 3.42 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 123.428 0.691 . . . . 0.0 112.576 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.88 114.89 22.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -149.64 132.57 16.13 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -119.2 163.63 16.79 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.7 95.74 2.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.305 -1.77 . . . . 0.0 106.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.0 t -112.86 -22.33 10.71 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -51.33 147.13 6.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 123.859 0.724 . . . . 0.0 112.728 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.3 t -60.51 160.3 9.14 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.19 -148.01 32.37 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 27.8 p -128.9 172.26 11.5 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.1 p -151.55 136.93 17.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.438 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB1' ' HZ2' ' A' ' 70' ' ' LYS . . . -79.93 112.56 17.34 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.979 0.799 . . . . 0.0 111.788 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.02 146.48 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.989 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -125.18 -14.51 6.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.382 1.051 . . . . 0.0 108.456 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -70.69 100.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -86.99 56.64 4.1 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.551 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.1 -97.16 0.63 Allowed Glycine 0 N--CA 1.501 3.017 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.231 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.1 162.35 14.01 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CD2' HG12 ' A' ' 5' ' ' VAL . 36.5 m-85 -144.56 108.72 4.78 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.367 1.079 . . . . 0.0 111.788 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 1.5 t70 -108.7 162.31 14.29 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.18 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -148.67 157.77 43.68 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.53 -1.213 . . . . 0.0 108.469 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 t -146.68 103.1 3.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 124.668 1.23 . . . . 0.0 108.947 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -79.05 151.81 31.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.282 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -174.82 73.39 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.86 -37.19 2.32 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.021 -1.899 . . . . 0.0 111.402 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -89.9 125.49 35.37 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.507 0.67 . . . . 0.0 112.188 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 m -85.58 164.15 17.93 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.284 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.4 148.42 27.45 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.374 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.5 148.53 34.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 124.479 1.112 . . . . 0.0 109.684 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -87.13 159.69 18.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.206 1.003 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -137.91 113.84 9.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 111.58 -2.555 . . . . 0.0 108.331 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.447 ' H ' ' CE1' ' A' ' 54' ' ' HIS . 16.7 t30 -55.47 -14.62 2.09 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.349 1.031 . . . . 0.0 113.11 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.431 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -119.51 132.13 55.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.134 0.896 . . . . 0.0 109.983 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.94 150.58 0.26 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 114.038 -1.437 . . . . 0.0 113.592 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.9 34.03 37.05 Favored Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.421 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.4 p 39.03 44.66 0.92 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.783 0.931 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -86.07 37.7 0.73 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.337 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.86 -145.64 4.36 Favored Glycine 0 N--CA 1.495 2.576 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.321 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -103.88 157.18 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.65 175.73 6.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.808 0.693 . . . . 0.0 111.434 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.447 ' CE1' ' H ' ' A' ' 45' ' ' ASN . 72.3 m80 -142.83 -59.0 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 123.974 0.796 . . . . 0.0 111.717 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.9 m -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.885 0.74 . . . . 0.0 111.312 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.8 ttt85 -95.35 163.63 13.17 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.684 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -140.72 149.72 42.54 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.38 -5.19 3.01 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 124.638 1.211 . . . . 0.0 110.159 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.4 m -149.86 150.81 32.49 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.7 p -45.66 119.27 2.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.889 0.743 . . . . 0.0 111.172 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.49 92.01 3.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.12 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 36.1 ptt180 -82.96 68.31 9.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.02 159.13 21.26 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.869 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.448 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 58.5 m -138.96 27.12 2.42 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.064 0.935 . . . . 0.0 109.449 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -82.7 164.96 44.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.644 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.05 167.44 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.356 2.037 . . . . 0.0 110.649 170.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.27 177.1 2.93 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.823 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 69' ' ' TRP . . . -160.0 -6.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.509 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 4.0 m-90 -142.5 -160.54 1.11 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HZ2' ' HB1' ' A' ' 25' ' ' ALA . 28.5 tptp -128.74 -45.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 123.28 0.362 . . . . 0.0 111.341 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.2 p -124.77 166.01 16.98 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 124.337 1.023 . . . . 0.0 112.745 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.52 126.22 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -106.01 143.04 34.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.1 mt -143.49 117.19 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.81 162.27 28.82 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.022 0.826 . . . . 0.0 110.829 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.156 -1.878 . . . . 0.0 110.702 179.922 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 27.7 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.404 ' CB ' ' HE ' ' A' ' 17' ' ' ARG . . . -161.21 147.21 14.38 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 36.2 t80 -97.91 108.44 21.15 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.084 -1.417 . . . . 0.0 109.537 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 m -93.49 131.47 38.68 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 m -136.49 148.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 123.668 0.605 . . . . 0.0 111.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.438 ' CE3' ' HA ' ' A' ' 11' ' ' CYS . 21.2 m-90 -115.76 160.75 19.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.7 p -69.55 -9.97 56.2 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.61 153.41 18.2 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 123.752 0.657 . . . . 0.0 111.584 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.41 -64.25 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.685 0 O-C-N 123.118 1.062 . . . . 0.0 111.656 17.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.86 -150.87 15.62 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.438 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 1.6 p -93.07 41.97 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.824 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -124.41 -128.32 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 38.3 -142.05 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.589 ' NH1' HE22 ' A' ' 28' ' ' GLN . 56.7 ttt180 -70.75 140.78 51.44 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -106.86 148.22 28.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.083 0.865 . . . . 0.0 111.194 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.29 167.21 30.7 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.404 ' HE ' ' CB ' ' A' ' 2' ' ' ALA . 80.5 ttt180 -140.17 158.84 43.41 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.463 0.649 . . . . 0.0 112.317 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -142.36 84.84 1.88 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.869 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -112.98 17.22 19.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.739 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -63.07 127.32 30.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.758 0.789 . . . . 0.0 111.364 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -73.34 119.69 17.93 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.545 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.58 -98.58 0.88 Allowed Glycine 0 N--CA 1.493 2.439 0 O-C-N 124.535 1.147 . . . . 0.0 111.182 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.473 ' SG ' ' CD2' ' A' ' 73' ' ' PHE . 60.1 m -142.24 147.03 35.82 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.157 0.563 . . . . 0.0 112.132 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.6 p -160.42 126.83 4.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.72 126.88 31.51 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 136.65 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 123.757 0.66 . . . . 0.0 109.687 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -100.97 -46.57 5.06 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.477 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.589 HE22 ' NH1' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -51.43 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.704 1.252 . . . . 0.0 111.944 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -90.47 68.96 6.83 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.243 1.021 . . . . 0.0 108.596 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.84 -106.73 0.26 Allowed Glycine 0 N--CA 1.493 2.499 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.463 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.46 160.03 27.64 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CE1' ' CE2' ' A' ' 67' ' ' PHE . 49.2 m-85 -147.61 159.05 44.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.585 0.815 . . . . 0.0 108.879 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -169.8 159.42 7.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 59.7 t80 -135.54 159.87 40.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 t -147.14 91.36 1.98 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.469 1.106 . . . . 0.0 108.269 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -70.33 150.3 46.47 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.075 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.5 p -140.08 -35.26 0.52 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 39' ' ' GLN . . . -174.99 -12.09 0.02 OUTLIER Glycine 0 N--CA 1.479 1.558 0 CA-C-N 112.322 -2.217 . . . . 0.0 108.24 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.41 ' H ' ' H ' ' A' ' 38' ' ' GLY . 24.7 mp0 -112.77 126.81 55.83 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.2 m -81.21 168.43 18.51 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.035 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.91 113.54 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.477 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.55 165.33 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 57' ' ' PHE . 40.0 mt -129.56 102.36 6.34 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.391 0.615 . . . . 0.0 109.639 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 49' ' ' CYS . 59.7 m-85 -84.01 133.42 34.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.718 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -74.23 -8.64 56.9 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -120.64 138.35 53.97 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.27 145.61 1.63 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.94 54.4 11.94 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.974 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.458 ' HA ' ' CG ' ' A' ' 44' ' ' TYR . 25.7 p 44.31 22.29 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 t -90.55 45.51 1.27 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.542 0.687 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.81 -130.81 2.04 Favored Glycine 0 N--CA 1.495 2.605 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.387 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.31 144.21 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 124.595 0.821 . . . . 0.0 109.44 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.69 103.69 5.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.517 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.32 -40.2 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.779 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.423 ' HB ' HD12 ' A' ' 43' ' ' LEU . 55.5 m -144.03 164.75 29.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.152 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -147.1 -172.38 3.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.718 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.536 ' CE2' HD11 ' A' ' 43' ' ' LEU . 53.7 m-85 -143.81 104.24 4.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.023 0.827 . . . . 0.0 112.858 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.65 -12.23 55.96 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 t -153.8 141.93 20.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 91.2 p -41.16 132.85 2.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.66 121.83 7.76 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 123.994 0.809 . . . . 0.0 111.968 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -83.37 91.85 7.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 60.99 4.6 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 m -57.03 -18.27 13.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -77.2 160.18 76.35 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.82 139.91 68.26 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.091 1.861 . . . . 0.0 109.163 169.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.04 -146.17 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.39 21.2 0.28 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.038 -1.077 . . . . 0.0 114.996 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 5.3 m-90 -108.15 146.36 32.83 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -84.41 -46.69 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.0 p -131.65 174.7 9.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 124.496 1.123 . . . . 0.0 113.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 3' ' ' PHE . 7.1 tt -136.52 137.37 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 112.699 -2.046 . . . . 0.0 109.967 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.473 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 4.7 t80 -107.98 129.91 55.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.2 mt -119.3 129.63 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -61.61 80.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.789 1.93 . . . . 0.0 114.109 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.319 179.858 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.46 ' HB1' ' HE ' ' A' ' 17' ' ' ARG . . . -153.59 104.69 2.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.945 0.778 . . . . 0.0 110.348 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 45.9 t80 -96.87 89.29 4.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -75.42 152.52 37.98 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG2' HE21 ' A' ' 28' ' ' GLN . 11.9 m -148.84 158.13 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.693 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.496 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.6 m-90 -134.59 145.44 48.66 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.417 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 84.1 p -61.54 -38.98 89.42 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 167.35 149.71 6.15 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.723 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -78.51 -56.13 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.808 0 N-CA-C 109.34 -1.061 . . . . 0.0 109.34 9.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.77 -132.54 6.18 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 64' ' ' CYS . 25.0 p -89.65 48.23 1.57 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -140.01 80.18 1.75 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.324 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 5.8 p30 171.71 -146.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -64.91 171.28 3.6 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.0 23.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -161.18 134.14 6.31 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HE ' ' HB1' ' A' ' 2' ' ' ALA . 78.6 ttt180 -108.23 131.62 54.49 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -110.15 78.7 1.14 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.08 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -116.16 -8.2 11.78 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.98 139.7 58.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.052 0.845 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.16 104.71 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.002 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.09 -177.12 19.58 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.126 0.892 . . . . 0.0 113.117 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 m -77.2 143.31 39.12 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.749 -1.225 . . . . 0.0 109.923 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.4 p -148.11 126.69 12.47 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.012 0.82 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.32 119.47 22.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.354 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.63 115.41 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.134 -1.393 . . . . 0.0 109.451 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -95.2 -29.29 14.61 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.499 HE21 ' CG2' ' A' ' 5' ' ' VAL . 4.2 mp0 -77.91 95.61 4.81 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.862 0.726 . . . . 0.0 109.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -80.56 40.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.53 -103.3 2.75 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.06 18.55 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.6 m-85 -150.84 120.54 7.01 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 7.3 m-20 -114.98 106.76 14.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.196 0.31 . . . . 0.0 110.817 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 73.7 t80 -80.95 157.68 25.47 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -148.15 109.12 4.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.353 1.033 . . . . 0.0 108.55 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -84.03 152.21 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.483 -2.144 . . . . 0.0 110.536 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.42 52.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.7 -32.0 5.55 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.583 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -94.15 125.3 38.7 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.477 0.656 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.588 HG22 ' H ' ' A' ' 41' ' ' ALA . 23.3 m -86.54 -170.49 3.1 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.584 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.588 ' H ' HG22 ' A' ' 40' ' ' THR . . . -160.23 151.1 18.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.76 152.74 41.84 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.536 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.3 mm? -117.22 123.59 47.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.315 0.384 . . . . 0.0 111.359 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 46' ' ' GLN . 96.3 m-85 -115.51 128.86 56.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 125.067 1.479 . . . . 0.0 108.496 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -73.66 13.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.877 0.736 . . . . 0.0 112.02 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 44' ' ' TYR . 62.1 mm-40 -133.67 127.26 32.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.46 139.03 2.2 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.58 50.69 56.29 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.783 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 79.4 m 50.27 23.49 1.22 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.4 m -83.93 40.79 0.77 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.402 0.62 . . . . 0.0 112.424 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.17 -149.96 5.5 Favored Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.237 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.85 145.74 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.76 164.95 4.28 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.929 0.768 . . . . 0.0 111.921 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -146.59 -48.85 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.441 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -133.07 152.27 51.97 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.134 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -141.03 119.17 12.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.448 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 30.5 m-85 -97.06 122.0 39.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.091 0.87 . . . . 0.0 111.35 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.65 24.38 4.91 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.0 p -165.46 128.9 2.23 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.595 -0.802 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.0 m -41.27 110.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.12 0.887 . . . . 0.0 111.967 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.16 91.58 3.56 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.271 0.982 . . . . 0.0 111.19 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 92.4 mtt-85 -74.29 79.96 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.39 144.96 25.32 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.136 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.454 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 66.8 m -134.73 47.02 2.4 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.446 1.117 . . . . 0.0 109.242 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -140.75 154.95 69.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.683 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -55.83 156.11 20.33 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.988 2.459 . . . . 0.0 111.611 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -123.49 -135.63 0.29 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.866 0.729 . . . . 0.0 112.182 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.28 -3.33 0.06 OUTLIER Glycine 0 N--CA 1.497 2.75 0 CA-C-O 118.601 -1.11 . . . . 0.0 115.251 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.536 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 3.0 m-90 -90.62 166.57 13.11 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.77 1.285 . . . . 0.0 110.395 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -100.19 -41.58 7.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.828 0.705 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.8 p -138.1 177.09 8.14 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.314 1.009 . . . . 0.0 112.391 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.447 HD13 ' CB ' ' A' ' 3' ' ' PHE . 15.3 tt -144.39 127.33 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.695 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.615 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 7.3 t80 -84.85 94.4 8.73 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.406 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -76.9 116.26 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.366 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -68.66 137.12 53.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 123.906 0.754 . . . . 0.0 110.407 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.672 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.93 121.13 26.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.463 ' CG ' HD13 ' A' ' 72' ' ' ILE . 33.3 t80 -92.78 173.86 7.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.1 m -158.84 152.85 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -150.91 158.18 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.671 1.232 . . . . 0.0 108.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.1 m-90 -132.5 145.85 51.48 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -52.43 -42.71 64.33 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 145.08 152.55 5.65 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -82.07 -60.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 123.15 1.079 . . . . 0.0 111.53 17.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.56 -141.55 11.09 Favored Glycine 0 N--CA 1.485 1.917 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 p -94.31 44.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.656 -1.272 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -123.21 -129.3 0.26 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 38.2 -144.31 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -76.81 128.27 34.3 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -94.43 154.02 17.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.186 0.929 . . . . 0.0 112.266 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -161.64 118.51 2.17 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -86.38 157.1 19.93 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.463 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -136.53 61.49 1.63 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.054 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.4 p -94.43 6.51 48.52 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.008 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.56 118.25 7.92 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 103.83 0.25 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.458 1.099 . . . . 0.0 108.196 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.71 -164.33 18.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.88 150.21 30.67 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 p -160.24 132.12 6.09 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.961 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.21 115.91 19.15 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.04 105.75 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.545 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -96.2 -16.68 21.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.987 -1.461 . . . . 0.0 113.67 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -76.09 94.81 3.52 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.39 0.614 . . . . 0.0 110.312 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -83.91 60.27 5.72 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.145 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.59 -90.04 0.68 Allowed Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.19 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.86 169.12 21.64 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 47.4 p90 -161.73 135.36 6.5 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.57 158.74 24.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.543 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 58.9 t80 -130.03 157.36 42.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -146.94 100.31 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 124.069 0.856 . . . . 0.0 110.128 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -81.12 149.1 29.31 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.644 -1.617 . . . . 0.0 107.835 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -168.48 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.092 0.87 . . . . 0.0 109.342 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.99 -43.17 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.25 166.87 22.75 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.3 p -87.63 -174.58 4.84 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 113.305 -1.77 . . . . 0.0 111.105 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -158.11 113.68 2.71 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.605 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.66 157.05 27.33 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 43' ' ' LEU . 10.7 tp -126.38 94.64 4.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.851 0.834 . . . . 0.0 109.907 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -79.86 141.42 36.17 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.603 -1.635 . . . . 0.0 114.094 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.26 23.09 12.99 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.256 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -131.75 141.65 49.57 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.056 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.9 132.89 37.81 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.102 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.16 68.49 Favored Glycine 0 N--CA 1.495 2.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.173 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.2 m 54.33 29.15 10.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.356 0.68 . . . . 0.0 112.438 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.6 p -85.98 52.07 2.38 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.979 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.61 -121.91 0.61 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.12 150.17 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.59 178.93 1.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.142 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.534 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 18.6 t-80 -139.3 -69.55 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.888 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -118.16 83.07 1.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.127 0.892 . . . . 0.0 108.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 57' ' ' PHE . 5.1 tmm_? -70.57 162.19 29.32 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.6 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.543 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 51.4 m-85 -131.11 135.76 47.78 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.43 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.73 -2.57 4.34 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.1 m -152.58 136.82 16.58 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.3 m -38.05 112.33 0.21 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.153 0.908 . . . . 0.0 111.15 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.71 106.9 11.35 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 124.279 0.987 . . . . 0.0 113.196 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -80.73 75.2 7.64 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.69 165.28 13.79 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.493 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.3 m -149.92 4.91 0.57 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -69.07 152.44 96.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.537 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.6 150.13 88.77 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.777 2.318 . . . . 0.0 110.198 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' HD2' ' H ' ' A' ' 69' ' ' TRP . 38.9 p90 -154.43 -172.65 4.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 123.985 0.803 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.15 54.77 0.36 Allowed Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.557 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.534 ' HE1' ' CB ' ' A' ' 54' ' ' HIS . 1.9 m-90 -88.4 150.33 23.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 11.6 mptt -86.0 -22.83 27.1 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.504 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.1 p -175.66 167.81 3.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.628 1.205 . . . . 0.0 113.131 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.463 HD13 ' CG ' ' A' ' 3' ' ' PHE . 7.3 tt -130.7 130.3 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.838 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.95 93.28 4.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.484 1.115 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.5 mm -72.53 113.4 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.887 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -64.35 108.83 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.743 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.405 ' N ' ' H ' ' A' ' 38' ' ' GLY . 71.5 p . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 130.02 11.55 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CB ' HD13 ' A' ' 72' ' ' ILE . 79.7 t80 -93.74 91.21 6.89 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.94 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.0 m -73.39 148.87 42.95 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.42 137.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 123.801 0.688 . . . . 0.0 109.684 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.562 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 19.9 m-90 -112.93 155.22 25.11 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -66.66 -42.55 86.46 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.97 156.04 9.14 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -76.97 -51.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.753 0 O-C-N 122.651 0.816 . . . . 0.0 110.786 8.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.97 -111.16 3.04 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.7 p -111.99 53.4 0.73 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -138.19 69.41 1.39 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 2.3 p30 178.31 -144.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.423 HH22 ' CG ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -79.72 177.57 8.79 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.375 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -162.17 178.8 8.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' CG ' HH22 ' A' ' 14' ' ' ARG . 59.9 mt-10 -143.38 121.76 12.35 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 112.899 -1.955 . . . . 0.0 107.725 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -100.51 100.03 10.72 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.147 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.9 92.58 6.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -103.23 -31.18 10.22 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.22 127.89 34.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.827 0.704 . . . . 0.0 109.251 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.4 p -69.92 123.45 21.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.489 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.8 176.55 28.08 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.1 m -82.44 74.14 9.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.258 0.622 . . . . 0.0 109.609 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -85.28 132.12 34.31 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.282 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 142.48 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.76 149.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -142.39 14.87 2.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.903 0.752 . . . . 0.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -103.37 104.57 14.69 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.189 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.1 59.03 4.34 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.844 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.2 -78.15 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.553 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.75 175.39 32.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -161.01 131.79 5.31 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 8.1 m-20 -115.39 103.72 11.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.562 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.61 154.81 29.97 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -142.42 103.46 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 124.35 1.031 . . . . 0.0 108.224 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.53 113.57 15.47 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.184 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.8 p -146.28 -39.67 0.22 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' H ' ' N ' ' A' ' 1' ' ' SER . . . -91.99 -62.04 1.19 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -160.35 177.78 10.26 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.984 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.8 p -66.27 174.64 2.53 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.629 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.39 124.43 3.62 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.78 167.75 11.24 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.559 HD12 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -130.32 105.16 7.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.304 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -86.04 147.92 25.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -96.42 14.23 25.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.061 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.451 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 56.8 mm-40 -138.21 141.33 40.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.62 128.34 20.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.553 1.158 . . . . 0.0 112.14 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.52 53.24 33.13 Favored Glycine 0 N--CA 1.496 2.642 0 CA-C-N 114.306 -1.315 . . . . 0.0 112.652 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 76.8 m 51.67 29.21 5.43 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.1 m -81.59 34.73 0.39 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.797 0.808 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.451 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.94 -145.38 4.28 Favored Glycine 0 N--CA 1.494 2.511 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.965 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.27 153.15 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 113.823 -1.189 . . . . 0.0 108.527 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.21 -169.08 0.46 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.58 0.55 . . . . 0.0 111.314 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.472 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 38.3 t-80 -153.93 -59.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.708 0.63 . . . . 0.0 110.249 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.1 m -112.9 119.84 39.36 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.243 0.964 . . . . 0.0 111.661 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -94.07 149.08 21.56 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.633 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.47 148.27 52.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.864 0.727 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.52 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.494 2.561 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.086 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -156.11 135.3 12.14 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -37.72 117.08 0.54 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.68 85.08 2.06 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.95 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 68.8 mtp85 -73.41 71.51 1.29 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.97 152.44 20.7 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.884 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 63.6 m -134.33 40.07 3.03 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -113.03 143.38 29.03 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.392 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -63.07 170.9 6.9 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.367 2.044 . . . . 0.0 111.325 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.36 -169.87 2.45 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.066 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.96 58.1 0.46 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.559 ' CG ' HD12 ' A' ' 43' ' ' LEU . 5.0 m-90 -105.54 146.28 29.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.62 -46.24 10.96 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.099 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.1 p -153.99 156.35 37.26 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.962 1.414 . . . . 0.0 113.088 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.441 HD13 ' CB ' ' A' ' 3' ' ' PHE . 6.2 tt -112.67 131.28 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.69 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.567 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 13.6 t80 -100.51 88.43 3.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.481 1.113 . . . . 0.0 111.124 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -85.58 137.82 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -89.71 170.53 10.37 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.178 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 116.166 -1.873 . . . . 0.0 111.358 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.91 141.72 5.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.927 0.767 . . . . 0.0 112.088 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.577 ' CG ' HD13 ' A' ' 72' ' ' ILE . 50.8 t80 -92.57 140.9 29.08 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.4 m -128.6 151.03 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.4 ' CG1' ' CE2' ' A' ' 3' ' ' PHE . 16.2 m -147.34 166.77 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.153 0.908 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 30.5 m-90 -141.47 133.35 27.42 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 88.8 p -43.5 -33.51 1.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 134.99 154.11 6.99 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -82.58 -57.93 0.1 OUTLIER 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.315 1.166 . . . . 0.0 111.151 13.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.64 -145.34 14.98 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.03 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 63' ' ' ALA . 76.2 m -93.3 50.42 1.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.59 -1.305 . . . . 0.0 111.886 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.64 -126.97 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 37.76 -141.88 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 119.57 1.077 . . . . 0.0 113.734 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 58.2 ttp180 -69.89 154.41 41.99 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.52 111.65 14.03 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.432 0.457 . . . . 0.0 112.135 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -117.54 166.77 11.98 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -151.71 157.0 41.46 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.613 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -142.38 93.61 2.55 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.4 p -100.05 -11.37 20.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -55.74 128.19 33.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 123.856 0.723 . . . . 0.0 111.516 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.66 167.3 17.27 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.0 -84.26 1.29 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.3 p -174.31 157.31 2.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.497 0.763 . . . . 0.0 111.062 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -160.19 146.76 15.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.246 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.72 163.65 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.827 0.705 . . . . 0.0 109.623 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mt -134.57 151.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.674 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -23.07 4.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.205 0.941 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HG3' HH21 ' A' ' 14' ' ' ARG . 16.6 mp0 -82.76 97.34 8.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.939 0.774 . . . . 0.0 110.808 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -82.95 12.97 4.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.37 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.76 -112.97 0.39 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.266 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.6 159.44 19.75 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 124.982 1.048 . . . . 0.0 110.837 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -161.28 131.64 5.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.456 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 8.2 t70 -104.47 174.87 5.69 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.151 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 65.3 t80 -148.8 157.89 43.76 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.406 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 55.4 m -139.23 139.06 37.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -122.18 138.85 54.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.903 1.377 . . . . 0.0 113.202 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.4 p -152.35 66.68 0.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.89 36.5 93.37 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -153.63 99.49 2.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -71.97 157.48 37.75 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.08 166.42 15.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.712 1.258 . . . . 0.0 110.314 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.78 152.21 40.0 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.125 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 80.9 mt -113.17 98.63 7.26 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.385 1.088 . . . . 0.0 110.071 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.39 115.2 14.8 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.638 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -48.46 -65.22 0.6 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.012 1.445 . . . . 0.0 109.97 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.57 155.89 36.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.402 1.064 . . . . 0.0 112.142 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.54 179.44 7.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.503 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.37 54.3 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.977 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 24.0 m 59.35 30.7 20.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.7 p -115.84 35.7 4.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.719 0.771 . . . . 0.0 111.269 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.97 157.6 15.08 Favored Glycine 0 N--CA 1.493 2.496 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.13 149.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.91 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.713 0.768 . . . . 0.0 109.296 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.428 ' HB3' ' HE1' ' A' ' 69' ' ' TRP . 21.5 t-80 -79.69 -23.34 42.49 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.266 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.467 ' HB ' HD12 ' A' ' 43' ' ' LEU . 50.0 m -146.92 136.34 22.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.958 0.787 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -114.52 147.33 39.55 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.33 1.019 . . . . 0.0 111.79 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 21.7 m-85 -132.31 98.61 4.44 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.44 1.088 . . . . 0.0 108.248 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.54 12.14 66.41 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.3 t -164.47 142.14 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.6 p -40.51 127.9 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.141 0.9 . . . . 0.0 111.916 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 33' ' ' ASP . . . -132.56 113.34 12.94 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 124.051 0.844 . . . . 0.0 112.767 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -81.26 71.36 8.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.396 1.06 . . . . 0.0 112.803 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.406 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . -91.28 157.98 16.83 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.379 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.2 m -147.39 10.06 0.96 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.55 0.69 . . . . 0.0 109.567 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -74.68 167.78 33.16 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.729 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -56.29 144.51 81.86 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.205 1.936 . . . . 0.0 111.936 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -73.99 167.42 21.54 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.14 17.13 1.18 Allowed Glycine 0 N--CA 1.501 3.014 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.47 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.476 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.0 m-90 -138.43 -166.65 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -129.98 -36.71 1.54 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.7 p -134.09 168.87 18.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 124.306 1.004 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.577 HD13 ' CG ' ' A' ' 3' ' ' PHE . 3.3 tt -130.78 121.47 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.533 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -98.02 119.05 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.889 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.9 mt -117.94 150.3 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -74.28 -179.75 4.09 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 116.896 -1.526 . . . . 0.0 109.799 179.804 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.78 121.37 2.85 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.188 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.489 ' CG ' HD13 ' A' ' 72' ' ' ILE . 76.8 t80 -93.63 102.56 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.173 0.92 . . . . 0.0 110.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.6 m -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -151.82 138.64 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 123.774 0.672 . . . . 0.0 110.086 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.53 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 24.9 m-90 -109.3 150.48 27.91 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.1 p -61.35 -38.76 88.1 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.98 153.64 6.66 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.88 -56.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.769 0 O-C-N 122.858 0.925 . . . . 0.0 109.982 7.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.19 -132.35 6.27 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.06 54.98 1.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -139.42 64.2 1.47 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.004 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 4.7 p30 -178.46 -150.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.76 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -72.05 169.62 15.6 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.94 173.66 12.22 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -151.11 140.41 21.34 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.056 -1.884 . . . . 0.0 107.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -110.93 153.06 26.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 123.735 0.647 . . . . 0.0 111.243 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -139.5 75.17 1.5 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -105.71 -20.97 13.29 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.179 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.59 135.13 57.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 123.632 0.583 . . . . 0.0 110.338 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -60.64 109.35 1.01 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.465 1.103 . . . . 0.0 110.35 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.66 166.95 13.7 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.8 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 m -78.73 74.8 5.26 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.618 -1.291 . . . . 0.0 109.88 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -80.6 136.0 36.16 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -78.44 126.86 31.36 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.427 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.3 mp -89.22 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -135.76 -29.92 1.01 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.707 0.63 . . . . 0.0 112.045 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -78.85 104.53 9.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.787 0.679 . . . . 0.0 109.279 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -90.26 18.27 6.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.347 1.03 . . . . 0.0 113.675 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.01 -87.59 0.25 Allowed Glycine 0 N--CA 1.497 2.745 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.297 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.23 169.83 20.44 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -161.62 132.17 5.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 2.9 t70 -107.05 166.06 10.89 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.321 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 68.6 t80 -145.7 151.89 38.75 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -132.62 151.48 51.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -135.71 133.91 38.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 124.213 0.946 . . . . 0.0 110.473 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.0 p -149.67 70.03 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.61 98.11 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.844 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -158.37 115.37 2.84 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.153 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 m -83.25 165.84 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.122 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.63 162.08 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.643 -1.617 . . . . 0.0 108.301 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.53 137.28 21.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.86 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' A' ' 69' ' ' TRP . 3.9 mm? -91.71 158.71 16.22 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -147.74 121.29 9.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 125.28 1.612 . . . . 0.0 109.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -66.3 -8.03 22.46 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.456 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -122.95 134.08 54.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 124.074 0.859 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 133.57 8.1 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.844 -1.526 . . . . 0.0 115.006 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.01 44.49 83.11 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.7 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 71.9 m 52.17 31.9 9.79 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -82.73 29.43 0.45 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.207 1.003 . . . . 0.0 112.796 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.2 -175.17 31.94 Favored Glycine 0 N--CA 1.49 2.258 0 CA-C-N 113.219 -1.809 . . . . 0.0 108.863 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -81.9 156.5 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.78 161.92 28.85 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.589 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -123.37 -32.42 3.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 124.346 1.029 . . . . 0.0 110.459 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -141.06 167.42 22.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.998 0.812 . . . . 0.0 109.085 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -143.29 143.4 31.69 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.498 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 23.0 m-85 -139.36 105.2 5.16 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.058 0.849 . . . . 0.0 110.184 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.19 31.44 5.46 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.0 t -175.51 127.25 0.25 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -30.64 111.19 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 124.507 1.13 . . . . 0.0 113.074 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.478 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -120.29 93.68 4.13 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 124.306 1.004 . . . . 0.0 109.831 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -81.97 68.03 8.2 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.23 -1.35 . . . . 0.0 113.168 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.78 169.18 12.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.794 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.31 39.84 0.84 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.409 1.1 . . . . 0.0 108.439 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -100.44 165.55 14.2 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 112.741 -2.027 . . . . 0.0 109.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.06 164.79 33.56 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.539 2.159 . . . . 0.0 110.339 164.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.54 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 30.9 p90 -162.26 -163.72 0.96 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.511 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.47 43.32 0.43 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.55 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CE3' ' CD2' ' A' ' 67' ' ' PHE . 4.8 m-90 -91.73 133.38 35.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.77 -48.93 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 37.3 p -135.57 169.8 16.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.988 1.43 . . . . 0.0 112.743 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.489 HD13 ' CG ' ' A' ' 3' ' ' PHE . 10.9 tt -140.31 119.26 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.95 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.672 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 37.1 t80 -84.2 121.06 26.95 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.144 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.4 mm -108.7 132.41 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -85.7 -179.9 6.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.895 0.747 . . . . 0.0 110.024 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 115.532 -2.175 . . . . 0.0 110.23 179.77 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.96 132.22 11.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CG ' HD13 ' A' ' 72' ' ' ILE . 85.2 t80 -95.75 93.59 7.18 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.895 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.6 m -72.51 152.3 41.97 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 28' ' ' GLN . 33.2 m -150.01 155.13 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 124.267 0.979 . . . . 0.0 110.88 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.57 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.0 m-90 -133.93 157.23 46.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.5 p -60.45 -40.55 91.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.496 1.123 . . . . 0.0 113.127 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.1 157.05 8.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.2 -45.22 0.37 Allowed 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.152 1.08 . . . . 0.0 111.386 19.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.29 -137.75 8.84 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -105.44 40.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.189 -1.506 . . . . 0.0 107.349 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -140.65 68.16 1.35 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.57 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -169.83 -88.17 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.556 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -90.46 91.73 8.58 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.248 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 115.06 5.22 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.821 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -145.98 154.58 42.05 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -151.05 151.61 32.26 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.0 93.79 4.14 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.477 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.4 p -105.65 -26.81 11.68 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -52.11 145.08 11.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 123.958 0.786 . . . . 0.0 112.912 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 t -65.67 168.36 7.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.183 0.927 . . . . 0.0 109.349 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.49 -177.63 43.28 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 107.194 -2.362 . . . . 0.0 107.194 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 29.7 p -96.34 142.65 28.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.213 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.7 p -127.24 140.22 52.38 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.708 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.36 122.08 25.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 123.865 0.728 . . . . 0.0 109.776 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.54 150.06 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.823 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -134.41 -13.55 2.32 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.24 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 21.5 mm-40 -86.2 84.72 7.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 123.07 1.414 . . . . 0.0 109.807 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -89.99 64.67 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.886 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.29 -58.26 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.533 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.1 168.74 35.84 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -161.1 132.03 5.35 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.152 -1.019 . . . . 0.0 113.723 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -114.15 104.47 12.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.781 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.487 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 79.0 t80 -82.68 153.42 25.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -146.04 100.79 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.277 0.986 . . . . 0.0 109.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -72.04 134.45 45.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.199 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.1 p -146.58 55.11 1.13 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.93 -23.56 13.6 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 113.863 -1.517 . . . . 0.0 110.555 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -99.13 125.83 44.76 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.175 0.512 . . . . 0.0 111.501 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 m -85.98 164.84 17.16 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.89 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.61 171.04 13.03 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.33 131.42 6.5 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.346 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.546 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -96.49 116.73 29.55 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.632 0.729 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -99.43 122.62 42.79 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 0.0 110.567 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -74.55 -1.39 21.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -111.64 139.4 47.12 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 138.75 56.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 124.018 0.824 . . . . 0.0 110.775 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.519 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 52.91 43.95 61.35 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.8 p 39.33 40.04 0.51 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.3 m -89.25 42.02 1.07 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.973 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.68 -122.18 0.62 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.388 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.59 153.07 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.64 -174.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.34 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 52.4 t-80 -148.55 -45.58 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.819 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -138.91 116.02 10.99 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.058 0.849 . . . . 0.0 109.428 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -96.28 152.27 18.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.863 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 17.9 m-85 -131.2 114.8 15.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.064 0.853 . . . . 0.0 110.153 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.48 11.42 28.26 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 p -161.05 135.62 7.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 123.979 0.458 . . . . 0.0 110.437 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 m -39.67 115.82 0.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.319 1.012 . . . . 0.0 112.408 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.04 93.73 4.19 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.205 0.941 . . . . 0.0 109.242 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -74.48 75.37 1.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.333 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.35 161.87 15.41 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.201 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 m -148.1 58.44 1.1 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.079 0.943 . . . . 0.0 110.307 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.49 153.42 43.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 113.751 -1.568 . . . . 0.0 108.864 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.98 178.37 2.43 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.354 2.036 . . . . 0.0 110.28 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.25 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.072 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.89 19.15 3.74 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-O 118.504 -1.165 . . . . 0.0 114.033 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.546 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 5.1 m-90 -91.87 161.0 15.02 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 118.852 1.326 . . . . 0.0 111.014 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.63 -41.39 7.74 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.162 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 p -146.28 -179.94 7.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.432 1.082 . . . . 0.0 110.985 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.51 HD13 ' CG ' ' A' ' 3' ' ' PHE . 11.0 tt -146.5 117.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.369 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.59 114.16 19.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.062 -1.881 . . . . 0.0 108.772 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.65 140.02 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.54 150.74 29.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.142 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 116.576 -1.678 . . . . 0.0 110.373 179.888 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 19' ' ' SER . . . -152.29 103.99 2.9 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.185 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.458 ' CB ' HD13 ' A' ' 72' ' ' ILE . 85.4 t80 -96.69 90.69 5.39 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.07 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -77.49 154.57 32.39 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 16' ' ' GLU . 12.4 m -148.28 166.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 123.703 0.627 . . . . 0.0 109.397 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.465 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 29.4 m-90 -141.88 139.64 32.66 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -51.95 -41.15 61.84 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.494 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.12 151.03 5.47 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -79.07 -62.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.592 0 O-C-N 122.975 0.987 . . . . 0.0 111.396 19.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.18 -129.41 6.55 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 p -95.5 49.96 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.292 -0.954 . . . . 0.0 111.373 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.33 -132.01 0.26 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.494 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.9 p30 36.66 -150.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -78.63 -176.75 5.02 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -153.17 159.79 42.75 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 60.1 mm-40 -139.78 163.76 31.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 111.724 -2.489 . . . . 0.0 104.677 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -146.87 136.39 22.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -117.27 73.83 0.89 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.683 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 76.2 p -95.9 -5.63 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.032 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -66.71 111.74 3.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.084 0.865 . . . . 0.0 108.872 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 7.0 p -64.85 114.95 4.85 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.028 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.37 -95.83 0.16 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.58 -1.295 . . . . 0.0 114.405 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -156.19 133.06 10.43 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.612 0.831 . . . . 0.0 110.118 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -160.24 134.22 7.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.473 0.483 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.76 126.09 30.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.402 ' H ' ' HA ' ' A' ' 71' ' ' SER . 24.8 mt -86.39 150.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -137.03 0.64 2.39 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.758 0.661 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -101.26 101.16 11.79 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.836 0.827 . . . . 0.0 109.596 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -79.53 -2.97 44.66 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.662 -1.608 . . . . 0.0 113.749 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.58 -101.89 0.03 OUTLIER Glycine 0 N--CA 1.497 2.722 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.38 166.22 14.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 63' ' ' ALA . 30.8 p90 -161.45 145.27 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.84 152.51 43.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -121.5 157.02 31.54 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 t -145.59 101.24 3.54 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -70.67 137.46 49.86 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 111.952 -2.385 . . . . 0.0 108.778 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.6 m -143.52 61.89 1.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.66 -14.05 10.81 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.711 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -113.49 125.04 53.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 120.933 0.396 . . . . 0.0 111.693 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.1 m -80.15 162.18 24.86 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.45 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.17 174.3 6.41 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.419 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.1 140.97 19.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.638 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -112.56 133.04 54.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 123.639 0.587 . . . . 0.0 111.554 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -117.77 134.28 55.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 125.033 1.458 . . . . 0.0 111.601 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -66.93 -36.57 82.53 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.065 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -92.4 119.72 32.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.971 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -39.13 146.99 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 125.433 1.708 . . . . 0.0 113.814 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.5 39.42 93.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.409 ' H ' ' CB ' ' A' ' 71' ' ' SER . 31.1 p 43.79 35.85 1.17 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 125.007 1.063 . . . . 0.0 111.543 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -90.23 46.05 1.32 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.205 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.44 -135.57 1.86 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.307 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.47 154.61 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.196 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.13 178.32 1.91 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.437 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -156.56 -40.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -142.95 129.33 20.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.979 0.799 . . . . 0.0 110.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.91 135.32 54.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -115.36 114.0 24.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.776 0.673 . . . . 0.0 110.663 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.84 13.05 38.35 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 p -164.34 136.14 4.6 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m -41.1 121.6 1.6 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.11 0.881 . . . . 0.0 111.724 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.25 111.76 9.9 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -78.2 76.21 4.72 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.775 0.672 . . . . 0.0 111.294 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . . . -90.91 71.92 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.389 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.5 m -62.23 -6.91 3.48 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -70.87 164.13 58.75 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.52 178.57 2.57 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.62 2.213 . . . . 0.0 111.614 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 -149.26 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.07 15.74 0.43 Allowed Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.161 0.913 . . . . 0.0 110.855 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.638 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 1.9 m-90 -100.93 126.22 47.55 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -90.45 2.79 55.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.143 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 49' ' ' CYS . 27.1 p -163.58 173.66 12.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.05 0.844 . . . . 0.0 112.468 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.458 HD13 ' CB ' ' A' ' 3' ' ' PHE . 6.7 tt -149.27 123.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.128 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -99.51 127.41 45.57 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -131.9 143.98 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -72.54 164.88 25.73 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.043 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 116.883 -1.532 . . . . 0.0 110.566 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 96.92 2.92 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 121.004 0.431 . . . . 0.0 111.291 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 64.7 t80 -97.31 101.99 13.66 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.5 m -84.38 155.54 22.25 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -150.71 161.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 123.31 0.381 . . . . 0.0 111.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.642 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 21.2 m-90 -145.98 140.14 26.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 m -55.19 -21.77 14.96 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' CA ' ' HA3' ' A' ' 30' ' ' GLY . . . 124.46 163.94 11.81 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 123.782 0.676 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.3 -54.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.678 0 O-C-N 123.058 1.031 . . . . 0.0 111.462 13.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.07 -123.55 4.57 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 75.3 m -122.16 80.2 1.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -147.79 -54.73 0.21 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.305 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.642 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.6 p30 -49.31 -120.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.99 80.9 0.08 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.66 110.26 3.65 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -131.45 172.66 11.93 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -153.38 158.67 41.83 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.735 -0.786 . . . . 0.0 113.119 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -136.77 80.16 1.8 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.843 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.1 t -108.68 1.33 21.12 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.687 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -61.4 118.64 7.22 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.781 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -62.29 102.13 0.28 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.322 1.014 . . . . 0.0 108.946 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.33 -118.48 1.02 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.3 t -140.71 154.59 46.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 124.315 0.656 . . . . 0.0 111.762 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 p -160.15 139.54 10.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.88 140.97 38.02 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.673 0.608 . . . . 0.0 111.772 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 72' ' ' ILE . 19.2 mt -117.56 127.29 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.815 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -125.7 32.85 5.21 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.046 0.841 . . . . 0.0 108.779 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.409 ' H ' HG22 ' A' ' 26' ' ' ILE . 30.4 mm-40 -113.47 99.27 7.64 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.284 -1.325 . . . . 0.0 108.285 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.14 18.26 6.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 111.85 -2.432 . . . . 0.0 112.491 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.497 ' HA3' ' CA ' ' A' ' 8' ' ' GLY . . . -92.24 -74.64 1.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.908 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 64' ' ' CYS . . . -152.84 164.46 30.79 Favored Glycine 0 N--CA 1.486 2.006 0 CA-C-N 113.836 -1.182 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 23.4 p90 -161.23 132.25 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.79 161.8 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.362 -1.744 . . . . 0.0 107.253 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -142.25 153.16 43.73 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -146.86 114.03 6.23 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.654 1.222 . . . . 0.0 108.203 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.2 112.49 17.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.357 -2.201 . . . . 0.0 105.295 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.4 m -132.66 -66.6 0.67 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.74 -70.05 1.31 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -141.31 -168.52 2.65 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.226 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -77.17 -167.95 1.0 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.122 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.12 142.04 12.89 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.687 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.41 149.32 38.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.266 0.979 . . . . 0.0 108.818 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 55' ' ' THR . 38.1 mt -114.16 101.35 9.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.747 0.654 . . . . 0.0 111.3 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.53 144.92 26.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.368 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -91.99 -0.19 57.48 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.423 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 85.2 mm-40 -113.89 148.26 37.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 123.553 0.533 . . . . 0.0 110.137 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.72 134.03 55.86 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.827 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.33 30.85 77.33 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.433 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.7 m 54.7 29.42 11.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 124.61 0.829 . . . . 0.0 112.623 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 t -88.45 59.81 5.36 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.868 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -157.48 -125.45 0.85 Allowed Glycine 0 N--CA 1.495 2.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.834 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.79 144.08 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.2 121.88 21.01 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.484 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.78 -60.29 2.41 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.442 ' HB ' HD12 ' A' ' 43' ' ' LEU . 94.1 m -124.49 148.87 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.697 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.97 -177.89 4.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 123.545 0.528 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 43' ' ' LEU . 44.3 m-85 -141.32 158.08 44.36 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.685 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 59' ' ' SER . . . -148.08 -11.87 0.15 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.412 ' H ' ' H ' ' A' ' 58' ' ' GLY . 67.2 m -151.35 147.18 26.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -41.47 117.84 0.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.929 0.768 . . . . 0.0 112.78 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.8 99.82 7.37 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.331 1.02 . . . . 0.0 109.428 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -84.79 70.18 10.8 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.39 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.24 165.47 13.44 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 31' ' ' GLY . 67.4 m -150.85 26.64 0.73 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.842 0.83 . . . . 0.0 111.958 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -97.25 168.51 10.09 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.111 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.34 178.49 0.86 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.364 2.043 . . . . 0.0 110.946 163.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.85 -151.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.21 49.17 0.4 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 4.2 m-90 -127.37 142.17 51.5 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 1.8 tpmt? -93.85 -20.74 19.78 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.5 p -161.93 178.43 8.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 124.29 0.993 . . . . 0.0 112.052 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' A' ' 26' ' ' ILE . 11.0 tt -140.4 123.85 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.52 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -91.47 84.64 5.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.931 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.4 mm -69.19 125.05 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -72.06 136.21 46.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.805 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.55 0 CA-C-N 113.316 -1.766 . . . . 0.0 111.549 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.66 134.56 5.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CG ' HD13 ' A' ' 72' ' ' ILE . 88.5 t80 -101.76 107.06 18.16 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.886 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.8 m -91.75 152.3 20.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 28' ' ' GLN . 10.7 m -154.46 152.92 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.719 0.637 . . . . 0.0 111.062 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.415 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 18.1 m-90 -122.63 153.28 39.55 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 23.3 t -55.93 -50.56 70.39 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 163.61 154.17 7.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -80.05 -56.0 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 118.273 1.037 . . . . 0.0 110.075 12.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.5 -136.32 8.28 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -87.85 42.33 1.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.3 -0.95 . . . . 0.0 112.554 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -111.93 -135.0 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 7' ' ' SER . 6.8 p30 34.8 -141.21 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -89.44 156.74 18.47 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.02 171.61 7.28 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.905 0.753 . . . . 0.0 111.991 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -171.82 125.44 0.57 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -98.42 155.49 17.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -138.16 94.84 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.4 p -130.42 13.69 5.53 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.604 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -54.75 128.5 33.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.632 0.582 . . . . 0.0 110.959 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.4 t -69.55 94.22 0.75 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.457 1.123 . . . . 0.0 108.913 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.29 -106.06 0.36 Allowed Glycine 0 N--CA 1.488 2.129 1 N-CA-C 101.287 -4.725 . . . . 0.0 101.287 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.26 164.29 25.05 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.992 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 p -158.1 148.3 20.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 126.62 31.03 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.388 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mt -78.78 148.9 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.576 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -124.92 -32.36 3.05 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.288 0.993 . . . . 0.0 111.615 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 14.1 mm-40 -71.63 97.44 1.72 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.146 0.974 . . . . 0.0 110.636 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -90.42 61.29 4.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.369 -2.196 . . . . 0.0 109.545 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.98 -89.82 0.25 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.37 157.54 17.64 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' HG12 ' A' ' 5' ' ' VAL . 3.3 m-85 -143.99 117.44 9.11 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.775 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -126.83 153.12 46.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.056 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 92.5 t80 -133.35 155.07 50.13 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -137.11 131.26 32.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -109.69 148.34 31.54 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.411 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -166.56 55.12 0.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.52 -33.84 4.02 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.42 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -82.06 120.78 25.72 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.451 0.643 . . . . 0.0 110.726 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 m -91.9 168.78 11.18 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.201 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.04 147.28 23.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 123.63 0.581 . . . . 0.0 112.275 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.26 150.23 29.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.477 HD21 ' CE3' ' A' ' 69' ' ' TRP . 25.8 tp -120.11 108.68 14.55 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -89.09 124.16 34.05 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.123 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 57.5 t-20 -63.56 -41.81 98.39 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.152 -1.84 . . . . 0.0 106.66 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.564 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -78.93 157.43 28.22 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.274 -1.785 . . . . 0.0 108.06 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.1 172.94 6.04 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 33.96 44.79 0.37 Allowed Glycine 0 N--CA 1.505 3.251 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.601 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.9 p 34.35 61.64 0.53 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 125.218 1.187 . . . . 0.0 113.214 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 46' ' ' GLN . 70.9 m -78.31 -154.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.641 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.02 162.26 49.88 Favored Glycine 0 N--CA 1.498 2.815 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.258 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t 61.87 107.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 113.416 -1.392 . . . . 0.0 112.381 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.95 -174.95 2.84 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.756 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.465 ' CD2' ' HE1' ' A' ' 69' ' ' TRP . 8.8 t60 -136.91 -49.86 0.64 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 m -138.16 160.86 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.87 127.68 14.39 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.736 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.44 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 25.3 m-85 -101.78 146.04 28.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.24 0.962 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.27 17.13 0.79 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 p -165.82 129.87 2.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.9 m -37.03 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.079 0.862 . . . . 0.0 113.112 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.98 101.55 8.86 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 115.041 -0.982 . . . . 0.0 112.041 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -83.13 76.73 9.84 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.68 165.5 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.445 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 m -153.8 36.55 0.45 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 121.763 0.792 . . . . 0.0 109.374 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 35.7 m120 -70.07 -167.04 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.094 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.576 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 65' ' ' ASN . 1.4 Cg_endo -73.3 165.94 31.26 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.733 2.288 . . . . 0.0 111.24 144.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.75 171.11 15.44 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.41 18.1 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.672 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 13.7 m-90 -141.93 -162.59 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.97 0.453 . . . . 0.0 112.0 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.2 -30.22 0.47 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.927 0.767 . . . . 0.0 111.04 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 p -150.32 162.45 40.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.918 0.761 . . . . 0.0 111.809 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.529 HD13 ' CG ' ' A' ' 3' ' ' PHE . 10.2 tt -137.88 134.78 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.243 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -96.02 106.78 18.99 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.403 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -101.03 139.31 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -105.39 162.61 13.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.034 0.834 . . . . 0.0 110.741 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 116.94 -1.505 . . . . 0.0 110.475 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.64 95.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 123.97 0.793 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 87.8 t80 -82.18 98.92 8.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.313 1.008 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -84.11 151.76 24.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 p -163.25 146.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.525 1.155 . . . . 0.0 112.506 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 8.2 m-90 -124.23 151.41 44.16 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 111.851 -2.431 . . . . 0.0 107.304 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.7 p -68.82 9.84 0.34 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.34 163.21 37.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -76.66 -53.79 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.649 0 O-C-N 123.055 1.029 . . . . 0.0 111.107 16.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.52 -143.5 13.83 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 71.5 m -107.85 70.81 0.78 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -142.14 -49.06 0.37 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.942 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.65 ' H ' HD22 ' A' ' 13' ' ' ASN . 1.4 p30 -53.94 -135.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.717 -2.038 . . . . 0.0 115.974 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 94.4 mtt-85 -54.25 129.27 34.52 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.76 116.15 31.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.928 0.767 . . . . 0.0 110.565 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -147.81 138.84 23.4 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -123.78 158.69 31.17 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -136.32 82.17 1.93 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.5 p -105.71 -14.76 15.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.555 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.69 141.68 58.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.185 0.928 . . . . 0.0 109.544 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 44.0 t -71.76 174.7 6.49 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.02 -112.02 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 p -172.42 147.31 1.9 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.094 0.526 . . . . 0.0 111.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -158.77 154.45 26.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.171 0.919 . . . . 0.0 110.987 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.93 140.36 36.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.373 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.2 mt -97.0 115.78 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.158 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -79.27 -45.39 19.84 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.559 ' CD ' ' H ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -81.83 82.11 7.61 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.798 -1.546 . . . . 0.0 108.699 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.7 55.85 2.83 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.035 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.09 -114.35 2.85 Favored Glycine 0 N--CA 1.498 2.801 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.357 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.54 158.35 28.55 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-O 118.412 -1.215 . . . . 0.0 110.329 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 26.1 p90 -161.76 134.92 6.23 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -110.42 167.73 9.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 77.1 t80 -145.3 155.62 43.32 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.3 t -144.99 109.64 4.98 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -81.78 147.64 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 113.056 -1.884 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -173.36 76.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.62 -26.3 3.64 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-N 112.788 -2.006 . . . . 0.0 113.06 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -109.14 137.19 47.42 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.4 m -97.79 166.48 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.761 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.81 174.77 9.41 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.309 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.55 122.37 3.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.153 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.456 HD13 ' CZ3' ' A' ' 69' ' ' TRP . 98.4 mt -99.22 135.88 39.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 123.847 0.717 . . . . 0.0 111.615 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 8.8 p90 -148.24 138.43 22.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.212 0.945 . . . . 0.0 109.255 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.4 ' HA ' ' N ' ' A' ' 70' ' ' LYS . 17.4 t30 -72.59 -10.27 59.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.621 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' N ' ' CD ' ' A' ' 46' ' ' GLN . 8.0 mp0 -86.4 89.66 7.95 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.321 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.22 164.9 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.87 28.09 72.97 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.011 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 m 60.64 18.51 8.52 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.052 0.501 . . . . 0.0 110.614 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -90.49 41.04 1.04 Allowed 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -161.69 -170.29 26.19 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.081 -1.533 . . . . 0.0 115.921 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.21 145.96 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 112.351 -1.924 . . . . 0.0 107.772 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 179.98 0.12 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -153.27 -48.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.574 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 m -132.83 106.14 7.55 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.824 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -96.54 158.08 15.6 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 44.4 m-85 -126.0 106.04 9.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 124.189 0.931 . . . . 0.0 110.664 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.43 -4.31 57.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 t -155.47 140.15 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -35.91 110.86 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -92.98 -178.48 4.82 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -166.2 51.88 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.25 0.547 . . . . 0.0 111.576 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.78 165.47 16.0 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.1 m -147.56 11.09 0.98 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.945 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -79.84 157.59 73.92 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.73 143.92 27.82 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.452 2.101 . . . . 0.0 112.043 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.16 156.68 37.01 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.787 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.26 22.5 3.22 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 123.996 0.81 . . . . 0.0 111.417 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.456 ' CZ3' HD13 ' A' ' 43' ' ' LEU . 13.2 m-90 -138.26 -161.58 1.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 45' ' ' ASN . 18.6 ttpt -138.63 -20.14 1.04 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.544 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 p -153.72 170.28 21.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.267 0.979 . . . . 0.0 110.795 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 43' ' ' LEU . 14.4 tt -137.04 149.48 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.465 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -119.93 136.19 54.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.7 mt -138.44 155.95 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 124.069 0.856 . . . . 0.0 110.738 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -88.12 173.18 8.99 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.99 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 88.8 m . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.771 -1.585 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.741 0.305 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.407 ' CB ' ' HE ' ' A' ' 17' ' ' ARG . . . -159.09 174.23 15.21 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.403 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -137.67 97.43 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.53 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.1 m -77.3 150.52 35.25 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -148.61 153.96 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 123.622 0.576 . . . . 0.0 110.39 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.598 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 25.0 m-90 -135.61 142.97 45.34 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.5 p -66.18 0.85 1.77 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' ' C ' ' A' ' 9' ' ' PRO . . . 104.29 155.33 23.48 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 123.504 0.502 . . . . 0.0 113.349 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.452 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 12.1 Cg_endo -72.93 -54.88 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.851 0 O-C-N 123.023 1.012 . . . . 0.0 112.863 18.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.33 -128.67 5.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -108.89 69.44 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 113.96 -1.12 . . . . 0.0 109.419 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -143.4 -55.71 0.39 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.125 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.598 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.8 p30 -47.05 -118.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 5.9 tpm_? -62.78 100.77 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.352 0.596 . . . . 0.0 111.76 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.59 83.46 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.062 0.934 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -101.57 161.79 13.38 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.43 -1.713 . . . . 0.0 107.652 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.407 ' HE ' ' CB ' ' A' ' 2' ' ' ALA . 74.5 ttt180 -142.06 153.65 44.36 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -135.63 83.09 1.99 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.7 p -108.76 -12.01 14.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.056 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -53.09 143.53 17.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.336 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 126.92 29.61 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.819 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.58 28.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.572 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 20.2 p -114.15 162.23 16.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.5 p -160.57 158.59 29.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.351 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.43 151.25 30.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 123.699 0.625 . . . . 0.0 110.554 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 28' ' ' GLN . 3.3 mp -121.26 131.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 124.275 0.984 . . . . 0.0 109.333 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -101.28 -6.65 23.88 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.196 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.5 ' H ' HG22 ' A' ' 26' ' ' ILE . 26.2 mp0 -93.62 64.79 3.6 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.471 1.605 . . . . 0.0 108.729 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HG3' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -77.14 8.8 3.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 111.187 -2.733 . . . . 0.0 115.063 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA3' ' CA ' ' A' ' 8' ' ' GLY . . . -74.2 -61.97 3.07 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.627 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.95 161.3 28.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.67 135.1 6.41 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -109.89 161.2 15.7 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 90.1 t80 -132.22 158.05 42.77 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.9 t -140.4 121.98 15.2 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -104.56 111.58 24.32 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.8 p -148.53 -49.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.6 -80.08 1.03 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -137.53 -176.93 4.57 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.5 m -75.95 170.81 15.53 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.45 169.63 21.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.257 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -152.94 163.93 38.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.04 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.596 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.0 mm? -111.27 143.36 42.17 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.82 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.76 120.26 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.737 1.273 . . . . 0.0 108.681 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -62.34 -5.68 2.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.164 0.915 . . . . 0.0 112.193 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.9 123.17 38.02 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.971 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.543 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -37.98 148.13 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.436 -1.711 . . . . 0.0 114.305 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.572 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.96 37.47 44.83 Favored Glycine 0 N--CA 1.494 2.521 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.0 p 36.27 45.11 0.32 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.978 1.046 . . . . 0.0 113.192 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -85.31 41.66 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.676 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.52 -120.05 0.54 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.0 156.05 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.434 0.726 . . . . 0.0 109.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.62 165.09 17.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.624 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -132.4 -62.82 0.82 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.7 m -110.53 142.68 42.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -133.25 126.67 32.04 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.34 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.491 ' CE2' HD21 ' A' ' 43' ' ' LEU . 37.4 m-85 -94.33 132.99 38.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.17 0.918 . . . . 0.0 110.892 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.28 8.04 5.97 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.6 p -162.19 136.22 6.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.3 p -42.05 116.6 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 123.619 0.574 . . . . 0.0 110.976 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.5 107.43 12.86 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.54 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -78.13 73.82 4.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.516 1.135 . . . . 0.0 112.773 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 156.3 18.28 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.69 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.7 m -144.96 18.37 1.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -82.37 162.78 55.16 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.331 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -53.96 152.48 23.48 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.342 2.028 . . . . 0.0 110.589 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -69.8 166.14 19.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.759 0.662 . . . . 0.0 110.344 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.55 -0.72 1.53 Allowed Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.86 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.596 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.3 m-90 -127.1 -141.82 0.27 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 20.3 ttmm -146.58 -25.16 0.42 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.021 0.373 . . . . 0.0 110.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.451 ' HA ' HD12 ' A' ' 26' ' ' ILE . 6.4 p -146.91 158.73 44.0 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.795 0.807 . . . . 0.0 111.98 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.403 ' N ' HD11 ' A' ' 26' ' ' ILE . 6.5 tp -119.35 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 112.884 -1.962 . . . . 0.0 108.319 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -104.01 125.78 50.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.594 1.184 . . . . 0.0 108.392 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 mm -113.82 134.2 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -67.1 88.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 124.362 1.039 . . . . 0.0 110.476 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.79 -1.576 . . . . 0.0 114.491 179.896 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.36 119.88 2.77 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.355 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.436 ' CB ' HD13 ' A' ' 72' ' ' ILE . 72.4 t80 -87.63 92.11 8.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.44 ' HA ' ' HG2' ' A' ' 17' ' ' ARG . 57.1 m -73.1 152.63 41.13 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' A' ' 32' ' ' TYR . 34.8 m -154.31 153.59 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.571 1.169 . . . . 0.0 110.26 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.491 ' HB3' HD21 ' A' ' 13' ' ' ASN . 29.8 m-90 -135.63 150.09 49.53 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 96.4 p -63.41 -10.44 17.09 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 106.71 158.83 21.65 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.409 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 11.4 Cg_endo -73.43 -53.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.63 0 O-C-N 122.897 0.946 . . . . 0.0 110.885 25.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.51 -123.69 4.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 74.0 m -101.39 39.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.799 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -109.26 -130.65 0.3 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.1 p30 36.24 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -82.01 149.31 28.19 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.227 0.329 . . . . 0.0 110.261 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.63 152.72 23.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 123.765 0.666 . . . . 0.0 112.758 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -163.2 143.18 8.92 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.458 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 79.5 mtt85 -124.55 159.84 29.72 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.47 86.31 2.26 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.558 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -114.46 -8.17 12.81 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.25 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -54.6 121.01 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.19 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.45 97.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.421 1.076 . . . . 0.0 109.872 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.95 -177.48 21.88 Favored Glycine 0 N--CA 1.493 2.461 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.3 m -79.97 141.3 36.12 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.961 -1.119 . . . . 0.0 109.959 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.2 p -156.45 136.93 13.1 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.202 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -79.02 130.52 35.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 123.726 0.641 . . . . 0.0 112.614 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.2 mt -88.61 138.72 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -105.79 -56.27 2.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.041 0.838 . . . . 0.0 112.658 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.576 ' CD ' ' H ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -77.25 76.36 3.8 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 123.38 1.562 . . . . 0.0 111.146 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -71.93 18.87 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.245 -2.252 . . . . 0.0 115.46 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.35 -76.29 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.17 168.66 21.37 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB3' HG12 ' A' ' 5' ' ' VAL . 44.6 p90 -161.63 130.31 4.39 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 14.0 m-20 -114.42 101.1 8.83 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.098 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 3' ' ' PHE . 54.0 t80 -78.49 151.42 32.6 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.9 p -135.82 147.55 48.33 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 124.782 1.301 . . . . 0.0 107.703 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CG ' ' N ' ' A' ' 37' ' ' THR . 77.8 t80 -132.14 156.74 45.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.359 1.037 . . . . 0.0 108.506 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' A' ' 36' ' ' TYR . 5.8 t -163.49 -24.21 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.022 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.408 ' H ' ' H ' ' A' ' 37' ' ' THR . . . -169.05 -25.34 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -123.71 118.56 27.52 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.8 m -83.62 170.65 14.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.009 -1.905 . . . . 0.0 109.406 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.77 159.57 41.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.013 0.821 . . . . 0.0 111.066 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.13 133.24 24.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.049 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.506 ' HG ' ' CE3' ' A' ' 69' ' ' TRP . 4.3 mm? -79.59 169.43 18.02 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.691 0.619 . . . . 0.0 109.433 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -153.52 124.06 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.512 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.472 ' HB2' HE22 ' A' ' 46' ' ' GLN . 35.3 m120 -70.67 -30.83 67.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.472 HE22 ' HB2' ' A' ' 45' ' ' ASN . 10.8 mp0 -89.65 112.38 23.61 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -41.5 143.35 0.48 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.78 41.58 90.9 Favored Glycine 0 N--CA 1.497 2.724 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.963 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 60.7 m 52.76 30.8 9.44 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.162 0.566 . . . . 0.0 112.414 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.6 t -81.0 30.56 0.32 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.278 1.037 . . . . 0.0 113.006 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.68 -161.66 12.12 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.624 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.6 t -95.64 145.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.97 148.56 50.89 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.571 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.665 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 12.6 t-80 -95.62 -69.41 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 m -112.36 118.84 36.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 123.94 0.775 . . . . 0.0 111.036 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -98.77 170.34 8.84 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.215 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.09 -172.39 2.82 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.424 0.63 . . . . 0.0 111.087 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.42 -36.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -145.53 159.32 43.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.877 -1.161 . . . . 0.0 108.99 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -42.29 117.39 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.53 90.26 3.3 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.761 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 86.1 mtm180 -75.29 69.78 2.15 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.09 168.3 11.73 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.798 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.38 8.97 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.779 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -75.92 157.16 83.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.12 156.28 65.5 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.074 1.849 . . . . 0.0 109.421 167.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CG ' ' CE3' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -138.14 -164.4 1.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.31 27.38 2.76 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.15 0.906 . . . . 0.0 112.663 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.665 ' HE1' ' CG ' ' A' ' 54' ' ' HIS . 4.9 m-90 -94.29 131.73 39.6 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -86.41 -18.11 32.61 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.379 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 63.2 p -156.42 179.55 9.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.292 0.995 . . . . 0.0 113.007 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 43' ' ' LEU . 13.9 tt -153.35 141.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.344 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.596 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 69.2 t80 -104.97 135.15 46.85 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.497 -1.683 . . . . 0.0 107.907 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.6 mm -123.2 132.58 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -76.19 173.21 11.64 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 116.11 -1.9 . . . . 0.0 111.51 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.478 ' H3 ' ' HB ' ' A' ' 37' ' ' THR . 53.7 m . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.89 129.0 49.45 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -98.14 94.03 6.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 124.297 0.998 . . . . 0.0 109.838 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -77.09 155.17 32.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.577 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 25.2 m -154.56 160.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 124.211 0.944 . . . . 0.0 108.91 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 31.6 m-90 -139.65 135.86 33.7 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -43.37 -44.28 5.55 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.518 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 147.1 151.65 5.47 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -79.44 -62.86 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.593 0 O-C-N 123.002 1.001 . . . . 0.0 111.794 18.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.43 -138.47 10.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.09 52.89 2.37 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.105 -1.047 . . . . 0.0 111.919 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -132.18 -130.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.518 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.1 p30 35.42 -144.01 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 58.6 ttm-85 -66.31 149.36 50.48 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.11 148.73 45.35 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 123.44 0.462 . . . . 0.0 111.646 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -166.78 153.59 8.85 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.348 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -123.09 153.35 40.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.08 0.863 . . . . 0.0 111.313 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -134.59 79.87 1.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.523 -1.671 . . . . 0.0 107.423 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -103.45 8.97 37.9 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.731 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -58.73 138.05 57.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.164 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.95 155.91 36.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.009 0.818 . . . . 0.0 110.049 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.4 -92.47 1.66 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 103.828 -3.709 . . . . 0.0 103.828 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -171.56 164.79 6.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.93 1.018 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 p -160.0 141.73 12.84 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.448 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.49 135.77 36.73 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 71' ' ' SER . 3.2 mp -102.98 156.38 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -121.22 -20.51 6.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 124.155 0.91 . . . . 0.0 110.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.36 97.34 2.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.15 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -90.1 62.91 5.68 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.04 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 -118.31 1.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.33 162.89 26.08 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 125.077 1.104 . . . . 0.0 111.325 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 14.9 p90 -161.73 136.01 6.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 3.4 t70 -120.76 165.88 14.5 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.362 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.41 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 70.3 t80 -133.86 155.61 49.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -147.21 85.56 1.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.36 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CB ' ' HA ' ' A' ' 59' ' ' SER . 2.2 t80 -49.09 133.82 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 112.948 -1.933 . . . . 0.0 113.293 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.478 ' HB ' ' H3 ' ' A' ' 1' ' ' SER . 50.4 m -152.48 82.85 1.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.73 19.06 57.92 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.83 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 76' ' ' CYS . 5.5 tp-100 -159.86 161.36 34.41 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.344 -0.943 . . . . 0.0 113.195 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -112.67 177.42 4.64 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.487 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.76 172.29 13.51 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.568 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.57 150.79 28.11 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.555 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -106.65 126.88 52.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.611 0.72 . . . . 0.0 111.365 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.64 101.47 10.78 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -61.36 -13.67 21.5 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.916 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -92.92 130.52 38.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.71 151.49 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.99 22.86 67.16 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.741 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 21.5 m 59.64 13.99 3.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.175 0.573 . . . . 0.0 112.471 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -87.61 63.04 7.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.939 0.775 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.0 -137.67 2.93 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.094 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.54 175.52 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.25 144.26 26.54 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.732 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.402 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 21.2 m-70 -120.44 -51.46 2.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.8 m -123.18 121.51 36.1 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.505 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.68 118.89 37.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.253 0.971 . . . . 0.0 111.606 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -102.04 93.56 5.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.344 1.028 . . . . 0.0 108.351 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.29 -23.3 44.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.418 ' HA ' ' CB ' ' A' ' 36' ' ' TYR . 35.1 t -135.59 144.07 45.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.485 0.756 . . . . 0.0 109.258 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -35.06 124.01 0.58 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.435 1.084 . . . . 0.0 111.929 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 33' ' ' ASP . . . -137.65 105.74 5.71 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.787 0.68 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -76.44 75.18 3.19 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.325 1.016 . . . . 0.0 112.905 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -90.8 153.69 20.05 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.289 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.53 19.86 2.03 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -79.18 165.02 51.52 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -56.0 148.22 59.28 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.938 1.759 . . . . 0.0 110.372 172.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.27 173.01 4.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.788 0.68 . . . . 0.0 109.473 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.19 7.46 0.12 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.197 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.555 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.2 m-90 -128.29 -171.29 2.42 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.957 0.445 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HB2' ' HZ3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -126.94 -24.67 3.44 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.546 ' HA ' HD12 ' A' ' 26' ' ' ILE . 10.1 p -146.53 163.69 34.96 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.681 0.613 . . . . 0.0 111.399 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.04 114.68 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.975 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -93.79 121.06 34.85 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.52 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 76' ' ' CYS . 31.3 mt -130.08 128.54 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.461 ' H ' ' CD ' ' A' ' 75' ' ' GLN . 3.2 mp0 -78.35 9.86 3.54 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.481 ' N ' ' HG2' ' A' ' 39' ' ' GLN . 14.6 p . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.38 123.68 10.92 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.525 ' CG ' HD13 ' A' ' 72' ' ' ILE . 67.3 t80 -89.65 104.6 17.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' ASP . 53.1 m -94.16 137.02 33.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -139.59 162.32 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.472 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 18.2 m-90 -128.18 140.33 51.97 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.449 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 78.2 p -55.58 -31.18 61.98 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.515 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 142.06 148.38 5.0 Favored Glycine 0 N--CA 1.5 2.929 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.41 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 28.1 Cg_endo -73.61 -65.14 0.03 OUTLIER 'Cis proline' 0 N--CA 1.503 2.066 0 CA-C-N 118.428 1.114 . . . . 0.0 112.581 20.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.33 -125.42 4.12 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 105.393 -3.083 . . . . 0.0 105.393 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -99.27 73.01 1.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -139.18 -53.11 0.56 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.138 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 7.6 p30 -57.22 -136.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.926 -1.943 . . . . 0.0 116.145 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 14' ' ' ARG . 31.3 mtm105 -58.13 141.07 51.42 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.17 82.24 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 124.73 1.269 . . . . 0.0 111.168 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.67 165.03 14.47 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.189 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -152.19 156.21 39.32 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.454 0.645 . . . . 0.0 112.374 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.93 69.19 1.36 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.2 t -90.7 -18.64 24.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.355 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -57.09 129.59 42.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.609 0.568 . . . . 0.0 111.602 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.48 122.18 15.64 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.552 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.43 -169.99 13.51 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-O 122.596 1.109 . . . . 0.0 114.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.5 t -56.74 130.38 45.29 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.612 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -160.81 120.42 2.68 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.615 0.572 . . . . 0.0 111.02 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.433 ' HB2' ' H ' ' A' ' 48' ' ' GLY . . . -79.72 126.3 30.76 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 mt -87.75 154.52 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -138.6 -9.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.571 0.545 . . . . 0.0 110.939 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.86 105.32 7.85 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.165 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.76 62.01 5.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.177 0.923 . . . . 0.0 108.845 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.74 -108.27 0.69 Allowed Glycine 0 N--CA 1.497 2.744 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.06 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.03 166.49 21.25 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -146.1 165.5 28.91 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 3.2 t70 -169.22 163.11 10.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 41' ' ' ALA . 58.0 t80 -138.61 155.81 48.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -142.3 94.8 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.19 0.932 . . . . 0.0 109.436 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.86 151.42 31.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.042 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -174.19 -22.8 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.366 1.041 . . . . 0.0 108.653 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.37 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -122.02 159.81 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.5 p -91.11 -163.8 1.09 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.844 -1.98 . . . . 0.0 110.444 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . . . -155.11 176.18 12.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.9 131.21 6.75 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 114.942 -1.027 . . . . 0.0 108.308 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -92.12 154.94 18.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.81 120.04 14.7 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.802 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -62.86 -7.48 5.18 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -118.05 122.08 42.24 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.856 0.722 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -40.08 145.84 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 124.685 1.241 . . . . 0.0 113.749 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 25' ' ' ALA . . . 58.99 42.47 96.9 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.819 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.7 p 44.11 25.57 0.12 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.156 1.15 . . . . 0.0 112.977 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 t -87.24 44.02 1.15 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.633 0.73 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.54 -155.26 6.39 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.405 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.55 150.14 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.04 156.52 33.52 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.336 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.473 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -141.3 -45.88 0.38 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.026 0.829 . . . . 0.0 110.968 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -137.13 118.89 15.07 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.775 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -105.37 162.48 13.41 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.738 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -139.65 133.88 31.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.043 0.839 . . . . 0.0 110.351 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.87 14.9 5.18 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.5 t -162.68 124.17 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 m -35.88 113.88 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 124.291 0.994 . . . . 0.0 112.955 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.84 15.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.957 0.786 . . . . 0.0 110.529 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -86.95 94.46 9.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 158.94 16.53 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.49 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.2 m -151.37 15.08 0.7 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -88.56 166.24 23.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.01 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -50.03 165.23 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.692 2.261 . . . . 0.0 112.245 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.58 179.36 2.14 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.556 0.694 . . . . 0.0 111.804 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.22 -5.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.141 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.502 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.6 m-90 -138.79 -156.19 0.66 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -140.87 -40.74 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.7 p -131.95 178.38 6.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 124.704 1.253 . . . . 0.0 111.377 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.525 HD13 ' CG ' ' A' ' 3' ' ' PHE . 11.2 tt -150.91 147.39 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.77 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -119.94 130.42 54.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.528 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.36 152.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 66.7 mt-30 -73.85 -159.59 0.08 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 75' ' ' GLN . 24.4 p . . . . . 0 N--CA 1.504 2.23 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.59 134.5 42.38 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.377 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 55.5 t80 -109.15 91.3 3.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.437 1.086 . . . . 0.0 108.85 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.0 m -81.25 133.81 35.5 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.978 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.14 145.65 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 123.645 0.591 . . . . 0.0 111.382 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.506 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 8.4 m-90 -114.3 143.27 45.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 79.1 p -64.34 -10.27 23.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' N ' ' HA3' ' A' ' 30' ' ' GLY . . . 120.35 154.6 9.42 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 123.596 0.56 . . . . 0.0 113.326 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -75.35 -64.18 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.835 0 O-C-N 123.221 1.116 . . . . 0.0 112.468 12.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.42 -136.13 6.39 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -106.12 66.07 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.411 -1.395 . . . . 0.0 109.792 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -141.86 -59.39 0.47 Allowed 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.774 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 2.0 p30 -32.56 -104.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -72.18 -164.16 0.13 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.412 1.005 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.69 59.68 0.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.834 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.13 151.14 28.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -145.75 116.81 7.82 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.385 0.612 . . . . 0.0 111.488 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -97.9 73.08 2.26 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.884 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.7 p -81.32 -14.29 57.48 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -64.63 133.27 51.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 123.949 0.781 . . . . 0.0 110.835 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.6 m -63.29 175.51 0.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.359 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.74 -161.94 45.85 Favored Glycine 0 N--CA 1.492 2.381 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.18 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -97.95 125.27 42.79 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.5 p -131.14 135.84 47.82 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.003 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.99 117.8 20.4 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 72' ' ' ILE . 2.3 mp -82.52 138.01 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.377 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -118.86 59.59 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.99 98.77 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.663 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -91.3 61.11 4.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' N ' ' A' ' 8' ' ' GLY . . . -144.06 -109.63 0.68 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.647 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.72 166.87 21.75 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -147.37 147.29 30.15 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 2.3 t70 -151.0 154.21 36.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -128.16 157.6 40.36 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.1 m -144.52 93.57 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.774 0.797 . . . . 0.0 110.016 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -71.4 151.75 43.76 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.775 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -172.76 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.222 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.53 -64.59 0.22 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -126.83 166.17 17.95 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.5 p -93.06 171.97 8.61 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.888 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.78 178.55 5.87 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.579 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.88 131.61 6.98 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' CE3' ' A' ' 69' ' ' TRP . 4.5 mm? -81.94 161.63 23.0 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -137.61 106.5 5.95 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.556 -2.111 . . . . 0.0 107.92 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 14.2 t30 -55.27 -23.67 24.17 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.316 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -95.98 135.57 37.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.161 0.913 . . . . 0.0 109.768 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.47 119.06 1.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.898 1.374 . . . . 0.0 113.074 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 43.71 74.21 0.21 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 124.618 1.199 . . . . 0.0 113.458 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 44.22 25.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m -82.35 32.13 0.4 Allowed 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.988 0.899 . . . . 0.0 112.238 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.74 -129.61 1.04 Allowed Glycine 0 N--CA 1.49 2.257 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.2 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -127.22 162.21 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.33 -177.39 1.12 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.046 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -148.62 -60.88 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.3 m -104.22 167.6 9.65 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.069 0.856 . . . . 0.0 109.796 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -142.45 144.77 33.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.462 1.101 . . . . 0.0 109.923 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -128.12 100.62 5.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.102 0.876 . . . . 0.0 109.528 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.37 -25.17 52.15 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.954 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.9 p -148.99 148.29 29.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.07 0.512 . . . . 0.0 111.339 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -33.78 115.32 0.22 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 124.434 1.083 . . . . 0.0 112.353 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.73 108.58 10.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.097 0.873 . . . . 0.0 111.644 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -82.03 87.5 6.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.101 0.876 . . . . 0.0 112.999 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 163.26 14.69 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.87 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 m -148.0 11.6 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.14 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -69.76 164.13 53.77 Favored Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.234 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.54 165.02 1.81 Allowed 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.45 2.1 . . . . 0.0 110.464 167.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.57 174.01 3.77 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.694 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 69' ' ' TRP . . . -159.48 -3.52 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.434 ' CE3' ' HG ' ' A' ' 43' ' ' LEU . 3.5 m-90 -143.13 -176.02 4.75 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -114.26 -39.34 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 p -132.58 165.7 23.79 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 6.9 tp -125.35 112.75 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.204 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -90.81 143.37 26.79 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.445 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.6 mt -135.05 132.5 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -60.2 -37.58 80.7 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.162 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 115.71 -2.09 . . . . 0.0 115.114 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.12 121.03 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.469 ' CB ' HD13 ' A' ' 72' ' ' ILE . 70.7 t80 -97.83 84.47 3.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.293 0.996 . . . . 0.0 110.076 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -68.07 151.04 47.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.74 154.93 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.482 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.5 m-90 -134.08 140.8 46.87 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.3 p -48.88 -43.33 38.96 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.558 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.11 157.27 7.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -81.47 -62.13 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.537 0 O-C-N 123.023 1.012 . . . . 0.0 110.33 14.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -128.0 3.12 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -106.98 49.61 0.8 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.706 -1.247 . . . . 0.0 109.308 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -119.49 -128.49 0.28 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.558 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 11.0 p30 35.94 -142.11 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -77.06 140.12 40.22 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.41 131.33 49.14 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.837 0.711 . . . . 0.0 110.662 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -136.83 118.37 14.85 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -98.23 124.67 42.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.276 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.14 81.98 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.9 m -106.21 -20.1 13.5 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.773 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -50.16 139.38 14.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.368 1.043 . . . . 0.0 112.912 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 162.69 11.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -151.16 43.3 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 22.0 p -129.98 154.19 47.63 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.029 -1.068 . . . . 0.0 113.558 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -143.39 151.76 40.79 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.118 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.47 124.47 28.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.031 0.832 . . . . 0.0 112.09 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.9 mp -80.71 118.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -93.14 -25.67 17.77 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.467 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -78.91 102.52 8.3 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 80.3 tttt -90.06 13.49 14.78 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.181 0.926 . . . . 0.0 111.43 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.32 -90.02 0.37 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.466 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.48 169.86 21.18 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -162.0 136.4 6.83 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -120.35 131.79 55.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.441 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.434 ' CG ' ' N ' ' A' ' 35' ' ' SER . 59.5 t80 -101.55 160.65 14.26 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.3 t -147.0 90.14 1.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -74.71 137.27 41.98 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.886 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -148.95 -44.99 0.14 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.751 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.8 -42.37 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.04 134.4 55.0 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.2 m -81.61 168.9 17.68 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.679 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.94 24.28 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.666 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.08 146.19 28.75 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.533 HD12 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -109.33 98.8 8.15 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.252 -179.546 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -75.63 130.48 38.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.764 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -94.59 27.71 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.498 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.36 145.21 29.21 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.93 142.32 12.02 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.425 -1.261 . . . . 0.0 114.281 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.93 33.46 13.4 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 113.538 -1.664 . . . . 0.0 113.512 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.3 p 41.44 42.76 1.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.7 p -98.78 47.4 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.633 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.71 -128.34 0.95 Allowed Glycine 0 N--CA 1.498 2.816 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.487 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -119.3 140.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.471 0.748 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.49 153.1 27.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -107.65 -36.81 6.33 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.12 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -138.82 123.74 18.84 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.07 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -101.7 163.29 12.33 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -138.86 92.8 2.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.668 0.605 . . . . 0.0 112.459 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.02 16.07 62.11 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.8 t -170.46 138.31 1.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.1 p -44.61 129.45 6.85 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.06 97.05 4.5 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.97 0.794 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.0 mtt-85 -72.04 71.65 0.83 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.06 14.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.326 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.5 m -142.95 -11.26 0.77 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -71.47 156.41 91.52 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.964 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.37 176.98 0.93 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.684 2.256 . . . . 0.0 112.056 173.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' A' ' 29' ' ' LYS . 39.8 p90 -158.12 -167.45 2.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.088 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.43 56.52 0.46 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.533 ' CG ' HD12 ' A' ' 43' ' ' LEU . 5.0 m-90 -109.36 163.38 13.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.68 -44.58 5.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.54 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 p -155.41 164.65 38.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.716 1.26 . . . . 0.0 112.432 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 3' ' ' PHE . 7.1 tt -125.98 129.83 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.721 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -99.22 147.69 24.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 125.255 1.597 . . . . 0.0 107.418 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.3 mt -141.97 137.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.99 149.46 32.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.947 0.779 . . . . 0.0 111.267 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 116.919 -1.515 . . . . 0.0 110.515 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 19' ' ' SER . . . -157.39 107.84 2.25 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CB ' HD13 ' A' ' 72' ' ' ILE . 56.2 t80 -96.89 93.78 6.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.051 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -76.17 148.2 37.93 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 m -149.64 132.36 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.8 0.688 . . . . 0.0 110.384 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.5 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 23.6 m-90 -103.72 152.21 22.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -65.25 -10.41 31.8 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.837 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.97 160.75 19.71 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 123.976 0.798 . . . . 0.0 112.066 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.93 -58.61 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 O-C-N 123.134 1.07 . . . . 0.0 111.797 17.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.21 -132.06 7.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 69.1 m -109.77 73.11 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.45 -51.03 0.47 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.933 0.873 . . . . 0.0 110.401 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.591 ' H ' HD22 ' A' ' 13' ' ' ASN . 2.9 p30 -56.93 -159.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.417 -2.174 . . . . 0.0 114.302 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -70.55 172.92 7.71 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -155.83 178.34 10.38 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -150.08 141.16 23.01 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 111.362 -2.654 . . . . 0.0 105.256 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.33 131.02 53.95 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.524 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -103.96 68.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.652 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 58.6 p -86.8 -13.23 45.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -59.1 124.94 21.62 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.38 123.65 21.77 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.504 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -167.73 13.89 Favored Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -78.48 145.75 34.79 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.1 p -160.04 131.77 6.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.611 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -78.81 138.28 38.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 123.641 0.588 . . . . 0.0 111.784 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.27 146.32 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -125.7 -22.55 4.21 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.041 0.838 . . . . 0.0 109.876 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -74.45 100.25 3.78 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.197 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.14 62.93 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.221 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.41 -105.49 1.17 Allowed Glycine 0 N--CA 1.495 2.614 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.25 170.63 14.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -161.27 130.17 4.56 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 13.0 m-20 -114.69 105.81 13.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.375 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 35' ' ' SER . 83.6 t80 -80.7 157.48 25.88 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.201 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.3 m -142.47 129.23 20.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 124.843 1.339 . . . . 0.0 108.992 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -112.05 146.84 37.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.6 t -164.06 -33.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.695 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 39' ' ' GLN . . . -157.64 -9.31 0.05 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.411 ' H ' ' H ' ' A' ' 38' ' ' GLY . 28.5 mp0 -131.21 131.96 44.34 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 m -81.96 174.14 11.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.29 159.2 43.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.614 0.721 . . . . 0.0 112.14 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.54 145.84 35.61 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.665 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' A' ' 57' ' ' PHE . 47.5 mt -116.55 96.24 5.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.458 0.647 . . . . 0.0 112.073 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -85.94 136.0 33.44 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.741 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -87.2 5.08 39.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.347 -1.751 . . . . 0.0 110.726 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 82.7 mm-40 -115.97 150.54 37.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.855 0.722 . . . . 0.0 110.827 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 132.97 54.69 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.522 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.88 31.03 74.59 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.365 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.0 m 55.41 30.74 15.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.6 t -90.76 59.51 4.19 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.151 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.02 -147.7 5.0 Favored Glycine 0 N--CA 1.497 2.713 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.174 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -111.24 142.5 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 114.239 -0.98 . . . . 0.0 108.366 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.82 119.7 23.07 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.45 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -79.58 -36.54 38.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.459 ' HB ' HD12 ' A' ' 43' ' ' LEU . 55.3 m -145.65 133.79 21.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.049 0.843 . . . . 0.0 110.035 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -118.92 149.62 41.27 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.096 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 43' ' ' LEU . 25.7 m-85 -123.2 132.07 53.91 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.055 0.847 . . . . 0.0 111.143 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -2.42 11.22 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -154.32 139.52 17.5 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.4 m -37.73 120.26 0.81 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.04 0.838 . . . . 0.0 112.75 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.71 88.1 2.83 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 124.111 0.882 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 74.4 mtp180 -73.72 69.8 1.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.43 14.65 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.734 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.9 m -147.77 36.37 0.87 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.775 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -110.04 162.42 20.49 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.132 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.44 175.64 3.29 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.452 2.101 . . . . 0.0 111.649 171.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 15.4 p90 -161.22 -165.51 1.35 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.31 56.11 0.41 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.443 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.4 m0 -114.8 127.45 55.73 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -82.54 -8.48 59.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 123.72 0.637 . . . . 0.0 109.968 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 30.8 p -174.29 165.25 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.466 1.104 . . . . 0.0 112.213 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.486 HD13 ' CB ' ' A' ' 3' ' ' PHE . 11.1 tt -134.18 122.35 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-N 112.627 -2.078 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -99.48 107.8 20.08 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.847 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.7 mt -104.62 147.56 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.364 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -72.21 -172.4 0.9 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.118 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 116.25 -1.833 . . . . 0.0 110.387 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.49 142.77 1.69 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.655 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.424 ' CB ' HD13 ' A' ' 72' ' ' ILE . 88.7 t80 -93.87 104.04 16.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.696 1.248 . . . . 0.0 112.3 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -81.2 158.72 24.79 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 32' ' ' TYR . 10.3 m -153.62 122.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 124.008 0.818 . . . . 0.0 112.184 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.551 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.1 m-90 -95.58 146.5 24.42 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.6 p -60.44 -16.61 37.91 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.362 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.19 162.54 13.14 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 124.283 0.99 . . . . 0.0 112.181 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -75.21 -59.64 0.11 OUTLIER 'Cis proline' 0 N--CA 1.498 1.766 0 O-C-N 123.12 1.063 . . . . 0.0 111.053 11.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.47 -147.63 22.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HA ' ' CG ' ' A' ' 6' ' ' TRP . 7.6 p -102.25 66.84 1.02 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -136.89 -49.16 0.63 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 3.8 p30 -56.97 -152.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.256 -1.793 . . . . 0.0 114.519 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -74.35 162.49 28.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.7 12.97 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -147.39 154.88 41.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.997 -1.911 . . . . 0.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -115.95 144.34 44.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.737 0.648 . . . . 0.0 110.604 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -125.94 95.48 4.43 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.773 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -114.52 -7.43 12.81 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.894 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -49.7 123.29 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.881 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 23.8 t -72.71 90.23 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.745 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.24 113.59 21.7 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -124.87 132.93 53.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.882 0.739 . . . . 0.0 112.939 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 71' ' ' SER . . . -81.87 116.7 21.65 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.546 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.401 HD11 ' CG2' ' A' ' 72' ' ' ILE . 28.5 mt -79.9 135.95 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.551 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -106.87 -32.12 8.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.571 1.169 . . . . 0.0 111.37 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 27.7 mp0 -79.44 91.62 5.14 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.593 1.187 . . . . 0.0 108.173 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -90.49 62.72 5.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.566 -2.106 . . . . 0.0 111.753 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.08 -113.48 1.33 Allowed Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.022 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 165.44 34.03 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' HG12 ' A' ' 5' ' ' VAL . 8.9 p90 -161.89 129.47 4.01 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 1.1 t70 -112.07 167.98 9.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.6 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 59.5 t80 -148.41 155.33 41.09 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.184 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 58.5 m -137.25 147.11 45.51 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' CB ' ' HA ' ' A' ' 59' ' ' SER . 80.1 t80 -134.3 145.53 49.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.717 1.261 . . . . 0.0 109.768 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -172.85 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.751 0.657 . . . . 0.0 111.561 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.8 -12.64 1.3 Allowed Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.044 0.84 . . . . 0.0 111.536 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.31 20.55 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.7 m -84.56 166.65 17.01 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.938 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.41 157.7 46.0 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 131.89 10.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.914 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.71 163.61 13.69 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 49' ' ' CYS . 5.6 p90 -167.75 135.08 2.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.652 -2.067 . . . . 0.0 108.905 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -66.91 11.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.261 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 mm-40 -131.69 113.54 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.394 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.5 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -40.61 147.41 0.11 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.618 1.199 . . . . 0.0 112.428 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.98 44.74 62.08 Favored Glycine 0 N--CA 1.499 2.846 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.725 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 5.1 p 42.06 36.84 0.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 m -95.54 42.69 1.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.748 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.19 -164.4 15.21 Favored Glycine 0 N--CA 1.5 2.961 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.229 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.43 153.69 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.46 143.94 26.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -112.62 -52.69 2.77 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.662 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -122.75 106.37 10.87 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -96.4 117.39 30.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.215 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.42 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 50.4 m-85 -91.75 108.33 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 123.717 0.636 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.93 45.51 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.408 ' HA ' ' CB ' ' A' ' 36' ' ' TYR . 39.0 t -146.32 159.85 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.46 0.741 . . . . 0.0 109.374 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.0 p -36.05 124.72 0.75 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.218 0.949 . . . . 0.0 113.308 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -133.42 101.21 5.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.143 0.902 . . . . 0.0 110.65 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 30.2 ptt180 -84.46 68.52 10.31 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.37 168.87 15.18 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.397 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 16.7 m -147.88 10.83 0.93 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.54 164.29 39.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.42 147.14 79.64 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 110.559 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.62 162.21 6.8 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 124.012 0.82 . . . . 0.0 109.874 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.55 18.76 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -136.14 -155.67 0.65 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.562 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 19.4 ttmm -141.1 -32.31 0.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 3.5 p -154.26 162.46 41.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.091 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 HD13 ' CB ' ' A' ' 3' ' ' PHE . 16.7 tt -129.44 143.6 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.015 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -113.67 132.1 55.91 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.488 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.0 mt -138.09 146.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 124.263 0.977 . . . . 0.0 108.753 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -88.41 169.08 12.1 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 91.4 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 116.099 -1.905 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.865 0.364 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.09 52.19 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.324 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -110.8 151.99 27.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 33' ' ' ASP . 92.0 m -140.13 148.65 41.98 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 32' ' ' TYR . 17.9 m -154.69 155.04 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.347 1.029 . . . . 0.0 112.854 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.553 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 9.1 m-90 -125.83 154.35 42.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.6 m -78.48 -13.35 59.87 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.438 ' H ' HD21 ' A' ' 13' ' ' ASN . . . 145.49 145.62 4.3 Favored Glycine 0 N--CA 1.504 3.231 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.687 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -76.04 -53.78 0.15 OUTLIER 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 118.171 0.985 . . . . 0.0 110.091 8.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.22 -127.6 4.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 105.25 -3.14 . . . . 0.0 105.25 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' HA ' ' CG ' ' A' ' 6' ' ' TRP . 21.8 p -96.87 57.53 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -138.81 53.33 1.77 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.674 -0.811 . . . . 0.0 112.425 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.553 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -173.53 -122.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -48.66 145.87 3.42 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 123.428 0.691 . . . . 0.0 112.576 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.88 114.89 22.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -149.64 132.57 16.13 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -119.2 163.63 16.79 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.7 95.74 2.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.305 -1.77 . . . . 0.0 106.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.0 t -112.86 -22.33 10.71 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -51.33 147.13 6.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 123.859 0.724 . . . . 0.0 112.728 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.3 t -60.51 160.3 9.14 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.19 -148.01 32.37 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 27.8 p -128.9 172.26 11.5 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.1 p -151.55 136.93 17.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.438 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB1' ' HZ2' ' A' ' 70' ' ' LYS . . . -79.93 112.56 17.34 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.979 0.799 . . . . 0.0 111.788 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.02 146.48 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.989 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -125.18 -14.51 6.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.382 1.051 . . . . 0.0 108.456 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -70.69 100.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -86.99 56.64 4.1 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.551 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.1 -97.16 0.63 Allowed Glycine 0 N--CA 1.501 3.017 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.231 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.1 162.35 14.01 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CD2' HG12 ' A' ' 5' ' ' VAL . 36.5 m-85 -144.56 108.72 4.78 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.367 1.079 . . . . 0.0 111.788 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 1.5 t70 -108.7 162.31 14.29 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.18 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -148.67 157.77 43.68 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.53 -1.213 . . . . 0.0 108.469 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 t -146.68 103.1 3.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 124.668 1.23 . . . . 0.0 108.947 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -79.05 151.81 31.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.282 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -174.82 73.39 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.86 -37.19 2.32 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.021 -1.899 . . . . 0.0 111.402 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -89.9 125.49 35.37 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.507 0.67 . . . . 0.0 112.188 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 m -85.58 164.15 17.93 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.284 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.4 148.42 27.45 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.374 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.5 148.53 34.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 124.479 1.112 . . . . 0.0 109.684 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -87.13 159.69 18.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.206 1.003 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -137.91 113.84 9.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 111.58 -2.555 . . . . 0.0 108.331 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.447 ' H ' ' CE1' ' A' ' 54' ' ' HIS . 16.7 t30 -55.47 -14.62 2.09 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.349 1.031 . . . . 0.0 113.11 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.431 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -119.51 132.13 55.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.134 0.896 . . . . 0.0 109.983 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.94 150.58 0.26 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 114.038 -1.437 . . . . 0.0 113.592 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.9 34.03 37.05 Favored Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.421 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.4 p 39.03 44.66 0.92 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.783 0.931 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -86.07 37.7 0.73 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.337 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.86 -145.64 4.36 Favored Glycine 0 N--CA 1.495 2.576 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.321 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -103.88 157.18 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.65 175.73 6.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.808 0.693 . . . . 0.0 111.434 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.447 ' CE1' ' H ' ' A' ' 45' ' ' ASN . 72.3 m80 -142.83 -59.0 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 123.974 0.796 . . . . 0.0 111.717 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.9 m -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.885 0.74 . . . . 0.0 111.312 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.8 ttt85 -95.35 163.63 13.17 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.684 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -140.72 149.72 42.54 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.38 -5.19 3.01 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 124.638 1.211 . . . . 0.0 110.159 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.4 m -149.86 150.81 32.49 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.7 p -45.66 119.27 2.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.889 0.743 . . . . 0.0 111.172 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.49 92.01 3.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.12 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 36.1 ptt180 -82.96 68.31 9.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.02 159.13 21.26 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.869 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.448 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 58.5 m -138.96 27.12 2.42 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.064 0.935 . . . . 0.0 109.449 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -82.7 164.96 44.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.644 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.05 167.44 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.356 2.037 . . . . 0.0 110.649 170.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.27 177.1 2.93 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.823 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 69' ' ' TRP . . . -160.0 -6.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.509 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 4.0 m-90 -142.5 -160.54 1.11 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HZ2' ' HB1' ' A' ' 25' ' ' ALA . 28.5 tptp -128.74 -45.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 123.28 0.362 . . . . 0.0 111.341 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.2 p -124.77 166.01 16.98 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 124.337 1.023 . . . . 0.0 112.745 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.52 126.22 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -106.01 143.04 34.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.1 mt -143.49 117.19 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.81 162.27 28.82 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.022 0.826 . . . . 0.0 110.829 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.156 -1.878 . . . . 0.0 110.702 179.922 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 27.7 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' CB ' ' HE ' ' A' ' 17' ' ' ARG . . . -161.21 147.21 14.38 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 36.2 t80 -97.91 108.44 21.15 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.084 -1.417 . . . . 0.0 109.537 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 m -93.49 131.47 38.68 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 m -136.49 148.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 123.668 0.605 . . . . 0.0 111.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.438 ' CE3' ' HA ' ' A' ' 11' ' ' CYS . 21.2 m-90 -115.76 160.75 19.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.7 p -69.55 -9.97 56.2 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.61 153.41 18.2 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 123.752 0.657 . . . . 0.0 111.584 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.41 -64.25 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.685 0 O-C-N 123.118 1.062 . . . . 0.0 111.656 17.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.86 -150.87 15.62 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.438 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 1.6 p -93.07 41.97 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.824 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -124.41 -128.32 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 38.3 -142.05 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.589 ' NH1' HE22 ' A' ' 28' ' ' GLN . 56.7 ttt180 -70.75 140.78 51.44 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -106.86 148.22 28.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.083 0.865 . . . . 0.0 111.194 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.29 167.21 30.7 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.404 ' HE ' ' CB ' ' A' ' 2' ' ' ALA . 80.5 ttt180 -140.17 158.84 43.41 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.463 0.649 . . . . 0.0 112.317 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -142.36 84.84 1.88 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.869 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -112.98 17.22 19.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.739 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -63.07 127.32 30.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.758 0.789 . . . . 0.0 111.364 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -73.34 119.69 17.93 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.545 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.58 -98.58 0.88 Allowed Glycine 0 N--CA 1.493 2.439 0 O-C-N 124.535 1.147 . . . . 0.0 111.182 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.473 ' SG ' ' CD2' ' A' ' 73' ' ' PHE . 60.1 m -142.24 147.03 35.82 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.157 0.563 . . . . 0.0 112.132 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.6 p -160.42 126.83 4.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.72 126.88 31.51 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 136.65 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 123.757 0.66 . . . . 0.0 109.687 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -100.97 -46.57 5.06 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.477 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.589 HE22 ' NH1' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -51.43 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.704 1.252 . . . . 0.0 111.944 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -90.47 68.96 6.83 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.243 1.021 . . . . 0.0 108.596 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.84 -106.73 0.26 Allowed Glycine 0 N--CA 1.493 2.499 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.463 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.46 160.03 27.64 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CE1' ' CE2' ' A' ' 67' ' ' PHE . 49.2 m-85 -147.61 159.05 44.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.585 0.815 . . . . 0.0 108.879 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -169.8 159.42 7.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 59.7 t80 -135.54 159.87 40.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 t -147.14 91.36 1.98 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.469 1.106 . . . . 0.0 108.269 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -70.33 150.3 46.47 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.075 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.5 p -140.08 -35.26 0.52 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 39' ' ' GLN . . . -174.99 -12.09 0.02 OUTLIER Glycine 0 N--CA 1.479 1.558 0 CA-C-N 112.322 -2.217 . . . . 0.0 108.24 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.41 ' H ' ' H ' ' A' ' 38' ' ' GLY . 24.7 mp0 -112.77 126.81 55.83 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.2 m -81.21 168.43 18.51 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.035 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.91 113.54 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.477 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.55 165.33 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 57' ' ' PHE . 40.0 mt -129.56 102.36 6.34 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.391 0.615 . . . . 0.0 109.639 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 49' ' ' CYS . 59.7 m-85 -84.01 133.42 34.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.718 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -74.23 -8.64 56.9 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -120.64 138.35 53.97 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.27 145.61 1.63 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.94 54.4 11.94 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.974 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.458 ' HA ' ' CG ' ' A' ' 44' ' ' TYR . 25.7 p 44.31 22.29 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 t -90.55 45.51 1.27 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.542 0.687 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.81 -130.81 2.04 Favored Glycine 0 N--CA 1.495 2.605 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.387 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.31 144.21 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 124.595 0.821 . . . . 0.0 109.44 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.69 103.69 5.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.517 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.32 -40.2 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.779 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.423 ' HB ' HD12 ' A' ' 43' ' ' LEU . 55.5 m -144.03 164.75 29.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.152 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -147.1 -172.38 3.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.718 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.536 ' CE2' HD11 ' A' ' 43' ' ' LEU . 53.7 m-85 -143.81 104.24 4.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.023 0.827 . . . . 0.0 112.858 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.65 -12.23 55.96 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 t -153.8 141.93 20.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 91.2 p -41.16 132.85 2.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.66 121.83 7.76 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 123.994 0.809 . . . . 0.0 111.968 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -83.37 91.85 7.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 60.99 4.6 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 m -57.03 -18.27 13.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -77.2 160.18 76.35 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.82 139.91 68.26 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.091 1.861 . . . . 0.0 109.163 169.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.04 -146.17 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.39 21.2 0.28 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.038 -1.077 . . . . 0.0 114.996 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 5.3 m-90 -108.15 146.36 32.83 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -84.41 -46.69 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.0 p -131.65 174.7 9.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 124.496 1.123 . . . . 0.0 113.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 3' ' ' PHE . 7.1 tt -136.52 137.37 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 112.699 -2.046 . . . . 0.0 109.967 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.473 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 4.7 t80 -107.98 129.91 55.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.2 mt -119.3 129.63 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -61.61 80.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.789 1.93 . . . . 0.0 114.109 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.319 179.858 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.46 ' HB1' ' HE ' ' A' ' 17' ' ' ARG . . . -153.59 104.69 2.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.945 0.778 . . . . 0.0 110.348 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 45.9 t80 -96.87 89.29 4.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -75.42 152.52 37.98 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG2' HE21 ' A' ' 28' ' ' GLN . 11.9 m -148.84 158.13 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.693 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.496 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.6 m-90 -134.59 145.44 48.66 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.417 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 84.1 p -61.54 -38.98 89.42 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 167.35 149.71 6.15 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.723 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -78.51 -56.13 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.808 0 N-CA-C 109.34 -1.061 . . . . 0.0 109.34 9.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.77 -132.54 6.18 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 64' ' ' CYS . 25.0 p -89.65 48.23 1.57 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -140.01 80.18 1.75 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.324 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 5.8 p30 171.71 -146.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -64.91 171.28 3.6 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.0 23.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -161.18 134.14 6.31 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HE ' ' HB1' ' A' ' 2' ' ' ALA . 78.6 ttt180 -108.23 131.62 54.49 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -110.15 78.7 1.14 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.08 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -116.16 -8.2 11.78 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.98 139.7 58.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.052 0.845 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.16 104.71 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.002 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.09 -177.12 19.58 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.126 0.892 . . . . 0.0 113.117 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 m -77.2 143.31 39.12 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.749 -1.225 . . . . 0.0 109.923 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.4 p -148.11 126.69 12.47 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.012 0.82 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.32 119.47 22.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.354 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.63 115.41 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.134 -1.393 . . . . 0.0 109.451 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -95.2 -29.29 14.61 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.499 HE21 ' CG2' ' A' ' 5' ' ' VAL . 4.2 mp0 -77.91 95.61 4.81 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.862 0.726 . . . . 0.0 109.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -80.56 40.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.53 -103.3 2.75 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.06 18.55 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.6 m-85 -150.84 120.54 7.01 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 7.3 m-20 -114.98 106.76 14.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.196 0.31 . . . . 0.0 110.817 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 73.7 t80 -80.95 157.68 25.47 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -148.15 109.12 4.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.353 1.033 . . . . 0.0 108.55 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -84.03 152.21 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.483 -2.144 . . . . 0.0 110.536 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.42 52.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.7 -32.0 5.55 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.583 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -94.15 125.3 38.7 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.477 0.656 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.588 HG22 ' H ' ' A' ' 41' ' ' ALA . 23.3 m -86.54 -170.49 3.1 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.584 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.588 ' H ' HG22 ' A' ' 40' ' ' THR . . . -160.23 151.1 18.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.76 152.74 41.84 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.536 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.3 mm? -117.22 123.59 47.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.315 0.384 . . . . 0.0 111.359 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 46' ' ' GLN . 96.3 m-85 -115.51 128.86 56.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 125.067 1.479 . . . . 0.0 108.496 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -73.66 13.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.877 0.736 . . . . 0.0 112.02 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 44' ' ' TYR . 62.1 mm-40 -133.67 127.26 32.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.46 139.03 2.2 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.58 50.69 56.29 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.783 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 79.4 m 50.27 23.49 1.22 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.4 m -83.93 40.79 0.77 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.402 0.62 . . . . 0.0 112.424 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.17 -149.96 5.5 Favored Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.237 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.85 145.74 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.76 164.95 4.28 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.929 0.768 . . . . 0.0 111.921 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -146.59 -48.85 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.441 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -133.07 152.27 51.97 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.134 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -141.03 119.17 12.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.448 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 30.5 m-85 -97.06 122.0 39.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.091 0.87 . . . . 0.0 111.35 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.65 24.38 4.91 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.0 p -165.46 128.9 2.23 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.595 -0.802 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.0 m -41.27 110.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.12 0.887 . . . . 0.0 111.967 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.16 91.58 3.56 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.271 0.982 . . . . 0.0 111.19 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 92.4 mtt-85 -74.29 79.96 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.39 144.96 25.32 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.136 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.454 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 66.8 m -134.73 47.02 2.4 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.446 1.117 . . . . 0.0 109.242 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -140.75 154.95 69.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.683 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -55.83 156.11 20.33 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.988 2.459 . . . . 0.0 111.611 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -123.49 -135.63 0.29 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.866 0.729 . . . . 0.0 112.182 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.28 -3.33 0.06 OUTLIER Glycine 0 N--CA 1.497 2.75 0 CA-C-O 118.601 -1.11 . . . . 0.0 115.251 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.536 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 3.0 m-90 -90.62 166.57 13.11 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.77 1.285 . . . . 0.0 110.395 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -100.19 -41.58 7.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.828 0.705 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.8 p -138.1 177.09 8.14 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.314 1.009 . . . . 0.0 112.391 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.447 HD13 ' CB ' ' A' ' 3' ' ' PHE . 15.3 tt -144.39 127.33 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.695 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.615 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 7.3 t80 -84.85 94.4 8.73 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.406 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -76.9 116.26 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.366 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -68.66 137.12 53.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 123.906 0.754 . . . . 0.0 110.407 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.672 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.93 121.13 26.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.463 ' CG ' HD13 ' A' ' 72' ' ' ILE . 33.3 t80 -92.78 173.86 7.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.1 m -158.84 152.85 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -150.91 158.18 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.671 1.232 . . . . 0.0 108.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.1 m-90 -132.5 145.85 51.48 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -52.43 -42.71 64.33 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 145.08 152.55 5.65 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -82.07 -60.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 123.15 1.079 . . . . 0.0 111.53 17.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.56 -141.55 11.09 Favored Glycine 0 N--CA 1.485 1.917 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 p -94.31 44.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.656 -1.272 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -123.21 -129.3 0.26 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 38.2 -144.31 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -76.81 128.27 34.3 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -94.43 154.02 17.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.186 0.929 . . . . 0.0 112.266 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -161.64 118.51 2.17 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -86.38 157.1 19.93 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.463 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -136.53 61.49 1.63 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.054 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.4 p -94.43 6.51 48.52 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.008 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.56 118.25 7.92 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 103.83 0.25 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.458 1.099 . . . . 0.0 108.196 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.71 -164.33 18.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.88 150.21 30.67 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 p -160.24 132.12 6.09 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.961 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.21 115.91 19.15 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.04 105.75 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.545 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -96.2 -16.68 21.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.987 -1.461 . . . . 0.0 113.67 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -76.09 94.81 3.52 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.39 0.614 . . . . 0.0 110.312 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -83.91 60.27 5.72 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.145 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.59 -90.04 0.68 Allowed Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.19 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.86 169.12 21.64 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 47.4 p90 -161.73 135.36 6.5 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.57 158.74 24.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.543 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 58.9 t80 -130.03 157.36 42.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -146.94 100.31 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 124.069 0.856 . . . . 0.0 110.128 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -81.12 149.1 29.31 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.644 -1.617 . . . . 0.0 107.835 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -168.48 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.092 0.87 . . . . 0.0 109.342 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.99 -43.17 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.25 166.87 22.75 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.3 p -87.63 -174.58 4.84 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 113.305 -1.77 . . . . 0.0 111.105 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -158.11 113.68 2.71 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.605 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.66 157.05 27.33 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 43' ' ' LEU . 10.7 tp -126.38 94.64 4.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.851 0.834 . . . . 0.0 109.907 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -79.86 141.42 36.17 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.603 -1.635 . . . . 0.0 114.094 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.26 23.09 12.99 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.256 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -131.75 141.65 49.57 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.056 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.9 132.89 37.81 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.102 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.16 68.49 Favored Glycine 0 N--CA 1.495 2.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.173 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.2 m 54.33 29.15 10.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.356 0.68 . . . . 0.0 112.438 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.6 p -85.98 52.07 2.38 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.979 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.61 -121.91 0.61 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.12 150.17 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.59 178.93 1.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.142 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.534 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 18.6 t-80 -139.3 -69.55 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.888 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -118.16 83.07 1.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.127 0.892 . . . . 0.0 108.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 57' ' ' PHE . 5.1 tmm_? -70.57 162.19 29.32 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.6 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.543 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 51.4 m-85 -131.11 135.76 47.78 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.43 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.73 -2.57 4.34 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.1 m -152.58 136.82 16.58 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.3 m -38.05 112.33 0.21 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.153 0.908 . . . . 0.0 111.15 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.71 106.9 11.35 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 124.279 0.987 . . . . 0.0 113.196 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -80.73 75.2 7.64 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.69 165.28 13.79 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.493 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.3 m -149.92 4.91 0.57 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -69.07 152.44 96.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.537 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.6 150.13 88.77 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.777 2.318 . . . . 0.0 110.198 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' HD2' ' H ' ' A' ' 69' ' ' TRP . 38.9 p90 -154.43 -172.65 4.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 123.985 0.803 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.15 54.77 0.36 Allowed Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.557 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.534 ' HE1' ' CB ' ' A' ' 54' ' ' HIS . 1.9 m-90 -88.4 150.33 23.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 11.6 mptt -86.0 -22.83 27.1 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.504 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.1 p -175.66 167.81 3.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.628 1.205 . . . . 0.0 113.131 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.463 HD13 ' CG ' ' A' ' 3' ' ' PHE . 7.3 tt -130.7 130.3 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.838 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.95 93.28 4.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.484 1.115 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.5 mm -72.53 113.4 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.887 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -64.35 108.83 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.743 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.405 ' N ' ' H ' ' A' ' 38' ' ' GLY . 71.5 p . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 130.02 11.55 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CB ' HD13 ' A' ' 72' ' ' ILE . 79.7 t80 -93.74 91.21 6.89 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.94 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.0 m -73.39 148.87 42.95 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.42 137.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 123.801 0.688 . . . . 0.0 109.684 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.562 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 19.9 m-90 -112.93 155.22 25.11 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -66.66 -42.55 86.46 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.97 156.04 9.14 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -76.97 -51.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.753 0 O-C-N 122.651 0.816 . . . . 0.0 110.786 8.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.97 -111.16 3.04 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.7 p -111.99 53.4 0.73 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -138.19 69.41 1.39 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 2.3 p30 178.31 -144.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.423 HH22 ' CG ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -79.72 177.57 8.79 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.375 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -162.17 178.8 8.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' CG ' HH22 ' A' ' 14' ' ' ARG . 59.9 mt-10 -143.38 121.76 12.35 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 112.899 -1.955 . . . . 0.0 107.725 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -100.51 100.03 10.72 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.147 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.9 92.58 6.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -103.23 -31.18 10.22 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.22 127.89 34.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.827 0.704 . . . . 0.0 109.251 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.4 p -69.92 123.45 21.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.489 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.8 176.55 28.08 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.1 m -82.44 74.14 9.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.258 0.622 . . . . 0.0 109.609 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -85.28 132.12 34.31 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.282 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 142.48 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.76 149.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -142.39 14.87 2.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.903 0.752 . . . . 0.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -103.37 104.57 14.69 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.189 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.1 59.03 4.34 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.844 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.2 -78.15 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.553 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.75 175.39 32.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -161.01 131.79 5.31 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 8.1 m-20 -115.39 103.72 11.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.562 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.61 154.81 29.97 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -142.42 103.46 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 124.35 1.031 . . . . 0.0 108.224 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.53 113.57 15.47 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.184 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.8 p -146.28 -39.67 0.22 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' H ' ' N ' ' A' ' 1' ' ' SER . . . -91.99 -62.04 1.19 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -160.35 177.78 10.26 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.984 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.8 p -66.27 174.64 2.53 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.629 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.39 124.43 3.62 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.78 167.75 11.24 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.559 HD12 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -130.32 105.16 7.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.304 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -86.04 147.92 25.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -96.42 14.23 25.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.061 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.451 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 56.8 mm-40 -138.21 141.33 40.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.62 128.34 20.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.553 1.158 . . . . 0.0 112.14 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.52 53.24 33.13 Favored Glycine 0 N--CA 1.496 2.642 0 CA-C-N 114.306 -1.315 . . . . 0.0 112.652 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 76.8 m 51.67 29.21 5.43 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.1 m -81.59 34.73 0.39 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.797 0.808 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.451 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.94 -145.38 4.28 Favored Glycine 0 N--CA 1.494 2.511 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.965 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.27 153.15 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 113.823 -1.189 . . . . 0.0 108.527 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.21 -169.08 0.46 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.58 0.55 . . . . 0.0 111.314 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.472 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 38.3 t-80 -153.93 -59.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.708 0.63 . . . . 0.0 110.249 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.1 m -112.9 119.84 39.36 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.243 0.964 . . . . 0.0 111.661 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -94.07 149.08 21.56 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.633 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.47 148.27 52.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.864 0.727 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.52 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.494 2.561 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.086 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -156.11 135.3 12.14 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -37.72 117.08 0.54 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.68 85.08 2.06 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.95 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 68.8 mtp85 -73.41 71.51 1.29 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.97 152.44 20.7 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.884 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 63.6 m -134.33 40.07 3.03 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -113.03 143.38 29.03 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.392 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -63.07 170.9 6.9 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.367 2.044 . . . . 0.0 111.325 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.36 -169.87 2.45 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.066 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.96 58.1 0.46 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.559 ' CG ' HD12 ' A' ' 43' ' ' LEU . 5.0 m-90 -105.54 146.28 29.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.62 -46.24 10.96 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.099 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.1 p -153.99 156.35 37.26 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.962 1.414 . . . . 0.0 113.088 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.441 HD13 ' CB ' ' A' ' 3' ' ' PHE . 6.2 tt -112.67 131.28 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.69 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.567 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 13.6 t80 -100.51 88.43 3.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.481 1.113 . . . . 0.0 111.124 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -85.58 137.82 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -89.71 170.53 10.37 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.178 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 116.166 -1.873 . . . . 0.0 111.358 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.91 141.72 5.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.927 0.767 . . . . 0.0 112.088 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.577 ' CG ' HD13 ' A' ' 72' ' ' ILE . 50.8 t80 -92.57 140.9 29.08 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.4 m -128.6 151.03 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.4 ' CG1' ' CE2' ' A' ' 3' ' ' PHE . 16.2 m -147.34 166.77 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.153 0.908 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 30.5 m-90 -141.47 133.35 27.42 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 88.8 p -43.5 -33.51 1.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 134.99 154.11 6.99 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -82.58 -57.93 0.1 OUTLIER 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.315 1.166 . . . . 0.0 111.151 13.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.64 -145.34 14.98 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.03 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 63' ' ' ALA . 76.2 m -93.3 50.42 1.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.59 -1.305 . . . . 0.0 111.886 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.64 -126.97 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 37.76 -141.88 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 119.57 1.077 . . . . 0.0 113.734 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 58.2 ttp180 -69.89 154.41 41.99 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.52 111.65 14.03 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.432 0.457 . . . . 0.0 112.135 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -117.54 166.77 11.98 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -151.71 157.0 41.46 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.613 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -142.38 93.61 2.55 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.4 p -100.05 -11.37 20.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -55.74 128.19 33.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 123.856 0.723 . . . . 0.0 111.516 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.66 167.3 17.27 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.0 -84.26 1.29 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.3 p -174.31 157.31 2.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.497 0.763 . . . . 0.0 111.062 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -160.19 146.76 15.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.246 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.72 163.65 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.827 0.705 . . . . 0.0 109.623 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mt -134.57 151.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.674 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -23.07 4.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.205 0.941 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HG3' HH21 ' A' ' 14' ' ' ARG . 16.6 mp0 -82.76 97.34 8.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.939 0.774 . . . . 0.0 110.808 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -82.95 12.97 4.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.37 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.76 -112.97 0.39 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.266 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.6 159.44 19.75 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 124.982 1.048 . . . . 0.0 110.837 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -161.28 131.64 5.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.456 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 8.2 t70 -104.47 174.87 5.69 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.151 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 65.3 t80 -148.8 157.89 43.76 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.406 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 55.4 m -139.23 139.06 37.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -122.18 138.85 54.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.903 1.377 . . . . 0.0 113.202 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.4 p -152.35 66.68 0.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.89 36.5 93.37 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -153.63 99.49 2.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -71.97 157.48 37.75 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.08 166.42 15.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.712 1.258 . . . . 0.0 110.314 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.78 152.21 40.0 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.125 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 80.9 mt -113.17 98.63 7.26 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.385 1.088 . . . . 0.0 110.071 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.39 115.2 14.8 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.638 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -48.46 -65.22 0.6 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.012 1.445 . . . . 0.0 109.97 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.57 155.89 36.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.402 1.064 . . . . 0.0 112.142 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.54 179.44 7.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.503 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.37 54.3 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.977 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 24.0 m 59.35 30.7 20.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.7 p -115.84 35.7 4.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.719 0.771 . . . . 0.0 111.269 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.97 157.6 15.08 Favored Glycine 0 N--CA 1.493 2.496 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.13 149.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.91 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.713 0.768 . . . . 0.0 109.296 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.428 ' HB3' ' HE1' ' A' ' 69' ' ' TRP . 21.5 t-80 -79.69 -23.34 42.49 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.266 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.467 ' HB ' HD12 ' A' ' 43' ' ' LEU . 50.0 m -146.92 136.34 22.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.958 0.787 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -114.52 147.33 39.55 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.33 1.019 . . . . 0.0 111.79 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 21.7 m-85 -132.31 98.61 4.44 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.44 1.088 . . . . 0.0 108.248 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.54 12.14 66.41 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.3 t -164.47 142.14 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.6 p -40.51 127.9 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.141 0.9 . . . . 0.0 111.916 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 33' ' ' ASP . . . -132.56 113.34 12.94 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 124.051 0.844 . . . . 0.0 112.767 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -81.26 71.36 8.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.396 1.06 . . . . 0.0 112.803 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.406 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . -91.28 157.98 16.83 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.379 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.2 m -147.39 10.06 0.96 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.55 0.69 . . . . 0.0 109.567 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -74.68 167.78 33.16 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.729 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -56.29 144.51 81.86 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.205 1.936 . . . . 0.0 111.936 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -73.99 167.42 21.54 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.14 17.13 1.18 Allowed Glycine 0 N--CA 1.501 3.014 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.47 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.476 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.0 m-90 -138.43 -166.65 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -129.98 -36.71 1.54 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.7 p -134.09 168.87 18.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 124.306 1.004 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.577 HD13 ' CG ' ' A' ' 3' ' ' PHE . 3.3 tt -130.78 121.47 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.533 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -98.02 119.05 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.889 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.9 mt -117.94 150.3 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -74.28 -179.75 4.09 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 116.896 -1.526 . . . . 0.0 109.799 179.804 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.78 121.37 2.85 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.188 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.489 ' CG ' HD13 ' A' ' 72' ' ' ILE . 76.8 t80 -93.63 102.56 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.173 0.92 . . . . 0.0 110.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.6 m -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -151.82 138.64 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 123.774 0.672 . . . . 0.0 110.086 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.53 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 24.9 m-90 -109.3 150.48 27.91 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.1 p -61.35 -38.76 88.1 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.98 153.64 6.66 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.88 -56.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.769 0 O-C-N 122.858 0.925 . . . . 0.0 109.982 7.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.19 -132.35 6.27 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.06 54.98 1.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -139.42 64.2 1.47 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.004 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 4.7 p30 -178.46 -150.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.76 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -72.05 169.62 15.6 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.94 173.66 12.22 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -151.11 140.41 21.34 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.056 -1.884 . . . . 0.0 107.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -110.93 153.06 26.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 123.735 0.647 . . . . 0.0 111.243 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -139.5 75.17 1.5 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -105.71 -20.97 13.29 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.179 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.59 135.13 57.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 123.632 0.583 . . . . 0.0 110.338 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -60.64 109.35 1.01 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.465 1.103 . . . . 0.0 110.35 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.66 166.95 13.7 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.8 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 m -78.73 74.8 5.26 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.618 -1.291 . . . . 0.0 109.88 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -80.6 136.0 36.16 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -78.44 126.86 31.36 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.427 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.3 mp -89.22 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -135.76 -29.92 1.01 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.707 0.63 . . . . 0.0 112.045 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -78.85 104.53 9.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.787 0.679 . . . . 0.0 109.279 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -90.26 18.27 6.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.347 1.03 . . . . 0.0 113.675 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.01 -87.59 0.25 Allowed Glycine 0 N--CA 1.497 2.745 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.297 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.23 169.83 20.44 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -161.62 132.17 5.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 2.9 t70 -107.05 166.06 10.89 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.321 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 68.6 t80 -145.7 151.89 38.75 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -132.62 151.48 51.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -135.71 133.91 38.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 124.213 0.946 . . . . 0.0 110.473 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.0 p -149.67 70.03 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.61 98.11 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.844 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -158.37 115.37 2.84 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.153 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 m -83.25 165.84 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.122 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.63 162.08 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.643 -1.617 . . . . 0.0 108.301 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.53 137.28 21.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.86 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' A' ' 69' ' ' TRP . 3.9 mm? -91.71 158.71 16.22 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -147.74 121.29 9.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 125.28 1.612 . . . . 0.0 109.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -66.3 -8.03 22.46 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.456 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -122.95 134.08 54.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 124.074 0.859 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 133.57 8.1 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.844 -1.526 . . . . 0.0 115.006 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.01 44.49 83.11 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.7 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 71.9 m 52.17 31.9 9.79 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -82.73 29.43 0.45 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.207 1.003 . . . . 0.0 112.796 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.2 -175.17 31.94 Favored Glycine 0 N--CA 1.49 2.258 0 CA-C-N 113.219 -1.809 . . . . 0.0 108.863 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -81.9 156.5 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.78 161.92 28.85 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.589 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -123.37 -32.42 3.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 124.346 1.029 . . . . 0.0 110.459 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -141.06 167.42 22.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.998 0.812 . . . . 0.0 109.085 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -143.29 143.4 31.69 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.498 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 23.0 m-85 -139.36 105.2 5.16 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.058 0.849 . . . . 0.0 110.184 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.19 31.44 5.46 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.0 t -175.51 127.25 0.25 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -30.64 111.19 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 124.507 1.13 . . . . 0.0 113.074 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.478 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -120.29 93.68 4.13 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 124.306 1.004 . . . . 0.0 109.831 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -81.97 68.03 8.2 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.23 -1.35 . . . . 0.0 113.168 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.78 169.18 12.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.794 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.31 39.84 0.84 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.409 1.1 . . . . 0.0 108.439 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -100.44 165.55 14.2 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 112.741 -2.027 . . . . 0.0 109.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.06 164.79 33.56 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.539 2.159 . . . . 0.0 110.339 164.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.54 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 30.9 p90 -162.26 -163.72 0.96 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.511 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.47 43.32 0.43 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.55 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CE3' ' CD2' ' A' ' 67' ' ' PHE . 4.8 m-90 -91.73 133.38 35.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.77 -48.93 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 37.3 p -135.57 169.8 16.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.988 1.43 . . . . 0.0 112.743 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.489 HD13 ' CG ' ' A' ' 3' ' ' PHE . 10.9 tt -140.31 119.26 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.95 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.672 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 37.1 t80 -84.2 121.06 26.95 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.144 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.4 mm -108.7 132.41 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -85.7 -179.9 6.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.895 0.747 . . . . 0.0 110.024 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 115.532 -2.175 . . . . 0.0 110.23 179.77 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.96 132.22 11.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CG ' HD13 ' A' ' 72' ' ' ILE . 85.2 t80 -95.75 93.59 7.18 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.895 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.6 m -72.51 152.3 41.97 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 28' ' ' GLN . 33.2 m -150.01 155.13 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 124.267 0.979 . . . . 0.0 110.88 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.57 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.0 m-90 -133.93 157.23 46.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.5 p -60.45 -40.55 91.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.496 1.123 . . . . 0.0 113.127 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.1 157.05 8.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.2 -45.22 0.37 Allowed 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.152 1.08 . . . . 0.0 111.386 19.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.29 -137.75 8.84 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -105.44 40.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.189 -1.506 . . . . 0.0 107.349 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -140.65 68.16 1.35 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.57 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -169.83 -88.17 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.556 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -90.46 91.73 8.58 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.248 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 115.06 5.22 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.821 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -145.98 154.58 42.05 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -151.05 151.61 32.26 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.0 93.79 4.14 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.477 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.4 p -105.65 -26.81 11.68 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -52.11 145.08 11.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 123.958 0.786 . . . . 0.0 112.912 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 t -65.67 168.36 7.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.183 0.927 . . . . 0.0 109.349 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.49 -177.63 43.28 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 107.194 -2.362 . . . . 0.0 107.194 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 29.7 p -96.34 142.65 28.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.213 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.7 p -127.24 140.22 52.38 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.708 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.36 122.08 25.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 123.865 0.728 . . . . 0.0 109.776 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.54 150.06 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.823 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -134.41 -13.55 2.32 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.24 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 21.5 mm-40 -86.2 84.72 7.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 123.07 1.414 . . . . 0.0 109.807 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -89.99 64.67 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.886 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.29 -58.26 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.533 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.1 168.74 35.84 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -161.1 132.03 5.35 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.152 -1.019 . . . . 0.0 113.723 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -114.15 104.47 12.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.781 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.487 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 79.0 t80 -82.68 153.42 25.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -146.04 100.79 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.277 0.986 . . . . 0.0 109.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -72.04 134.45 45.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.199 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.1 p -146.58 55.11 1.13 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.93 -23.56 13.6 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 113.863 -1.517 . . . . 0.0 110.555 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -99.13 125.83 44.76 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.175 0.512 . . . . 0.0 111.501 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 m -85.98 164.84 17.16 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.89 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.61 171.04 13.03 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.33 131.42 6.5 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.346 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.546 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -96.49 116.73 29.55 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.632 0.729 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -99.43 122.62 42.79 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 0.0 110.567 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -74.55 -1.39 21.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -111.64 139.4 47.12 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 138.75 56.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 124.018 0.824 . . . . 0.0 110.775 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.519 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 52.91 43.95 61.35 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.8 p 39.33 40.04 0.51 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.3 m -89.25 42.02 1.07 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.973 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.68 -122.18 0.62 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.388 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.59 153.07 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.64 -174.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.34 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 52.4 t-80 -148.55 -45.58 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.819 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -138.91 116.02 10.99 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.058 0.849 . . . . 0.0 109.428 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -96.28 152.27 18.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.863 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 17.9 m-85 -131.2 114.8 15.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.064 0.853 . . . . 0.0 110.153 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.48 11.42 28.26 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 p -161.05 135.62 7.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 123.979 0.458 . . . . 0.0 110.437 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 m -39.67 115.82 0.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.319 1.012 . . . . 0.0 112.408 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.04 93.73 4.19 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.205 0.941 . . . . 0.0 109.242 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -74.48 75.37 1.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.333 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.35 161.87 15.41 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.201 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 m -148.1 58.44 1.1 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.079 0.943 . . . . 0.0 110.307 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.49 153.42 43.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 113.751 -1.568 . . . . 0.0 108.864 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.98 178.37 2.43 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.354 2.036 . . . . 0.0 110.28 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.25 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.072 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.89 19.15 3.74 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-O 118.504 -1.165 . . . . 0.0 114.033 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.546 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 5.1 m-90 -91.87 161.0 15.02 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 118.852 1.326 . . . . 0.0 111.014 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.63 -41.39 7.74 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.162 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 p -146.28 -179.94 7.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.432 1.082 . . . . 0.0 110.985 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.51 HD13 ' CG ' ' A' ' 3' ' ' PHE . 11.0 tt -146.5 117.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.369 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.59 114.16 19.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.062 -1.881 . . . . 0.0 108.772 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.65 140.02 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.54 150.74 29.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.142 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 116.576 -1.678 . . . . 0.0 110.373 179.888 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 19' ' ' SER . . . -152.29 103.99 2.9 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.185 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.458 ' CB ' HD13 ' A' ' 72' ' ' ILE . 85.4 t80 -96.69 90.69 5.39 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.07 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -77.49 154.57 32.39 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 16' ' ' GLU . 12.4 m -148.28 166.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 123.703 0.627 . . . . 0.0 109.397 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.465 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 29.4 m-90 -141.88 139.64 32.66 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -51.95 -41.15 61.84 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.494 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.12 151.03 5.47 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -79.07 -62.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.592 0 O-C-N 122.975 0.987 . . . . 0.0 111.396 19.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.18 -129.41 6.55 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 p -95.5 49.96 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.292 -0.954 . . . . 0.0 111.373 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.33 -132.01 0.26 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.494 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.9 p30 36.66 -150.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -78.63 -176.75 5.02 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -153.17 159.79 42.75 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 60.1 mm-40 -139.78 163.76 31.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 111.724 -2.489 . . . . 0.0 104.677 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -146.87 136.39 22.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -117.27 73.83 0.89 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.683 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 76.2 p -95.9 -5.63 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.032 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -66.71 111.74 3.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.084 0.865 . . . . 0.0 108.872 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 7.0 p -64.85 114.95 4.85 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.028 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.37 -95.83 0.16 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.58 -1.295 . . . . 0.0 114.405 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -156.19 133.06 10.43 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.612 0.831 . . . . 0.0 110.118 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -160.24 134.22 7.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.473 0.483 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.76 126.09 30.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.402 ' H ' ' HA ' ' A' ' 71' ' ' SER . 24.8 mt -86.39 150.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -137.03 0.64 2.39 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.758 0.661 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -101.26 101.16 11.79 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.836 0.827 . . . . 0.0 109.596 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -79.53 -2.97 44.66 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.662 -1.608 . . . . 0.0 113.749 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.58 -101.89 0.03 OUTLIER Glycine 0 N--CA 1.497 2.722 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.38 166.22 14.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 63' ' ' ALA . 30.8 p90 -161.45 145.27 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.84 152.51 43.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -121.5 157.02 31.54 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 t -145.59 101.24 3.54 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -70.67 137.46 49.86 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 111.952 -2.385 . . . . 0.0 108.778 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.6 m -143.52 61.89 1.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.66 -14.05 10.81 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.711 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -113.49 125.04 53.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 120.933 0.396 . . . . 0.0 111.693 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.1 m -80.15 162.18 24.86 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.45 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.17 174.3 6.41 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.419 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.1 140.97 19.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.638 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -112.56 133.04 54.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 123.639 0.587 . . . . 0.0 111.554 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -117.77 134.28 55.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 125.033 1.458 . . . . 0.0 111.601 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -66.93 -36.57 82.53 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.065 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -92.4 119.72 32.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.971 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -39.13 146.99 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 125.433 1.708 . . . . 0.0 113.814 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.5 39.42 93.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.409 ' H ' ' CB ' ' A' ' 71' ' ' SER . 31.1 p 43.79 35.85 1.17 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 125.007 1.063 . . . . 0.0 111.543 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -90.23 46.05 1.32 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.205 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.44 -135.57 1.86 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.307 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.47 154.61 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.196 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.13 178.32 1.91 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.437 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -156.56 -40.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -142.95 129.33 20.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.979 0.799 . . . . 0.0 110.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.91 135.32 54.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -115.36 114.0 24.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.776 0.673 . . . . 0.0 110.663 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.84 13.05 38.35 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 p -164.34 136.14 4.6 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m -41.1 121.6 1.6 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.11 0.881 . . . . 0.0 111.724 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.25 111.76 9.9 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -78.2 76.21 4.72 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.775 0.672 . . . . 0.0 111.294 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . . . -90.91 71.92 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.389 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.5 m -62.23 -6.91 3.48 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -70.87 164.13 58.75 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.52 178.57 2.57 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.62 2.213 . . . . 0.0 111.614 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 -149.26 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.07 15.74 0.43 Allowed Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.161 0.913 . . . . 0.0 110.855 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.638 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 1.9 m-90 -100.93 126.22 47.55 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -90.45 2.79 55.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.143 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 49' ' ' CYS . 27.1 p -163.58 173.66 12.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.05 0.844 . . . . 0.0 112.468 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.458 HD13 ' CB ' ' A' ' 3' ' ' PHE . 6.7 tt -149.27 123.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.128 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -99.51 127.41 45.57 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -131.9 143.98 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -72.54 164.88 25.73 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.043 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 116.883 -1.532 . . . . 0.0 110.566 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 96.92 2.92 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 121.004 0.431 . . . . 0.0 111.291 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 64.7 t80 -97.31 101.99 13.66 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.5 m -84.38 155.54 22.25 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -150.71 161.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 123.31 0.381 . . . . 0.0 111.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.642 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 21.2 m-90 -145.98 140.14 26.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 m -55.19 -21.77 14.96 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' CA ' ' HA3' ' A' ' 30' ' ' GLY . . . 124.46 163.94 11.81 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 123.782 0.676 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.3 -54.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.678 0 O-C-N 123.058 1.031 . . . . 0.0 111.462 13.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.07 -123.55 4.57 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 75.3 m -122.16 80.2 1.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -147.79 -54.73 0.21 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.305 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.642 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.6 p30 -49.31 -120.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.99 80.9 0.08 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.66 110.26 3.65 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -131.45 172.66 11.93 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -153.38 158.67 41.83 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.735 -0.786 . . . . 0.0 113.119 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -136.77 80.16 1.8 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.843 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.1 t -108.68 1.33 21.12 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.687 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -61.4 118.64 7.22 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.781 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -62.29 102.13 0.28 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.322 1.014 . . . . 0.0 108.946 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.33 -118.48 1.02 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.3 t -140.71 154.59 46.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 124.315 0.656 . . . . 0.0 111.762 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 p -160.15 139.54 10.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.88 140.97 38.02 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.673 0.608 . . . . 0.0 111.772 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 72' ' ' ILE . 19.2 mt -117.56 127.29 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.815 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -125.7 32.85 5.21 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.046 0.841 . . . . 0.0 108.779 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.409 ' H ' HG22 ' A' ' 26' ' ' ILE . 30.4 mm-40 -113.47 99.27 7.64 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.284 -1.325 . . . . 0.0 108.285 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.14 18.26 6.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 111.85 -2.432 . . . . 0.0 112.491 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.497 ' HA3' ' CA ' ' A' ' 8' ' ' GLY . . . -92.24 -74.64 1.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.908 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 64' ' ' CYS . . . -152.84 164.46 30.79 Favored Glycine 0 N--CA 1.486 2.006 0 CA-C-N 113.836 -1.182 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 23.4 p90 -161.23 132.25 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.79 161.8 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.362 -1.744 . . . . 0.0 107.253 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -142.25 153.16 43.73 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -146.86 114.03 6.23 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.654 1.222 . . . . 0.0 108.203 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.2 112.49 17.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.357 -2.201 . . . . 0.0 105.295 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.4 m -132.66 -66.6 0.67 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.74 -70.05 1.31 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -141.31 -168.52 2.65 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.226 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -77.17 -167.95 1.0 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.122 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.12 142.04 12.89 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.687 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.41 149.32 38.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.266 0.979 . . . . 0.0 108.818 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 55' ' ' THR . 38.1 mt -114.16 101.35 9.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.747 0.654 . . . . 0.0 111.3 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.53 144.92 26.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.368 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -91.99 -0.19 57.48 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.423 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 85.2 mm-40 -113.89 148.26 37.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 123.553 0.533 . . . . 0.0 110.137 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.72 134.03 55.86 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.827 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.33 30.85 77.33 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.433 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.7 m 54.7 29.42 11.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 124.61 0.829 . . . . 0.0 112.623 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 t -88.45 59.81 5.36 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.868 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -157.48 -125.45 0.85 Allowed Glycine 0 N--CA 1.495 2.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.834 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.79 144.08 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.2 121.88 21.01 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.484 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.78 -60.29 2.41 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.442 ' HB ' HD12 ' A' ' 43' ' ' LEU . 94.1 m -124.49 148.87 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.697 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.97 -177.89 4.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 123.545 0.528 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 43' ' ' LEU . 44.3 m-85 -141.32 158.08 44.36 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.685 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 59' ' ' SER . . . -148.08 -11.87 0.15 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.412 ' H ' ' H ' ' A' ' 58' ' ' GLY . 67.2 m -151.35 147.18 26.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -41.47 117.84 0.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.929 0.768 . . . . 0.0 112.78 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.8 99.82 7.37 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.331 1.02 . . . . 0.0 109.428 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -84.79 70.18 10.8 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.39 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.24 165.47 13.44 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 31' ' ' GLY . 67.4 m -150.85 26.64 0.73 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.842 0.83 . . . . 0.0 111.958 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -97.25 168.51 10.09 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.111 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.34 178.49 0.86 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.364 2.043 . . . . 0.0 110.946 163.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.85 -151.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.21 49.17 0.4 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 4.2 m-90 -127.37 142.17 51.5 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 1.8 tpmt? -93.85 -20.74 19.78 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.5 p -161.93 178.43 8.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 124.29 0.993 . . . . 0.0 112.052 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' A' ' 26' ' ' ILE . 11.0 tt -140.4 123.85 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.52 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -91.47 84.64 5.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.931 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.4 mm -69.19 125.05 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -72.06 136.21 46.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.805 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.55 0 CA-C-N 113.316 -1.766 . . . . 0.0 111.549 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.66 134.56 5.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CG ' HD13 ' A' ' 72' ' ' ILE . 88.5 t80 -101.76 107.06 18.16 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.886 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.8 m -91.75 152.3 20.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 28' ' ' GLN . 10.7 m -154.46 152.92 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.719 0.637 . . . . 0.0 111.062 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.415 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 18.1 m-90 -122.63 153.28 39.55 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 23.3 t -55.93 -50.56 70.39 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 163.61 154.17 7.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -80.05 -56.0 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 118.273 1.037 . . . . 0.0 110.075 12.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.5 -136.32 8.28 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -87.85 42.33 1.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.3 -0.95 . . . . 0.0 112.554 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -111.93 -135.0 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 7' ' ' SER . 6.8 p30 34.8 -141.21 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -89.44 156.74 18.47 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.02 171.61 7.28 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.905 0.753 . . . . 0.0 111.991 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -171.82 125.44 0.57 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -98.42 155.49 17.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -138.16 94.84 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.4 p -130.42 13.69 5.53 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.604 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -54.75 128.5 33.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.632 0.582 . . . . 0.0 110.959 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.4 t -69.55 94.22 0.75 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.457 1.123 . . . . 0.0 108.913 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.29 -106.06 0.36 Allowed Glycine 0 N--CA 1.488 2.129 1 N-CA-C 101.287 -4.725 . . . . 0.0 101.287 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.26 164.29 25.05 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.992 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 p -158.1 148.3 20.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 126.62 31.03 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.388 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mt -78.78 148.9 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.576 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -124.92 -32.36 3.05 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.288 0.993 . . . . 0.0 111.615 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 14.1 mm-40 -71.63 97.44 1.72 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.146 0.974 . . . . 0.0 110.636 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -90.42 61.29 4.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.369 -2.196 . . . . 0.0 109.545 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.98 -89.82 0.25 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.37 157.54 17.64 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' HG12 ' A' ' 5' ' ' VAL . 3.3 m-85 -143.99 117.44 9.11 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.775 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -126.83 153.12 46.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.056 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 92.5 t80 -133.35 155.07 50.13 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -137.11 131.26 32.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -109.69 148.34 31.54 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.411 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -166.56 55.12 0.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.52 -33.84 4.02 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.42 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -82.06 120.78 25.72 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.451 0.643 . . . . 0.0 110.726 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 m -91.9 168.78 11.18 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.201 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.04 147.28 23.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 123.63 0.581 . . . . 0.0 112.275 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.26 150.23 29.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.477 HD21 ' CE3' ' A' ' 69' ' ' TRP . 25.8 tp -120.11 108.68 14.55 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -89.09 124.16 34.05 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.123 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 57.5 t-20 -63.56 -41.81 98.39 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.152 -1.84 . . . . 0.0 106.66 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.564 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -78.93 157.43 28.22 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.274 -1.785 . . . . 0.0 108.06 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.1 172.94 6.04 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 33.96 44.79 0.37 Allowed Glycine 0 N--CA 1.505 3.251 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.601 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.9 p 34.35 61.64 0.53 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 125.218 1.187 . . . . 0.0 113.214 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 46' ' ' GLN . 70.9 m -78.31 -154.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.641 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.02 162.26 49.88 Favored Glycine 0 N--CA 1.498 2.815 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.258 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t 61.87 107.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 113.416 -1.392 . . . . 0.0 112.381 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.95 -174.95 2.84 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.756 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.465 ' CD2' ' HE1' ' A' ' 69' ' ' TRP . 8.8 t60 -136.91 -49.86 0.64 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 m -138.16 160.86 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.87 127.68 14.39 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.736 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.44 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 25.3 m-85 -101.78 146.04 28.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.24 0.962 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.27 17.13 0.79 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 p -165.82 129.87 2.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.9 m -37.03 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.079 0.862 . . . . 0.0 113.112 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.98 101.55 8.86 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 115.041 -0.982 . . . . 0.0 112.041 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -83.13 76.73 9.84 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.68 165.5 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.445 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 m -153.8 36.55 0.45 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 121.763 0.792 . . . . 0.0 109.374 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 35.7 m120 -70.07 -167.04 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.094 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.576 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 65' ' ' ASN . 1.4 Cg_endo -73.3 165.94 31.26 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.733 2.288 . . . . 0.0 111.24 144.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.75 171.11 15.44 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.41 18.1 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.672 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 13.7 m-90 -141.93 -162.59 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.97 0.453 . . . . 0.0 112.0 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.2 -30.22 0.47 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.927 0.767 . . . . 0.0 111.04 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 p -150.32 162.45 40.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.918 0.761 . . . . 0.0 111.809 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.529 HD13 ' CG ' ' A' ' 3' ' ' PHE . 10.2 tt -137.88 134.78 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.243 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -96.02 106.78 18.99 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.403 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -101.03 139.31 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -105.39 162.61 13.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.034 0.834 . . . . 0.0 110.741 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 116.94 -1.505 . . . . 0.0 110.475 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.64 95.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 123.97 0.793 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 87.8 t80 -82.18 98.92 8.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.313 1.008 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -84.11 151.76 24.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 p -163.25 146.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.525 1.155 . . . . 0.0 112.506 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 8.2 m-90 -124.23 151.41 44.16 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 111.851 -2.431 . . . . 0.0 107.304 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.7 p -68.82 9.84 0.34 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.34 163.21 37.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -76.66 -53.79 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.649 0 O-C-N 123.055 1.029 . . . . 0.0 111.107 16.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.52 -143.5 13.83 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 71.5 m -107.85 70.81 0.78 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -142.14 -49.06 0.37 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.942 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.65 ' H ' HD22 ' A' ' 13' ' ' ASN . 1.4 p30 -53.94 -135.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.717 -2.038 . . . . 0.0 115.974 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 94.4 mtt-85 -54.25 129.27 34.52 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.76 116.15 31.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.928 0.767 . . . . 0.0 110.565 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -147.81 138.84 23.4 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -123.78 158.69 31.17 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -136.32 82.17 1.93 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.5 p -105.71 -14.76 15.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.555 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.69 141.68 58.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.185 0.928 . . . . 0.0 109.544 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 44.0 t -71.76 174.7 6.49 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.02 -112.02 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 p -172.42 147.31 1.9 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.094 0.526 . . . . 0.0 111.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -158.77 154.45 26.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.171 0.919 . . . . 0.0 110.987 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.93 140.36 36.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.373 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.2 mt -97.0 115.78 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.158 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -79.27 -45.39 19.84 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.559 ' CD ' ' H ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -81.83 82.11 7.61 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.798 -1.546 . . . . 0.0 108.699 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.7 55.85 2.83 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.035 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.09 -114.35 2.85 Favored Glycine 0 N--CA 1.498 2.801 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.357 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.54 158.35 28.55 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-O 118.412 -1.215 . . . . 0.0 110.329 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 26.1 p90 -161.76 134.92 6.23 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -110.42 167.73 9.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 77.1 t80 -145.3 155.62 43.32 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.3 t -144.99 109.64 4.98 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -81.78 147.64 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 113.056 -1.884 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -173.36 76.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.62 -26.3 3.64 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-N 112.788 -2.006 . . . . 0.0 113.06 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -109.14 137.19 47.42 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.4 m -97.79 166.48 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.761 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.81 174.77 9.41 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.309 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.55 122.37 3.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.153 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.456 HD13 ' CZ3' ' A' ' 69' ' ' TRP . 98.4 mt -99.22 135.88 39.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 123.847 0.717 . . . . 0.0 111.615 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 8.8 p90 -148.24 138.43 22.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.212 0.945 . . . . 0.0 109.255 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.4 ' HA ' ' N ' ' A' ' 70' ' ' LYS . 17.4 t30 -72.59 -10.27 59.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.621 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' N ' ' CD ' ' A' ' 46' ' ' GLN . 8.0 mp0 -86.4 89.66 7.95 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.321 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.22 164.9 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.87 28.09 72.97 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.011 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 m 60.64 18.51 8.52 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.052 0.501 . . . . 0.0 110.614 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -90.49 41.04 1.04 Allowed 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -161.69 -170.29 26.19 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.081 -1.533 . . . . 0.0 115.921 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.21 145.96 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 112.351 -1.924 . . . . 0.0 107.772 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 179.98 0.12 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -153.27 -48.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.574 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 m -132.83 106.14 7.55 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.824 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -96.54 158.08 15.6 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 44.4 m-85 -126.0 106.04 9.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 124.189 0.931 . . . . 0.0 110.664 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.43 -4.31 57.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 t -155.47 140.15 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -35.91 110.86 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -92.98 -178.48 4.82 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -166.2 51.88 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.25 0.547 . . . . 0.0 111.576 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.78 165.47 16.0 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.1 m -147.56 11.09 0.98 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.945 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -79.84 157.59 73.92 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.73 143.92 27.82 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.452 2.101 . . . . 0.0 112.043 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.16 156.68 37.01 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.787 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.26 22.5 3.22 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 123.996 0.81 . . . . 0.0 111.417 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.456 ' CZ3' HD13 ' A' ' 43' ' ' LEU . 13.2 m-90 -138.26 -161.58 1.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 45' ' ' ASN . 18.6 ttpt -138.63 -20.14 1.04 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.544 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 p -153.72 170.28 21.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.267 0.979 . . . . 0.0 110.795 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 43' ' ' LEU . 14.4 tt -137.04 149.48 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.465 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -119.93 136.19 54.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.7 mt -138.44 155.95 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 124.069 0.856 . . . . 0.0 110.738 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -88.12 173.18 8.99 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.99 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 88.8 m . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.771 -1.585 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.741 0.305 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' CB ' ' HE ' ' A' ' 17' ' ' ARG . . . -159.09 174.23 15.21 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.403 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -137.67 97.43 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.53 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.1 m -77.3 150.52 35.25 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -148.61 153.96 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 123.622 0.576 . . . . 0.0 110.39 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.598 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 25.0 m-90 -135.61 142.97 45.34 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.5 p -66.18 0.85 1.77 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' ' C ' ' A' ' 9' ' ' PRO . . . 104.29 155.33 23.48 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 123.504 0.502 . . . . 0.0 113.349 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.452 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 12.1 Cg_endo -72.93 -54.88 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.851 0 O-C-N 123.023 1.012 . . . . 0.0 112.863 18.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.33 -128.67 5.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -108.89 69.44 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 113.96 -1.12 . . . . 0.0 109.419 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -143.4 -55.71 0.39 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.125 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.598 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.8 p30 -47.05 -118.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 5.9 tpm_? -62.78 100.77 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.352 0.596 . . . . 0.0 111.76 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.59 83.46 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.062 0.934 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -101.57 161.79 13.38 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.43 -1.713 . . . . 0.0 107.652 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.407 ' HE ' ' CB ' ' A' ' 2' ' ' ALA . 74.5 ttt180 -142.06 153.65 44.36 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -135.63 83.09 1.99 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.7 p -108.76 -12.01 14.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.056 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -53.09 143.53 17.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.336 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 126.92 29.61 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.819 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.58 28.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.572 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 20.2 p -114.15 162.23 16.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.5 p -160.57 158.59 29.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.351 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.43 151.25 30.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 123.699 0.625 . . . . 0.0 110.554 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 28' ' ' GLN . 3.3 mp -121.26 131.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 124.275 0.984 . . . . 0.0 109.333 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -101.28 -6.65 23.88 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.196 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' H ' HG22 ' A' ' 26' ' ' ILE . 26.2 mp0 -93.62 64.79 3.6 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.471 1.605 . . . . 0.0 108.729 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HG3' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -77.14 8.8 3.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 111.187 -2.733 . . . . 0.0 115.063 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA3' ' CA ' ' A' ' 8' ' ' GLY . . . -74.2 -61.97 3.07 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.627 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.95 161.3 28.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.67 135.1 6.41 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -109.89 161.2 15.7 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 90.1 t80 -132.22 158.05 42.77 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.9 t -140.4 121.98 15.2 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -104.56 111.58 24.32 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.8 p -148.53 -49.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.6 -80.08 1.03 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -137.53 -176.93 4.57 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.5 m -75.95 170.81 15.53 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.45 169.63 21.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.257 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -152.94 163.93 38.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.04 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.596 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.0 mm? -111.27 143.36 42.17 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.82 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.76 120.26 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.737 1.273 . . . . 0.0 108.681 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -62.34 -5.68 2.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.164 0.915 . . . . 0.0 112.193 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.9 123.17 38.02 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.971 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.543 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -37.98 148.13 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.436 -1.711 . . . . 0.0 114.305 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.572 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.96 37.47 44.83 Favored Glycine 0 N--CA 1.494 2.521 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.0 p 36.27 45.11 0.32 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.978 1.046 . . . . 0.0 113.192 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -85.31 41.66 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.676 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.52 -120.05 0.54 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.0 156.05 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.434 0.726 . . . . 0.0 109.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.62 165.09 17.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.624 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -132.4 -62.82 0.82 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.7 m -110.53 142.68 42.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -133.25 126.67 32.04 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.34 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.491 ' CE2' HD21 ' A' ' 43' ' ' LEU . 37.4 m-85 -94.33 132.99 38.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.17 0.918 . . . . 0.0 110.892 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.28 8.04 5.97 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.6 p -162.19 136.22 6.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.3 p -42.05 116.6 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 123.619 0.574 . . . . 0.0 110.976 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.5 107.43 12.86 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.54 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -78.13 73.82 4.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.516 1.135 . . . . 0.0 112.773 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 156.3 18.28 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.69 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.7 m -144.96 18.37 1.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -82.37 162.78 55.16 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.331 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -53.96 152.48 23.48 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.342 2.028 . . . . 0.0 110.589 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -69.8 166.14 19.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.759 0.662 . . . . 0.0 110.344 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.55 -0.72 1.53 Allowed Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.86 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.596 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.3 m-90 -127.1 -141.82 0.27 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 20.3 ttmm -146.58 -25.16 0.42 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.021 0.373 . . . . 0.0 110.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.451 ' HA ' HD12 ' A' ' 26' ' ' ILE . 6.4 p -146.91 158.73 44.0 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.795 0.807 . . . . 0.0 111.98 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.403 ' N ' HD11 ' A' ' 26' ' ' ILE . 6.5 tp -119.35 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 112.884 -1.962 . . . . 0.0 108.319 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -104.01 125.78 50.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.594 1.184 . . . . 0.0 108.392 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 mm -113.82 134.2 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -67.1 88.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 124.362 1.039 . . . . 0.0 110.476 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.79 -1.576 . . . . 0.0 114.491 179.896 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.36 119.88 2.77 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.355 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.436 ' CB ' HD13 ' A' ' 72' ' ' ILE . 72.4 t80 -87.63 92.11 8.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.44 ' HA ' ' HG2' ' A' ' 17' ' ' ARG . 57.1 m -73.1 152.63 41.13 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' A' ' 32' ' ' TYR . 34.8 m -154.31 153.59 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.571 1.169 . . . . 0.0 110.26 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.491 ' HB3' HD21 ' A' ' 13' ' ' ASN . 29.8 m-90 -135.63 150.09 49.53 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 96.4 p -63.41 -10.44 17.09 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 106.71 158.83 21.65 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.409 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 11.4 Cg_endo -73.43 -53.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.63 0 O-C-N 122.897 0.946 . . . . 0.0 110.885 25.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.51 -123.69 4.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 74.0 m -101.39 39.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.799 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -109.26 -130.65 0.3 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.1 p30 36.24 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -82.01 149.31 28.19 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.227 0.329 . . . . 0.0 110.261 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.63 152.72 23.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 123.765 0.666 . . . . 0.0 112.758 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -163.2 143.18 8.92 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.458 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 79.5 mtt85 -124.55 159.84 29.72 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.47 86.31 2.26 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.558 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -114.46 -8.17 12.81 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.25 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -54.6 121.01 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.19 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.45 97.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.421 1.076 . . . . 0.0 109.872 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.95 -177.48 21.88 Favored Glycine 0 N--CA 1.493 2.461 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.3 m -79.97 141.3 36.12 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.961 -1.119 . . . . 0.0 109.959 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.2 p -156.45 136.93 13.1 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.202 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -79.02 130.52 35.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 123.726 0.641 . . . . 0.0 112.614 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.2 mt -88.61 138.72 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -105.79 -56.27 2.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.041 0.838 . . . . 0.0 112.658 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.576 ' CD ' ' H ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -77.25 76.36 3.8 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 123.38 1.562 . . . . 0.0 111.146 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -71.93 18.87 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.245 -2.252 . . . . 0.0 115.46 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.35 -76.29 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.17 168.66 21.37 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB3' HG12 ' A' ' 5' ' ' VAL . 44.6 p90 -161.63 130.31 4.39 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 14.0 m-20 -114.42 101.1 8.83 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.098 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 3' ' ' PHE . 54.0 t80 -78.49 151.42 32.6 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.9 p -135.82 147.55 48.33 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 124.782 1.301 . . . . 0.0 107.703 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CG ' ' N ' ' A' ' 37' ' ' THR . 77.8 t80 -132.14 156.74 45.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.359 1.037 . . . . 0.0 108.506 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' A' ' 36' ' ' TYR . 5.8 t -163.49 -24.21 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.022 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.408 ' H ' ' H ' ' A' ' 37' ' ' THR . . . -169.05 -25.34 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -123.71 118.56 27.52 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.8 m -83.62 170.65 14.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.009 -1.905 . . . . 0.0 109.406 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.77 159.57 41.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.013 0.821 . . . . 0.0 111.066 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.13 133.24 24.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.049 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.506 ' HG ' ' CE3' ' A' ' 69' ' ' TRP . 4.3 mm? -79.59 169.43 18.02 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.691 0.619 . . . . 0.0 109.433 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -153.52 124.06 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.512 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.472 ' HB2' HE22 ' A' ' 46' ' ' GLN . 35.3 m120 -70.67 -30.83 67.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.472 HE22 ' HB2' ' A' ' 45' ' ' ASN . 10.8 mp0 -89.65 112.38 23.61 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -41.5 143.35 0.48 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.78 41.58 90.9 Favored Glycine 0 N--CA 1.497 2.724 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.963 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 60.7 m 52.76 30.8 9.44 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.162 0.566 . . . . 0.0 112.414 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.6 t -81.0 30.56 0.32 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.278 1.037 . . . . 0.0 113.006 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.68 -161.66 12.12 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.624 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.6 t -95.64 145.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.97 148.56 50.89 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.571 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.665 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 12.6 t-80 -95.62 -69.41 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 m -112.36 118.84 36.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 123.94 0.775 . . . . 0.0 111.036 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -98.77 170.34 8.84 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.215 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.09 -172.39 2.82 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.424 0.63 . . . . 0.0 111.087 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.42 -36.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -145.53 159.32 43.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.877 -1.161 . . . . 0.0 108.99 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -42.29 117.39 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.53 90.26 3.3 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.761 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 86.1 mtm180 -75.29 69.78 2.15 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.09 168.3 11.73 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.798 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.38 8.97 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.779 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -75.92 157.16 83.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.12 156.28 65.5 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.074 1.849 . . . . 0.0 109.421 167.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CG ' ' CE3' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -138.14 -164.4 1.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.31 27.38 2.76 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.15 0.906 . . . . 0.0 112.663 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.665 ' HE1' ' CG ' ' A' ' 54' ' ' HIS . 4.9 m-90 -94.29 131.73 39.6 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -86.41 -18.11 32.61 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.379 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 63.2 p -156.42 179.55 9.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.292 0.995 . . . . 0.0 113.007 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 43' ' ' LEU . 13.9 tt -153.35 141.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.344 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.596 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 69.2 t80 -104.97 135.15 46.85 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.497 -1.683 . . . . 0.0 107.907 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.6 mm -123.2 132.58 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -76.19 173.21 11.64 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 116.11 -1.9 . . . . 0.0 111.51 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.478 ' H3 ' ' HB ' ' A' ' 37' ' ' THR . 53.7 m . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.89 129.0 49.45 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -98.14 94.03 6.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 124.297 0.998 . . . . 0.0 109.838 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -77.09 155.17 32.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.577 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 25.2 m -154.56 160.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 124.211 0.944 . . . . 0.0 108.91 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 31.6 m-90 -139.65 135.86 33.7 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -43.37 -44.28 5.55 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 147.1 151.65 5.47 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -79.44 -62.86 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.593 0 O-C-N 123.002 1.001 . . . . 0.0 111.794 18.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.43 -138.47 10.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.09 52.89 2.37 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.105 -1.047 . . . . 0.0 111.919 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -132.18 -130.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.518 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.1 p30 35.42 -144.01 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 58.6 ttm-85 -66.31 149.36 50.48 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.11 148.73 45.35 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 123.44 0.462 . . . . 0.0 111.646 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -166.78 153.59 8.85 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.348 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -123.09 153.35 40.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.08 0.863 . . . . 0.0 111.313 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -134.59 79.87 1.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.523 -1.671 . . . . 0.0 107.423 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -103.45 8.97 37.9 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.731 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -58.73 138.05 57.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.164 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.95 155.91 36.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.009 0.818 . . . . 0.0 110.049 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.4 -92.47 1.66 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 103.828 -3.709 . . . . 0.0 103.828 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -171.56 164.79 6.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.93 1.018 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 p -160.0 141.73 12.84 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.448 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.49 135.77 36.73 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 71' ' ' SER . 3.2 mp -102.98 156.38 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -121.22 -20.51 6.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 124.155 0.91 . . . . 0.0 110.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.36 97.34 2.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.15 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -90.1 62.91 5.68 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.04 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 -118.31 1.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.33 162.89 26.08 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 125.077 1.104 . . . . 0.0 111.325 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 14.9 p90 -161.73 136.01 6.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 3.4 t70 -120.76 165.88 14.5 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.362 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.41 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 70.3 t80 -133.86 155.61 49.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -147.21 85.56 1.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.36 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CB ' ' HA ' ' A' ' 59' ' ' SER . 2.2 t80 -49.09 133.82 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 112.948 -1.933 . . . . 0.0 113.293 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.478 ' HB ' ' H3 ' ' A' ' 1' ' ' SER . 50.4 m -152.48 82.85 1.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.73 19.06 57.92 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.83 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 76' ' ' CYS . 5.5 tp-100 -159.86 161.36 34.41 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.344 -0.943 . . . . 0.0 113.195 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -112.67 177.42 4.64 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.487 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.76 172.29 13.51 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.568 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.57 150.79 28.11 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.555 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -106.65 126.88 52.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.611 0.72 . . . . 0.0 111.365 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.64 101.47 10.78 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -61.36 -13.67 21.5 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.916 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -92.92 130.52 38.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.71 151.49 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.99 22.86 67.16 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.741 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 21.5 m 59.64 13.99 3.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.175 0.573 . . . . 0.0 112.471 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -87.61 63.04 7.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.939 0.775 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.0 -137.67 2.93 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.094 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.54 175.52 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.25 144.26 26.54 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.732 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.402 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 21.2 m-70 -120.44 -51.46 2.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.8 m -123.18 121.51 36.1 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.505 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.68 118.89 37.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.253 0.971 . . . . 0.0 111.606 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -102.04 93.56 5.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.344 1.028 . . . . 0.0 108.351 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.29 -23.3 44.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.418 ' HA ' ' CB ' ' A' ' 36' ' ' TYR . 35.1 t -135.59 144.07 45.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.485 0.756 . . . . 0.0 109.258 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -35.06 124.01 0.58 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.435 1.084 . . . . 0.0 111.929 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 33' ' ' ASP . . . -137.65 105.74 5.71 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.787 0.68 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -76.44 75.18 3.19 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.325 1.016 . . . . 0.0 112.905 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -90.8 153.69 20.05 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.289 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.53 19.86 2.03 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -79.18 165.02 51.52 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -56.0 148.22 59.28 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.938 1.759 . . . . 0.0 110.372 172.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.27 173.01 4.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.788 0.68 . . . . 0.0 109.473 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.19 7.46 0.12 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.197 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.555 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.2 m-90 -128.29 -171.29 2.42 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.957 0.445 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HB2' ' HZ3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -126.94 -24.67 3.44 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.546 ' HA ' HD12 ' A' ' 26' ' ' ILE . 10.1 p -146.53 163.69 34.96 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.681 0.613 . . . . 0.0 111.399 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.04 114.68 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.975 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -93.79 121.06 34.85 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.52 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 76' ' ' CYS . 31.3 mt -130.08 128.54 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.461 ' H ' ' CD ' ' A' ' 75' ' ' GLN . 3.2 mp0 -78.35 9.86 3.54 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.481 ' N ' ' HG2' ' A' ' 39' ' ' GLN . 14.6 p . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.38 123.68 10.92 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.525 ' CG ' HD13 ' A' ' 72' ' ' ILE . 67.3 t80 -89.65 104.6 17.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' ASP . 53.1 m -94.16 137.02 33.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -139.59 162.32 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.472 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 18.2 m-90 -128.18 140.33 51.97 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.449 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 78.2 p -55.58 -31.18 61.98 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.515 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 142.06 148.38 5.0 Favored Glycine 0 N--CA 1.5 2.929 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.41 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 28.1 Cg_endo -73.61 -65.14 0.03 OUTLIER 'Cis proline' 0 N--CA 1.503 2.066 0 CA-C-N 118.428 1.114 . . . . 0.0 112.581 20.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.33 -125.42 4.12 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 105.393 -3.083 . . . . 0.0 105.393 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -99.27 73.01 1.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -139.18 -53.11 0.56 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.138 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 7.6 p30 -57.22 -136.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.926 -1.943 . . . . 0.0 116.145 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 14' ' ' ARG . 31.3 mtm105 -58.13 141.07 51.42 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.17 82.24 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 124.73 1.269 . . . . 0.0 111.168 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.67 165.03 14.47 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.189 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -152.19 156.21 39.32 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.454 0.645 . . . . 0.0 112.374 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.93 69.19 1.36 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.2 t -90.7 -18.64 24.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.355 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -57.09 129.59 42.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.609 0.568 . . . . 0.0 111.602 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.48 122.18 15.64 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.552 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.43 -169.99 13.51 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-O 122.596 1.109 . . . . 0.0 114.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.5 t -56.74 130.38 45.29 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.612 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -160.81 120.42 2.68 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.615 0.572 . . . . 0.0 111.02 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.433 ' HB2' ' H ' ' A' ' 48' ' ' GLY . . . -79.72 126.3 30.76 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 mt -87.75 154.52 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -138.6 -9.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.571 0.545 . . . . 0.0 110.939 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.86 105.32 7.85 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.165 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.76 62.01 5.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.177 0.923 . . . . 0.0 108.845 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.74 -108.27 0.69 Allowed Glycine 0 N--CA 1.497 2.744 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.06 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.03 166.49 21.25 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -146.1 165.5 28.91 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 3.2 t70 -169.22 163.11 10.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 41' ' ' ALA . 58.0 t80 -138.61 155.81 48.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -142.3 94.8 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.19 0.932 . . . . 0.0 109.436 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.86 151.42 31.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.042 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -174.19 -22.8 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.366 1.041 . . . . 0.0 108.653 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.37 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -122.02 159.81 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.5 p -91.11 -163.8 1.09 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.844 -1.98 . . . . 0.0 110.444 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . . . -155.11 176.18 12.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.9 131.21 6.75 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 114.942 -1.027 . . . . 0.0 108.308 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -92.12 154.94 18.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.81 120.04 14.7 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.802 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -62.86 -7.48 5.18 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -118.05 122.08 42.24 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.856 0.722 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -40.08 145.84 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 124.685 1.241 . . . . 0.0 113.749 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 25' ' ' ALA . . . 58.99 42.47 96.9 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.819 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.7 p 44.11 25.57 0.12 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.156 1.15 . . . . 0.0 112.977 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 t -87.24 44.02 1.15 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.633 0.73 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.54 -155.26 6.39 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.405 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.55 150.14 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.04 156.52 33.52 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.336 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.473 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -141.3 -45.88 0.38 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.026 0.829 . . . . 0.0 110.968 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -137.13 118.89 15.07 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.775 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -105.37 162.48 13.41 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.738 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -139.65 133.88 31.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.043 0.839 . . . . 0.0 110.351 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.87 14.9 5.18 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.5 t -162.68 124.17 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 m -35.88 113.88 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 124.291 0.994 . . . . 0.0 112.955 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.84 15.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.957 0.786 . . . . 0.0 110.529 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -86.95 94.46 9.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 158.94 16.53 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.49 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.2 m -151.37 15.08 0.7 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -88.56 166.24 23.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.01 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -50.03 165.23 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.692 2.261 . . . . 0.0 112.245 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.58 179.36 2.14 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.556 0.694 . . . . 0.0 111.804 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.22 -5.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.141 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.502 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.6 m-90 -138.79 -156.19 0.66 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -140.87 -40.74 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.7 p -131.95 178.38 6.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 124.704 1.253 . . . . 0.0 111.377 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.525 HD13 ' CG ' ' A' ' 3' ' ' PHE . 11.2 tt -150.91 147.39 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.77 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -119.94 130.42 54.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.528 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.36 152.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 66.7 mt-30 -73.85 -159.59 0.08 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 75' ' ' GLN . 24.4 p . . . . . 0 N--CA 1.504 2.23 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.59 134.5 42.38 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.377 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 55.5 t80 -109.15 91.3 3.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.437 1.086 . . . . 0.0 108.85 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.0 m -81.25 133.81 35.5 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.978 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.14 145.65 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 123.645 0.591 . . . . 0.0 111.382 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.506 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 8.4 m-90 -114.3 143.27 45.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 79.1 p -64.34 -10.27 23.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' N ' ' HA3' ' A' ' 30' ' ' GLY . . . 120.35 154.6 9.42 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 123.596 0.56 . . . . 0.0 113.326 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -75.35 -64.18 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.835 0 O-C-N 123.221 1.116 . . . . 0.0 112.468 12.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.42 -136.13 6.39 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -106.12 66.07 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.411 -1.395 . . . . 0.0 109.792 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -141.86 -59.39 0.47 Allowed 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.774 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 2.0 p30 -32.56 -104.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -72.18 -164.16 0.13 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.412 1.005 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.69 59.68 0.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.834 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.13 151.14 28.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -145.75 116.81 7.82 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.385 0.612 . . . . 0.0 111.488 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -97.9 73.08 2.26 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.884 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.7 p -81.32 -14.29 57.48 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -64.63 133.27 51.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 123.949 0.781 . . . . 0.0 110.835 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.6 m -63.29 175.51 0.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.359 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.74 -161.94 45.85 Favored Glycine 0 N--CA 1.492 2.381 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.18 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -97.95 125.27 42.79 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.5 p -131.14 135.84 47.82 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.003 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.99 117.8 20.4 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 72' ' ' ILE . 2.3 mp -82.52 138.01 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.377 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -118.86 59.59 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.99 98.77 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.663 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -91.3 61.11 4.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' N ' ' A' ' 8' ' ' GLY . . . -144.06 -109.63 0.68 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.647 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.72 166.87 21.75 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -147.37 147.29 30.15 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 2.3 t70 -151.0 154.21 36.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -128.16 157.6 40.36 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.1 m -144.52 93.57 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.774 0.797 . . . . 0.0 110.016 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -71.4 151.75 43.76 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.775 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -172.76 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.222 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.53 -64.59 0.22 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -126.83 166.17 17.95 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.5 p -93.06 171.97 8.61 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.888 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.78 178.55 5.87 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.579 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.88 131.61 6.98 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' CE3' ' A' ' 69' ' ' TRP . 4.5 mm? -81.94 161.63 23.0 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -137.61 106.5 5.95 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.556 -2.111 . . . . 0.0 107.92 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 14.2 t30 -55.27 -23.67 24.17 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.316 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -95.98 135.57 37.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.161 0.913 . . . . 0.0 109.768 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.47 119.06 1.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.898 1.374 . . . . 0.0 113.074 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 43.71 74.21 0.21 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 124.618 1.199 . . . . 0.0 113.458 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 44.22 25.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m -82.35 32.13 0.4 Allowed 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.988 0.899 . . . . 0.0 112.238 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.74 -129.61 1.04 Allowed Glycine 0 N--CA 1.49 2.257 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.2 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -127.22 162.21 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.33 -177.39 1.12 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.046 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -148.62 -60.88 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.3 m -104.22 167.6 9.65 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.069 0.856 . . . . 0.0 109.796 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -142.45 144.77 33.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.462 1.101 . . . . 0.0 109.923 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -128.12 100.62 5.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.102 0.876 . . . . 0.0 109.528 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.37 -25.17 52.15 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.954 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.9 p -148.99 148.29 29.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.07 0.512 . . . . 0.0 111.339 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -33.78 115.32 0.22 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 124.434 1.083 . . . . 0.0 112.353 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.73 108.58 10.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.097 0.873 . . . . 0.0 111.644 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -82.03 87.5 6.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.101 0.876 . . . . 0.0 112.999 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 163.26 14.69 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.87 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 m -148.0 11.6 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.14 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -69.76 164.13 53.77 Favored Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.234 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.54 165.02 1.81 Allowed 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.45 2.1 . . . . 0.0 110.464 167.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.57 174.01 3.77 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.694 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 69' ' ' TRP . . . -159.48 -3.52 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.434 ' CE3' ' HG ' ' A' ' 43' ' ' LEU . 3.5 m-90 -143.13 -176.02 4.75 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -114.26 -39.34 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 p -132.58 165.7 23.79 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 6.9 tp -125.35 112.75 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.204 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -90.81 143.37 26.79 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.445 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.6 mt -135.05 132.5 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -60.2 -37.58 80.7 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.162 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 115.71 -2.09 . . . . 0.0 115.114 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.12 121.03 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.469 ' CB ' HD13 ' A' ' 72' ' ' ILE . 70.7 t80 -97.83 84.47 3.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.293 0.996 . . . . 0.0 110.076 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -68.07 151.04 47.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.74 154.93 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.482 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.5 m-90 -134.08 140.8 46.87 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.3 p -48.88 -43.33 38.96 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.558 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.11 157.27 7.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -81.47 -62.13 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.537 0 O-C-N 123.023 1.012 . . . . 0.0 110.33 14.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -128.0 3.12 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -106.98 49.61 0.8 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.706 -1.247 . . . . 0.0 109.308 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -119.49 -128.49 0.28 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.558 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 11.0 p30 35.94 -142.11 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -77.06 140.12 40.22 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.41 131.33 49.14 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.837 0.711 . . . . 0.0 110.662 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -136.83 118.37 14.85 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -98.23 124.67 42.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.276 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.14 81.98 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.9 m -106.21 -20.1 13.5 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.773 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -50.16 139.38 14.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.368 1.043 . . . . 0.0 112.912 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 162.69 11.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -151.16 43.3 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 22.0 p -129.98 154.19 47.63 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.029 -1.068 . . . . 0.0 113.558 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -143.39 151.76 40.79 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.118 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.47 124.47 28.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.031 0.832 . . . . 0.0 112.09 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.9 mp -80.71 118.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -93.14 -25.67 17.77 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.467 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -78.91 102.52 8.3 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 80.3 tttt -90.06 13.49 14.78 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.181 0.926 . . . . 0.0 111.43 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.32 -90.02 0.37 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.466 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.48 169.86 21.18 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -162.0 136.4 6.83 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -120.35 131.79 55.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.441 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.434 ' CG ' ' N ' ' A' ' 35' ' ' SER . 59.5 t80 -101.55 160.65 14.26 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.3 t -147.0 90.14 1.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -74.71 137.27 41.98 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.886 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -148.95 -44.99 0.14 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.751 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.8 -42.37 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.04 134.4 55.0 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.2 m -81.61 168.9 17.68 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.679 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.94 24.28 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.666 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.08 146.19 28.75 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.533 HD12 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -109.33 98.8 8.15 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.252 -179.546 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -75.63 130.48 38.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.764 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -94.59 27.71 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.498 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.36 145.21 29.21 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.93 142.32 12.02 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.425 -1.261 . . . . 0.0 114.281 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.93 33.46 13.4 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 113.538 -1.664 . . . . 0.0 113.512 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.3 p 41.44 42.76 1.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.7 p -98.78 47.4 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.633 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.71 -128.34 0.95 Allowed Glycine 0 N--CA 1.498 2.816 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.487 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -119.3 140.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.471 0.748 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.49 153.1 27.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -107.65 -36.81 6.33 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.12 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -138.82 123.74 18.84 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.07 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -101.7 163.29 12.33 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -138.86 92.8 2.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.668 0.605 . . . . 0.0 112.459 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.02 16.07 62.11 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.8 t -170.46 138.31 1.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.1 p -44.61 129.45 6.85 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.06 97.05 4.5 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.97 0.794 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.0 mtt-85 -72.04 71.65 0.83 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.06 14.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.326 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.5 m -142.95 -11.26 0.77 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -71.47 156.41 91.52 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.964 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.37 176.98 0.93 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.684 2.256 . . . . 0.0 112.056 173.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' A' ' 29' ' ' LYS . 39.8 p90 -158.12 -167.45 2.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.088 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.43 56.52 0.46 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.533 ' CG ' HD12 ' A' ' 43' ' ' LEU . 5.0 m-90 -109.36 163.38 13.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.68 -44.58 5.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.54 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 p -155.41 164.65 38.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.716 1.26 . . . . 0.0 112.432 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 3' ' ' PHE . 7.1 tt -125.98 129.83 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.721 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -99.22 147.69 24.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 125.255 1.597 . . . . 0.0 107.418 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.3 mt -141.97 137.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.99 149.46 32.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.947 0.779 . . . . 0.0 111.267 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 116.919 -1.515 . . . . 0.0 110.515 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 19' ' ' SER . . . -157.39 107.84 2.25 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CB ' HD13 ' A' ' 72' ' ' ILE . 56.2 t80 -96.89 93.78 6.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.051 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -76.17 148.2 37.93 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 m -149.64 132.36 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.8 0.688 . . . . 0.0 110.384 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.5 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 23.6 m-90 -103.72 152.21 22.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -65.25 -10.41 31.8 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.837 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.97 160.75 19.71 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 123.976 0.798 . . . . 0.0 112.066 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.93 -58.61 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 O-C-N 123.134 1.07 . . . . 0.0 111.797 17.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.21 -132.06 7.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 69.1 m -109.77 73.11 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.45 -51.03 0.47 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.933 0.873 . . . . 0.0 110.401 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.591 ' H ' HD22 ' A' ' 13' ' ' ASN . 2.9 p30 -56.93 -159.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.417 -2.174 . . . . 0.0 114.302 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -70.55 172.92 7.71 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -155.83 178.34 10.38 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -150.08 141.16 23.01 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 111.362 -2.654 . . . . 0.0 105.256 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.33 131.02 53.95 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.524 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -103.96 68.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.652 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 58.6 p -86.8 -13.23 45.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -59.1 124.94 21.62 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.38 123.65 21.77 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.504 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -167.73 13.89 Favored Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -78.48 145.75 34.79 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.1 p -160.04 131.77 6.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.611 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -78.81 138.28 38.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 123.641 0.588 . . . . 0.0 111.784 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.27 146.32 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -125.7 -22.55 4.21 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.041 0.838 . . . . 0.0 109.876 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -74.45 100.25 3.78 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.197 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.14 62.93 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.221 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.41 -105.49 1.17 Allowed Glycine 0 N--CA 1.495 2.614 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.25 170.63 14.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -161.27 130.17 4.56 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 13.0 m-20 -114.69 105.81 13.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.375 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 35' ' ' SER . 83.6 t80 -80.7 157.48 25.88 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.201 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.3 m -142.47 129.23 20.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 124.843 1.339 . . . . 0.0 108.992 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -112.05 146.84 37.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.6 t -164.06 -33.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.695 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 39' ' ' GLN . . . -157.64 -9.31 0.05 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.411 ' H ' ' H ' ' A' ' 38' ' ' GLY . 28.5 mp0 -131.21 131.96 44.34 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 m -81.96 174.14 11.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.29 159.2 43.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.614 0.721 . . . . 0.0 112.14 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.54 145.84 35.61 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.665 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' A' ' 57' ' ' PHE . 47.5 mt -116.55 96.24 5.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.458 0.647 . . . . 0.0 112.073 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -85.94 136.0 33.44 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.741 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -87.2 5.08 39.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.347 -1.751 . . . . 0.0 110.726 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 82.7 mm-40 -115.97 150.54 37.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.855 0.722 . . . . 0.0 110.827 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 132.97 54.69 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.522 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.88 31.03 74.59 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.365 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.0 m 55.41 30.74 15.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.6 t -90.76 59.51 4.19 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.151 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.02 -147.7 5.0 Favored Glycine 0 N--CA 1.497 2.713 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.174 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -111.24 142.5 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 114.239 -0.98 . . . . 0.0 108.366 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.82 119.7 23.07 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.45 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -79.58 -36.54 38.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.459 ' HB ' HD12 ' A' ' 43' ' ' LEU . 55.3 m -145.65 133.79 21.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.049 0.843 . . . . 0.0 110.035 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -118.92 149.62 41.27 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.096 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 43' ' ' LEU . 25.7 m-85 -123.2 132.07 53.91 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.055 0.847 . . . . 0.0 111.143 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -2.42 11.22 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -154.32 139.52 17.5 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.4 m -37.73 120.26 0.81 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.04 0.838 . . . . 0.0 112.75 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.71 88.1 2.83 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 124.111 0.882 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 74.4 mtp180 -73.72 69.8 1.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.43 14.65 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.734 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.9 m -147.77 36.37 0.87 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.775 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -110.04 162.42 20.49 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.132 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.44 175.64 3.29 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.452 2.101 . . . . 0.0 111.649 171.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 15.4 p90 -161.22 -165.51 1.35 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.31 56.11 0.41 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.443 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.4 m0 -114.8 127.45 55.73 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -82.54 -8.48 59.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 123.72 0.637 . . . . 0.0 109.968 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 30.8 p -174.29 165.25 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.466 1.104 . . . . 0.0 112.213 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.486 HD13 ' CB ' ' A' ' 3' ' ' PHE . 11.1 tt -134.18 122.35 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-N 112.627 -2.078 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -99.48 107.8 20.08 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.847 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.7 mt -104.62 147.56 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.364 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -72.21 -172.4 0.9 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.118 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 116.25 -1.833 . . . . 0.0 110.387 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.49 142.77 1.69 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.655 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.424 ' CB ' HD13 ' A' ' 72' ' ' ILE . 88.7 t80 -93.87 104.04 16.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.696 1.248 . . . . 0.0 112.3 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -81.2 158.72 24.79 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 32' ' ' TYR . 10.3 m -153.62 122.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 124.008 0.818 . . . . 0.0 112.184 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.551 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.1 m-90 -95.58 146.5 24.42 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.6 p -60.44 -16.61 37.91 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.362 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.19 162.54 13.14 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 124.283 0.99 . . . . 0.0 112.181 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -75.21 -59.64 0.11 OUTLIER 'Cis proline' 0 N--CA 1.498 1.766 0 O-C-N 123.12 1.063 . . . . 0.0 111.053 11.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.47 -147.63 22.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HA ' ' CG ' ' A' ' 6' ' ' TRP . 7.6 p -102.25 66.84 1.02 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -136.89 -49.16 0.63 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 3.8 p30 -56.97 -152.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.256 -1.793 . . . . 0.0 114.519 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -74.35 162.49 28.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.7 12.97 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -147.39 154.88 41.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.997 -1.911 . . . . 0.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -115.95 144.34 44.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.737 0.648 . . . . 0.0 110.604 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -125.94 95.48 4.43 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.773 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -114.52 -7.43 12.81 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.894 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -49.7 123.29 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.881 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 23.8 t -72.71 90.23 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.745 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.24 113.59 21.7 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -124.87 132.93 53.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.882 0.739 . . . . 0.0 112.939 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 71' ' ' SER . . . -81.87 116.7 21.65 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.546 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.401 HD11 ' CG2' ' A' ' 72' ' ' ILE . 28.5 mt -79.9 135.95 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.551 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -106.87 -32.12 8.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.571 1.169 . . . . 0.0 111.37 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 27.7 mp0 -79.44 91.62 5.14 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.593 1.187 . . . . 0.0 108.173 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -90.49 62.72 5.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.566 -2.106 . . . . 0.0 111.753 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.08 -113.48 1.33 Allowed Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.022 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 165.44 34.03 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' HG12 ' A' ' 5' ' ' VAL . 8.9 p90 -161.89 129.47 4.01 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 1.1 t70 -112.07 167.98 9.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.6 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 59.5 t80 -148.41 155.33 41.09 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.184 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 58.5 m -137.25 147.11 45.51 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' CB ' ' HA ' ' A' ' 59' ' ' SER . 80.1 t80 -134.3 145.53 49.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.717 1.261 . . . . 0.0 109.768 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -172.85 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.751 0.657 . . . . 0.0 111.561 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.8 -12.64 1.3 Allowed Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.044 0.84 . . . . 0.0 111.536 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.31 20.55 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.7 m -84.56 166.65 17.01 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.938 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.41 157.7 46.0 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 131.89 10.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.914 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.71 163.61 13.69 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 49' ' ' CYS . 5.6 p90 -167.75 135.08 2.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.652 -2.067 . . . . 0.0 108.905 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -66.91 11.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.261 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 mm-40 -131.69 113.54 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.394 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.5 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -40.61 147.41 0.11 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.618 1.199 . . . . 0.0 112.428 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.98 44.74 62.08 Favored Glycine 0 N--CA 1.499 2.846 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.725 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 5.1 p 42.06 36.84 0.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 m -95.54 42.69 1.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.748 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.19 -164.4 15.21 Favored Glycine 0 N--CA 1.5 2.961 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.229 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.43 153.69 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.46 143.94 26.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -112.62 -52.69 2.77 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.662 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -122.75 106.37 10.87 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -96.4 117.39 30.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.215 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 50.4 m-85 -91.75 108.33 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 123.717 0.636 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.93 45.51 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.408 ' HA ' ' CB ' ' A' ' 36' ' ' TYR . 39.0 t -146.32 159.85 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.46 0.741 . . . . 0.0 109.374 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.0 p -36.05 124.72 0.75 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.218 0.949 . . . . 0.0 113.308 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -133.42 101.21 5.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.143 0.902 . . . . 0.0 110.65 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 30.2 ptt180 -84.46 68.52 10.31 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.37 168.87 15.18 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.397 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 16.7 m -147.88 10.83 0.93 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.54 164.29 39.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.42 147.14 79.64 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 110.559 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.62 162.21 6.8 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 124.012 0.82 . . . . 0.0 109.874 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.55 18.76 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -136.14 -155.67 0.65 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.562 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 19.4 ttmm -141.1 -32.31 0.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 3.5 p -154.26 162.46 41.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.091 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 HD13 ' CB ' ' A' ' 3' ' ' PHE . 16.7 tt -129.44 143.6 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.015 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -113.67 132.1 55.91 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.488 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.0 mt -138.09 146.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 124.263 0.977 . . . . 0.0 108.753 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -88.41 169.08 12.1 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 91.4 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 116.099 -1.905 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.865 0.364 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.09 52.19 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.324 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -110.8 151.99 27.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 33' ' ' ASP . 92.0 m -140.13 148.65 41.98 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 32' ' ' TYR . 17.9 m -154.69 155.04 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.347 1.029 . . . . 0.0 112.854 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.553 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 9.1 m-90 -125.83 154.35 42.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.6 m -78.48 -13.35 59.87 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.438 ' H ' HD21 ' A' ' 13' ' ' ASN . . . 145.49 145.62 4.3 Favored Glycine 0 N--CA 1.504 3.231 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.687 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -76.04 -53.78 0.15 OUTLIER 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 118.171 0.985 . . . . 0.0 110.091 8.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.22 -127.6 4.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 105.25 -3.14 . . . . 0.0 105.25 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.473 ' HA ' ' CG ' ' A' ' 6' ' ' TRP . 21.8 p -96.87 57.53 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -138.81 53.33 1.77 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.674 -0.811 . . . . 0.0 112.425 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.553 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -173.53 -122.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -48.66 145.87 3.42 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 123.428 0.691 . . . . 0.0 112.576 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.88 114.89 22.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -149.64 132.57 16.13 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -119.2 163.63 16.79 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.7 95.74 2.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.305 -1.77 . . . . 0.0 106.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.0 t -112.86 -22.33 10.71 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -51.33 147.13 6.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 123.859 0.724 . . . . 0.0 112.728 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.3 t -60.51 160.3 9.14 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.19 -148.01 32.37 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 27.8 p -128.9 172.26 11.5 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.1 p -151.55 136.93 17.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.438 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB1' ' HZ2' ' A' ' 70' ' ' LYS . . . -79.93 112.56 17.34 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.979 0.799 . . . . 0.0 111.788 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.02 146.48 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.989 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -125.18 -14.51 6.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.382 1.051 . . . . 0.0 108.456 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -70.69 100.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -86.99 56.64 4.1 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.551 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.1 -97.16 0.63 Allowed Glycine 0 N--CA 1.501 3.017 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.231 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.1 162.35 14.01 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CD2' HG12 ' A' ' 5' ' ' VAL . 36.5 m-85 -144.56 108.72 4.78 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.367 1.079 . . . . 0.0 111.788 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 1.5 t70 -108.7 162.31 14.29 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.18 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -148.67 157.77 43.68 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.53 -1.213 . . . . 0.0 108.469 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 t -146.68 103.1 3.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 124.668 1.23 . . . . 0.0 108.947 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -79.05 151.81 31.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.282 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -174.82 73.39 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.86 -37.19 2.32 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.021 -1.899 . . . . 0.0 111.402 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -89.9 125.49 35.37 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.507 0.67 . . . . 0.0 112.188 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 m -85.58 164.15 17.93 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.284 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.4 148.42 27.45 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.374 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.5 148.53 34.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 124.479 1.112 . . . . 0.0 109.684 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -87.13 159.69 18.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.206 1.003 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -137.91 113.84 9.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 111.58 -2.555 . . . . 0.0 108.331 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.521 ' H ' ' CD2' ' A' ' 54' ' ' HIS . 16.7 t30 -55.47 -14.62 2.09 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.349 1.031 . . . . 0.0 113.11 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.431 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 2.9 pm0 -119.51 132.13 55.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.134 0.896 . . . . 0.0 109.983 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.94 150.58 0.26 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 114.038 -1.437 . . . . 0.0 113.592 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.9 34.03 37.05 Favored Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.421 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.4 p 39.03 44.66 0.92 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.783 0.931 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -86.07 37.7 0.73 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.337 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.86 -145.64 4.36 Favored Glycine 0 N--CA 1.495 2.576 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.321 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -103.88 157.18 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.65 175.73 6.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.808 0.693 . . . . 0.0 111.434 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.521 ' CD2' ' H ' ' A' ' 45' ' ' ASN . 69.4 m-70 -142.83 -59.0 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 123.974 0.796 . . . . 0.0 111.717 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.9 m -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.885 0.74 . . . . 0.0 111.312 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.8 ttt85 -95.35 163.63 13.17 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.684 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -140.72 149.72 42.54 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.38 -5.19 3.01 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 124.638 1.211 . . . . 0.0 110.159 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.4 m -149.86 150.81 32.49 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.7 p -45.66 119.27 2.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.889 0.743 . . . . 0.0 111.172 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.49 92.01 3.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.12 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 36.1 ptt180 -82.96 68.31 9.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.02 159.13 21.26 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.869 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.448 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 58.5 m -138.96 27.12 2.42 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.064 0.935 . . . . 0.0 109.449 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -82.7 164.96 44.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.644 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.05 167.44 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.356 2.037 . . . . 0.0 110.649 170.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.27 177.1 2.93 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.823 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 69' ' ' TRP . . . -160.0 -6.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.509 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 4.0 m-90 -142.5 -160.54 1.11 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HZ2' ' HB1' ' A' ' 25' ' ' ALA . 28.5 tptp -128.74 -45.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 123.28 0.362 . . . . 0.0 111.341 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.2 p -124.77 166.01 16.98 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 124.337 1.023 . . . . 0.0 112.745 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.52 126.22 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -106.01 143.04 34.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.1 mt -143.49 117.19 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.81 162.27 28.82 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.022 0.826 . . . . 0.0 110.829 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.156 -1.878 . . . . 0.0 110.702 179.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 27.7 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.404 ' CB ' ' HE ' ' A' ' 17' ' ' ARG . . . -161.21 147.21 14.38 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 36.2 t80 -97.91 108.44 21.15 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.084 -1.417 . . . . 0.0 109.537 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 m -93.49 131.47 38.68 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 m -136.49 148.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 123.668 0.605 . . . . 0.0 111.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.438 ' CE3' ' HA ' ' A' ' 11' ' ' CYS . 21.2 m-90 -115.76 160.75 19.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.7 p -69.55 -9.97 56.2 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.61 153.41 18.2 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 123.752 0.657 . . . . 0.0 111.584 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.41 -64.25 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.685 0 O-C-N 123.118 1.062 . . . . 0.0 111.656 17.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.86 -150.87 15.62 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.438 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 1.6 p -93.07 41.97 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.824 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -124.41 -128.32 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 38.3 -142.05 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -70.75 140.78 51.44 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -106.86 148.22 28.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.083 0.865 . . . . 0.0 111.194 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.29 167.21 30.7 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.404 ' HE ' ' CB ' ' A' ' 2' ' ' ALA . 80.5 ttt180 -140.17 158.84 43.41 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.463 0.649 . . . . 0.0 112.317 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -142.36 84.84 1.88 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.869 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -112.98 17.22 19.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.739 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -63.07 127.32 30.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.758 0.789 . . . . 0.0 111.364 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -73.34 119.69 17.93 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.545 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.58 -98.58 0.88 Allowed Glycine 0 N--CA 1.493 2.439 0 O-C-N 124.535 1.147 . . . . 0.0 111.182 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.473 ' SG ' ' CD2' ' A' ' 73' ' ' PHE . 60.1 m -142.24 147.03 35.82 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.157 0.563 . . . . 0.0 112.132 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.6 p -160.42 126.83 4.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.72 126.88 31.51 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 136.65 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 123.757 0.66 . . . . 0.0 109.687 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -100.97 -46.57 5.06 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.477 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.572 ' N ' HE21 ' A' ' 28' ' ' GLN . 0.0 OUTLIER -51.43 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.704 1.252 . . . . 0.0 111.944 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -90.47 68.96 6.83 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.243 1.021 . . . . 0.0 108.596 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.84 -106.73 0.26 Allowed Glycine 0 N--CA 1.493 2.499 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.463 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.46 160.03 27.64 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CE1' ' CE2' ' A' ' 67' ' ' PHE . 49.2 m-85 -147.61 159.05 44.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.585 0.815 . . . . 0.0 108.879 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -169.8 159.42 7.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 59.7 t80 -135.54 159.87 40.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 t -147.14 91.36 1.98 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.469 1.106 . . . . 0.0 108.269 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -70.33 150.3 46.47 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.075 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.5 p -140.08 -35.26 0.52 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 39' ' ' GLN . . . -174.99 -12.09 0.02 OUTLIER Glycine 0 N--CA 1.479 1.558 0 CA-C-N 112.322 -2.217 . . . . 0.0 108.24 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.41 ' H ' ' H ' ' A' ' 38' ' ' GLY . 24.7 mp0 -112.77 126.81 55.83 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.2 m -81.21 168.43 18.51 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.035 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.91 113.54 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.477 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.55 165.33 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 57' ' ' PHE . 40.0 mt -129.56 102.36 6.34 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.391 0.615 . . . . 0.0 109.639 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 49' ' ' CYS . 59.7 m-85 -84.01 133.42 34.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.718 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -74.23 -8.64 56.9 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -120.64 138.35 53.97 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.27 145.61 1.63 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.94 54.4 11.94 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.974 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.458 ' HA ' ' CG ' ' A' ' 44' ' ' TYR . 25.7 p 44.31 22.29 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 t -90.55 45.51 1.27 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.542 0.687 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.81 -130.81 2.04 Favored Glycine 0 N--CA 1.495 2.605 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.387 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.31 144.21 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 124.595 0.821 . . . . 0.0 109.44 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.69 103.69 5.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.517 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.32 -40.2 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.779 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.423 ' HB ' HD12 ' A' ' 43' ' ' LEU . 55.5 m -144.03 164.75 29.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.152 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -147.1 -172.38 3.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.718 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.536 ' CE2' HD11 ' A' ' 43' ' ' LEU . 53.7 m-85 -143.81 104.24 4.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.023 0.827 . . . . 0.0 112.858 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.65 -12.23 55.96 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 t -153.8 141.93 20.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 91.2 p -41.16 132.85 2.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.66 121.83 7.76 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 123.994 0.809 . . . . 0.0 111.968 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -83.37 91.85 7.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 60.99 4.6 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 m -57.03 -18.27 13.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -77.2 160.18 76.35 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.82 139.91 68.26 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.091 1.861 . . . . 0.0 109.163 169.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.04 -146.17 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.39 21.2 0.28 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.038 -1.077 . . . . 0.0 114.996 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 5.3 m-90 -108.15 146.36 32.83 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -84.41 -46.69 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.0 p -131.65 174.7 9.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 124.496 1.123 . . . . 0.0 113.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 3' ' ' PHE . 7.1 tt -136.52 137.37 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 112.699 -2.046 . . . . 0.0 109.967 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.473 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 4.7 t80 -107.98 129.91 55.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.2 mt -119.3 129.63 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -61.61 80.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.789 1.93 . . . . 0.0 114.109 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.319 179.858 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.46 ' HB1' ' HE ' ' A' ' 17' ' ' ARG . . . -153.59 104.69 2.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.945 0.778 . . . . 0.0 110.348 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 45.9 t80 -96.87 89.29 4.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -75.42 152.52 37.98 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 m -148.84 158.13 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.693 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.496 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.6 m-90 -134.59 145.44 48.66 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.417 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 84.1 p -61.54 -38.98 89.42 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 167.35 149.71 6.15 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.723 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -78.51 -56.13 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.808 0 N-CA-C 109.34 -1.061 . . . . 0.0 109.34 9.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.77 -132.54 6.18 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 64' ' ' CYS . 25.0 p -89.65 48.23 1.57 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -140.01 80.18 1.75 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.324 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 5.8 p30 171.71 -146.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.575 HH12 HE21 ' A' ' 28' ' ' GLN . 5.6 ptm180 -64.91 171.28 3.6 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.0 23.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -161.18 134.14 6.31 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HE ' ' HB1' ' A' ' 2' ' ' ALA . 78.6 ttt180 -108.23 131.62 54.49 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -110.15 78.7 1.14 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.08 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -116.16 -8.2 11.78 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.98 139.7 58.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.052 0.845 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.16 104.71 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.002 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.09 -177.12 19.58 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.126 0.892 . . . . 0.0 113.117 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 m -77.2 143.31 39.12 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.749 -1.225 . . . . 0.0 109.923 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.4 p -148.11 126.69 12.47 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.012 0.82 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.32 119.47 22.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.354 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.63 115.41 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.134 -1.393 . . . . 0.0 109.451 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -95.2 -29.29 14.61 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.575 HE21 HH12 ' A' ' 14' ' ' ARG . 22.7 mp0 -77.91 95.61 4.81 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.862 0.726 . . . . 0.0 109.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -80.56 40.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.53 -103.3 2.75 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.06 18.55 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.6 m-85 -150.84 120.54 7.01 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 7.3 m-20 -114.98 106.76 14.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.196 0.31 . . . . 0.0 110.817 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 73.7 t80 -80.95 157.68 25.47 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -148.15 109.12 4.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.353 1.033 . . . . 0.0 108.55 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -84.03 152.21 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.483 -2.144 . . . . 0.0 110.536 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.42 52.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.7 -32.0 5.55 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.583 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -94.15 125.3 38.7 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.477 0.656 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.588 HG22 ' H ' ' A' ' 41' ' ' ALA . 23.3 m -86.54 -170.49 3.1 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.584 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.588 ' H ' HG22 ' A' ' 40' ' ' THR . . . -160.23 151.1 18.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.76 152.74 41.84 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.536 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.3 mm? -117.22 123.59 47.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.315 0.384 . . . . 0.0 111.359 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 46' ' ' GLN . 96.3 m-85 -115.51 128.86 56.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 125.067 1.479 . . . . 0.0 108.496 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -73.66 13.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.877 0.736 . . . . 0.0 112.02 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 44' ' ' TYR . 62.1 mm-40 -133.67 127.26 32.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.46 139.03 2.2 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.58 50.69 56.29 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.783 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 79.4 m 50.27 23.49 1.22 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.4 m -83.93 40.79 0.77 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.402 0.62 . . . . 0.0 112.424 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.17 -149.96 5.5 Favored Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.237 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.85 145.74 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.76 164.95 4.28 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.929 0.768 . . . . 0.0 111.921 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -146.59 -48.85 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.441 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -133.07 152.27 51.97 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.134 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -141.03 119.17 12.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.448 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 30.5 m-85 -97.06 122.0 39.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.091 0.87 . . . . 0.0 111.35 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.65 24.38 4.91 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.0 p -165.46 128.9 2.23 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.595 -0.802 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.0 m -41.27 110.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.12 0.887 . . . . 0.0 111.967 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.16 91.58 3.56 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.271 0.982 . . . . 0.0 111.19 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 92.4 mtt-85 -74.29 79.96 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.39 144.96 25.32 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.136 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.454 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 66.8 m -134.73 47.02 2.4 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.446 1.117 . . . . 0.0 109.242 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -140.75 154.95 69.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.683 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -55.83 156.11 20.33 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.988 2.459 . . . . 0.0 111.611 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -123.49 -135.63 0.29 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.866 0.729 . . . . 0.0 112.182 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.28 -3.33 0.06 OUTLIER Glycine 0 N--CA 1.497 2.75 0 CA-C-O 118.601 -1.11 . . . . 0.0 115.251 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.536 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 3.0 m-90 -90.62 166.57 13.11 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.77 1.285 . . . . 0.0 110.395 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -100.19 -41.58 7.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.828 0.705 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.8 p -138.1 177.09 8.14 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.314 1.009 . . . . 0.0 112.391 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.447 HD13 ' CB ' ' A' ' 3' ' ' PHE . 15.3 tt -144.39 127.33 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.695 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.615 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 7.3 t80 -84.85 94.4 8.73 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.406 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -76.9 116.26 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.366 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -68.66 137.12 53.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 123.906 0.754 . . . . 0.0 110.407 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.672 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.93 121.13 26.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.463 ' CG ' HD13 ' A' ' 72' ' ' ILE . 33.3 t80 -92.78 173.86 7.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.1 m -158.84 152.85 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -150.91 158.18 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.671 1.232 . . . . 0.0 108.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.1 m-90 -132.5 145.85 51.48 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -52.43 -42.71 64.33 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 145.08 152.55 5.65 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -82.07 -60.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 123.15 1.079 . . . . 0.0 111.53 17.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.56 -141.55 11.09 Favored Glycine 0 N--CA 1.485 1.917 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 p -94.31 44.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.656 -1.272 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -123.21 -129.3 0.26 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 38.2 -144.31 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -76.81 128.27 34.3 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -94.43 154.02 17.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.186 0.929 . . . . 0.0 112.266 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -161.64 118.51 2.17 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -86.38 157.1 19.93 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.463 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -136.53 61.49 1.63 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.054 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.4 p -94.43 6.51 48.52 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.008 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.56 118.25 7.92 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 103.83 0.25 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.458 1.099 . . . . 0.0 108.196 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.71 -164.33 18.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.88 150.21 30.67 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 p -160.24 132.12 6.09 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.961 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.21 115.91 19.15 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.04 105.75 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.545 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -96.2 -16.68 21.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.987 -1.461 . . . . 0.0 113.67 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -76.09 94.81 3.52 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.39 0.614 . . . . 0.0 110.312 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -83.91 60.27 5.72 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.145 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.59 -90.04 0.68 Allowed Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.19 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.86 169.12 21.64 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 47.4 p90 -161.73 135.36 6.5 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.57 158.74 24.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.543 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 58.9 t80 -130.03 157.36 42.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -146.94 100.31 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 124.069 0.856 . . . . 0.0 110.128 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -81.12 149.1 29.31 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.644 -1.617 . . . . 0.0 107.835 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -168.48 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.092 0.87 . . . . 0.0 109.342 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.99 -43.17 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.25 166.87 22.75 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.3 p -87.63 -174.58 4.84 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 113.305 -1.77 . . . . 0.0 111.105 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -158.11 113.68 2.71 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.605 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.66 157.05 27.33 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 43' ' ' LEU . 10.7 tp -126.38 94.64 4.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.851 0.834 . . . . 0.0 109.907 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -79.86 141.42 36.17 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.603 -1.635 . . . . 0.0 114.094 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.26 23.09 12.99 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.256 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.75 141.65 49.57 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.056 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.9 132.89 37.81 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.102 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.16 68.49 Favored Glycine 0 N--CA 1.495 2.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.173 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.2 m 54.33 29.15 10.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.356 0.68 . . . . 0.0 112.438 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.6 p -85.98 52.07 2.38 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.979 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.61 -121.91 0.61 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.12 150.17 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.59 178.93 1.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.142 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.534 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 18.6 t-80 -139.3 -69.55 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.888 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -118.16 83.07 1.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.127 0.892 . . . . 0.0 108.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 57' ' ' PHE . 5.1 tmm_? -70.57 162.19 29.32 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.6 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.543 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 51.4 m-85 -131.11 135.76 47.78 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.43 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.73 -2.57 4.34 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.1 m -152.58 136.82 16.58 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.3 m -38.05 112.33 0.21 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.153 0.908 . . . . 0.0 111.15 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.71 106.9 11.35 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 124.279 0.987 . . . . 0.0 113.196 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -80.73 75.2 7.64 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.69 165.28 13.79 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.493 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.3 m -149.92 4.91 0.57 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -69.07 152.44 96.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.537 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.6 150.13 88.77 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.777 2.318 . . . . 0.0 110.198 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' HD2' ' H ' ' A' ' 69' ' ' TRP . 38.9 p90 -154.43 -172.65 4.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 123.985 0.803 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.15 54.77 0.36 Allowed Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.557 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.534 ' HE1' ' CB ' ' A' ' 54' ' ' HIS . 1.9 m-90 -88.4 150.33 23.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 11.6 mptt -86.0 -22.83 27.1 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.504 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.1 p -175.66 167.81 3.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.628 1.205 . . . . 0.0 113.131 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.463 HD13 ' CG ' ' A' ' 3' ' ' PHE . 7.3 tt -130.7 130.3 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.838 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.95 93.28 4.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.484 1.115 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.5 mm -72.53 113.4 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.887 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.433 HE21 ' HA ' ' A' ' 75' ' ' GLN . 3.7 mm-40 -64.35 108.83 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.743 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.405 ' N ' ' H ' ' A' ' 38' ' ' GLY . 71.5 p . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 130.02 11.55 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CB ' HD13 ' A' ' 72' ' ' ILE . 79.7 t80 -93.74 91.21 6.89 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.94 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.0 m -73.39 148.87 42.95 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.42 137.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 123.801 0.688 . . . . 0.0 109.684 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.562 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 19.9 m-90 -112.93 155.22 25.11 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -66.66 -42.55 86.46 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.97 156.04 9.14 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -76.97 -51.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.753 0 O-C-N 122.651 0.816 . . . . 0.0 110.786 8.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.97 -111.16 3.04 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.7 p -111.99 53.4 0.73 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -138.19 69.41 1.39 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 2.3 p30 178.31 -144.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.423 HH22 ' CG ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -79.72 177.57 8.79 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.375 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -162.17 178.8 8.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' CG ' HH22 ' A' ' 14' ' ' ARG . 59.9 mt-10 -143.38 121.76 12.35 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 112.899 -1.955 . . . . 0.0 107.725 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -100.51 100.03 10.72 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.147 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.9 92.58 6.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -103.23 -31.18 10.22 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.22 127.89 34.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.827 0.704 . . . . 0.0 109.251 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.4 p -69.92 123.45 21.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.489 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.8 176.55 28.08 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.1 m -82.44 74.14 9.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.258 0.622 . . . . 0.0 109.609 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -85.28 132.12 34.31 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.282 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 142.48 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.76 149.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -142.39 14.87 2.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.903 0.752 . . . . 0.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -103.37 104.57 14.69 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.189 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.1 59.03 4.34 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.844 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.2 -78.15 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.553 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.75 175.39 32.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -161.01 131.79 5.31 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 8.1 m-20 -115.39 103.72 11.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.562 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.61 154.81 29.97 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -142.42 103.46 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 124.35 1.031 . . . . 0.0 108.224 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.53 113.57 15.47 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.184 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.8 p -146.28 -39.67 0.22 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' H ' ' N ' ' A' ' 1' ' ' SER . . . -91.99 -62.04 1.19 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -160.35 177.78 10.26 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.984 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.8 p -66.27 174.64 2.53 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.629 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.39 124.43 3.62 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.78 167.75 11.24 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.559 HD12 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -130.32 105.16 7.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.304 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -86.04 147.92 25.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.445 HD21 ' HB2' ' A' ' 54' ' ' HIS . 27.2 m-80 -96.42 14.23 25.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.061 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.451 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 56.8 mm-40 -138.21 141.33 40.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.62 128.34 20.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.553 1.158 . . . . 0.0 112.14 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.52 53.24 33.13 Favored Glycine 0 N--CA 1.496 2.642 0 CA-C-N 114.306 -1.315 . . . . 0.0 112.652 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 76.8 m 51.67 29.21 5.43 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.1 m -81.59 34.73 0.39 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.797 0.808 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.451 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.94 -145.38 4.28 Favored Glycine 0 N--CA 1.494 2.511 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.965 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.27 153.15 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 113.823 -1.189 . . . . 0.0 108.527 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.21 -169.08 0.46 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.58 0.55 . . . . 0.0 111.314 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.472 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 5.7 t60 -153.93 -59.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.708 0.63 . . . . 0.0 110.249 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.1 m -112.9 119.84 39.36 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.243 0.964 . . . . 0.0 111.661 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -94.07 149.08 21.56 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.633 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.47 148.27 52.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.864 0.727 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.52 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.494 2.561 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.086 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -156.11 135.3 12.14 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -37.72 117.08 0.54 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.68 85.08 2.06 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.95 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 68.8 mtp85 -73.41 71.51 1.29 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.97 152.44 20.7 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.884 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 63.6 m -134.33 40.07 3.03 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -113.03 143.38 29.03 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.392 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -63.07 170.9 6.9 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.367 2.044 . . . . 0.0 111.325 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.36 -169.87 2.45 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.066 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.96 58.1 0.46 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.559 ' CG ' HD12 ' A' ' 43' ' ' LEU . 5.0 m-90 -105.54 146.28 29.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.62 -46.24 10.96 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.099 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.1 p -153.99 156.35 37.26 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.962 1.414 . . . . 0.0 113.088 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.441 HD13 ' CB ' ' A' ' 3' ' ' PHE . 6.2 tt -112.67 131.28 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.69 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.567 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 13.6 t80 -100.51 88.43 3.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.481 1.113 . . . . 0.0 111.124 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -85.58 137.82 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -89.71 170.53 10.37 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.178 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 116.166 -1.873 . . . . 0.0 111.358 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.91 141.72 5.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.927 0.767 . . . . 0.0 112.088 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.577 ' CG ' HD13 ' A' ' 72' ' ' ILE . 50.8 t80 -92.57 140.9 29.08 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.4 m -128.6 151.03 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.4 ' CG1' ' CE2' ' A' ' 3' ' ' PHE . 16.2 m -147.34 166.77 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.153 0.908 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 30.5 m-90 -141.47 133.35 27.42 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 88.8 p -43.5 -33.51 1.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 134.99 154.11 6.99 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -82.58 -57.93 0.1 OUTLIER 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.315 1.166 . . . . 0.0 111.151 13.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.64 -145.34 14.98 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.03 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 63' ' ' ALA . 76.2 m -93.3 50.42 1.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.59 -1.305 . . . . 0.0 111.886 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.64 -126.97 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 37.76 -141.88 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 119.57 1.077 . . . . 0.0 113.734 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 58.2 ttp180 -69.89 154.41 41.99 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.52 111.65 14.03 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.432 0.457 . . . . 0.0 112.135 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -117.54 166.77 11.98 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -151.71 157.0 41.46 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.613 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -142.38 93.61 2.55 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.4 p -100.05 -11.37 20.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -55.74 128.19 33.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 123.856 0.723 . . . . 0.0 111.516 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.66 167.3 17.27 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.0 -84.26 1.29 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.3 p -174.31 157.31 2.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.497 0.763 . . . . 0.0 111.062 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -160.19 146.76 15.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.246 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.72 163.65 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.827 0.705 . . . . 0.0 109.623 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mt -134.57 151.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.674 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -23.07 4.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.205 0.941 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HG3' HH21 ' A' ' 14' ' ' ARG . 16.6 mp0 -82.76 97.34 8.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.939 0.774 . . . . 0.0 110.808 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -82.95 12.97 4.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.37 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.76 -112.97 0.39 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.266 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.6 159.44 19.75 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 124.982 1.048 . . . . 0.0 110.837 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -161.28 131.64 5.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.456 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 8.2 t70 -104.47 174.87 5.69 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.151 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 65.3 t80 -148.8 157.89 43.76 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.406 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 55.4 m -139.23 139.06 37.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -122.18 138.85 54.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.903 1.377 . . . . 0.0 113.202 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.4 p -152.35 66.68 0.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.89 36.5 93.37 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -153.63 99.49 2.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -71.97 157.48 37.75 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.08 166.42 15.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.712 1.258 . . . . 0.0 110.314 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.78 152.21 40.0 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.125 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 80.9 mt -113.17 98.63 7.26 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.385 1.088 . . . . 0.0 110.071 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.39 115.2 14.8 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.638 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -48.46 -65.22 0.6 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.012 1.445 . . . . 0.0 109.97 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.57 155.89 36.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.402 1.064 . . . . 0.0 112.142 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.54 179.44 7.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.503 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.37 54.3 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.977 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 24.0 m 59.35 30.7 20.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.7 p -115.84 35.7 4.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.719 0.771 . . . . 0.0 111.269 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.97 157.6 15.08 Favored Glycine 0 N--CA 1.493 2.496 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.13 149.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.91 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.713 0.768 . . . . 0.0 109.296 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.428 ' HB3' ' HE1' ' A' ' 69' ' ' TRP . 21.5 t-80 -79.69 -23.34 42.49 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.266 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.467 ' HB ' HD12 ' A' ' 43' ' ' LEU . 50.0 m -146.92 136.34 22.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.958 0.787 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -114.52 147.33 39.55 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.33 1.019 . . . . 0.0 111.79 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 21.7 m-85 -132.31 98.61 4.44 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.44 1.088 . . . . 0.0 108.248 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.54 12.14 66.41 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.3 t -164.47 142.14 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.6 p -40.51 127.9 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.141 0.9 . . . . 0.0 111.916 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 33' ' ' ASP . . . -132.56 113.34 12.94 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 124.051 0.844 . . . . 0.0 112.767 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -81.26 71.36 8.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.396 1.06 . . . . 0.0 112.803 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.406 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . -91.28 157.98 16.83 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.379 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.2 m -147.39 10.06 0.96 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.55 0.69 . . . . 0.0 109.567 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -74.68 167.78 33.16 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.729 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -56.29 144.51 81.86 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.205 1.936 . . . . 0.0 111.936 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -73.99 167.42 21.54 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.14 17.13 1.18 Allowed Glycine 0 N--CA 1.501 3.014 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.47 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.476 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.0 m-90 -138.43 -166.65 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -129.98 -36.71 1.54 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.7 p -134.09 168.87 18.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 124.306 1.004 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.577 HD13 ' CG ' ' A' ' 3' ' ' PHE . 3.3 tt -130.78 121.47 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.533 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -98.02 119.05 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.889 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.9 mt -117.94 150.3 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -74.28 -179.75 4.09 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 116.896 -1.526 . . . . 0.0 109.799 179.804 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.78 121.37 2.85 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.188 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.489 ' CG ' HD13 ' A' ' 72' ' ' ILE . 76.8 t80 -93.63 102.56 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.173 0.92 . . . . 0.0 110.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.6 m -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -151.82 138.64 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 123.774 0.672 . . . . 0.0 110.086 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.53 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 24.9 m-90 -109.3 150.48 27.91 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.1 p -61.35 -38.76 88.1 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.98 153.64 6.66 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.88 -56.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.769 0 O-C-N 122.858 0.925 . . . . 0.0 109.982 7.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.19 -132.35 6.27 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.06 54.98 1.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -139.42 64.2 1.47 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.004 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 4.7 p30 -178.46 -150.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.76 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -72.05 169.62 15.6 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.94 173.66 12.22 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -151.11 140.41 21.34 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.056 -1.884 . . . . 0.0 107.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -110.93 153.06 26.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 123.735 0.647 . . . . 0.0 111.243 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -139.5 75.17 1.5 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -105.71 -20.97 13.29 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.179 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.59 135.13 57.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 123.632 0.583 . . . . 0.0 110.338 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -60.64 109.35 1.01 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.465 1.103 . . . . 0.0 110.35 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.66 166.95 13.7 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.8 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 m -78.73 74.8 5.26 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.618 -1.291 . . . . 0.0 109.88 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -80.6 136.0 36.16 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -78.44 126.86 31.36 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.427 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.3 mp -89.22 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -135.76 -29.92 1.01 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.707 0.63 . . . . 0.0 112.045 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -78.85 104.53 9.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.787 0.679 . . . . 0.0 109.279 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -90.26 18.27 6.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.347 1.03 . . . . 0.0 113.675 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.01 -87.59 0.25 Allowed Glycine 0 N--CA 1.497 2.745 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.297 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.23 169.83 20.44 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -161.62 132.17 5.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 2.9 t70 -107.05 166.06 10.89 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.321 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 68.6 t80 -145.7 151.89 38.75 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -132.62 151.48 51.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -135.71 133.91 38.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 124.213 0.946 . . . . 0.0 110.473 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.0 p -149.67 70.03 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.61 98.11 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.844 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -158.37 115.37 2.84 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.153 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 m -83.25 165.84 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.122 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.63 162.08 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.643 -1.617 . . . . 0.0 108.301 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.53 137.28 21.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.86 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' A' ' 69' ' ' TRP . 3.9 mm? -91.71 158.71 16.22 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -147.74 121.29 9.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 125.28 1.612 . . . . 0.0 109.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.418 HD21 ' CD2' ' A' ' 54' ' ' HIS . 95.0 m-20 -66.3 -8.03 22.46 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.456 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -122.95 134.08 54.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 124.074 0.859 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 133.57 8.1 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.844 -1.526 . . . . 0.0 115.006 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.01 44.49 83.11 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.7 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 71.9 m 52.17 31.9 9.79 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -82.73 29.43 0.45 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.207 1.003 . . . . 0.0 112.796 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.2 -175.17 31.94 Favored Glycine 0 N--CA 1.49 2.258 0 CA-C-N 113.219 -1.809 . . . . 0.0 108.863 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -81.9 156.5 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.78 161.92 28.85 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.589 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.418 ' CD2' HD21 ' A' ' 45' ' ' ASN . 57.2 t-80 -123.37 -32.42 3.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 124.346 1.029 . . . . 0.0 110.459 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -141.06 167.42 22.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.998 0.812 . . . . 0.0 109.085 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -143.29 143.4 31.69 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.498 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 23.0 m-85 -139.36 105.2 5.16 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.058 0.849 . . . . 0.0 110.184 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.19 31.44 5.46 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.0 t -175.51 127.25 0.25 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -30.64 111.19 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 124.507 1.13 . . . . 0.0 113.074 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.478 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -120.29 93.68 4.13 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 124.306 1.004 . . . . 0.0 109.831 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -81.97 68.03 8.2 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.23 -1.35 . . . . 0.0 113.168 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.78 169.18 12.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.794 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.31 39.84 0.84 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.409 1.1 . . . . 0.0 108.439 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -100.44 165.55 14.2 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 112.741 -2.027 . . . . 0.0 109.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.06 164.79 33.56 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.539 2.159 . . . . 0.0 110.339 164.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.54 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 30.9 p90 -162.26 -163.72 0.96 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.511 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.47 43.32 0.43 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.55 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CE3' ' CD2' ' A' ' 67' ' ' PHE . 4.8 m-90 -91.73 133.38 35.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.77 -48.93 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 37.3 p -135.57 169.8 16.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.988 1.43 . . . . 0.0 112.743 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.489 HD13 ' CG ' ' A' ' 3' ' ' PHE . 10.9 tt -140.31 119.26 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.95 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.672 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 37.1 t80 -84.2 121.06 26.95 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.144 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.4 mm -108.7 132.41 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -85.7 -179.9 6.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.895 0.747 . . . . 0.0 110.024 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 115.532 -2.175 . . . . 0.0 110.23 179.77 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.96 132.22 11.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CG ' HD13 ' A' ' 72' ' ' ILE . 85.2 t80 -95.75 93.59 7.18 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.895 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.6 m -72.51 152.3 41.97 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 28' ' ' GLN . 33.2 m -150.01 155.13 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 124.267 0.979 . . . . 0.0 110.88 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.57 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.0 m-90 -133.93 157.23 46.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.5 p -60.45 -40.55 91.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.496 1.123 . . . . 0.0 113.127 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.1 157.05 8.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.2 -45.22 0.37 Allowed 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.152 1.08 . . . . 0.0 111.386 19.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.29 -137.75 8.84 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -105.44 40.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.189 -1.506 . . . . 0.0 107.349 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -140.65 68.16 1.35 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.57 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -169.83 -88.17 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.556 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -90.46 91.73 8.58 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.248 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 115.06 5.22 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.821 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -145.98 154.58 42.05 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -151.05 151.61 32.26 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.0 93.79 4.14 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.477 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.4 p -105.65 -26.81 11.68 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -52.11 145.08 11.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 123.958 0.786 . . . . 0.0 112.912 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 t -65.67 168.36 7.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.183 0.927 . . . . 0.0 109.349 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.49 -177.63 43.28 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 107.194 -2.362 . . . . 0.0 107.194 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 29.7 p -96.34 142.65 28.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.213 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.7 p -127.24 140.22 52.38 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.708 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.36 122.08 25.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 123.865 0.728 . . . . 0.0 109.776 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.54 150.06 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.823 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -134.41 -13.55 2.32 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.24 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 21.5 mm-40 -86.2 84.72 7.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 123.07 1.414 . . . . 0.0 109.807 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -89.99 64.67 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.886 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.29 -58.26 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.533 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.1 168.74 35.84 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -161.1 132.03 5.35 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.152 -1.019 . . . . 0.0 113.723 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -114.15 104.47 12.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.781 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.487 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 79.0 t80 -82.68 153.42 25.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -146.04 100.79 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.277 0.986 . . . . 0.0 109.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -72.04 134.45 45.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.199 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.1 p -146.58 55.11 1.13 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.93 -23.56 13.6 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 113.863 -1.517 . . . . 0.0 110.555 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -99.13 125.83 44.76 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.175 0.512 . . . . 0.0 111.501 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 m -85.98 164.84 17.16 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.89 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.61 171.04 13.03 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.33 131.42 6.5 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.346 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.546 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -96.49 116.73 29.55 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.632 0.729 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -99.43 122.62 42.79 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 0.0 110.567 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -74.55 -1.39 21.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.64 139.4 47.12 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 138.75 56.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 124.018 0.824 . . . . 0.0 110.775 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.519 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 52.91 43.95 61.35 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.8 p 39.33 40.04 0.51 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.3 m -89.25 42.02 1.07 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.973 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.68 -122.18 0.62 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.388 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.59 153.07 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.64 -174.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.34 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 52.4 t-80 -148.55 -45.58 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.819 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -138.91 116.02 10.99 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.058 0.849 . . . . 0.0 109.428 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -96.28 152.27 18.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.863 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 17.9 m-85 -131.2 114.8 15.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.064 0.853 . . . . 0.0 110.153 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.48 11.42 28.26 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 p -161.05 135.62 7.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 123.979 0.458 . . . . 0.0 110.437 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 m -39.67 115.82 0.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.319 1.012 . . . . 0.0 112.408 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.04 93.73 4.19 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.205 0.941 . . . . 0.0 109.242 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -74.48 75.37 1.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.333 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.35 161.87 15.41 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.201 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 m -148.1 58.44 1.1 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.079 0.943 . . . . 0.0 110.307 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.49 153.42 43.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 113.751 -1.568 . . . . 0.0 108.864 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.98 178.37 2.43 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.354 2.036 . . . . 0.0 110.28 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.25 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.072 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.89 19.15 3.74 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-O 118.504 -1.165 . . . . 0.0 114.033 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.546 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 5.1 m-90 -91.87 161.0 15.02 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 118.852 1.326 . . . . 0.0 111.014 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.63 -41.39 7.74 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.162 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 p -146.28 -179.94 7.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.432 1.082 . . . . 0.0 110.985 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.51 HD13 ' CG ' ' A' ' 3' ' ' PHE . 11.0 tt -146.5 117.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.369 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.59 114.16 19.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.062 -1.881 . . . . 0.0 108.772 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.65 140.02 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.54 150.74 29.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.142 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 116.576 -1.678 . . . . 0.0 110.373 179.888 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 19' ' ' SER . . . -152.29 103.99 2.9 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.185 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.458 ' CB ' HD13 ' A' ' 72' ' ' ILE . 85.4 t80 -96.69 90.69 5.39 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.07 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -77.49 154.57 32.39 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 16' ' ' GLU . 12.4 m -148.28 166.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 123.703 0.627 . . . . 0.0 109.397 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.465 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 29.4 m-90 -141.88 139.64 32.66 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -51.95 -41.15 61.84 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.494 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.12 151.03 5.47 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -79.07 -62.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.592 0 O-C-N 122.975 0.987 . . . . 0.0 111.396 19.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.18 -129.41 6.55 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 p -95.5 49.96 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.292 -0.954 . . . . 0.0 111.373 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' N ' ' ND2' ' A' ' 12' ' ' ASN . 2.3 m-80 -124.33 -132.01 0.26 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.494 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.9 p30 36.66 -150.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -78.63 -176.75 5.02 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -153.17 159.79 42.75 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 60.1 mm-40 -139.78 163.76 31.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 111.724 -2.489 . . . . 0.0 104.677 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -146.87 136.39 22.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -117.27 73.83 0.89 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.683 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 76.2 p -95.9 -5.63 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.032 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -66.71 111.74 3.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.084 0.865 . . . . 0.0 108.872 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 7.0 p -64.85 114.95 4.85 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.028 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.37 -95.83 0.16 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.58 -1.295 . . . . 0.0 114.405 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -156.19 133.06 10.43 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.612 0.831 . . . . 0.0 110.118 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -160.24 134.22 7.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.473 0.483 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.76 126.09 30.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.402 ' H ' ' HA ' ' A' ' 71' ' ' SER . 24.8 mt -86.39 150.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -137.03 0.64 2.39 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.758 0.661 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -101.26 101.16 11.79 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.836 0.827 . . . . 0.0 109.596 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -79.53 -2.97 44.66 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.662 -1.608 . . . . 0.0 113.749 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.58 -101.89 0.03 OUTLIER Glycine 0 N--CA 1.497 2.722 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.38 166.22 14.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 63' ' ' ALA . 30.8 p90 -161.45 145.27 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.84 152.51 43.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -121.5 157.02 31.54 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 t -145.59 101.24 3.54 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -70.67 137.46 49.86 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 111.952 -2.385 . . . . 0.0 108.778 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.6 m -143.52 61.89 1.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.66 -14.05 10.81 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.711 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -113.49 125.04 53.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 120.933 0.396 . . . . 0.0 111.693 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.1 m -80.15 162.18 24.86 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.45 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.17 174.3 6.41 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.419 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.1 140.97 19.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.638 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -112.56 133.04 54.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 123.639 0.587 . . . . 0.0 111.554 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -117.77 134.28 55.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 125.033 1.458 . . . . 0.0 111.601 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -66.93 -36.57 82.53 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.065 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -92.4 119.72 32.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.971 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -39.13 146.99 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 125.433 1.708 . . . . 0.0 113.814 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.5 39.42 93.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.409 ' H ' ' CB ' ' A' ' 71' ' ' SER . 31.1 p 43.79 35.85 1.17 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 125.007 1.063 . . . . 0.0 111.543 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -90.23 46.05 1.32 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.205 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.44 -135.57 1.86 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.307 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.47 154.61 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.196 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.13 178.32 1.91 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.437 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -156.56 -40.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -142.95 129.33 20.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.979 0.799 . . . . 0.0 110.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.91 135.32 54.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -115.36 114.0 24.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.776 0.673 . . . . 0.0 110.663 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.84 13.05 38.35 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 p -164.34 136.14 4.6 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m -41.1 121.6 1.6 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.11 0.881 . . . . 0.0 111.724 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.25 111.76 9.9 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -78.2 76.21 4.72 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.775 0.672 . . . . 0.0 111.294 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . . . -90.91 71.92 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.389 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.5 m -62.23 -6.91 3.48 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -70.87 164.13 58.75 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.52 178.57 2.57 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.62 2.213 . . . . 0.0 111.614 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 -149.26 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.07 15.74 0.43 Allowed Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.161 0.913 . . . . 0.0 110.855 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.638 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 1.9 m-90 -100.93 126.22 47.55 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -90.45 2.79 55.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.143 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 49' ' ' CYS . 27.1 p -163.58 173.66 12.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.05 0.844 . . . . 0.0 112.468 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.458 HD13 ' CB ' ' A' ' 3' ' ' PHE . 6.7 tt -149.27 123.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.128 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -99.51 127.41 45.57 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -131.9 143.98 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -72.54 164.88 25.73 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.043 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 116.883 -1.532 . . . . 0.0 110.566 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 96.92 2.92 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 121.004 0.431 . . . . 0.0 111.291 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 64.7 t80 -97.31 101.99 13.66 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.5 m -84.38 155.54 22.25 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -150.71 161.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 123.31 0.381 . . . . 0.0 111.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.642 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 21.2 m-90 -145.98 140.14 26.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 m -55.19 -21.77 14.96 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' CA ' ' HA3' ' A' ' 30' ' ' GLY . . . 124.46 163.94 11.81 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 123.782 0.676 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.3 -54.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.678 0 O-C-N 123.058 1.031 . . . . 0.0 111.462 13.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.07 -123.55 4.57 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 75.3 m -122.16 80.2 1.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -147.79 -54.73 0.21 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.305 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.642 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.6 p30 -49.31 -120.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.99 80.9 0.08 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.66 110.26 3.65 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -131.45 172.66 11.93 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -153.38 158.67 41.83 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.735 -0.786 . . . . 0.0 113.119 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -136.77 80.16 1.8 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.843 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.1 t -108.68 1.33 21.12 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.687 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -61.4 118.64 7.22 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.781 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -62.29 102.13 0.28 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.322 1.014 . . . . 0.0 108.946 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.33 -118.48 1.02 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.3 t -140.71 154.59 46.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 124.315 0.656 . . . . 0.0 111.762 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 p -160.15 139.54 10.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.88 140.97 38.02 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.673 0.608 . . . . 0.0 111.772 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 72' ' ' ILE . 19.2 mt -117.56 127.29 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.815 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -125.7 32.85 5.21 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.046 0.841 . . . . 0.0 108.779 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.409 ' H ' HG22 ' A' ' 26' ' ' ILE . 30.4 mm-40 -113.47 99.27 7.64 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.284 -1.325 . . . . 0.0 108.285 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.14 18.26 6.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 111.85 -2.432 . . . . 0.0 112.491 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.497 ' HA3' ' CA ' ' A' ' 8' ' ' GLY . . . -92.24 -74.64 1.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.908 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 64' ' ' CYS . . . -152.84 164.46 30.79 Favored Glycine 0 N--CA 1.486 2.006 0 CA-C-N 113.836 -1.182 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 23.4 p90 -161.23 132.25 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.79 161.8 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.362 -1.744 . . . . 0.0 107.253 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -142.25 153.16 43.73 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -146.86 114.03 6.23 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.654 1.222 . . . . 0.0 108.203 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.2 112.49 17.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.357 -2.201 . . . . 0.0 105.295 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.4 m -132.66 -66.6 0.67 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.74 -70.05 1.31 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -141.31 -168.52 2.65 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.226 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -77.17 -167.95 1.0 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.122 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.12 142.04 12.89 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.687 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.41 149.32 38.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.266 0.979 . . . . 0.0 108.818 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 55' ' ' THR . 38.1 mt -114.16 101.35 9.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.747 0.654 . . . . 0.0 111.3 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.53 144.92 26.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.368 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -91.99 -0.19 57.48 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.423 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 85.2 mm-40 -113.89 148.26 37.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 123.553 0.533 . . . . 0.0 110.137 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.72 134.03 55.86 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.827 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.33 30.85 77.33 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.433 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.7 m 54.7 29.42 11.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 124.61 0.829 . . . . 0.0 112.623 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 t -88.45 59.81 5.36 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.868 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -157.48 -125.45 0.85 Allowed Glycine 0 N--CA 1.495 2.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.834 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.79 144.08 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.2 121.88 21.01 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.484 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.78 -60.29 2.41 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.442 ' HB ' HD12 ' A' ' 43' ' ' LEU . 94.1 m -124.49 148.87 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.697 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.97 -177.89 4.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 123.545 0.528 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 43' ' ' LEU . 44.3 m-85 -141.32 158.08 44.36 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.685 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 59' ' ' SER . . . -148.08 -11.87 0.15 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.412 ' H ' ' H ' ' A' ' 58' ' ' GLY . 67.2 m -151.35 147.18 26.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -41.47 117.84 0.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.929 0.768 . . . . 0.0 112.78 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.8 99.82 7.37 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.331 1.02 . . . . 0.0 109.428 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -84.79 70.18 10.8 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.39 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.24 165.47 13.44 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 31' ' ' GLY . 67.4 m -150.85 26.64 0.73 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.842 0.83 . . . . 0.0 111.958 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -97.25 168.51 10.09 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.111 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.34 178.49 0.86 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.364 2.043 . . . . 0.0 110.946 163.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.85 -151.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.21 49.17 0.4 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 4.2 m-90 -127.37 142.17 51.5 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 1.8 tpmt? -93.85 -20.74 19.78 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.5 p -161.93 178.43 8.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 124.29 0.993 . . . . 0.0 112.052 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' A' ' 26' ' ' ILE . 11.0 tt -140.4 123.85 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.52 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -91.47 84.64 5.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.931 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.4 mm -69.19 125.05 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -72.06 136.21 46.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.805 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.55 0 CA-C-N 113.316 -1.766 . . . . 0.0 111.549 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.66 134.56 5.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CG ' HD13 ' A' ' 72' ' ' ILE . 88.5 t80 -101.76 107.06 18.16 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.886 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.8 m -91.75 152.3 20.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 28' ' ' GLN . 10.7 m -154.46 152.92 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.719 0.637 . . . . 0.0 111.062 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.415 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 18.1 m-90 -122.63 153.28 39.55 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 23.3 t -55.93 -50.56 70.39 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 163.61 154.17 7.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -80.05 -56.0 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 118.273 1.037 . . . . 0.0 110.075 12.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.5 -136.32 8.28 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -87.85 42.33 1.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.3 -0.95 . . . . 0.0 112.554 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.444 ' N ' ' ND2' ' A' ' 12' ' ' ASN . 1.9 m-80 -111.93 -135.0 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 7' ' ' SER . 6.8 p30 34.8 -141.21 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -89.44 156.74 18.47 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.02 171.61 7.28 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.905 0.753 . . . . 0.0 111.991 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -171.82 125.44 0.57 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -98.42 155.49 17.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -138.16 94.84 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.4 p -130.42 13.69 5.53 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.604 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -54.75 128.5 33.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.632 0.582 . . . . 0.0 110.959 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.4 t -69.55 94.22 0.75 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.457 1.123 . . . . 0.0 108.913 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.29 -106.06 0.36 Allowed Glycine 0 N--CA 1.488 2.129 1 N-CA-C 101.287 -4.725 . . . . 0.0 101.287 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.26 164.29 25.05 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.992 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 p -158.1 148.3 20.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 126.62 31.03 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.388 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mt -78.78 148.9 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.576 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -124.92 -32.36 3.05 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.288 0.993 . . . . 0.0 111.615 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 14.1 mm-40 -71.63 97.44 1.72 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.146 0.974 . . . . 0.0 110.636 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -90.42 61.29 4.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.369 -2.196 . . . . 0.0 109.545 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.98 -89.82 0.25 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.37 157.54 17.64 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' HG12 ' A' ' 5' ' ' VAL . 3.3 m-85 -143.99 117.44 9.11 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.775 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -126.83 153.12 46.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.056 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 92.5 t80 -133.35 155.07 50.13 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -137.11 131.26 32.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -109.69 148.34 31.54 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.411 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -166.56 55.12 0.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.52 -33.84 4.02 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.42 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -82.06 120.78 25.72 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.451 0.643 . . . . 0.0 110.726 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 m -91.9 168.78 11.18 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.201 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.04 147.28 23.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 123.63 0.581 . . . . 0.0 112.275 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.26 150.23 29.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.477 HD21 ' CE3' ' A' ' 69' ' ' TRP . 25.8 tp -120.11 108.68 14.55 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -89.09 124.16 34.05 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.123 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 57.5 t-20 -63.56 -41.81 98.39 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.152 -1.84 . . . . 0.0 106.66 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.564 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -78.93 157.43 28.22 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.274 -1.785 . . . . 0.0 108.06 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.1 172.94 6.04 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 33.96 44.79 0.37 Allowed Glycine 0 N--CA 1.505 3.251 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.601 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.9 p 34.35 61.64 0.53 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 125.218 1.187 . . . . 0.0 113.214 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 46' ' ' GLN . 70.9 m -78.31 -154.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.641 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.02 162.26 49.88 Favored Glycine 0 N--CA 1.498 2.815 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.258 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t 61.87 107.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 113.416 -1.392 . . . . 0.0 112.381 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.95 -174.95 2.84 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.756 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.465 ' CD2' ' HE1' ' A' ' 69' ' ' TRP . 8.8 t60 -136.91 -49.86 0.64 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 m -138.16 160.86 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.87 127.68 14.39 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.736 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.44 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 25.3 m-85 -101.78 146.04 28.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.24 0.962 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.27 17.13 0.79 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 p -165.82 129.87 2.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.9 m -37.03 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.079 0.862 . . . . 0.0 113.112 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.98 101.55 8.86 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 115.041 -0.982 . . . . 0.0 112.041 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -83.13 76.73 9.84 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.68 165.5 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.445 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 m -153.8 36.55 0.45 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 121.763 0.792 . . . . 0.0 109.374 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 72.7 m-80 -70.07 -167.04 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.094 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.576 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 65' ' ' ASN . 1.4 Cg_endo -73.3 165.94 31.26 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.733 2.288 . . . . 0.0 111.24 144.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.75 171.11 15.44 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.41 18.1 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.672 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 13.7 m-90 -141.93 -162.59 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.97 0.453 . . . . 0.0 112.0 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.2 -30.22 0.47 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.927 0.767 . . . . 0.0 111.04 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 p -150.32 162.45 40.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.918 0.761 . . . . 0.0 111.809 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.529 HD13 ' CG ' ' A' ' 3' ' ' PHE . 10.2 tt -137.88 134.78 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.243 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -96.02 106.78 18.99 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.403 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -101.03 139.31 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -105.39 162.61 13.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.034 0.834 . . . . 0.0 110.741 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 116.94 -1.505 . . . . 0.0 110.475 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.64 95.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 123.97 0.793 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 87.8 t80 -82.18 98.92 8.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.313 1.008 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -84.11 151.76 24.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 p -163.25 146.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.525 1.155 . . . . 0.0 112.506 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 8.2 m-90 -124.23 151.41 44.16 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 111.851 -2.431 . . . . 0.0 107.304 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.7 p -68.82 9.84 0.34 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.34 163.21 37.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -76.66 -53.79 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.649 0 O-C-N 123.055 1.029 . . . . 0.0 111.107 16.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.52 -143.5 13.83 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 71.5 m -107.85 70.81 0.78 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -142.14 -49.06 0.37 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.942 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.65 ' H ' HD22 ' A' ' 13' ' ' ASN . 1.4 p30 -53.94 -135.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.717 -2.038 . . . . 0.0 115.974 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 94.4 mtt-85 -54.25 129.27 34.52 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.76 116.15 31.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.928 0.767 . . . . 0.0 110.565 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -147.81 138.84 23.4 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -123.78 158.69 31.17 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -136.32 82.17 1.93 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.5 p -105.71 -14.76 15.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.555 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.69 141.68 58.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.185 0.928 . . . . 0.0 109.544 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 44.0 t -71.76 174.7 6.49 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.02 -112.02 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 p -172.42 147.31 1.9 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.094 0.526 . . . . 0.0 111.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -158.77 154.45 26.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.171 0.919 . . . . 0.0 110.987 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.93 140.36 36.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.373 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.2 mt -97.0 115.78 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.158 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -79.27 -45.39 19.84 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.559 ' CD ' ' H ' ' A' ' 28' ' ' GLN . 1.7 pm0 -81.83 82.11 7.61 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.798 -1.546 . . . . 0.0 108.699 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.7 55.85 2.83 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.035 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.09 -114.35 2.85 Favored Glycine 0 N--CA 1.498 2.801 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.357 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.54 158.35 28.55 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-O 118.412 -1.215 . . . . 0.0 110.329 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 26.1 p90 -161.76 134.92 6.23 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -110.42 167.73 9.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 77.1 t80 -145.3 155.62 43.32 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.3 t -144.99 109.64 4.98 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -81.78 147.64 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 113.056 -1.884 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -173.36 76.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.62 -26.3 3.64 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-N 112.788 -2.006 . . . . 0.0 113.06 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -109.14 137.19 47.42 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.4 m -97.79 166.48 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.761 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.81 174.77 9.41 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.309 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.55 122.37 3.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.153 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.456 HD13 ' CZ3' ' A' ' 69' ' ' TRP . 98.4 mt -99.22 135.88 39.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 123.847 0.717 . . . . 0.0 111.615 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 8.8 p90 -148.24 138.43 22.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.212 0.945 . . . . 0.0 109.255 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.4 ' HA ' ' N ' ' A' ' 70' ' ' LYS . 17.4 t30 -72.59 -10.27 59.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.621 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' N ' ' CD ' ' A' ' 46' ' ' GLN . 3.1 mp0 -86.4 89.66 7.95 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.321 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.22 164.9 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.87 28.09 72.97 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.011 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 m 60.64 18.51 8.52 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.052 0.501 . . . . 0.0 110.614 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -90.49 41.04 1.04 Allowed 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -161.69 -170.29 26.19 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.081 -1.533 . . . . 0.0 115.921 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.21 145.96 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 112.351 -1.924 . . . . 0.0 107.772 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 179.98 0.12 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -153.27 -48.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.574 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 m -132.83 106.14 7.55 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.824 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -96.54 158.08 15.6 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 44.4 m-85 -126.0 106.04 9.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 124.189 0.931 . . . . 0.0 110.664 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.43 -4.31 57.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 t -155.47 140.15 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -35.91 110.86 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -92.98 -178.48 4.82 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -166.2 51.88 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.25 0.547 . . . . 0.0 111.576 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.78 165.47 16.0 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.1 m -147.56 11.09 0.98 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.945 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -79.84 157.59 73.92 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.73 143.92 27.82 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.452 2.101 . . . . 0.0 112.043 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.16 156.68 37.01 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.787 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.26 22.5 3.22 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 123.996 0.81 . . . . 0.0 111.417 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.456 ' CZ3' HD13 ' A' ' 43' ' ' LEU . 13.2 m-90 -138.26 -161.58 1.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 45' ' ' ASN . 18.6 ttpt -138.63 -20.14 1.04 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.544 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 p -153.72 170.28 21.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.267 0.979 . . . . 0.0 110.795 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 43' ' ' LEU . 14.4 tt -137.04 149.48 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.465 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -119.93 136.19 54.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.7 mt -138.44 155.95 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 124.069 0.856 . . . . 0.0 110.738 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -88.12 173.18 8.99 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.99 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 88.8 m . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.771 -1.585 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.741 0.305 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.407 ' CB ' ' HE ' ' A' ' 17' ' ' ARG . . . -159.09 174.23 15.21 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.403 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -137.67 97.43 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.53 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.1 m -77.3 150.52 35.25 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -148.61 153.96 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 123.622 0.576 . . . . 0.0 110.39 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.598 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 25.0 m-90 -135.61 142.97 45.34 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.5 p -66.18 0.85 1.77 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' ' C ' ' A' ' 9' ' ' PRO . . . 104.29 155.33 23.48 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 123.504 0.502 . . . . 0.0 113.349 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.452 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 12.1 Cg_endo -72.93 -54.88 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.851 0 O-C-N 123.023 1.012 . . . . 0.0 112.863 18.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.33 -128.67 5.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -108.89 69.44 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 113.96 -1.12 . . . . 0.0 109.419 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -143.4 -55.71 0.39 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.125 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.598 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.8 p30 -47.05 -118.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 5.9 tpm_? -62.78 100.77 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.352 0.596 . . . . 0.0 111.76 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.59 83.46 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.062 0.934 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -101.57 161.79 13.38 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.43 -1.713 . . . . 0.0 107.652 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.407 ' HE ' ' CB ' ' A' ' 2' ' ' ALA . 74.5 ttt180 -142.06 153.65 44.36 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -135.63 83.09 1.99 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.7 p -108.76 -12.01 14.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.056 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -53.09 143.53 17.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.336 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 126.92 29.61 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.819 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.58 28.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.572 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 20.2 p -114.15 162.23 16.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.5 p -160.57 158.59 29.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.351 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.43 151.25 30.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 123.699 0.625 . . . . 0.0 110.554 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 28' ' ' GLN . 3.3 mp -121.26 131.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 124.275 0.984 . . . . 0.0 109.333 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -101.28 -6.65 23.88 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.196 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.5 ' H ' HG22 ' A' ' 26' ' ' ILE . 26.2 mp0 -93.62 64.79 3.6 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.471 1.605 . . . . 0.0 108.729 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HG3' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -77.14 8.8 3.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 111.187 -2.733 . . . . 0.0 115.063 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA3' ' CA ' ' A' ' 8' ' ' GLY . . . -74.2 -61.97 3.07 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.627 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.95 161.3 28.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.67 135.1 6.41 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -109.89 161.2 15.7 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 90.1 t80 -132.22 158.05 42.77 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.9 t -140.4 121.98 15.2 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -104.56 111.58 24.32 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.8 p -148.53 -49.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.6 -80.08 1.03 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -137.53 -176.93 4.57 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.5 m -75.95 170.81 15.53 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.45 169.63 21.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.257 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -152.94 163.93 38.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.04 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.596 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.0 mm? -111.27 143.36 42.17 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.82 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.76 120.26 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.737 1.273 . . . . 0.0 108.681 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -62.34 -5.68 2.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.164 0.915 . . . . 0.0 112.193 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -125.9 123.17 38.02 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.971 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.543 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -37.98 148.13 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.436 -1.711 . . . . 0.0 114.305 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.572 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.96 37.47 44.83 Favored Glycine 0 N--CA 1.494 2.521 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.0 p 36.27 45.11 0.32 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.978 1.046 . . . . 0.0 113.192 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -85.31 41.66 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.676 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.52 -120.05 0.54 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.0 156.05 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.434 0.726 . . . . 0.0 109.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.62 165.09 17.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.624 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -132.4 -62.82 0.82 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.7 m -110.53 142.68 42.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -133.25 126.67 32.04 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.34 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.491 ' CE2' HD21 ' A' ' 43' ' ' LEU . 37.4 m-85 -94.33 132.99 38.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.17 0.918 . . . . 0.0 110.892 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.28 8.04 5.97 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.6 p -162.19 136.22 6.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.3 p -42.05 116.6 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 123.619 0.574 . . . . 0.0 110.976 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.5 107.43 12.86 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.54 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -78.13 73.82 4.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.516 1.135 . . . . 0.0 112.773 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 156.3 18.28 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.69 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.7 m -144.96 18.37 1.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -82.37 162.78 55.16 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.331 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -53.96 152.48 23.48 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.342 2.028 . . . . 0.0 110.589 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -69.8 166.14 19.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.759 0.662 . . . . 0.0 110.344 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.55 -0.72 1.53 Allowed Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.86 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.596 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.3 m-90 -127.1 -141.82 0.27 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 20.3 ttmm -146.58 -25.16 0.42 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.021 0.373 . . . . 0.0 110.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.451 ' HA ' HD12 ' A' ' 26' ' ' ILE . 6.4 p -146.91 158.73 44.0 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.795 0.807 . . . . 0.0 111.98 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.403 ' N ' HD11 ' A' ' 26' ' ' ILE . 6.5 tp -119.35 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 112.884 -1.962 . . . . 0.0 108.319 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -104.01 125.78 50.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.594 1.184 . . . . 0.0 108.392 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 mm -113.82 134.2 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -67.1 88.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 124.362 1.039 . . . . 0.0 110.476 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.79 -1.576 . . . . 0.0 114.491 179.896 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.36 119.88 2.77 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.355 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.436 ' CB ' HD13 ' A' ' 72' ' ' ILE . 72.4 t80 -87.63 92.11 8.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.44 ' HA ' ' HG2' ' A' ' 17' ' ' ARG . 57.1 m -73.1 152.63 41.13 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' A' ' 32' ' ' TYR . 34.8 m -154.31 153.59 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.571 1.169 . . . . 0.0 110.26 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.491 ' HB3' HD21 ' A' ' 13' ' ' ASN . 29.8 m-90 -135.63 150.09 49.53 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 96.4 p -63.41 -10.44 17.09 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 106.71 158.83 21.65 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.409 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 11.4 Cg_endo -73.43 -53.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.63 0 O-C-N 122.897 0.946 . . . . 0.0 110.885 25.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.51 -123.69 4.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 74.0 m -101.39 39.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.799 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.26 -130.65 0.3 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.1 p30 36.24 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -82.01 149.31 28.19 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.227 0.329 . . . . 0.0 110.261 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.63 152.72 23.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 123.765 0.666 . . . . 0.0 112.758 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -163.2 143.18 8.92 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.458 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 79.5 mtt85 -124.55 159.84 29.72 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.47 86.31 2.26 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.558 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -114.46 -8.17 12.81 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.25 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -54.6 121.01 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.19 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.45 97.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.421 1.076 . . . . 0.0 109.872 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.95 -177.48 21.88 Favored Glycine 0 N--CA 1.493 2.461 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.3 m -79.97 141.3 36.12 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.961 -1.119 . . . . 0.0 109.959 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.2 p -156.45 136.93 13.1 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.202 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -79.02 130.52 35.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 123.726 0.641 . . . . 0.0 112.614 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.2 mt -88.61 138.72 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -105.79 -56.27 2.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.041 0.838 . . . . 0.0 112.658 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.576 ' CD ' ' H ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -77.25 76.36 3.8 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 123.38 1.562 . . . . 0.0 111.146 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -71.93 18.87 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.245 -2.252 . . . . 0.0 115.46 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.35 -76.29 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.17 168.66 21.37 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB3' HG12 ' A' ' 5' ' ' VAL . 44.6 p90 -161.63 130.31 4.39 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 14.0 m-20 -114.42 101.1 8.83 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.098 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 3' ' ' PHE . 54.0 t80 -78.49 151.42 32.6 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.9 p -135.82 147.55 48.33 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 124.782 1.301 . . . . 0.0 107.703 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CG ' ' N ' ' A' ' 37' ' ' THR . 77.8 t80 -132.14 156.74 45.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.359 1.037 . . . . 0.0 108.506 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' A' ' 36' ' ' TYR . 5.8 t -163.49 -24.21 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.022 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.408 ' H ' ' H ' ' A' ' 37' ' ' THR . . . -169.05 -25.34 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -123.71 118.56 27.52 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.541 ' H ' ' NE2' ' A' ' 75' ' ' GLN . 60.8 m -83.62 170.65 14.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.009 -1.905 . . . . 0.0 109.406 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.77 159.57 41.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.013 0.821 . . . . 0.0 111.066 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.13 133.24 24.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.049 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.506 ' HG ' ' CE3' ' A' ' 69' ' ' TRP . 4.3 mm? -79.59 169.43 18.02 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.691 0.619 . . . . 0.0 109.433 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -153.52 124.06 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.512 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -70.67 -30.83 67.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 46' ' ' GLN . 3.5 mp0 -89.65 112.38 23.61 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -41.5 143.35 0.48 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.78 41.58 90.9 Favored Glycine 0 N--CA 1.497 2.724 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.963 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 60.7 m 52.76 30.8 9.44 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.162 0.566 . . . . 0.0 112.414 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.6 t -81.0 30.56 0.32 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.278 1.037 . . . . 0.0 113.006 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.68 -161.66 12.12 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.624 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.6 t -95.64 145.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.97 148.56 50.89 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.571 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.665 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 12.6 t-80 -95.62 -69.41 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 m -112.36 118.84 36.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 123.94 0.775 . . . . 0.0 111.036 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -98.77 170.34 8.84 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.215 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.09 -172.39 2.82 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.424 0.63 . . . . 0.0 111.087 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.42 -36.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -145.53 159.32 43.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.877 -1.161 . . . . 0.0 108.99 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -42.29 117.39 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.53 90.26 3.3 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.761 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 86.1 mtm180 -75.29 69.78 2.15 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.09 168.3 11.73 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.798 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.38 8.97 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.779 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.92 157.16 83.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.12 156.28 65.5 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.074 1.849 . . . . 0.0 109.421 167.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CG ' ' CE3' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -138.14 -164.4 1.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.31 27.38 2.76 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.15 0.906 . . . . 0.0 112.663 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.665 ' HE1' ' CG ' ' A' ' 54' ' ' HIS . 4.9 m-90 -94.29 131.73 39.6 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -86.41 -18.11 32.61 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.379 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 63.2 p -156.42 179.55 9.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.292 0.995 . . . . 0.0 113.007 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 43' ' ' LEU . 13.9 tt -153.35 141.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.344 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.596 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 69.2 t80 -104.97 135.15 46.85 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.497 -1.683 . . . . 0.0 107.907 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.6 mm -123.2 132.58 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.541 ' NE2' ' H ' ' A' ' 40' ' ' THR . 24.6 mt-30 -76.19 173.21 11.64 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 116.11 -1.9 . . . . 0.0 111.51 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.478 ' H3 ' ' HB ' ' A' ' 37' ' ' THR . 53.7 m . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.89 129.0 49.45 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -98.14 94.03 6.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 124.297 0.998 . . . . 0.0 109.838 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -77.09 155.17 32.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.577 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 25.2 m -154.56 160.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 124.211 0.944 . . . . 0.0 108.91 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 31.6 m-90 -139.65 135.86 33.7 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -43.37 -44.28 5.55 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.518 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 147.1 151.65 5.47 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -79.44 -62.86 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.593 0 O-C-N 123.002 1.001 . . . . 0.0 111.794 18.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.43 -138.47 10.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.09 52.89 2.37 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.105 -1.047 . . . . 0.0 111.919 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -132.18 -130.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.518 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.1 p30 35.42 -144.01 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 58.6 ttm-85 -66.31 149.36 50.48 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.11 148.73 45.35 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 123.44 0.462 . . . . 0.0 111.646 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -166.78 153.59 8.85 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.348 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -123.09 153.35 40.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.08 0.863 . . . . 0.0 111.313 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -134.59 79.87 1.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.523 -1.671 . . . . 0.0 107.423 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -103.45 8.97 37.9 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.731 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -58.73 138.05 57.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.164 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.95 155.91 36.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.009 0.818 . . . . 0.0 110.049 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.4 -92.47 1.66 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 103.828 -3.709 . . . . 0.0 103.828 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -171.56 164.79 6.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.93 1.018 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 p -160.0 141.73 12.84 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.448 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.49 135.77 36.73 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 71' ' ' SER . 3.2 mp -102.98 156.38 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -121.22 -20.51 6.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 124.155 0.91 . . . . 0.0 110.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.36 97.34 2.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.15 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -90.1 62.91 5.68 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.04 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 -118.31 1.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.33 162.89 26.08 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 125.077 1.104 . . . . 0.0 111.325 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 14.9 p90 -161.73 136.01 6.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 3.4 t70 -120.76 165.88 14.5 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.362 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.41 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 70.3 t80 -133.86 155.61 49.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -147.21 85.56 1.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.36 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CB ' ' HA ' ' A' ' 59' ' ' SER . 2.2 t80 -49.09 133.82 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 112.948 -1.933 . . . . 0.0 113.293 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.478 ' HB ' ' H3 ' ' A' ' 1' ' ' SER . 50.4 m -152.48 82.85 1.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.73 19.06 57.92 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.83 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 76' ' ' CYS . 5.5 tp-100 -159.86 161.36 34.41 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.344 -0.943 . . . . 0.0 113.195 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -112.67 177.42 4.64 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.487 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.76 172.29 13.51 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.568 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.57 150.79 28.11 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.555 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -106.65 126.88 52.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.611 0.72 . . . . 0.0 111.365 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.64 101.47 10.78 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -61.36 -13.67 21.5 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.916 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -92.92 130.52 38.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.71 151.49 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.99 22.86 67.16 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.741 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 21.5 m 59.64 13.99 3.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.175 0.573 . . . . 0.0 112.471 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -87.61 63.04 7.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.939 0.775 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.0 -137.67 2.93 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.094 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.54 175.52 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.25 144.26 26.54 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.732 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.402 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 21.2 m-70 -120.44 -51.46 2.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.8 m -123.18 121.51 36.1 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.505 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.68 118.89 37.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.253 0.971 . . . . 0.0 111.606 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -102.04 93.56 5.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.344 1.028 . . . . 0.0 108.351 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.29 -23.3 44.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.418 ' HA ' ' CB ' ' A' ' 36' ' ' TYR . 35.1 t -135.59 144.07 45.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.485 0.756 . . . . 0.0 109.258 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -35.06 124.01 0.58 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.435 1.084 . . . . 0.0 111.929 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 33' ' ' ASP . . . -137.65 105.74 5.71 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.787 0.68 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -76.44 75.18 3.19 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.325 1.016 . . . . 0.0 112.905 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -90.8 153.69 20.05 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.289 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.53 19.86 2.03 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -79.18 165.02 51.52 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -56.0 148.22 59.28 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.938 1.759 . . . . 0.0 110.372 172.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.27 173.01 4.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.788 0.68 . . . . 0.0 109.473 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.19 7.46 0.12 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.197 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.555 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.2 m-90 -128.29 -171.29 2.42 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.957 0.445 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HB2' ' HZ3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -126.94 -24.67 3.44 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.546 ' HA ' HD12 ' A' ' 26' ' ' ILE . 10.1 p -146.53 163.69 34.96 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.681 0.613 . . . . 0.0 111.399 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.04 114.68 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.975 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -93.79 121.06 34.85 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.52 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 76' ' ' CYS . 31.3 mt -130.08 128.54 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.461 ' H ' ' CD ' ' A' ' 75' ' ' GLN . 3.2 mp0 -78.35 9.86 3.54 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.481 ' N ' ' HG2' ' A' ' 39' ' ' GLN . 14.6 p . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.38 123.68 10.92 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.525 ' CG ' HD13 ' A' ' 72' ' ' ILE . 67.3 t80 -89.65 104.6 17.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' ASP . 53.1 m -94.16 137.02 33.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -139.59 162.32 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.472 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 18.2 m-90 -128.18 140.33 51.97 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.449 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 78.2 p -55.58 -31.18 61.98 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.515 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 142.06 148.38 5.0 Favored Glycine 0 N--CA 1.5 2.929 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.41 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 28.1 Cg_endo -73.61 -65.14 0.03 OUTLIER 'Cis proline' 0 N--CA 1.503 2.066 0 CA-C-N 118.428 1.114 . . . . 0.0 112.581 20.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.33 -125.42 4.12 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 105.393 -3.083 . . . . 0.0 105.393 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -99.27 73.01 1.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -139.18 -53.11 0.56 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.138 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 7.6 p30 -57.22 -136.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.926 -1.943 . . . . 0.0 116.145 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 14' ' ' ARG . 31.3 mtm105 -58.13 141.07 51.42 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.17 82.24 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 124.73 1.269 . . . . 0.0 111.168 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.67 165.03 14.47 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.189 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -152.19 156.21 39.32 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.454 0.645 . . . . 0.0 112.374 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.93 69.19 1.36 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.2 t -90.7 -18.64 24.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.355 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -57.09 129.59 42.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.609 0.568 . . . . 0.0 111.602 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.48 122.18 15.64 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.552 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.43 -169.99 13.51 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-O 122.596 1.109 . . . . 0.0 114.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.5 t -56.74 130.38 45.29 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.612 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -160.81 120.42 2.68 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.615 0.572 . . . . 0.0 111.02 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.433 ' HB2' ' H ' ' A' ' 48' ' ' GLY . . . -79.72 126.3 30.76 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 mt -87.75 154.52 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -138.6 -9.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.571 0.545 . . . . 0.0 110.939 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.86 105.32 7.85 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.165 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.76 62.01 5.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.177 0.923 . . . . 0.0 108.845 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.74 -108.27 0.69 Allowed Glycine 0 N--CA 1.497 2.744 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.06 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.03 166.49 21.25 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -146.1 165.5 28.91 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 3.2 t70 -169.22 163.11 10.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 41' ' ' ALA . 58.0 t80 -138.61 155.81 48.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -142.3 94.8 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.19 0.932 . . . . 0.0 109.436 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.86 151.42 31.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.042 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -174.19 -22.8 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.366 1.041 . . . . 0.0 108.653 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.37 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -122.02 159.81 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.5 p -91.11 -163.8 1.09 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.844 -1.98 . . . . 0.0 110.444 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . . . -155.11 176.18 12.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.9 131.21 6.75 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 114.942 -1.027 . . . . 0.0 108.308 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -92.12 154.94 18.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.81 120.04 14.7 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.802 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -62.86 -7.48 5.18 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -118.05 122.08 42.24 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.856 0.722 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -40.08 145.84 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 124.685 1.241 . . . . 0.0 113.749 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 25' ' ' ALA . . . 58.99 42.47 96.9 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.819 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.7 p 44.11 25.57 0.12 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.156 1.15 . . . . 0.0 112.977 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 t -87.24 44.02 1.15 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.633 0.73 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.54 -155.26 6.39 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.405 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.55 150.14 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.04 156.52 33.52 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.336 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.473 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -141.3 -45.88 0.38 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.026 0.829 . . . . 0.0 110.968 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -137.13 118.89 15.07 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.775 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -105.37 162.48 13.41 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.738 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -139.65 133.88 31.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.043 0.839 . . . . 0.0 110.351 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.87 14.9 5.18 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.5 t -162.68 124.17 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 m -35.88 113.88 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 124.291 0.994 . . . . 0.0 112.955 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.84 15.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.957 0.786 . . . . 0.0 110.529 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -86.95 94.46 9.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 158.94 16.53 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.49 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.2 m -151.37 15.08 0.7 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -88.56 166.24 23.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.01 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -50.03 165.23 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.692 2.261 . . . . 0.0 112.245 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.58 179.36 2.14 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.556 0.694 . . . . 0.0 111.804 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.22 -5.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.141 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.502 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.6 m-90 -138.79 -156.19 0.66 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -140.87 -40.74 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.7 p -131.95 178.38 6.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 124.704 1.253 . . . . 0.0 111.377 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.525 HD13 ' CG ' ' A' ' 3' ' ' PHE . 11.2 tt -150.91 147.39 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.77 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -119.94 130.42 54.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.528 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.36 152.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 66.7 mt-30 -73.85 -159.59 0.08 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 75' ' ' GLN . 24.4 p . . . . . 0 N--CA 1.504 2.23 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.59 134.5 42.38 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.377 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 55.5 t80 -109.15 91.3 3.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.437 1.086 . . . . 0.0 108.85 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.0 m -81.25 133.81 35.5 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.978 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.14 145.65 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 123.645 0.591 . . . . 0.0 111.382 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.506 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 8.4 m-90 -114.3 143.27 45.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 79.1 p -64.34 -10.27 23.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' N ' ' HA3' ' A' ' 30' ' ' GLY . . . 120.35 154.6 9.42 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 123.596 0.56 . . . . 0.0 113.326 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -75.35 -64.18 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.835 0 O-C-N 123.221 1.116 . . . . 0.0 112.468 12.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.42 -136.13 6.39 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -106.12 66.07 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.411 -1.395 . . . . 0.0 109.792 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -141.86 -59.39 0.47 Allowed 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.774 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 2.0 p30 -32.56 -104.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -72.18 -164.16 0.13 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.412 1.005 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.69 59.68 0.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.834 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.13 151.14 28.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -145.75 116.81 7.82 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.385 0.612 . . . . 0.0 111.488 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -97.9 73.08 2.26 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.884 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.7 p -81.32 -14.29 57.48 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -64.63 133.27 51.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 123.949 0.781 . . . . 0.0 110.835 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.6 m -63.29 175.51 0.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.359 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.74 -161.94 45.85 Favored Glycine 0 N--CA 1.492 2.381 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.18 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -97.95 125.27 42.79 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.5 p -131.14 135.84 47.82 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.003 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.99 117.8 20.4 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 72' ' ' ILE . 2.3 mp -82.52 138.01 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.377 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -118.86 59.59 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.99 98.77 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.663 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -91.3 61.11 4.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' N ' ' A' ' 8' ' ' GLY . . . -144.06 -109.63 0.68 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.647 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.72 166.87 21.75 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -147.37 147.29 30.15 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 2.3 t70 -151.0 154.21 36.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -128.16 157.6 40.36 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.1 m -144.52 93.57 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.774 0.797 . . . . 0.0 110.016 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -71.4 151.75 43.76 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.775 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -172.76 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.222 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.53 -64.59 0.22 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -126.83 166.17 17.95 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.5 p -93.06 171.97 8.61 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.888 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.78 178.55 5.87 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.579 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.88 131.61 6.98 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' CE3' ' A' ' 69' ' ' TRP . 4.5 mm? -81.94 161.63 23.0 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -137.61 106.5 5.95 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.556 -2.111 . . . . 0.0 107.92 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 14.2 t30 -55.27 -23.67 24.17 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.316 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -95.98 135.57 37.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.161 0.913 . . . . 0.0 109.768 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.47 119.06 1.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.898 1.374 . . . . 0.0 113.074 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 43.71 74.21 0.21 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 124.618 1.199 . . . . 0.0 113.458 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 44.22 25.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m -82.35 32.13 0.4 Allowed 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.988 0.899 . . . . 0.0 112.238 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.74 -129.61 1.04 Allowed Glycine 0 N--CA 1.49 2.257 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.2 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -127.22 162.21 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.33 -177.39 1.12 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.046 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.402 ' CD2' ' HE1' ' A' ' 69' ' ' TRP . 8.5 t60 -148.62 -60.88 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.3 m -104.22 167.6 9.65 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.069 0.856 . . . . 0.0 109.796 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -142.45 144.77 33.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.462 1.101 . . . . 0.0 109.923 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -128.12 100.62 5.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.102 0.876 . . . . 0.0 109.528 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.37 -25.17 52.15 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.954 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.9 p -148.99 148.29 29.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.07 0.512 . . . . 0.0 111.339 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -33.78 115.32 0.22 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 124.434 1.083 . . . . 0.0 112.353 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.73 108.58 10.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.097 0.873 . . . . 0.0 111.644 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -82.03 87.5 6.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.101 0.876 . . . . 0.0 112.999 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 163.26 14.69 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.87 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 m -148.0 11.6 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.14 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -69.76 164.13 53.77 Favored Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.234 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.54 165.02 1.81 Allowed 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.45 2.1 . . . . 0.0 110.464 167.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.57 174.01 3.77 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.694 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 69' ' ' TRP . . . -159.48 -3.52 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.434 ' CE3' ' HG ' ' A' ' 43' ' ' LEU . 3.5 m-90 -143.13 -176.02 4.75 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -114.26 -39.34 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 p -132.58 165.7 23.79 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 6.9 tp -125.35 112.75 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.204 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -90.81 143.37 26.79 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.445 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.6 mt -135.05 132.5 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -60.2 -37.58 80.7 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.162 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 115.71 -2.09 . . . . 0.0 115.114 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.12 121.03 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.469 ' CB ' HD13 ' A' ' 72' ' ' ILE . 70.7 t80 -97.83 84.47 3.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.293 0.996 . . . . 0.0 110.076 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -68.07 151.04 47.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.74 154.93 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.482 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.5 m-90 -134.08 140.8 46.87 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.3 p -48.88 -43.33 38.96 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.558 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.11 157.27 7.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -81.47 -62.13 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.537 0 O-C-N 123.023 1.012 . . . . 0.0 110.33 14.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -128.0 3.12 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -106.98 49.61 0.8 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.706 -1.247 . . . . 0.0 109.308 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -119.49 -128.49 0.28 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.558 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 11.0 p30 35.94 -142.11 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -77.06 140.12 40.22 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.41 131.33 49.14 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.837 0.711 . . . . 0.0 110.662 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -136.83 118.37 14.85 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -98.23 124.67 42.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.276 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.14 81.98 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.9 m -106.21 -20.1 13.5 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.773 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -50.16 139.38 14.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.368 1.043 . . . . 0.0 112.912 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 162.69 11.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -151.16 43.3 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 22.0 p -129.98 154.19 47.63 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.029 -1.068 . . . . 0.0 113.558 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -143.39 151.76 40.79 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.118 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.47 124.47 28.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.031 0.832 . . . . 0.0 112.09 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.9 mp -80.71 118.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -93.14 -25.67 17.77 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.467 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -78.91 102.52 8.3 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 80.3 tttt -90.06 13.49 14.78 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.181 0.926 . . . . 0.0 111.43 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.32 -90.02 0.37 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.466 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.48 169.86 21.18 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -162.0 136.4 6.83 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -120.35 131.79 55.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.441 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.434 ' CG ' ' N ' ' A' ' 35' ' ' SER . 59.5 t80 -101.55 160.65 14.26 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.3 t -147.0 90.14 1.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -74.71 137.27 41.98 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.886 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -148.95 -44.99 0.14 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.751 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.8 -42.37 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.04 134.4 55.0 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.2 m -81.61 168.9 17.68 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.679 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.94 24.28 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.666 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.08 146.19 28.75 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.533 HD12 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -109.33 98.8 8.15 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.252 -179.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -75.63 130.48 38.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.764 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -94.59 27.71 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.498 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.36 145.21 29.21 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.93 142.32 12.02 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.425 -1.261 . . . . 0.0 114.281 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.93 33.46 13.4 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 113.538 -1.664 . . . . 0.0 113.512 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.3 p 41.44 42.76 1.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.7 p -98.78 47.4 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.633 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.71 -128.34 0.95 Allowed Glycine 0 N--CA 1.498 2.816 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.487 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -119.3 140.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.471 0.748 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.49 153.1 27.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -107.65 -36.81 6.33 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.12 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -138.82 123.74 18.84 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.07 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -101.7 163.29 12.33 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -138.86 92.8 2.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.668 0.605 . . . . 0.0 112.459 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.02 16.07 62.11 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.8 t -170.46 138.31 1.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.1 p -44.61 129.45 6.85 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.06 97.05 4.5 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.97 0.794 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.0 mtt-85 -72.04 71.65 0.83 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.06 14.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.326 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.5 m -142.95 -11.26 0.77 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -71.47 156.41 91.52 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.964 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.37 176.98 0.93 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.684 2.256 . . . . 0.0 112.056 173.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' A' ' 29' ' ' LYS . 39.8 p90 -158.12 -167.45 2.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.088 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.43 56.52 0.46 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.533 ' CG ' HD12 ' A' ' 43' ' ' LEU . 5.0 m-90 -109.36 163.38 13.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.68 -44.58 5.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.54 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 p -155.41 164.65 38.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.716 1.26 . . . . 0.0 112.432 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 3' ' ' PHE . 7.1 tt -125.98 129.83 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.721 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -99.22 147.69 24.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 125.255 1.597 . . . . 0.0 107.418 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.3 mt -141.97 137.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.99 149.46 32.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.947 0.779 . . . . 0.0 111.267 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 116.919 -1.515 . . . . 0.0 110.515 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 19' ' ' SER . . . -157.39 107.84 2.25 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CB ' HD13 ' A' ' 72' ' ' ILE . 56.2 t80 -96.89 93.78 6.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.051 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -76.17 148.2 37.93 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 m -149.64 132.36 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.8 0.688 . . . . 0.0 110.384 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.5 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 23.6 m-90 -103.72 152.21 22.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -65.25 -10.41 31.8 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.837 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.97 160.75 19.71 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 123.976 0.798 . . . . 0.0 112.066 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.93 -58.61 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 O-C-N 123.134 1.07 . . . . 0.0 111.797 17.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.21 -132.06 7.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 69.1 m -109.77 73.11 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.45 -51.03 0.47 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.933 0.873 . . . . 0.0 110.401 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.591 ' H ' HD22 ' A' ' 13' ' ' ASN . 2.9 p30 -56.93 -159.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.417 -2.174 . . . . 0.0 114.302 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -70.55 172.92 7.71 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -155.83 178.34 10.38 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -150.08 141.16 23.01 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 111.362 -2.654 . . . . 0.0 105.256 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.33 131.02 53.95 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.524 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -103.96 68.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.652 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 58.6 p -86.8 -13.23 45.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -59.1 124.94 21.62 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.38 123.65 21.77 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.504 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -167.73 13.89 Favored Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -78.48 145.75 34.79 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.1 p -160.04 131.77 6.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.611 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -78.81 138.28 38.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 123.641 0.588 . . . . 0.0 111.784 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.27 146.32 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -125.7 -22.55 4.21 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.041 0.838 . . . . 0.0 109.876 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.484 ' H ' ' NE2' ' A' ' 28' ' ' GLN . 3.9 mp0 -74.45 100.25 3.78 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.197 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.14 62.93 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.221 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.41 -105.49 1.17 Allowed Glycine 0 N--CA 1.495 2.614 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.25 170.63 14.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -161.27 130.17 4.56 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 13.0 m-20 -114.69 105.81 13.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.375 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 35' ' ' SER . 83.6 t80 -80.7 157.48 25.88 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.201 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.3 m -142.47 129.23 20.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 124.843 1.339 . . . . 0.0 108.992 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -112.05 146.84 37.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.6 t -164.06 -33.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.695 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 39' ' ' GLN . . . -157.64 -9.31 0.05 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.411 ' H ' ' H ' ' A' ' 38' ' ' GLY . 28.5 mp0 -131.21 131.96 44.34 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 m -81.96 174.14 11.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.29 159.2 43.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.614 0.721 . . . . 0.0 112.14 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.54 145.84 35.61 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.665 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' A' ' 57' ' ' PHE . 47.5 mt -116.55 96.24 5.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.458 0.647 . . . . 0.0 112.073 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -85.94 136.0 33.44 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.741 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -87.2 5.08 39.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.347 -1.751 . . . . 0.0 110.726 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 82.7 mm-40 -115.97 150.54 37.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.855 0.722 . . . . 0.0 110.827 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 132.97 54.69 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.522 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.88 31.03 74.59 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.365 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.0 m 55.41 30.74 15.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.6 t -90.76 59.51 4.19 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.151 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.02 -147.7 5.0 Favored Glycine 0 N--CA 1.497 2.713 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.174 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -111.24 142.5 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 114.239 -0.98 . . . . 0.0 108.366 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.82 119.7 23.07 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.45 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -79.58 -36.54 38.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.459 ' HB ' HD12 ' A' ' 43' ' ' LEU . 55.3 m -145.65 133.79 21.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.049 0.843 . . . . 0.0 110.035 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -118.92 149.62 41.27 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.096 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 43' ' ' LEU . 25.7 m-85 -123.2 132.07 53.91 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.055 0.847 . . . . 0.0 111.143 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -2.42 11.22 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -154.32 139.52 17.5 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.4 m -37.73 120.26 0.81 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.04 0.838 . . . . 0.0 112.75 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.71 88.1 2.83 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 124.111 0.882 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 74.4 mtp180 -73.72 69.8 1.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.43 14.65 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.734 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.9 m -147.77 36.37 0.87 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.775 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -110.04 162.42 20.49 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.132 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.44 175.64 3.29 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.452 2.101 . . . . 0.0 111.649 171.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 15.4 p90 -161.22 -165.51 1.35 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.31 56.11 0.41 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.443 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.4 m0 -114.8 127.45 55.73 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -82.54 -8.48 59.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 123.72 0.637 . . . . 0.0 109.968 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 30.8 p -174.29 165.25 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.466 1.104 . . . . 0.0 112.213 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.486 HD13 ' CB ' ' A' ' 3' ' ' PHE . 11.1 tt -134.18 122.35 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-N 112.627 -2.078 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -99.48 107.8 20.08 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.847 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.7 mt -104.62 147.56 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.364 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -72.21 -172.4 0.9 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.118 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 116.25 -1.833 . . . . 0.0 110.387 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.49 142.77 1.69 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.655 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.424 ' CB ' HD13 ' A' ' 72' ' ' ILE . 88.7 t80 -93.87 104.04 16.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.696 1.248 . . . . 0.0 112.3 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -81.2 158.72 24.79 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 32' ' ' TYR . 10.3 m -153.62 122.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 124.008 0.818 . . . . 0.0 112.184 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.551 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.1 m-90 -95.58 146.5 24.42 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.6 p -60.44 -16.61 37.91 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.362 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.19 162.54 13.14 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 124.283 0.99 . . . . 0.0 112.181 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -75.21 -59.64 0.11 OUTLIER 'Cis proline' 0 N--CA 1.498 1.766 0 O-C-N 123.12 1.063 . . . . 0.0 111.053 11.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.47 -147.63 22.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HA ' ' CG ' ' A' ' 6' ' ' TRP . 7.6 p -102.25 66.84 1.02 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -136.89 -49.16 0.63 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 3.8 p30 -56.97 -152.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.256 -1.793 . . . . 0.0 114.519 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -74.35 162.49 28.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.7 12.97 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -147.39 154.88 41.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.997 -1.911 . . . . 0.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -115.95 144.34 44.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.737 0.648 . . . . 0.0 110.604 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -125.94 95.48 4.43 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.773 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -114.52 -7.43 12.81 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.894 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -49.7 123.29 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.881 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 23.8 t -72.71 90.23 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.745 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.24 113.59 21.7 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -124.87 132.93 53.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.882 0.739 . . . . 0.0 112.939 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 71' ' ' SER . . . -81.87 116.7 21.65 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.546 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.401 HD11 ' CG2' ' A' ' 72' ' ' ILE . 28.5 mt -79.9 135.95 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.551 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -106.87 -32.12 8.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.571 1.169 . . . . 0.0 111.37 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 27.7 mp0 -79.44 91.62 5.14 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.593 1.187 . . . . 0.0 108.173 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -90.49 62.72 5.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.566 -2.106 . . . . 0.0 111.753 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.08 -113.48 1.33 Allowed Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.022 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 165.44 34.03 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' HG12 ' A' ' 5' ' ' VAL . 8.9 p90 -161.89 129.47 4.01 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 1.1 t70 -112.07 167.98 9.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.6 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 59.5 t80 -148.41 155.33 41.09 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.184 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 58.5 m -137.25 147.11 45.51 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' CB ' ' HA ' ' A' ' 59' ' ' SER . 80.1 t80 -134.3 145.53 49.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.717 1.261 . . . . 0.0 109.768 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -172.85 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.751 0.657 . . . . 0.0 111.561 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.8 -12.64 1.3 Allowed Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.044 0.84 . . . . 0.0 111.536 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.31 20.55 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.7 m -84.56 166.65 17.01 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.938 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.41 157.7 46.0 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 131.89 10.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.914 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.71 163.61 13.69 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 49' ' ' CYS . 5.6 p90 -167.75 135.08 2.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.652 -2.067 . . . . 0.0 108.905 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.548 ' H ' HD22 ' A' ' 45' ' ' ASN . 2.0 m-80 -66.91 11.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.261 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 mm-40 -131.69 113.54 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.394 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.5 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -40.61 147.41 0.11 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.618 1.199 . . . . 0.0 112.428 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.98 44.74 62.08 Favored Glycine 0 N--CA 1.499 2.846 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.725 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 5.1 p 42.06 36.84 0.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 m -95.54 42.69 1.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.748 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.19 -164.4 15.21 Favored Glycine 0 N--CA 1.5 2.961 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.229 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.43 153.69 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.46 143.94 26.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.409 ' CD2' ' ND2' ' A' ' 45' ' ' ASN . 20.9 m-70 -112.62 -52.69 2.77 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.662 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -122.75 106.37 10.87 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -96.4 117.39 30.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.215 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.42 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 50.4 m-85 -91.75 108.33 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 123.717 0.636 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.93 45.51 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.408 ' HA ' ' CB ' ' A' ' 36' ' ' TYR . 39.0 t -146.32 159.85 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.46 0.741 . . . . 0.0 109.374 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.0 p -36.05 124.72 0.75 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.218 0.949 . . . . 0.0 113.308 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -133.42 101.21 5.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.143 0.902 . . . . 0.0 110.65 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 30.2 ptt180 -84.46 68.52 10.31 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.37 168.87 15.18 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.397 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 16.7 m -147.88 10.83 0.93 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -67.54 164.29 39.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.42 147.14 79.64 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 110.559 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.62 162.21 6.8 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 124.012 0.82 . . . . 0.0 109.874 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.55 18.76 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -136.14 -155.67 0.65 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.562 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 19.4 ttmm -141.1 -32.31 0.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 3.5 p -154.26 162.46 41.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.091 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 HD13 ' CB ' ' A' ' 3' ' ' PHE . 16.7 tt -129.44 143.6 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.015 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -113.67 132.1 55.91 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.488 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.0 mt -138.09 146.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 124.263 0.977 . . . . 0.0 108.753 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -88.41 169.08 12.1 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 91.4 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 116.099 -1.905 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.865 0.364 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.09 52.19 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.324 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -110.8 151.99 27.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 33' ' ' ASP . 92.0 m -140.13 148.65 41.98 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 32' ' ' TYR . 17.9 m -154.69 155.04 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.347 1.029 . . . . 0.0 112.854 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.553 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 9.1 m-90 -125.83 154.35 42.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.6 m -78.48 -13.35 59.87 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.438 ' H ' HD21 ' A' ' 13' ' ' ASN . . . 145.49 145.62 4.3 Favored Glycine 0 N--CA 1.504 3.231 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.687 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -76.04 -53.78 0.15 OUTLIER 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 118.171 0.985 . . . . 0.0 110.091 8.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.22 -127.6 4.49 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 105.25 -3.14 . . . . 0.0 105.25 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' HA ' ' CG ' ' A' ' 6' ' ' TRP . 21.8 p -96.87 57.53 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -138.81 53.33 1.77 Allowed 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.674 -0.811 . . . . 0.0 112.425 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.553 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -173.53 -122.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -48.66 145.87 3.42 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 123.428 0.691 . . . . 0.0 112.576 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.88 114.89 22.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -149.64 132.57 16.13 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -119.2 163.63 16.79 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.7 95.74 2.86 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.305 -1.77 . . . . 0.0 106.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.0 t -112.86 -22.33 10.71 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -51.33 147.13 6.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 123.859 0.724 . . . . 0.0 112.728 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.3 t -60.51 160.3 9.14 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.19 -148.01 32.37 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 27.8 p -128.9 172.26 11.5 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.1 p -151.55 136.93 17.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.438 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB1' ' HZ2' ' A' ' 70' ' ' LYS . . . -79.93 112.56 17.34 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.979 0.799 . . . . 0.0 111.788 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.02 146.48 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.989 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -125.18 -14.51 6.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.382 1.051 . . . . 0.0 108.456 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -70.69 100.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -86.99 56.64 4.1 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.551 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.1 -97.16 0.63 Allowed Glycine 0 N--CA 1.501 3.017 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.231 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.1 162.35 14.01 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' CD2' HG12 ' A' ' 5' ' ' VAL . 36.5 m-85 -144.56 108.72 4.78 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.367 1.079 . . . . 0.0 111.788 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 1.5 t70 -108.7 162.31 14.29 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.18 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -148.67 157.77 43.68 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.53 -1.213 . . . . 0.0 108.469 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 t -146.68 103.1 3.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 124.668 1.23 . . . . 0.0 108.947 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -79.05 151.81 31.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.282 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -174.82 73.39 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.86 -37.19 2.32 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.021 -1.899 . . . . 0.0 111.402 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -89.9 125.49 35.37 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.507 0.67 . . . . 0.0 112.188 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 m -85.58 164.15 17.93 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.284 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.4 148.42 27.45 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.374 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.5 148.53 34.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 124.479 1.112 . . . . 0.0 109.684 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -87.13 159.69 18.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.206 1.003 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -137.91 113.84 9.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 111.58 -2.555 . . . . 0.0 108.331 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.521 ' H ' ' CD2' ' A' ' 54' ' ' HIS . 16.7 t30 -55.47 -14.62 2.09 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.349 1.031 . . . . 0.0 113.11 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.431 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 2.9 pm0 -119.51 132.13 55.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.134 0.896 . . . . 0.0 109.983 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.94 150.58 0.26 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 114.038 -1.437 . . . . 0.0 113.592 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.9 34.03 37.05 Favored Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.421 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.4 p 39.03 44.66 0.92 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.783 0.931 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -86.07 37.7 0.73 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.337 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.86 -145.64 4.36 Favored Glycine 0 N--CA 1.495 2.576 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.321 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -103.88 157.18 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.65 175.73 6.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.808 0.693 . . . . 0.0 111.434 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.521 ' CD2' ' H ' ' A' ' 45' ' ' ASN . 69.4 m-70 -142.83 -59.0 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 123.974 0.796 . . . . 0.0 111.717 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.9 m -120.14 111.43 17.83 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.885 0.74 . . . . 0.0 111.312 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.8 ttt85 -95.35 163.63 13.17 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.684 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -140.72 149.72 42.54 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.38 -5.19 3.01 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 124.638 1.211 . . . . 0.0 110.159 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.4 m -149.86 150.81 32.49 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.7 p -45.66 119.27 2.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.889 0.743 . . . . 0.0 111.172 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.49 92.01 3.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.12 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 36.1 ptt180 -82.96 68.31 9.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.02 159.13 21.26 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.869 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.448 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 58.5 m -138.96 27.12 2.42 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.064 0.935 . . . . 0.0 109.449 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -82.7 164.96 44.56 Favored Pre-proline 0 N--CA 1.489 1.516 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.644 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.05 167.44 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.356 2.037 . . . . 0.0 110.649 170.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.27 177.1 2.93 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.823 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 69' ' ' TRP . . . -160.0 -6.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.509 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 4.0 m-90 -142.5 -160.54 1.11 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HZ2' ' HB1' ' A' ' 25' ' ' ALA . 28.5 tptp -128.74 -45.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 123.28 0.362 . . . . 0.0 111.341 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.2 p -124.77 166.01 16.98 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 124.337 1.023 . . . . 0.0 112.745 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.52 126.22 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -106.01 143.04 34.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.1 mt -143.49 117.19 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.81 162.27 28.82 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.022 0.826 . . . . 0.0 110.829 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.156 -1.878 . . . . 0.0 110.702 179.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 27.7 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' CB ' ' HE ' ' A' ' 17' ' ' ARG . . . -161.21 147.21 14.38 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 36.2 t80 -97.91 108.44 21.15 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.084 -1.417 . . . . 0.0 109.537 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 m -93.49 131.47 38.68 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 m -136.49 148.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 123.668 0.605 . . . . 0.0 111.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.438 ' CE3' ' HA ' ' A' ' 11' ' ' CYS . 21.2 m-90 -115.76 160.75 19.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.7 p -69.55 -9.97 56.2 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.61 153.41 18.2 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 123.752 0.657 . . . . 0.0 111.584 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.41 -64.25 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.685 0 O-C-N 123.118 1.062 . . . . 0.0 111.656 17.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.86 -150.87 15.62 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.438 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 1.6 p -93.07 41.97 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.704 -1.248 . . . . 0.0 109.824 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -124.41 -128.32 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 38.3 -142.05 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -70.75 140.78 51.44 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -106.86 148.22 28.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.083 0.865 . . . . 0.0 111.194 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.29 167.21 30.7 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.404 ' HE ' ' CB ' ' A' ' 2' ' ' ALA . 80.5 ttt180 -140.17 158.84 43.41 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.463 0.649 . . . . 0.0 112.317 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -142.36 84.84 1.88 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.869 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -112.98 17.22 19.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.739 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -63.07 127.32 30.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.758 0.789 . . . . 0.0 111.364 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -73.34 119.69 17.93 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.545 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.58 -98.58 0.88 Allowed Glycine 0 N--CA 1.493 2.439 0 O-C-N 124.535 1.147 . . . . 0.0 111.182 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.473 ' SG ' ' CD2' ' A' ' 73' ' ' PHE . 60.1 m -142.24 147.03 35.82 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.157 0.563 . . . . 0.0 112.132 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.6 p -160.42 126.83 4.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.72 126.88 31.51 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 136.65 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 123.757 0.66 . . . . 0.0 109.687 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -100.97 -46.57 5.06 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.477 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.572 ' N ' HE21 ' A' ' 28' ' ' GLN . 0.0 OUTLIER -51.43 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.704 1.252 . . . . 0.0 111.944 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -90.47 68.96 6.83 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.243 1.021 . . . . 0.0 108.596 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.84 -106.73 0.26 Allowed Glycine 0 N--CA 1.493 2.499 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.463 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.46 160.03 27.64 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CE1' ' CE2' ' A' ' 67' ' ' PHE . 49.2 m-85 -147.61 159.05 44.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.585 0.815 . . . . 0.0 108.879 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -169.8 159.42 7.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 59.7 t80 -135.54 159.87 40.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 t -147.14 91.36 1.98 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.469 1.106 . . . . 0.0 108.269 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -70.33 150.3 46.47 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.075 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.5 p -140.08 -35.26 0.52 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 39' ' ' GLN . . . -174.99 -12.09 0.02 OUTLIER Glycine 0 N--CA 1.479 1.558 0 CA-C-N 112.322 -2.217 . . . . 0.0 108.24 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.41 ' H ' ' H ' ' A' ' 38' ' ' GLY . 24.7 mp0 -112.77 126.81 55.83 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.2 m -81.21 168.43 18.51 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.035 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.91 113.54 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.477 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.55 165.33 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 57' ' ' PHE . 40.0 mt -129.56 102.36 6.34 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.391 0.615 . . . . 0.0 109.639 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 49' ' ' CYS . 59.7 m-85 -84.01 133.42 34.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.718 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -74.23 -8.64 56.9 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -120.64 138.35 53.97 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.27 145.61 1.63 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.94 54.4 11.94 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.974 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.458 ' HA ' ' CG ' ' A' ' 44' ' ' TYR . 25.7 p 44.31 22.29 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.5 t -90.55 45.51 1.27 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.542 0.687 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.81 -130.81 2.04 Favored Glycine 0 N--CA 1.495 2.605 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.387 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.31 144.21 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 124.595 0.821 . . . . 0.0 109.44 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.69 103.69 5.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.517 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.32 -40.2 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.779 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.423 ' HB ' HD12 ' A' ' 43' ' ' LEU . 55.5 m -144.03 164.75 29.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.152 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -147.1 -172.38 3.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.718 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.536 ' CE2' HD11 ' A' ' 43' ' ' LEU . 53.7 m-85 -143.81 104.24 4.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.023 0.827 . . . . 0.0 112.858 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.65 -12.23 55.96 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.1 t -153.8 141.93 20.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 91.2 p -41.16 132.85 2.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.66 121.83 7.76 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 123.994 0.809 . . . . 0.0 111.968 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -83.37 91.85 7.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 60.99 4.6 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 m -57.03 -18.27 13.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -77.2 160.18 76.35 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.82 139.91 68.26 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.091 1.861 . . . . 0.0 109.163 169.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.04 -146.17 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.39 21.2 0.28 Allowed Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.038 -1.077 . . . . 0.0 114.996 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 67' ' ' PHE . 5.3 m-90 -108.15 146.36 32.83 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -84.41 -46.69 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.0 p -131.65 174.7 9.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 124.496 1.123 . . . . 0.0 113.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 3' ' ' PHE . 7.1 tt -136.52 137.37 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 112.699 -2.046 . . . . 0.0 109.967 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.473 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 4.7 t80 -107.98 129.91 55.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.2 mt -119.3 129.63 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -61.61 80.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.789 1.93 . . . . 0.0 114.109 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.319 179.858 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.46 ' HB1' ' HE ' ' A' ' 17' ' ' ARG . . . -153.59 104.69 2.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.945 0.778 . . . . 0.0 110.348 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 32' ' ' TYR . 45.9 t80 -96.87 89.29 4.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -75.42 152.52 37.98 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 m -148.84 158.13 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.693 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.496 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.6 m-90 -134.59 145.44 48.66 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.417 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 84.1 p -61.54 -38.98 89.42 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 167.35 149.71 6.15 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.723 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -78.51 -56.13 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.808 0 N-CA-C 109.34 -1.061 . . . . 0.0 109.34 9.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.77 -132.54 6.18 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 64' ' ' CYS . 25.0 p -89.65 48.23 1.57 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -140.01 80.18 1.75 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.324 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 5.8 p30 171.71 -146.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.575 HH12 HE21 ' A' ' 28' ' ' GLN . 5.6 ptm180 -64.91 171.28 3.6 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.0 23.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -161.18 134.14 6.31 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HE ' ' HB1' ' A' ' 2' ' ' ALA . 78.6 ttt180 -108.23 131.62 54.49 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -110.15 78.7 1.14 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.08 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -116.16 -8.2 11.78 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.98 139.7 58.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 124.052 0.845 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.16 104.71 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.002 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.09 -177.12 19.58 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.126 0.892 . . . . 0.0 113.117 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 m -77.2 143.31 39.12 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.749 -1.225 . . . . 0.0 109.923 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.4 p -148.11 126.69 12.47 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.012 0.82 . . . . 0.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.32 119.47 22.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.354 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.63 115.41 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.134 -1.393 . . . . 0.0 109.451 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -95.2 -29.29 14.61 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.575 HE21 HH12 ' A' ' 14' ' ' ARG . 22.7 mp0 -77.91 95.61 4.81 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.862 0.726 . . . . 0.0 109.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -80.56 40.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.53 -103.3 2.75 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.98 165.06 18.55 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.6 m-85 -150.84 120.54 7.01 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 7.3 m-20 -114.98 106.76 14.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.196 0.31 . . . . 0.0 110.817 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 73.7 t80 -80.95 157.68 25.47 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -148.15 109.12 4.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.353 1.033 . . . . 0.0 108.55 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -84.03 152.21 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 112.483 -2.144 . . . . 0.0 110.536 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.42 52.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.7 -32.0 5.55 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.583 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -94.15 125.3 38.7 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.477 0.656 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.588 HG22 ' H ' ' A' ' 41' ' ' ALA . 23.3 m -86.54 -170.49 3.1 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.584 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.588 ' H ' HG22 ' A' ' 40' ' ' THR . . . -160.23 151.1 18.92 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.76 152.74 41.84 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.536 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.3 mm? -117.22 123.59 47.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.315 0.384 . . . . 0.0 111.359 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 46' ' ' GLN . 96.3 m-85 -115.51 128.86 56.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 125.067 1.479 . . . . 0.0 108.496 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -73.66 13.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 123.877 0.736 . . . . 0.0 112.02 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 44' ' ' TYR . 62.1 mm-40 -133.67 127.26 32.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.46 139.03 2.2 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.58 50.69 56.29 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.783 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 79.4 m 50.27 23.49 1.22 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.4 m -83.93 40.79 0.77 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.402 0.62 . . . . 0.0 112.424 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -156.17 -149.96 5.5 Favored Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.237 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.85 145.74 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.76 164.95 4.28 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 123.929 0.768 . . . . 0.0 111.921 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -146.59 -48.85 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.441 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -133.07 152.27 51.97 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.134 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -141.03 119.17 12.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.448 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 30.5 m-85 -97.06 122.0 39.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.091 0.87 . . . . 0.0 111.35 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.65 24.38 4.91 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.0 p -165.46 128.9 2.23 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.595 -0.802 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.0 m -41.27 110.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.12 0.887 . . . . 0.0 111.967 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.16 91.58 3.56 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.271 0.982 . . . . 0.0 111.19 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 92.4 mtt-85 -74.29 79.96 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.39 144.96 25.32 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.136 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.454 ' HB3' ' H ' ' A' ' 11' ' ' CYS . 66.8 m -134.73 47.02 2.4 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.446 1.117 . . . . 0.0 109.242 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -140.75 154.95 69.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.683 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -55.83 156.11 20.33 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.988 2.459 . . . . 0.0 111.611 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -123.49 -135.63 0.29 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.866 0.729 . . . . 0.0 112.182 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.28 -3.33 0.06 OUTLIER Glycine 0 N--CA 1.497 2.75 0 CA-C-O 118.601 -1.11 . . . . 0.0 115.251 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.536 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 3.0 m-90 -90.62 166.57 13.11 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.77 1.285 . . . . 0.0 110.395 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -100.19 -41.58 7.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.828 0.705 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.8 p -138.1 177.09 8.14 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.314 1.009 . . . . 0.0 112.391 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.447 HD13 ' CB ' ' A' ' 3' ' ' PHE . 15.3 tt -144.39 127.33 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.695 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.615 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 7.3 t80 -84.85 94.4 8.73 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.406 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -76.9 116.26 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.366 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -68.66 137.12 53.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 123.906 0.754 . . . . 0.0 110.407 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.672 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.93 121.13 26.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.463 ' CG ' HD13 ' A' ' 72' ' ' ILE . 33.3 t80 -92.78 173.86 7.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.1 m -158.84 152.85 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -150.91 158.18 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.671 1.232 . . . . 0.0 108.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.1 m-90 -132.5 145.85 51.48 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -52.43 -42.71 64.33 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 145.08 152.55 5.65 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -82.07 -60.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 123.15 1.079 . . . . 0.0 111.53 17.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.56 -141.55 11.09 Favored Glycine 0 N--CA 1.485 1.917 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 p -94.31 44.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.656 -1.272 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -123.21 -129.3 0.26 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 38.2 -144.31 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -76.81 128.27 34.3 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 6' ' ' TRP . . . -94.43 154.02 17.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.186 0.929 . . . . 0.0 112.266 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -161.64 118.51 2.17 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -86.38 157.1 19.93 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.463 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -136.53 61.49 1.63 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.054 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.4 p -94.43 6.51 48.52 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.008 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.56 118.25 7.92 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 103.83 0.25 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.458 1.099 . . . . 0.0 108.196 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.71 -164.33 18.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.88 150.21 30.67 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 p -160.24 132.12 6.09 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.961 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.21 115.91 19.15 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.04 105.75 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.545 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -96.2 -16.68 21.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 113.987 -1.461 . . . . 0.0 113.67 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -76.09 94.81 3.52 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.39 0.614 . . . . 0.0 110.312 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -83.91 60.27 5.72 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.145 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.59 -90.04 0.68 Allowed Glycine 0 N--CA 1.496 2.688 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.19 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.86 169.12 21.64 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 47.4 p90 -161.73 135.36 6.5 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.57 158.74 24.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.543 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 58.9 t80 -130.03 157.36 42.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -146.94 100.31 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 124.069 0.856 . . . . 0.0 110.128 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -81.12 149.1 29.31 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.644 -1.617 . . . . 0.0 107.835 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -168.48 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.092 0.87 . . . . 0.0 109.342 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.99 -43.17 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.25 166.87 22.75 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.3 p -87.63 -174.58 4.84 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 113.305 -1.77 . . . . 0.0 111.105 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -158.11 113.68 2.71 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.605 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.66 157.05 27.33 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 43' ' ' LEU . 10.7 tp -126.38 94.64 4.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.851 0.834 . . . . 0.0 109.907 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -79.86 141.42 36.17 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.603 -1.635 . . . . 0.0 114.094 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.26 23.09 12.99 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.256 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.75 141.65 49.57 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.056 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.9 132.89 37.81 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.102 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.16 68.49 Favored Glycine 0 N--CA 1.495 2.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.173 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.2 m 54.33 29.15 10.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.356 0.68 . . . . 0.0 112.438 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.6 p -85.98 52.07 2.38 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.979 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.61 -121.91 0.61 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.86 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.12 150.17 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.59 178.93 1.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.142 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.534 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 18.6 t-80 -139.3 -69.55 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.888 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -118.16 83.07 1.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.127 0.892 . . . . 0.0 108.824 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 57' ' ' PHE . 5.1 tmm_? -70.57 162.19 29.32 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.6 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.543 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 51.4 m-85 -131.11 135.76 47.78 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.43 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.73 -2.57 4.34 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.1 m -152.58 136.82 16.58 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.3 m -38.05 112.33 0.21 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.153 0.908 . . . . 0.0 111.15 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.71 106.9 11.35 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 124.279 0.987 . . . . 0.0 113.196 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -80.73 75.2 7.64 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.69 165.28 13.79 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.493 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.3 m -149.92 4.91 0.57 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -69.07 152.44 96.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.537 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.6 150.13 88.77 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.777 2.318 . . . . 0.0 110.198 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' HD2' ' H ' ' A' ' 69' ' ' TRP . 38.9 p90 -154.43 -172.65 4.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 123.985 0.803 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.15 54.77 0.36 Allowed Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.557 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.534 ' HE1' ' CB ' ' A' ' 54' ' ' HIS . 1.9 m-90 -88.4 150.33 23.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 11.6 mptt -86.0 -22.83 27.1 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.504 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.1 p -175.66 167.81 3.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.628 1.205 . . . . 0.0 113.131 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.463 HD13 ' CG ' ' A' ' 3' ' ' PHE . 7.3 tt -130.7 130.3 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 112.393 -2.185 . . . . 0.0 107.838 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.95 93.28 4.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.484 1.115 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.5 mm -72.53 113.4 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 113.723 -1.58 . . . . 0.0 107.887 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.433 HE21 ' HA ' ' A' ' 75' ' ' GLN . 3.7 mm-40 -64.35 108.83 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.743 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.405 ' N ' ' H ' ' A' ' 38' ' ' GLY . 71.5 p . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 130.02 11.55 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CB ' HD13 ' A' ' 72' ' ' ILE . 79.7 t80 -93.74 91.21 6.89 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.94 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.0 m -73.39 148.87 42.95 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.42 137.01 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 123.801 0.688 . . . . 0.0 109.684 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.562 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 19.9 m-90 -112.93 155.22 25.11 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -66.66 -42.55 86.46 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.97 156.04 9.14 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.142 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -76.97 -51.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.753 0 O-C-N 122.651 0.816 . . . . 0.0 110.786 8.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.97 -111.16 3.04 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.7 p -111.99 53.4 0.73 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -138.19 69.41 1.39 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 2.3 p30 178.31 -144.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.423 HH22 ' CG ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -79.72 177.57 8.79 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.375 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -162.17 178.8 8.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' CG ' HH22 ' A' ' 14' ' ' ARG . 59.9 mt-10 -143.38 121.76 12.35 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 112.899 -1.955 . . . . 0.0 107.725 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -100.51 100.03 10.72 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.147 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.9 92.58 6.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -103.23 -31.18 10.22 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -60.22 127.89 34.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 123.827 0.704 . . . . 0.0 109.251 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.4 p -69.92 123.45 21.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.489 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.8 176.55 28.08 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.1 m -82.44 74.14 9.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.258 0.622 . . . . 0.0 109.609 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -85.28 132.12 34.31 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.282 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 142.48 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.76 149.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -142.39 14.87 2.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.903 0.752 . . . . 0.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -103.37 104.57 14.69 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.189 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -90.1 59.03 4.34 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.844 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.2 -78.15 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.553 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.75 175.39 32.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -161.01 131.79 5.31 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 8.1 m-20 -115.39 103.72 11.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.562 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.61 154.81 29.97 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -142.42 103.46 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 124.35 1.031 . . . . 0.0 108.224 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.53 113.57 15.47 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.184 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.8 p -146.28 -39.67 0.22 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' H ' ' N ' ' A' ' 1' ' ' SER . . . -91.99 -62.04 1.19 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -160.35 177.78 10.26 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.984 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.8 p -66.27 174.64 2.53 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.629 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.39 124.43 3.62 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.78 167.75 11.24 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.559 HD12 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -130.32 105.16 7.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.304 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -86.04 147.92 25.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.445 HD21 ' HB2' ' A' ' 54' ' ' HIS . 27.2 m-80 -96.42 14.23 25.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.061 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.451 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 56.8 mm-40 -138.21 141.33 40.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.62 128.34 20.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 124.553 1.158 . . . . 0.0 112.14 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.52 53.24 33.13 Favored Glycine 0 N--CA 1.496 2.642 0 CA-C-N 114.306 -1.315 . . . . 0.0 112.652 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 76.8 m 51.67 29.21 5.43 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.1 m -81.59 34.73 0.39 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.797 0.808 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.451 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.94 -145.38 4.28 Favored Glycine 0 N--CA 1.494 2.511 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.965 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.27 153.15 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 113.823 -1.189 . . . . 0.0 108.527 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.21 -169.08 0.46 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.58 0.55 . . . . 0.0 111.314 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.472 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 5.7 t60 -153.93 -59.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.708 0.63 . . . . 0.0 110.249 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.1 m -112.9 119.84 39.36 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.243 0.964 . . . . 0.0 111.661 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -94.07 149.08 21.56 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.633 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.47 148.27 52.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.864 0.727 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.52 -3.7 0.08 OUTLIER Glycine 0 N--CA 1.494 2.561 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.086 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -156.11 135.3 12.14 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -37.72 117.08 0.54 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.68 85.08 2.06 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.95 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 68.8 mtp85 -73.41 71.51 1.29 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.97 152.44 20.7 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.884 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 63.6 m -134.33 40.07 3.03 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -113.03 143.38 29.03 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.392 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -63.07 170.9 6.9 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.367 2.044 . . . . 0.0 111.325 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.36 -169.87 2.45 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.066 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.96 58.1 0.46 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.559 ' CG ' HD12 ' A' ' 43' ' ' LEU . 5.0 m-90 -105.54 146.28 29.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.62 -46.24 10.96 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.099 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.1 p -153.99 156.35 37.26 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.962 1.414 . . . . 0.0 113.088 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.441 HD13 ' CB ' ' A' ' 3' ' ' PHE . 6.2 tt -112.67 131.28 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.69 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.567 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 13.6 t80 -100.51 88.43 3.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.481 1.113 . . . . 0.0 111.124 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -85.58 137.82 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -89.71 170.53 10.37 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.178 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 116.166 -1.873 . . . . 0.0 111.358 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.91 141.72 5.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.927 0.767 . . . . 0.0 112.088 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.577 ' CG ' HD13 ' A' ' 72' ' ' ILE . 50.8 t80 -92.57 140.9 29.08 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.4 m -128.6 151.03 49.94 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.4 ' CG1' ' CE2' ' A' ' 3' ' ' PHE . 16.2 m -147.34 166.77 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 124.153 0.908 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 30.5 m-90 -141.47 133.35 27.42 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 88.8 p -43.5 -33.51 1.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 134.99 154.11 6.99 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -82.58 -57.93 0.1 OUTLIER 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.315 1.166 . . . . 0.0 111.151 13.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.64 -145.34 14.98 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.03 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 63' ' ' ALA . 76.2 m -93.3 50.42 1.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.59 -1.305 . . . . 0.0 111.886 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.64 -126.97 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.8 p30 37.76 -141.88 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 119.57 1.077 . . . . 0.0 113.734 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 58.2 ttp180 -69.89 154.41 41.99 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -127.52 111.65 14.03 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.432 0.457 . . . . 0.0 112.135 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -117.54 166.77 11.98 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -151.71 157.0 41.46 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.613 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -142.38 93.61 2.55 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.4 p -100.05 -11.37 20.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -55.74 128.19 33.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 123.856 0.723 . . . . 0.0 111.516 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.66 167.3 17.27 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.0 -84.26 1.29 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.3 p -174.31 157.31 2.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.497 0.763 . . . . 0.0 111.062 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -160.19 146.76 15.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.246 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.72 163.65 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.827 0.705 . . . . 0.0 109.623 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mt -134.57 151.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.674 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -23.07 4.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.205 0.941 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HG3' HH21 ' A' ' 14' ' ' ARG . 16.6 mp0 -82.76 97.34 8.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.939 0.774 . . . . 0.0 110.808 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -82.95 12.97 4.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.37 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.76 -112.97 0.39 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.266 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.6 159.44 19.75 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 124.982 1.048 . . . . 0.0 110.837 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -161.28 131.64 5.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.456 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 8.2 t70 -104.47 174.87 5.69 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.151 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 65.3 t80 -148.8 157.89 43.76 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.406 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 55.4 m -139.23 139.06 37.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -122.18 138.85 54.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 124.903 1.377 . . . . 0.0 113.202 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.4 p -152.35 66.68 0.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.89 36.5 93.37 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -153.63 99.49 2.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -71.97 157.48 37.75 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.08 166.42 15.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.712 1.258 . . . . 0.0 110.314 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.78 152.21 40.0 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.125 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 80.9 mt -113.17 98.63 7.26 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.385 1.088 . . . . 0.0 110.071 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.39 115.2 14.8 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.638 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -48.46 -65.22 0.6 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.012 1.445 . . . . 0.0 109.97 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.57 155.89 36.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.402 1.064 . . . . 0.0 112.142 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.54 179.44 7.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.503 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.37 54.3 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.977 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 24.0 m 59.35 30.7 20.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.7 p -115.84 35.7 4.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.719 0.771 . . . . 0.0 111.269 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.97 157.6 15.08 Favored Glycine 0 N--CA 1.493 2.496 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.13 149.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.91 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.713 0.768 . . . . 0.0 109.296 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.428 ' HB3' ' HE1' ' A' ' 69' ' ' TRP . 21.5 t-80 -79.69 -23.34 42.49 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.266 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.467 ' HB ' HD12 ' A' ' 43' ' ' LEU . 50.0 m -146.92 136.34 22.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.958 0.787 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -114.52 147.33 39.55 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.33 1.019 . . . . 0.0 111.79 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 21.7 m-85 -132.31 98.61 4.44 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.44 1.088 . . . . 0.0 108.248 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.54 12.14 66.41 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.3 t -164.47 142.14 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.6 p -40.51 127.9 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.141 0.9 . . . . 0.0 111.916 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 33' ' ' ASP . . . -132.56 113.34 12.94 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 124.051 0.844 . . . . 0.0 112.767 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -81.26 71.36 8.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.396 1.06 . . . . 0.0 112.803 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.406 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . -91.28 157.98 16.83 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.379 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.2 m -147.39 10.06 0.96 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.55 0.69 . . . . 0.0 109.567 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -74.68 167.78 33.16 Favored Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.729 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -56.29 144.51 81.86 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.205 1.936 . . . . 0.0 111.936 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -73.99 167.42 21.54 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.14 17.13 1.18 Allowed Glycine 0 N--CA 1.501 3.014 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.47 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.476 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.0 m-90 -138.43 -166.65 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -129.98 -36.71 1.54 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.7 p -134.09 168.87 18.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 124.306 1.004 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.577 HD13 ' CG ' ' A' ' 3' ' ' PHE . 3.3 tt -130.78 121.47 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.533 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -98.02 119.05 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.889 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.9 mt -117.94 150.3 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -74.28 -179.75 4.09 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 116.896 -1.526 . . . . 0.0 109.799 179.804 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.78 121.37 2.85 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.188 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.489 ' CG ' HD13 ' A' ' 72' ' ' ILE . 76.8 t80 -93.63 102.56 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.173 0.92 . . . . 0.0 110.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.6 m -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -151.82 138.64 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 123.774 0.672 . . . . 0.0 110.086 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.53 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 24.9 m-90 -109.3 150.48 27.91 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.1 p -61.35 -38.76 88.1 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.98 153.64 6.66 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.88 -56.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.769 0 O-C-N 122.858 0.925 . . . . 0.0 109.982 7.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.19 -132.35 6.27 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.06 54.98 1.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -139.42 64.2 1.47 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.004 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 4.7 p30 -178.46 -150.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.76 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -72.05 169.62 15.6 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.94 173.66 12.22 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -151.11 140.41 21.34 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.056 -1.884 . . . . 0.0 107.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -110.93 153.06 26.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 123.735 0.647 . . . . 0.0 111.243 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -139.5 75.17 1.5 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -105.71 -20.97 13.29 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.179 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.59 135.13 57.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 123.632 0.583 . . . . 0.0 110.338 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -60.64 109.35 1.01 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 124.465 1.103 . . . . 0.0 110.35 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.66 166.95 13.7 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.8 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 m -78.73 74.8 5.26 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.618 -1.291 . . . . 0.0 109.88 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -80.6 136.0 36.16 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -78.44 126.86 31.36 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.427 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.3 mp -89.22 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -135.76 -29.92 1.01 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 123.707 0.63 . . . . 0.0 112.045 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -78.85 104.53 9.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.787 0.679 . . . . 0.0 109.279 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -90.26 18.27 6.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 124.347 1.03 . . . . 0.0 113.675 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.01 -87.59 0.25 Allowed Glycine 0 N--CA 1.497 2.745 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.297 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.23 169.83 20.44 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -161.62 132.17 5.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 2.9 t70 -107.05 166.06 10.89 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.321 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 68.6 t80 -145.7 151.89 38.75 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -132.62 151.48 51.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -135.71 133.91 38.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 124.213 0.946 . . . . 0.0 110.473 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.0 p -149.67 70.03 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.61 98.11 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.844 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -158.37 115.37 2.84 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.153 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 m -83.25 165.84 19.05 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.122 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.63 162.08 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.643 -1.617 . . . . 0.0 108.301 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.53 137.28 21.52 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.86 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' A' ' 69' ' ' TRP . 3.9 mm? -91.71 158.71 16.22 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -147.74 121.29 9.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 125.28 1.612 . . . . 0.0 109.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.418 HD21 ' CD2' ' A' ' 54' ' ' HIS . 95.0 m-20 -66.3 -8.03 22.46 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.456 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -122.95 134.08 54.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 124.074 0.859 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 133.57 8.1 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.844 -1.526 . . . . 0.0 115.006 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.01 44.49 83.11 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.7 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 71.9 m 52.17 31.9 9.79 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.2 p -82.73 29.43 0.45 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.207 1.003 . . . . 0.0 112.796 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.2 -175.17 31.94 Favored Glycine 0 N--CA 1.49 2.258 0 CA-C-N 113.219 -1.809 . . . . 0.0 108.863 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -81.9 156.5 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.78 161.92 28.85 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.589 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.418 ' CD2' HD21 ' A' ' 45' ' ' ASN . 57.2 t-80 -123.37 -32.42 3.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 124.346 1.029 . . . . 0.0 110.459 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -141.06 167.42 22.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.998 0.812 . . . . 0.0 109.085 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -143.29 143.4 31.69 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.498 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 23.0 m-85 -139.36 105.2 5.16 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.058 0.849 . . . . 0.0 110.184 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.19 31.44 5.46 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.0 t -175.51 127.25 0.25 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -30.64 111.19 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 124.507 1.13 . . . . 0.0 113.074 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.478 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -120.29 93.68 4.13 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 124.306 1.004 . . . . 0.0 109.831 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -81.97 68.03 8.2 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.23 -1.35 . . . . 0.0 113.168 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.78 169.18 12.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.794 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.0 m -149.31 39.84 0.84 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.409 1.1 . . . . 0.0 108.439 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -100.44 165.55 14.2 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 112.741 -2.027 . . . . 0.0 109.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.06 164.79 33.56 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.539 2.159 . . . . 0.0 110.339 164.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.54 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 30.9 p90 -162.26 -163.72 0.96 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.511 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.47 43.32 0.43 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.55 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CE3' ' CD2' ' A' ' 67' ' ' PHE . 4.8 m-90 -91.73 133.38 35.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.77 -48.93 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 37.3 p -135.57 169.8 16.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.988 1.43 . . . . 0.0 112.743 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.489 HD13 ' CG ' ' A' ' 3' ' ' PHE . 10.9 tt -140.31 119.26 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.95 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.672 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 37.1 t80 -84.2 121.06 26.95 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.144 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.4 mm -108.7 132.41 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -85.7 -179.9 6.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.895 0.747 . . . . 0.0 110.024 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 115.532 -2.175 . . . . 0.0 110.23 179.77 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.96 132.22 11.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CG ' HD13 ' A' ' 72' ' ' ILE . 85.2 t80 -95.75 93.59 7.18 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.895 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.6 m -72.51 152.3 41.97 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 28' ' ' GLN . 33.2 m -150.01 155.13 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 124.267 0.979 . . . . 0.0 110.88 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.57 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.0 m-90 -133.93 157.23 46.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.5 p -60.45 -40.55 91.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.496 1.123 . . . . 0.0 113.127 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 134.1 157.05 8.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.2 -45.22 0.37 Allowed 'Cis proline' 0 N--CA 1.493 1.477 0 O-C-N 123.152 1.08 . . . . 0.0 111.386 19.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.29 -137.75 8.84 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -105.44 40.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.189 -1.506 . . . . 0.0 107.349 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -140.65 68.16 1.35 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.57 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -169.83 -88.17 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.556 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -90.46 91.73 8.58 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.248 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 115.06 5.22 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.821 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -145.98 154.58 42.05 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -151.05 151.61 32.26 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.0 93.79 4.14 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.477 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.4 p -105.65 -26.81 11.68 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -52.11 145.08 11.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 123.958 0.786 . . . . 0.0 112.912 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 t -65.67 168.36 7.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.183 0.927 . . . . 0.0 109.349 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.49 -177.63 43.28 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 107.194 -2.362 . . . . 0.0 107.194 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 29.7 p -96.34 142.65 28.21 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.213 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.7 p -127.24 140.22 52.38 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.708 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.36 122.08 25.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 123.865 0.728 . . . . 0.0 109.776 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.54 150.06 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.823 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -134.41 -13.55 2.32 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.24 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 21.5 mm-40 -86.2 84.72 7.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 123.07 1.414 . . . . 0.0 109.807 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -89.99 64.67 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.886 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.29 -58.26 0.06 OUTLIER Glycine 0 N--CA 1.495 2.621 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.533 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.1 168.74 35.84 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -161.1 132.03 5.35 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.152 -1.019 . . . . 0.0 113.723 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -114.15 104.47 12.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.781 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.487 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 79.0 t80 -82.68 153.42 25.37 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -146.04 100.79 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.277 0.986 . . . . 0.0 109.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -72.04 134.45 45.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.199 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.1 p -146.58 55.11 1.13 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.93 -23.56 13.6 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 113.863 -1.517 . . . . 0.0 110.555 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -99.13 125.83 44.76 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.175 0.512 . . . . 0.0 111.501 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 m -85.98 164.84 17.16 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.89 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.61 171.04 13.03 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.33 131.42 6.5 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.346 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.546 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -96.49 116.73 29.55 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.632 0.729 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -99.43 122.62 42.79 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 0.0 110.567 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -74.55 -1.39 21.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.64 139.4 47.12 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 138.75 56.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 124.018 0.824 . . . . 0.0 110.775 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.519 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 52.91 43.95 61.35 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.8 p 39.33 40.04 0.51 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.3 m -89.25 42.02 1.07 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.973 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.68 -122.18 0.62 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.388 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.59 153.07 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.64 -174.91 0.34 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.34 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 52.4 t-80 -148.55 -45.58 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.819 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -138.91 116.02 10.99 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.058 0.849 . . . . 0.0 109.428 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -96.28 152.27 18.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.863 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 17.9 m-85 -131.2 114.8 15.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.064 0.853 . . . . 0.0 110.153 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.48 11.42 28.26 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 p -161.05 135.62 7.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 123.979 0.458 . . . . 0.0 110.437 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 m -39.67 115.82 0.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.319 1.012 . . . . 0.0 112.408 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.04 93.73 4.19 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.205 0.941 . . . . 0.0 109.242 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -74.48 75.37 1.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.333 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.35 161.87 15.41 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.201 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 m -148.1 58.44 1.1 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.079 0.943 . . . . 0.0 110.307 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.49 153.42 43.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 113.751 -1.568 . . . . 0.0 108.864 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.98 178.37 2.43 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.354 2.036 . . . . 0.0 110.28 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.25 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.072 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.89 19.15 3.74 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-O 118.504 -1.165 . . . . 0.0 114.033 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.546 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 5.1 m-90 -91.87 161.0 15.02 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 118.852 1.326 . . . . 0.0 111.014 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.63 -41.39 7.74 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.162 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 p -146.28 -179.94 7.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.432 1.082 . . . . 0.0 110.985 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.51 HD13 ' CG ' ' A' ' 3' ' ' PHE . 11.0 tt -146.5 117.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.369 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.59 114.16 19.29 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.062 -1.881 . . . . 0.0 108.772 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.65 140.02 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.54 150.74 29.48 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.142 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 116.576 -1.678 . . . . 0.0 110.373 179.888 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.043 0.449 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 19' ' ' SER . . . -152.29 103.99 2.9 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.185 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.458 ' CB ' HD13 ' A' ' 72' ' ' ILE . 85.4 t80 -96.69 90.69 5.39 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.07 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -77.49 154.57 32.39 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 16' ' ' GLU . 12.4 m -148.28 166.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 123.703 0.627 . . . . 0.0 109.397 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.465 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 29.4 m-90 -141.88 139.64 32.66 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -51.95 -41.15 61.84 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.494 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.12 151.03 5.47 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -79.07 -62.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.592 0 O-C-N 122.975 0.987 . . . . 0.0 111.396 19.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.18 -129.41 6.55 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 p -95.5 49.96 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.292 -0.954 . . . . 0.0 111.373 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' N ' ' ND2' ' A' ' 12' ' ' ASN . 2.3 m-80 -124.33 -132.01 0.26 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.494 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.9 p30 36.66 -150.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -78.63 -176.75 5.02 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -153.17 159.79 42.75 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 60.1 mm-40 -139.78 163.76 31.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 111.724 -2.489 . . . . 0.0 104.677 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -146.87 136.39 22.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -117.27 73.83 0.89 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.683 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 76.2 p -95.9 -5.63 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.032 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -66.71 111.74 3.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.084 0.865 . . . . 0.0 108.872 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 7.0 p -64.85 114.95 4.85 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.028 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.37 -95.83 0.16 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.58 -1.295 . . . . 0.0 114.405 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -156.19 133.06 10.43 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.612 0.831 . . . . 0.0 110.118 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -160.24 134.22 7.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.473 0.483 . . . . 0.0 112.021 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.76 126.09 30.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.402 ' H ' ' HA ' ' A' ' 71' ' ' SER . 24.8 mt -86.39 150.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -137.03 0.64 2.39 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.758 0.661 . . . . 0.0 111.027 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -101.26 101.16 11.79 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.836 0.827 . . . . 0.0 109.596 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -79.53 -2.97 44.66 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.662 -1.608 . . . . 0.0 113.749 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.58 -101.89 0.03 OUTLIER Glycine 0 N--CA 1.497 2.722 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.38 166.22 14.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 63' ' ' ALA . 30.8 p90 -161.45 145.27 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.84 152.51 43.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -121.5 157.02 31.54 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 t -145.59 101.24 3.54 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -70.67 137.46 49.86 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 111.952 -2.385 . . . . 0.0 108.778 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.6 m -143.52 61.89 1.38 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.66 -14.05 10.81 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.711 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -113.49 125.04 53.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 120.933 0.396 . . . . 0.0 111.693 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.1 m -80.15 162.18 24.86 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.45 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.17 174.3 6.41 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.419 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.1 140.97 19.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.638 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -112.56 133.04 54.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 123.639 0.587 . . . . 0.0 111.554 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -117.77 134.28 55.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 125.033 1.458 . . . . 0.0 111.601 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -66.93 -36.57 82.53 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.065 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -92.4 119.72 32.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.971 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -39.13 146.99 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 125.433 1.708 . . . . 0.0 113.814 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.5 39.42 93.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.409 ' H ' ' CB ' ' A' ' 71' ' ' SER . 31.1 p 43.79 35.85 1.17 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 125.007 1.063 . . . . 0.0 111.543 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -90.23 46.05 1.32 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.205 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.44 -135.57 1.86 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.307 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.47 154.61 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.196 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.13 178.32 1.91 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.437 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -156.56 -40.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.1 m -142.95 129.33 20.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.979 0.799 . . . . 0.0 110.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.91 135.32 54.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -115.36 114.0 24.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.776 0.673 . . . . 0.0 110.663 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.84 13.05 38.35 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 p -164.34 136.14 4.6 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m -41.1 121.6 1.6 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.11 0.881 . . . . 0.0 111.724 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.25 111.76 9.9 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -78.2 76.21 4.72 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 123.775 0.672 . . . . 0.0 111.294 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . . . -90.91 71.92 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.389 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.5 m -62.23 -6.91 3.48 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -70.87 164.13 58.75 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.52 178.57 2.57 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.62 2.213 . . . . 0.0 111.614 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 -149.26 0.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.07 15.74 0.43 Allowed Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.161 0.913 . . . . 0.0 110.855 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.638 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 1.9 m-90 -100.93 126.22 47.55 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -90.45 2.79 55.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.143 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 49' ' ' CYS . 27.1 p -163.58 173.66 12.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.05 0.844 . . . . 0.0 112.468 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.458 HD13 ' CB ' ' A' ' 3' ' ' PHE . 6.7 tt -149.27 123.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.128 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -99.51 127.41 45.57 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -131.9 143.98 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -72.54 164.88 25.73 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.043 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 116.883 -1.532 . . . . 0.0 110.566 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 96.92 2.92 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 121.004 0.431 . . . . 0.0 111.291 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 64.7 t80 -97.31 101.99 13.66 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.5 m -84.38 155.54 22.25 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -150.71 161.03 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 123.31 0.381 . . . . 0.0 111.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.642 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 21.2 m-90 -145.98 140.14 26.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 m -55.19 -21.77 14.96 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' CA ' ' HA3' ' A' ' 30' ' ' GLY . . . 124.46 163.94 11.81 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 123.782 0.676 . . . . 0.0 111.47 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.3 -54.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.678 0 O-C-N 123.058 1.031 . . . . 0.0 111.462 13.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.07 -123.55 4.57 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 75.3 m -122.16 80.2 1.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -147.79 -54.73 0.21 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.305 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.642 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.6 p30 -49.31 -120.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -65.99 80.9 0.08 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.66 110.26 3.65 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -131.45 172.66 11.93 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -153.38 158.67 41.83 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.735 -0.786 . . . . 0.0 113.119 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -136.77 80.16 1.8 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.843 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.1 t -108.68 1.33 21.12 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.687 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -61.4 118.64 7.22 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.781 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -62.29 102.13 0.28 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.322 1.014 . . . . 0.0 108.946 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.33 -118.48 1.02 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.3 t -140.71 154.59 46.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 124.315 0.656 . . . . 0.0 111.762 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 p -160.15 139.54 10.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.88 140.97 38.02 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.673 0.608 . . . . 0.0 111.772 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 72' ' ' ILE . 19.2 mt -117.56 127.29 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.815 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -125.7 32.85 5.21 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.046 0.841 . . . . 0.0 108.779 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.409 ' H ' HG22 ' A' ' 26' ' ' ILE . 30.4 mm-40 -113.47 99.27 7.64 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.284 -1.325 . . . . 0.0 108.285 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.14 18.26 6.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 111.85 -2.432 . . . . 0.0 112.491 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.497 ' HA3' ' CA ' ' A' ' 8' ' ' GLY . . . -92.24 -74.64 1.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.908 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 64' ' ' CYS . . . -152.84 164.46 30.79 Favored Glycine 0 N--CA 1.486 2.006 0 CA-C-N 113.836 -1.182 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 23.4 p90 -161.23 132.25 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.79 161.8 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.362 -1.744 . . . . 0.0 107.253 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -142.25 153.16 43.73 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -146.86 114.03 6.23 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.654 1.222 . . . . 0.0 108.203 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.2 112.49 17.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 112.357 -2.201 . . . . 0.0 105.295 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.4 m -132.66 -66.6 0.67 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.74 -70.05 1.31 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -141.31 -168.52 2.65 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.226 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -77.17 -167.95 1.0 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.122 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.12 142.04 12.89 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.687 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.41 149.32 38.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.266 0.979 . . . . 0.0 108.818 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 55' ' ' THR . 38.1 mt -114.16 101.35 9.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.747 0.654 . . . . 0.0 111.3 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.53 144.92 26.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.368 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -91.99 -0.19 57.48 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.423 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 85.2 mm-40 -113.89 148.26 37.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 123.553 0.533 . . . . 0.0 110.137 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.72 134.03 55.86 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.827 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.33 30.85 77.33 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.433 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.7 m 54.7 29.42 11.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 124.61 0.829 . . . . 0.0 112.623 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 t -88.45 59.81 5.36 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.868 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -157.48 -125.45 0.85 Allowed Glycine 0 N--CA 1.495 2.599 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.834 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.79 144.08 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.2 121.88 21.01 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.484 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.78 -60.29 2.41 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.442 ' HB ' HD12 ' A' ' 43' ' ' LEU . 94.1 m -124.49 148.87 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.697 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.97 -177.89 4.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 123.545 0.528 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 43' ' ' LEU . 44.3 m-85 -141.32 158.08 44.36 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.685 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 59' ' ' SER . . . -148.08 -11.87 0.15 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.412 ' H ' ' H ' ' A' ' 58' ' ' GLY . 67.2 m -151.35 147.18 26.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -41.47 117.84 0.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.929 0.768 . . . . 0.0 112.78 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.8 99.82 7.37 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.331 1.02 . . . . 0.0 109.428 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -84.79 70.18 10.8 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.39 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.24 165.47 13.44 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 31' ' ' GLY . 67.4 m -150.85 26.64 0.73 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.842 0.83 . . . . 0.0 111.958 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -97.25 168.51 10.09 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.111 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.34 178.49 0.86 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.364 2.043 . . . . 0.0 110.946 163.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.85 -151.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.21 49.17 0.4 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 4.2 m-90 -127.37 142.17 51.5 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 1.8 tpmt? -93.85 -20.74 19.78 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.5 p -161.93 178.43 8.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 124.29 0.993 . . . . 0.0 112.052 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' A' ' 26' ' ' ILE . 11.0 tt -140.4 123.85 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.52 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -91.47 84.64 5.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.931 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.4 mm -69.19 125.05 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -72.06 136.21 46.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.805 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.55 0 CA-C-N 113.316 -1.766 . . . . 0.0 111.549 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.66 134.56 5.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CG ' HD13 ' A' ' 72' ' ' ILE . 88.5 t80 -101.76 107.06 18.16 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.886 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.8 m -91.75 152.3 20.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 28' ' ' GLN . 10.7 m -154.46 152.92 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.719 0.637 . . . . 0.0 111.062 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.415 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 18.1 m-90 -122.63 153.28 39.55 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 23.3 t -55.93 -50.56 70.39 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 163.61 154.17 7.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -80.05 -56.0 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 118.273 1.037 . . . . 0.0 110.075 12.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.5 -136.32 8.28 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -87.85 42.33 1.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.3 -0.95 . . . . 0.0 112.554 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.444 ' N ' ' ND2' ' A' ' 12' ' ' ASN . 1.9 m-80 -111.93 -135.0 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 7' ' ' SER . 6.8 p30 34.8 -141.21 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -89.44 156.74 18.47 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.02 171.61 7.28 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.905 0.753 . . . . 0.0 111.991 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -171.82 125.44 0.57 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -98.42 155.49 17.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -138.16 94.84 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.4 p -130.42 13.69 5.53 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.604 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -54.75 128.5 33.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.632 0.582 . . . . 0.0 110.959 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.4 t -69.55 94.22 0.75 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.457 1.123 . . . . 0.0 108.913 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.29 -106.06 0.36 Allowed Glycine 0 N--CA 1.488 2.129 1 N-CA-C 101.287 -4.725 . . . . 0.0 101.287 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.26 164.29 25.05 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.992 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 p -158.1 148.3 20.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.29 126.62 31.03 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.388 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mt -78.78 148.9 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.576 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -124.92 -32.36 3.05 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.288 0.993 . . . . 0.0 111.615 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 14.1 mm-40 -71.63 97.44 1.72 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.146 0.974 . . . . 0.0 110.636 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -90.42 61.29 4.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.369 -2.196 . . . . 0.0 109.545 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.98 -89.82 0.25 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.37 157.54 17.64 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' HG12 ' A' ' 5' ' ' VAL . 3.3 m-85 -143.99 117.44 9.11 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.775 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -126.83 153.12 46.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.056 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 92.5 t80 -133.35 155.07 50.13 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -137.11 131.26 32.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -109.69 148.34 31.54 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.411 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -166.56 55.12 0.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.52 -33.84 4.02 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.42 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -82.06 120.78 25.72 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.451 0.643 . . . . 0.0 110.726 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 m -91.9 168.78 11.18 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.201 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.04 147.28 23.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 123.63 0.581 . . . . 0.0 112.275 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.26 150.23 29.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.477 HD21 ' CE3' ' A' ' 69' ' ' TRP . 25.8 tp -120.11 108.68 14.55 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -89.09 124.16 34.05 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.123 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 57.5 t-20 -63.56 -41.81 98.39 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.152 -1.84 . . . . 0.0 106.66 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.564 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -78.93 157.43 28.22 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.274 -1.785 . . . . 0.0 108.06 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.1 172.94 6.04 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 33.96 44.79 0.37 Allowed Glycine 0 N--CA 1.505 3.251 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.601 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.9 p 34.35 61.64 0.53 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 125.218 1.187 . . . . 0.0 113.214 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 46' ' ' GLN . 70.9 m -78.31 -154.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.641 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.02 162.26 49.88 Favored Glycine 0 N--CA 1.498 2.815 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.258 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t 61.87 107.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 113.416 -1.392 . . . . 0.0 112.381 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.95 -174.95 2.84 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.756 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.465 ' CD2' ' HE1' ' A' ' 69' ' ' TRP . 8.8 t60 -136.91 -49.86 0.64 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 m -138.16 160.86 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.87 127.68 14.39 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.736 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.44 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 25.3 m-85 -101.78 146.04 28.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.24 0.962 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.27 17.13 0.79 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 p -165.82 129.87 2.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.9 m -37.03 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.079 0.862 . . . . 0.0 113.112 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.98 101.55 8.86 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 115.041 -0.982 . . . . 0.0 112.041 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -83.13 76.73 9.84 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.68 165.5 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.445 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 m -153.8 36.55 0.45 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 121.763 0.792 . . . . 0.0 109.374 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 72.7 m-80 -70.07 -167.04 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.094 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.576 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 65' ' ' ASN . 1.4 Cg_endo -73.3 165.94 31.26 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.733 2.288 . . . . 0.0 111.24 144.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.75 171.11 15.44 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.41 18.1 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.672 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 13.7 m-90 -141.93 -162.59 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 123.97 0.453 . . . . 0.0 112.0 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.2 -30.22 0.47 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 123.927 0.767 . . . . 0.0 111.04 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 p -150.32 162.45 40.49 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.918 0.761 . . . . 0.0 111.809 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.529 HD13 ' CG ' ' A' ' 3' ' ' PHE . 10.2 tt -137.88 134.78 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.243 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -96.02 106.78 18.99 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.403 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -101.03 139.31 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -105.39 162.61 13.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 124.034 0.834 . . . . 0.0 110.741 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 116.94 -1.505 . . . . 0.0 110.475 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.64 95.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 123.97 0.793 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 32' ' ' TYR . 87.8 t80 -82.18 98.92 8.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.313 1.008 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -84.11 151.76 24.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 p -163.25 146.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.525 1.155 . . . . 0.0 112.506 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 8.2 m-90 -124.23 151.41 44.16 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 111.851 -2.431 . . . . 0.0 107.304 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.7 p -68.82 9.84 0.34 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.34 163.21 37.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -76.66 -53.79 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.649 0 O-C-N 123.055 1.029 . . . . 0.0 111.107 16.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.52 -143.5 13.83 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 71.5 m -107.85 70.81 0.78 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -142.14 -49.06 0.37 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.942 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.65 ' H ' HD22 ' A' ' 13' ' ' ASN . 1.4 p30 -53.94 -135.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.717 -2.038 . . . . 0.0 115.974 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 94.4 mtt-85 -54.25 129.27 34.52 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.76 116.15 31.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.928 0.767 . . . . 0.0 110.565 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -147.81 138.84 23.4 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -123.78 158.69 31.17 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -136.32 82.17 1.93 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.5 p -105.71 -14.76 15.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.555 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.69 141.68 58.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.185 0.928 . . . . 0.0 109.544 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 44.0 t -71.76 174.7 6.49 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.02 -112.02 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 p -172.42 147.31 1.9 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.094 0.526 . . . . 0.0 111.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -158.77 154.45 26.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.171 0.919 . . . . 0.0 110.987 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.93 140.36 36.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.373 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.2 mt -97.0 115.78 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.158 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -79.27 -45.39 19.84 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.559 ' CD ' ' H ' ' A' ' 28' ' ' GLN . 1.7 pm0 -81.83 82.11 7.61 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.798 -1.546 . . . . 0.0 108.699 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.7 55.85 2.83 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.035 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.09 -114.35 2.85 Favored Glycine 0 N--CA 1.498 2.801 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.357 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.54 158.35 28.55 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-O 118.412 -1.215 . . . . 0.0 110.329 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 26.1 p90 -161.76 134.92 6.23 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -110.42 167.73 9.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 77.1 t80 -145.3 155.62 43.32 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.3 t -144.99 109.64 4.98 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -81.78 147.64 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 113.056 -1.884 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -173.36 76.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.62 -26.3 3.64 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-N 112.788 -2.006 . . . . 0.0 113.06 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -109.14 137.19 47.42 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.4 m -97.79 166.48 11.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.761 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.81 174.77 9.41 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.309 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.55 122.37 3.13 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.153 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.456 HD13 ' CZ3' ' A' ' 69' ' ' TRP . 98.4 mt -99.22 135.88 39.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 123.847 0.717 . . . . 0.0 111.615 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 8.8 p90 -148.24 138.43 22.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.212 0.945 . . . . 0.0 109.255 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.4 ' HA ' ' N ' ' A' ' 70' ' ' LYS . 17.4 t30 -72.59 -10.27 59.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.621 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' N ' ' CD ' ' A' ' 46' ' ' GLN . 3.1 mp0 -86.4 89.66 7.95 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.321 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.22 164.9 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.87 28.09 72.97 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.011 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 m 60.64 18.51 8.52 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.052 0.501 . . . . 0.0 110.614 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -90.49 41.04 1.04 Allowed 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -161.69 -170.29 26.19 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.081 -1.533 . . . . 0.0 115.921 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.21 145.96 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 112.351 -1.924 . . . . 0.0 107.772 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 179.98 0.12 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -153.27 -48.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.574 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.0 m -132.83 106.14 7.55 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.824 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -96.54 158.08 15.6 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 44.4 m-85 -126.0 106.04 9.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 124.189 0.931 . . . . 0.0 110.664 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.43 -4.31 57.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 t -155.47 140.15 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -35.91 110.86 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -92.98 -178.48 4.82 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -166.2 51.88 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.25 0.547 . . . . 0.0 111.576 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.78 165.47 16.0 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 58.1 m -147.56 11.09 0.98 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.945 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -79.84 157.59 73.92 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.73 143.92 27.82 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.452 2.101 . . . . 0.0 112.043 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.16 156.68 37.01 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.787 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.26 22.5 3.22 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 123.996 0.81 . . . . 0.0 111.417 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.456 ' CZ3' HD13 ' A' ' 43' ' ' LEU . 13.2 m-90 -138.26 -161.58 1.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 45' ' ' ASN . 18.6 ttpt -138.63 -20.14 1.04 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.544 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 p -153.72 170.28 21.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.267 0.979 . . . . 0.0 110.795 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 43' ' ' LEU . 14.4 tt -137.04 149.48 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.465 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -119.93 136.19 54.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.7 mt -138.44 155.95 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 124.069 0.856 . . . . 0.0 110.738 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -88.12 173.18 8.99 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.99 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.405 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 88.8 m . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.771 -1.585 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.741 0.305 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' CB ' ' HE ' ' A' ' 17' ' ' ARG . . . -159.09 174.23 15.21 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.403 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -137.67 97.43 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.53 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.1 m -77.3 150.52 35.25 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -148.61 153.96 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 123.622 0.576 . . . . 0.0 110.39 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.598 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 25.0 m-90 -135.61 142.97 45.34 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.5 p -66.18 0.85 1.77 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' ' C ' ' A' ' 9' ' ' PRO . . . 104.29 155.33 23.48 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 123.504 0.502 . . . . 0.0 113.349 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.452 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 12.1 Cg_endo -72.93 -54.88 0.14 OUTLIER 'Cis proline' 0 N--CA 1.499 1.851 0 O-C-N 123.023 1.012 . . . . 0.0 112.863 18.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.33 -128.67 5.67 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -108.89 69.44 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 113.96 -1.12 . . . . 0.0 109.419 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -143.4 -55.71 0.39 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.125 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.598 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 1.8 p30 -47.05 -118.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 5.9 tpm_? -62.78 100.77 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.352 0.596 . . . . 0.0 111.76 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.59 83.46 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.062 0.934 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -101.57 161.79 13.38 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.43 -1.713 . . . . 0.0 107.652 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.407 ' HE ' ' CB ' ' A' ' 2' ' ' ALA . 74.5 ttt180 -142.06 153.65 44.36 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -135.63 83.09 1.99 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.7 p -108.76 -12.01 14.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.056 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -53.09 143.53 17.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.336 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 126.92 29.61 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 113.554 -1.657 . . . . 0.0 113.819 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.58 28.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.572 ' SG ' ' C ' ' A' ' 48' ' ' GLY . 20.2 p -114.15 162.23 16.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.5 p -160.57 158.59 29.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.351 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.43 151.25 30.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 123.699 0.625 . . . . 0.0 110.554 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 28' ' ' GLN . 3.3 mp -121.26 131.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 124.275 0.984 . . . . 0.0 109.333 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -101.28 -6.65 23.88 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.196 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' H ' HG22 ' A' ' 26' ' ' ILE . 26.2 mp0 -93.62 64.79 3.6 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.471 1.605 . . . . 0.0 108.729 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HG3' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -77.14 8.8 3.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 111.187 -2.733 . . . . 0.0 115.063 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA3' ' CA ' ' A' ' 8' ' ' GLY . . . -74.2 -61.97 3.07 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.627 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.95 161.3 28.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.67 135.1 6.41 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -109.89 161.2 15.7 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 90.1 t80 -132.22 158.05 42.77 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.9 t -140.4 121.98 15.2 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -104.56 111.58 24.32 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.8 p -148.53 -49.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.6 -80.08 1.03 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -137.53 -176.93 4.57 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.5 m -75.95 170.81 15.53 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.413 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.45 169.63 21.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.257 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -152.94 163.93 38.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.04 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.596 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.0 mm? -111.27 143.36 42.17 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.82 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.76 120.26 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.737 1.273 . . . . 0.0 108.681 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -62.34 -5.68 2.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.164 0.915 . . . . 0.0 112.193 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -125.9 123.17 38.02 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.971 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.543 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -37.98 148.13 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.436 -1.711 . . . . 0.0 114.305 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.572 ' C ' ' SG ' ' A' ' 23' ' ' CYS . . . 51.96 37.47 44.83 Favored Glycine 0 N--CA 1.494 2.521 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.0 p 36.27 45.11 0.32 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.978 1.046 . . . . 0.0 113.192 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -85.31 41.66 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.676 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.52 -120.05 0.54 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.0 156.05 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.434 0.726 . . . . 0.0 109.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.62 165.09 17.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.624 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -132.4 -62.82 0.82 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.7 m -110.53 142.68 42.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -133.25 126.67 32.04 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.34 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.491 ' CE2' HD21 ' A' ' 43' ' ' LEU . 37.4 m-85 -94.33 132.99 38.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.17 0.918 . . . . 0.0 110.892 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.28 8.04 5.97 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.6 p -162.19 136.22 6.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.3 p -42.05 116.6 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 123.619 0.574 . . . . 0.0 110.976 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.5 107.43 12.86 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.54 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -78.13 73.82 4.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.516 1.135 . . . . 0.0 112.773 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 156.3 18.28 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.69 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.7 m -144.96 18.37 1.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -82.37 162.78 55.16 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.331 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -53.96 152.48 23.48 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.342 2.028 . . . . 0.0 110.589 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -69.8 166.14 19.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.759 0.662 . . . . 0.0 110.344 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.55 -0.72 1.53 Allowed Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.86 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.596 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.3 m-90 -127.1 -141.82 0.27 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 20.3 ttmm -146.58 -25.16 0.42 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.021 0.373 . . . . 0.0 110.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.451 ' HA ' HD12 ' A' ' 26' ' ' ILE . 6.4 p -146.91 158.73 44.0 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.795 0.807 . . . . 0.0 111.98 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.403 ' N ' HD11 ' A' ' 26' ' ' ILE . 6.5 tp -119.35 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 112.884 -1.962 . . . . 0.0 108.319 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -104.01 125.78 50.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.594 1.184 . . . . 0.0 108.392 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 mm -113.82 134.2 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -67.1 88.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 124.362 1.039 . . . . 0.0 110.476 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.79 -1.576 . . . . 0.0 114.491 179.896 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.36 119.88 2.77 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.355 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.436 ' CB ' HD13 ' A' ' 72' ' ' ILE . 72.4 t80 -87.63 92.11 8.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.44 ' HA ' ' HG2' ' A' ' 17' ' ' ARG . 57.1 m -73.1 152.63 41.13 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' A' ' 32' ' ' TYR . 34.8 m -154.31 153.59 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.571 1.169 . . . . 0.0 110.26 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.491 ' HB3' HD21 ' A' ' 13' ' ' ASN . 29.8 m-90 -135.63 150.09 49.53 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 96.4 p -63.41 -10.44 17.09 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 106.71 158.83 21.65 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.409 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 11.4 Cg_endo -73.43 -53.4 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.63 0 O-C-N 122.897 0.946 . . . . 0.0 110.885 25.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.51 -123.69 4.39 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 74.0 m -101.39 39.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.799 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.26 -130.65 0.3 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 10.1 p30 36.24 -141.59 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -82.01 149.31 28.19 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.227 0.329 . . . . 0.0 110.261 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.63 152.72 23.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 123.765 0.666 . . . . 0.0 112.758 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -163.2 143.18 8.92 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.458 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 79.5 mtt85 -124.55 159.84 29.72 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.47 86.31 2.26 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.558 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -114.46 -8.17 12.81 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.25 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -54.6 121.01 7.53 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.19 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.45 97.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.421 1.076 . . . . 0.0 109.872 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.95 -177.48 21.88 Favored Glycine 0 N--CA 1.493 2.461 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.3 m -79.97 141.3 36.12 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.961 -1.119 . . . . 0.0 109.959 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.2 p -156.45 136.93 13.1 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.202 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -79.02 130.52 35.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 123.726 0.641 . . . . 0.0 112.614 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.2 mt -88.61 138.72 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -105.79 -56.27 2.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.041 0.838 . . . . 0.0 112.658 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.576 ' CD ' ' H ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -77.25 76.36 3.8 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 123.38 1.562 . . . . 0.0 111.146 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -71.93 18.87 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.245 -2.252 . . . . 0.0 115.46 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.35 -76.29 0.4 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.17 168.66 21.37 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB3' HG12 ' A' ' 5' ' ' VAL . 44.6 p90 -161.63 130.31 4.39 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 14.0 m-20 -114.42 101.1 8.83 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.098 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 3' ' ' PHE . 54.0 t80 -78.49 151.42 32.6 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.9 p -135.82 147.55 48.33 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 124.782 1.301 . . . . 0.0 107.703 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CG ' ' N ' ' A' ' 37' ' ' THR . 77.8 t80 -132.14 156.74 45.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.359 1.037 . . . . 0.0 108.506 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' A' ' 36' ' ' TYR . 5.8 t -163.49 -24.21 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.022 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.408 ' H ' ' H ' ' A' ' 37' ' ' THR . . . -169.05 -25.34 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -123.71 118.56 27.52 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.541 ' H ' ' NE2' ' A' ' 75' ' ' GLN . 60.8 m -83.62 170.65 14.08 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.009 -1.905 . . . . 0.0 109.406 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.77 159.57 41.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.013 0.821 . . . . 0.0 111.066 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.13 133.24 24.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.049 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.506 ' HG ' ' CE3' ' A' ' 69' ' ' TRP . 4.3 mm? -79.59 169.43 18.02 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.691 0.619 . . . . 0.0 109.433 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -153.52 124.06 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.512 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -70.67 -30.83 67.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 46' ' ' GLN . 3.5 mp0 -89.65 112.38 23.61 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -41.5 143.35 0.48 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.78 41.58 90.9 Favored Glycine 0 N--CA 1.497 2.724 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.963 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 73' ' ' PHE . 60.7 m 52.76 30.8 9.44 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.162 0.566 . . . . 0.0 112.414 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.6 t -81.0 30.56 0.32 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.278 1.037 . . . . 0.0 113.006 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.68 -161.66 12.12 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.624 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.6 t -95.64 145.99 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.97 148.56 50.89 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.881 -1.128 . . . . 0.0 112.571 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.665 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 12.6 t-80 -95.62 -69.41 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 m -112.36 118.84 36.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 123.94 0.775 . . . . 0.0 111.036 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -98.77 170.34 8.84 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.215 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.09 -172.39 2.82 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.424 0.63 . . . . 0.0 111.087 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.42 -36.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -145.53 159.32 43.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.877 -1.161 . . . . 0.0 108.99 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -42.29 117.39 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.53 90.26 3.3 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.761 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 86.1 mtm180 -75.29 69.78 2.15 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.09 168.3 11.73 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.798 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.38 8.97 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.779 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.92 157.16 83.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.12 156.28 65.5 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.074 1.849 . . . . 0.0 109.421 167.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CG ' ' CE3' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -138.14 -164.4 1.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.31 27.38 2.76 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.15 0.906 . . . . 0.0 112.663 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.665 ' HE1' ' CG ' ' A' ' 54' ' ' HIS . 4.9 m-90 -94.29 131.73 39.6 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -86.41 -18.11 32.61 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.379 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 63.2 p -156.42 179.55 9.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.292 0.995 . . . . 0.0 113.007 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 43' ' ' LEU . 13.9 tt -153.35 141.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.344 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.596 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 69.2 t80 -104.97 135.15 46.85 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.497 -1.683 . . . . 0.0 107.907 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.6 mm -123.2 132.58 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.541 ' NE2' ' H ' ' A' ' 40' ' ' THR . 24.6 mt-30 -76.19 173.21 11.64 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 116.11 -1.9 . . . . 0.0 111.51 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.478 ' H3 ' ' HB ' ' A' ' 37' ' ' THR . 53.7 m . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.89 129.0 49.45 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -98.14 94.03 6.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 124.297 0.998 . . . . 0.0 109.838 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -77.09 155.17 32.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.577 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 25.2 m -154.56 160.43 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 124.211 0.944 . . . . 0.0 108.91 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 14' ' ' ARG . 31.6 m-90 -139.65 135.86 33.7 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -43.37 -44.28 5.55 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 147.1 151.65 5.47 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -79.44 -62.86 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.593 0 O-C-N 123.002 1.001 . . . . 0.0 111.794 18.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.43 -138.47 10.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.09 52.89 2.37 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.105 -1.047 . . . . 0.0 111.919 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -132.18 -130.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.518 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 13.1 p30 35.42 -144.01 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 58.6 ttm-85 -66.31 149.36 50.48 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.11 148.73 45.35 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 123.44 0.462 . . . . 0.0 111.646 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -166.78 153.59 8.85 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.348 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -123.09 153.35 40.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.08 0.863 . . . . 0.0 111.313 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -134.59 79.87 1.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.523 -1.671 . . . . 0.0 107.423 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.1 p -103.45 8.97 37.9 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.731 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -58.73 138.05 57.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.164 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.95 155.91 36.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.009 0.818 . . . . 0.0 110.049 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.4 -92.47 1.66 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 103.828 -3.709 . . . . 0.0 103.828 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -171.56 164.79 6.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.93 1.018 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 p -160.0 141.73 12.84 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.448 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.49 135.77 36.73 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 71' ' ' SER . 3.2 mp -102.98 156.38 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -121.22 -20.51 6.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 124.155 0.91 . . . . 0.0 110.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.36 97.34 2.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.15 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -90.1 62.91 5.68 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.04 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 -118.31 1.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.33 162.89 26.08 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 125.077 1.104 . . . . 0.0 111.325 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 14.9 p90 -161.73 136.01 6.87 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 3.4 t70 -120.76 165.88 14.5 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.362 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.41 ' N ' ' CG ' ' A' ' 33' ' ' ASP . 70.3 t80 -133.86 155.61 49.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -147.21 85.56 1.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.36 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CB ' ' HA ' ' A' ' 59' ' ' SER . 2.2 t80 -49.09 133.82 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 112.948 -1.933 . . . . 0.0 113.293 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.478 ' HB ' ' H3 ' ' A' ' 1' ' ' SER . 50.4 m -152.48 82.85 1.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.73 19.06 57.92 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.83 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 76' ' ' CYS . 5.5 tp-100 -159.86 161.36 34.41 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.344 -0.943 . . . . 0.0 113.195 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -112.67 177.42 4.64 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.487 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.76 172.29 13.51 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.568 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.57 150.79 28.11 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.555 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.4 mm? -106.65 126.88 52.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.611 0.72 . . . . 0.0 111.365 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.64 101.47 10.78 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -61.36 -13.67 21.5 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.916 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -92.92 130.52 38.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.71 151.49 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.99 22.86 67.16 Favored Glycine 0 N--CA 1.491 2.358 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.741 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 21.5 m 59.64 13.99 3.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.175 0.573 . . . . 0.0 112.471 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -87.61 63.04 7.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.939 0.775 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.0 -137.67 2.93 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.094 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.54 175.52 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.25 144.26 26.54 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.732 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.402 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 21.2 m-70 -120.44 -51.46 2.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.8 m -123.18 121.51 36.1 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.505 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.68 118.89 37.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.253 0.971 . . . . 0.0 111.606 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -102.04 93.56 5.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 124.344 1.028 . . . . 0.0 108.351 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.29 -23.3 44.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.418 ' HA ' ' CB ' ' A' ' 36' ' ' TYR . 35.1 t -135.59 144.07 45.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.485 0.756 . . . . 0.0 109.258 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -35.06 124.01 0.58 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.435 1.084 . . . . 0.0 111.929 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 33' ' ' ASP . . . -137.65 105.74 5.71 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.787 0.68 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -76.44 75.18 3.19 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.325 1.016 . . . . 0.0 112.905 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -90.8 153.69 20.05 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.289 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.53 19.86 2.03 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -79.18 165.02 51.52 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -56.0 148.22 59.28 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.938 1.759 . . . . 0.0 110.372 172.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.27 173.01 4.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 123.788 0.68 . . . . 0.0 109.473 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.19 7.46 0.12 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.197 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.555 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 8.2 m-90 -128.29 -171.29 2.42 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 123.957 0.445 . . . . 0.0 110.181 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HB2' ' HZ3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -126.94 -24.67 3.44 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.546 ' HA ' HD12 ' A' ' 26' ' ' ILE . 10.1 p -146.53 163.69 34.96 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.681 0.613 . . . . 0.0 111.399 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.04 114.68 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.975 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -93.79 121.06 34.85 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.52 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 76' ' ' CYS . 31.3 mt -130.08 128.54 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.461 ' H ' ' CD ' ' A' ' 75' ' ' GLN . 3.2 mp0 -78.35 9.86 3.54 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.481 ' N ' ' HG2' ' A' ' 39' ' ' GLN . 14.6 p . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.38 123.68 10.92 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.525 ' CG ' HD13 ' A' ' 72' ' ' ILE . 67.3 t80 -89.65 104.6 17.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' ASP . 53.1 m -94.16 137.02 33.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -139.59 162.32 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.472 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 18.2 m-90 -128.18 140.33 51.97 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.449 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 78.2 p -55.58 -31.18 61.98 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.515 ' H ' ' CG ' ' A' ' 13' ' ' ASN . . . 142.06 148.38 5.0 Favored Glycine 0 N--CA 1.5 2.929 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.41 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' C ' ' HA2' ' A' ' 8' ' ' GLY . 28.1 Cg_endo -73.61 -65.14 0.03 OUTLIER 'Cis proline' 0 N--CA 1.503 2.066 0 CA-C-N 118.428 1.114 . . . . 0.0 112.581 20.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.33 -125.42 4.12 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 105.393 -3.083 . . . . 0.0 105.393 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -99.27 73.01 1.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -139.18 -53.11 0.56 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.138 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 7.6 p30 -57.22 -136.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.926 -1.943 . . . . 0.0 116.145 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 14' ' ' ARG . 31.3 mtm105 -58.13 141.07 51.42 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.17 82.24 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 124.73 1.269 . . . . 0.0 111.168 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.67 165.03 14.47 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.189 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -152.19 156.21 39.32 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.454 0.645 . . . . 0.0 112.374 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.93 69.19 1.36 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.2 t -90.7 -18.64 24.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.355 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -57.09 129.59 42.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.609 0.568 . . . . 0.0 111.602 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.48 122.18 15.64 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.552 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.43 -169.99 13.51 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-O 122.596 1.109 . . . . 0.0 114.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.5 t -56.74 130.38 45.29 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.612 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -160.81 120.42 2.68 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.615 0.572 . . . . 0.0 111.02 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.433 ' HB2' ' H ' ' A' ' 48' ' ' GLY . . . -79.72 126.3 30.76 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 mt -87.75 154.52 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -138.6 -9.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 123.571 0.545 . . . . 0.0 110.939 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.86 105.32 7.85 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.165 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.76 62.01 5.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.177 0.923 . . . . 0.0 108.845 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.74 -108.27 0.69 Allowed Glycine 0 N--CA 1.497 2.744 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.06 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.03 166.49 21.25 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -146.1 165.5 28.91 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' CG ' ' N ' ' A' ' 34' ' ' PHE . 3.2 t70 -169.22 163.11 10.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 41' ' ' ALA . 58.0 t80 -138.61 155.81 48.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -142.3 94.8 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.19 0.932 . . . . 0.0 109.436 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -78.86 151.42 31.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.042 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -174.19 -22.8 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.366 1.041 . . . . 0.0 108.653 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.37 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -122.02 159.81 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.5 p -91.11 -163.8 1.09 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.844 -1.98 . . . . 0.0 110.444 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . . . -155.11 176.18 12.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.9 131.21 6.75 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 114.942 -1.027 . . . . 0.0 108.308 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 69' ' ' TRP . 4.2 mm? -92.12 154.94 18.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.81 120.04 14.7 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.802 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -62.86 -7.48 5.18 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -118.05 122.08 42.24 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.856 0.722 . . . . 0.0 110.047 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -40.08 145.84 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 124.685 1.241 . . . . 0.0 113.749 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 25' ' ' ALA . . . 58.99 42.47 96.9 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.819 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.7 p 44.11 25.57 0.12 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.156 1.15 . . . . 0.0 112.977 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 t -87.24 44.02 1.15 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.633 0.73 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.54 -155.26 6.39 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.405 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.55 150.14 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.04 156.52 33.52 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.336 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.473 ' CG ' ' HE1' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -141.3 -45.88 0.38 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.026 0.829 . . . . 0.0 110.968 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.3 m -137.13 118.89 15.07 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.775 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -105.37 162.48 13.41 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.738 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -139.65 133.88 31.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.043 0.839 . . . . 0.0 110.351 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.87 14.9 5.18 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.5 t -162.68 124.17 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 m -35.88 113.88 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 124.291 0.994 . . . . 0.0 112.955 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.84 15.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.957 0.786 . . . . 0.0 110.529 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -86.95 94.46 9.61 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.84 158.94 16.53 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.49 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.2 m -151.37 15.08 0.7 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -88.56 166.24 23.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.01 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -50.03 165.23 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.692 2.261 . . . . 0.0 112.245 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.58 179.36 2.14 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.556 0.694 . . . . 0.0 111.804 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.22 -5.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.141 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.502 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.6 m-90 -138.79 -156.19 0.66 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -140.87 -40.74 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.7 p -131.95 178.38 6.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 124.704 1.253 . . . . 0.0 111.377 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.525 HD13 ' CG ' ' A' ' 3' ' ' PHE . 11.2 tt -150.91 147.39 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.77 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -119.94 130.42 54.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.528 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.36 152.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 66.7 mt-30 -73.85 -159.59 0.08 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 75' ' ' GLN . 24.4 p . . . . . 0 N--CA 1.504 2.23 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.59 134.5 42.38 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.377 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 55.5 t80 -109.15 91.3 3.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.437 1.086 . . . . 0.0 108.85 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.0 m -81.25 133.81 35.5 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.978 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.14 145.65 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 123.645 0.591 . . . . 0.0 111.382 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.506 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 8.4 m-90 -114.3 143.27 45.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.456 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 79.1 p -64.34 -10.27 23.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' N ' ' HA3' ' A' ' 30' ' ' GLY . . . 120.35 154.6 9.42 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 123.596 0.56 . . . . 0.0 113.326 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -75.35 -64.18 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.835 0 O-C-N 123.221 1.116 . . . . 0.0 112.468 12.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.42 -136.13 6.39 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -106.12 66.07 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.411 -1.395 . . . . 0.0 109.792 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -141.86 -59.39 0.47 Allowed 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.774 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 2.0 p30 -32.56 -104.57 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -72.18 -164.16 0.13 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.412 1.005 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.69 59.68 0.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.834 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.13 151.14 28.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -145.75 116.81 7.82 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.385 0.612 . . . . 0.0 111.488 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -97.9 73.08 2.26 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.884 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.7 p -81.32 -14.29 57.48 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -64.63 133.27 51.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 123.949 0.781 . . . . 0.0 110.835 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.6 m -63.29 175.51 0.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.359 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.74 -161.94 45.85 Favored Glycine 0 N--CA 1.492 2.381 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.18 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -97.95 125.27 42.79 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.5 p -131.14 135.84 47.82 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.003 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.99 117.8 20.4 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 72' ' ' ILE . 2.3 mp -82.52 138.01 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.377 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -118.86 59.59 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.99 98.77 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.663 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -91.3 61.11 4.36 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' N ' ' A' ' 8' ' ' GLY . . . -144.06 -109.63 0.68 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.647 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.72 166.87 21.75 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -147.37 147.29 30.15 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 2.3 t70 -151.0 154.21 36.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -128.16 157.6 40.36 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.1 m -144.52 93.57 2.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.774 0.797 . . . . 0.0 110.016 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -71.4 151.75 43.76 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.775 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -172.76 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.222 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.53 -64.59 0.22 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -126.83 166.17 17.95 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.5 p -93.06 171.97 8.61 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.888 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.78 178.55 5.87 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.579 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.88 131.61 6.98 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' CE3' ' A' ' 69' ' ' TRP . 4.5 mm? -81.94 161.63 23.0 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -137.61 106.5 5.95 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.556 -2.111 . . . . 0.0 107.92 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 14.2 t30 -55.27 -23.67 24.17 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.316 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -95.98 135.57 37.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.161 0.913 . . . . 0.0 109.768 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.47 119.06 1.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.898 1.374 . . . . 0.0 113.074 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 43.71 74.21 0.21 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 124.618 1.199 . . . . 0.0 113.458 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 44.22 25.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m -82.35 32.13 0.4 Allowed 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.988 0.899 . . . . 0.0 112.238 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.74 -129.61 1.04 Allowed Glycine 0 N--CA 1.49 2.257 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.2 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -127.22 162.21 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.33 -177.39 1.12 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.046 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.402 ' CD2' ' HE1' ' A' ' 69' ' ' TRP . 8.5 t60 -148.62 -60.88 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.3 m -104.22 167.6 9.65 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.069 0.856 . . . . 0.0 109.796 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -142.45 144.77 33.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.462 1.101 . . . . 0.0 109.923 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -128.12 100.62 5.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.102 0.876 . . . . 0.0 109.528 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.37 -25.17 52.15 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.954 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.9 p -148.99 148.29 29.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.07 0.512 . . . . 0.0 111.339 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -33.78 115.32 0.22 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 124.434 1.083 . . . . 0.0 112.353 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.73 108.58 10.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.097 0.873 . . . . 0.0 111.644 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -82.03 87.5 6.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.101 0.876 . . . . 0.0 112.999 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.5 163.26 14.69 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.87 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 m -148.0 11.6 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.14 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -69.76 164.13 53.77 Favored Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.234 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.54 165.02 1.81 Allowed 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 122.45 2.1 . . . . 0.0 110.464 167.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.57 174.01 3.77 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.694 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 69' ' ' TRP . . . -159.48 -3.52 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.434 ' CE3' ' HG ' ' A' ' 43' ' ' LEU . 3.5 m-90 -143.13 -176.02 4.75 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -114.26 -39.34 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 p -132.58 165.7 23.79 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 6.9 tp -125.35 112.75 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.204 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -90.81 143.37 26.79 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.445 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.6 mt -135.05 132.5 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -60.2 -37.58 80.7 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.162 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 115.71 -2.09 . . . . 0.0 115.114 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.12 121.03 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.469 ' CB ' HD13 ' A' ' 72' ' ' ILE . 70.7 t80 -97.83 84.47 3.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.293 0.996 . . . . 0.0 110.076 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -68.07 151.04 47.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.74 154.93 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.482 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 28.5 m-90 -134.08 140.8 46.87 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.3 p -48.88 -43.33 38.96 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.558 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 151.11 157.27 7.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -81.47 -62.13 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.537 0 O-C-N 123.023 1.012 . . . . 0.0 110.33 14.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -128.0 3.12 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -106.98 49.61 0.8 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.706 -1.247 . . . . 0.0 109.308 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -119.49 -128.49 0.28 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.558 ' ND2' ' H ' ' A' ' 8' ' ' GLY . 11.0 p30 35.94 -142.11 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -77.06 140.12 40.22 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.41 131.33 49.14 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.837 0.711 . . . . 0.0 110.662 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -136.83 118.37 14.85 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -98.23 124.67 42.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.276 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.14 81.98 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.9 m -106.21 -20.1 13.5 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.773 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -50.16 139.38 14.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.368 1.043 . . . . 0.0 112.912 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 162.69 11.01 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -151.16 43.3 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 22.0 p -129.98 154.19 47.63 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.029 -1.068 . . . . 0.0 113.558 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -143.39 151.76 40.79 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.118 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.47 124.47 28.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.031 0.832 . . . . 0.0 112.09 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 26' ' ' ILE . 2.9 mp -80.71 118.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -93.14 -25.67 17.77 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.467 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -78.91 102.52 8.3 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 80.3 tttt -90.06 13.49 14.78 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 124.181 0.926 . . . . 0.0 111.43 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.32 -90.02 0.37 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.466 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.48 169.86 21.18 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -162.0 136.4 6.83 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -120.35 131.79 55.0 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.441 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.434 ' CG ' ' N ' ' A' ' 35' ' ' SER . 59.5 t80 -101.55 160.65 14.26 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 47.3 t -147.0 90.14 1.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -74.71 137.27 41.98 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.886 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -148.95 -44.99 0.14 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.751 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.8 -42.37 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.04 134.4 55.0 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.2 m -81.61 168.9 17.68 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.679 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.94 24.28 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.666 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.08 146.19 28.75 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.533 HD12 ' CG ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -109.33 98.8 8.15 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.252 -179.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -75.63 130.48 38.82 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.764 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -94.59 27.71 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.498 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.36 145.21 29.21 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.85 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.93 142.32 12.02 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.425 -1.261 . . . . 0.0 114.281 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.93 33.46 13.4 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 113.538 -1.664 . . . . 0.0 113.512 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.3 p 41.44 42.76 1.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.7 p -98.78 47.4 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.633 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.71 -128.34 0.95 Allowed Glycine 0 N--CA 1.498 2.816 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.487 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -119.3 140.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.471 0.748 . . . . 0.0 110.671 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.49 153.1 27.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -107.65 -36.81 6.33 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.12 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -138.82 123.74 18.84 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.07 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -101.7 163.29 12.33 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -138.86 92.8 2.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.668 0.605 . . . . 0.0 112.459 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.02 16.07 62.11 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.8 t -170.46 138.31 1.51 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.1 p -44.61 129.45 6.85 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.06 97.05 4.5 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 123.97 0.794 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.0 mtt-85 -72.04 71.65 0.83 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.06 14.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.326 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.5 m -142.95 -11.26 0.77 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -71.47 156.41 91.52 Favored Pre-proline 0 N--CA 1.492 1.663 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.964 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.37 176.98 0.93 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.684 2.256 . . . . 0.0 112.056 173.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' A' ' 29' ' ' LYS . 39.8 p90 -158.12 -167.45 2.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.088 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.43 56.52 0.46 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.533 ' CG ' HD12 ' A' ' 43' ' ' LEU . 5.0 m-90 -109.36 163.38 13.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -100.68 -44.58 5.77 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.54 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 p -155.41 164.65 38.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.716 1.26 . . . . 0.0 112.432 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 3' ' ' PHE . 7.1 tt -125.98 129.83 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 113.106 -1.861 . . . . 0.0 110.721 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -99.22 147.69 24.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 125.255 1.597 . . . . 0.0 107.418 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.3 mt -141.97 137.02 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.99 149.46 32.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.947 0.779 . . . . 0.0 111.267 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 116.919 -1.515 . . . . 0.0 110.515 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 19' ' ' SER . . . -157.39 107.84 2.25 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CB ' HD13 ' A' ' 72' ' ' ILE . 56.2 t80 -96.89 93.78 6.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.051 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -76.17 148.2 37.93 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 m -149.64 132.36 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 123.8 0.688 . . . . 0.0 110.384 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.5 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 23.6 m-90 -103.72 152.21 22.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -65.25 -10.41 31.8 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.837 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.97 160.75 19.71 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 123.976 0.798 . . . . 0.0 112.066 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.93 -58.61 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 O-C-N 123.134 1.07 . . . . 0.0 111.797 17.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.21 -132.06 7.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' CZ3' ' A' ' 6' ' ' TRP . 69.1 m -109.77 73.11 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.45 -51.03 0.47 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.933 0.873 . . . . 0.0 110.401 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.591 ' H ' HD22 ' A' ' 13' ' ' ASN . 2.9 p30 -56.93 -159.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.417 -2.174 . . . . 0.0 114.302 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -70.55 172.92 7.71 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 6' ' ' TRP . . . -155.83 178.34 10.38 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -150.08 141.16 23.01 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 111.362 -2.654 . . . . 0.0 105.256 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -121.33 131.02 53.95 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.524 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -103.96 68.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.652 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 58.6 p -86.8 -13.23 45.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -59.1 124.94 21.62 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.38 123.65 21.77 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.504 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -167.73 13.89 Favored Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -78.48 145.75 34.79 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.1 p -160.04 131.77 6.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.611 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -78.81 138.28 38.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 123.641 0.588 . . . . 0.0 111.784 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.27 146.32 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -125.7 -22.55 4.21 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.041 0.838 . . . . 0.0 109.876 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.484 ' H ' ' NE2' ' A' ' 28' ' ' GLN . 3.9 mp0 -74.45 100.25 3.78 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.197 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.14 62.93 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.221 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.41 -105.49 1.17 Allowed Glycine 0 N--CA 1.495 2.614 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.25 170.63 14.33 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -161.27 130.17 4.56 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 13.0 m-20 -114.69 105.81 13.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.375 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 35' ' ' SER . 83.6 t80 -80.7 157.48 25.88 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.201 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.3 m -142.47 129.23 20.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 124.843 1.339 . . . . 0.0 108.992 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -112.05 146.84 37.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.6 t -164.06 -33.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.695 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 39' ' ' GLN . . . -157.64 -9.31 0.05 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.411 ' H ' ' H ' ' A' ' 38' ' ' GLY . 28.5 mp0 -131.21 131.96 44.34 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 m -81.96 174.14 11.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.29 159.2 43.39 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.614 0.721 . . . . 0.0 112.14 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.54 145.84 35.61 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.665 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' A' ' 57' ' ' PHE . 47.5 mt -116.55 96.24 5.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.458 0.647 . . . . 0.0 112.073 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -85.94 136.0 33.44 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.741 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -87.2 5.08 39.86 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.347 -1.751 . . . . 0.0 110.726 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 82.7 mm-40 -115.97 150.54 37.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.855 0.722 . . . . 0.0 110.827 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.4 132.97 54.69 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.522 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.88 31.03 74.59 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.365 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.0 m 55.41 30.74 15.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.6 t -90.76 59.51 4.19 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.151 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.02 -147.7 5.0 Favored Glycine 0 N--CA 1.497 2.713 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.174 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -111.24 142.5 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 114.239 -0.98 . . . . 0.0 108.366 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.82 119.7 23.07 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.45 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -79.58 -36.54 38.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.459 ' HB ' HD12 ' A' ' 43' ' ' LEU . 55.3 m -145.65 133.79 21.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.049 0.843 . . . . 0.0 110.035 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -118.92 149.62 41.27 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.096 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 43' ' ' LEU . 25.7 m-85 -123.2 132.07 53.91 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.055 0.847 . . . . 0.0 111.143 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -2.42 11.22 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -154.32 139.52 17.5 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.4 m -37.73 120.26 0.81 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.04 0.838 . . . . 0.0 112.75 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.71 88.1 2.83 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 124.111 0.882 . . . . 0.0 109.727 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 74.4 mtp180 -73.72 69.8 1.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.19 162.43 14.65 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.734 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.9 m -147.77 36.37 0.87 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.775 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -110.04 162.42 20.49 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.132 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.44 175.64 3.29 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.452 2.101 . . . . 0.0 111.649 171.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CD2' ' CE3' ' A' ' 69' ' ' TRP . 15.4 p90 -161.22 -165.51 1.35 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.31 56.11 0.41 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.443 ' CG ' ' HB3' ' A' ' 43' ' ' LEU . 6.4 m0 -114.8 127.45 55.73 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -82.54 -8.48 59.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 123.72 0.637 . . . . 0.0 109.968 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 30.8 p -174.29 165.25 4.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.466 1.104 . . . . 0.0 112.213 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.486 HD13 ' CB ' ' A' ' 3' ' ' PHE . 11.1 tt -134.18 122.35 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-N 112.627 -2.078 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -99.48 107.8 20.08 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.847 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.7 mt -104.62 147.56 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.364 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -72.21 -172.4 0.9 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.118 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 116.25 -1.833 . . . . 0.0 110.387 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.49 142.77 1.69 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.849 0.718 . . . . 0.0 112.655 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.424 ' CB ' HD13 ' A' ' 72' ' ' ILE . 88.7 t80 -93.87 104.04 16.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 124.696 1.248 . . . . 0.0 112.3 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -81.2 158.72 24.79 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 32' ' ' TYR . 10.3 m -153.62 122.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 124.008 0.818 . . . . 0.0 112.184 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.551 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 14.1 m-90 -95.58 146.5 24.42 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.6 p -60.44 -16.61 37.91 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.362 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 116.19 162.54 13.14 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 124.283 0.99 . . . . 0.0 112.181 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -75.21 -59.64 0.11 OUTLIER 'Cis proline' 0 N--CA 1.498 1.766 0 O-C-N 123.12 1.063 . . . . 0.0 111.053 11.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.47 -147.63 22.23 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HA ' ' CG ' ' A' ' 6' ' ' TRP . 7.6 p -102.25 66.84 1.02 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -136.89 -49.16 0.63 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 6' ' ' TRP . 3.8 p30 -56.97 -152.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.256 -1.793 . . . . 0.0 114.519 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -74.35 162.49 28.82 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.7 12.97 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -147.39 154.88 41.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.997 -1.911 . . . . 0.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -115.95 144.34 44.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.737 0.648 . . . . 0.0 110.604 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -125.94 95.48 4.43 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.773 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -114.52 -7.43 12.81 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.894 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -49.7 123.29 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.881 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 76' ' ' CYS . 23.8 t -72.71 90.23 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.745 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.24 113.59 21.7 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -124.87 132.93 53.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 123.882 0.739 . . . . 0.0 112.939 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 71' ' ' SER . . . -81.87 116.7 21.65 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.546 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.401 HD11 ' CG2' ' A' ' 72' ' ' ILE . 28.5 mt -79.9 135.95 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.551 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -106.87 -32.12 8.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.571 1.169 . . . . 0.0 111.37 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 27.7 mp0 -79.44 91.62 5.14 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.593 1.187 . . . . 0.0 108.173 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -90.49 62.72 5.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.566 -2.106 . . . . 0.0 111.753 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.08 -113.48 1.33 Allowed Glycine 0 N--CA 1.495 2.582 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.022 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 165.44 34.03 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' HG12 ' A' ' 5' ' ' VAL . 8.9 p90 -161.89 129.47 4.01 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 1.1 t70 -112.07 167.98 9.96 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.6 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 59.5 t80 -148.41 155.33 41.09 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.184 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 58.5 m -137.25 147.11 45.51 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' CB ' ' HA ' ' A' ' 59' ' ' SER . 80.1 t80 -134.3 145.53 49.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 124.717 1.261 . . . . 0.0 109.768 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -172.85 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.751 0.657 . . . . 0.0 111.561 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.8 -12.64 1.3 Allowed Glycine 0 N--CA 1.496 2.672 0 O-C-N 124.044 0.84 . . . . 0.0 111.536 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.31 20.55 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.7 m -84.56 166.65 17.01 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.938 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.41 157.7 46.0 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 131.89 10.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.914 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.71 163.61 13.69 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 49' ' ' CYS . 5.6 p90 -167.75 135.08 2.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.652 -2.067 . . . . 0.0 108.905 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.548 ' H ' HD22 ' A' ' 45' ' ' ASN . 2.0 m-80 -66.91 11.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.261 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' CG ' ' HA3' ' A' ' 51' ' ' GLY . 50.4 mm-40 -131.69 113.54 13.69 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.394 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.5 ' H ' ' HD2' ' A' ' 70' ' ' LYS . . . -40.61 147.41 0.11 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.618 1.199 . . . . 0.0 112.428 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.98 44.74 62.08 Favored Glycine 0 N--CA 1.499 2.846 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.725 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HA ' ' CE1' ' A' ' 44' ' ' TYR . 5.1 p 42.06 36.84 0.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 m -95.54 42.69 1.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.748 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' CG ' ' A' ' 46' ' ' GLN . . . -160.19 -164.4 15.21 Favored Glycine 0 N--CA 1.5 2.961 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.229 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.43 153.69 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.46 143.94 26.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.409 ' CD2' ' ND2' ' A' ' 45' ' ' ASN . 20.9 m-70 -112.62 -52.69 2.77 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.662 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -122.75 106.37 10.87 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -96.4 117.39 30.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.215 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . 50.4 m-85 -91.75 108.33 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 123.717 0.636 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.93 45.51 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.408 ' HA ' ' CB ' ' A' ' 36' ' ' TYR . 39.0 t -146.32 159.85 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.46 0.741 . . . . 0.0 109.374 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.0 p -36.05 124.72 0.75 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.218 0.949 . . . . 0.0 113.308 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' PHE . . . -133.42 101.21 5.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.143 0.902 . . . . 0.0 110.65 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 30.2 ptt180 -84.46 68.52 10.31 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.37 168.87 15.18 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.397 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 16.7 m -147.88 10.83 0.93 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -67.54 164.29 39.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.42 147.14 79.64 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 110.559 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.62 162.21 6.8 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 124.012 0.82 . . . . 0.0 109.874 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.55 18.76 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -136.14 -155.67 0.65 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.562 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HD2' ' H ' ' A' ' 47' ' ' ALA . 19.4 ttmm -141.1 -32.31 0.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 3.5 p -154.26 162.46 41.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.091 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 HD13 ' CB ' ' A' ' 3' ' ' PHE . 16.7 tt -129.44 143.6 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.015 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -113.67 132.1 55.91 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.488 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.0 mt -138.09 146.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 124.263 0.977 . . . . 0.0 108.753 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -88.41 169.08 12.1 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 91.4 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 116.099 -1.905 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 stop_ save_